<?xml version="1.0" encoding="UTF-8"?><DescriptorRecordSet><DescriptorRecord>
<DescriptorUI>D054880</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A recessively inherited, progressive lysosomal storage disease caused by a deficiency of GLYCOSYLASPARAGINASE activity. The lack of this enzyme activity results in the accumulation of N-acetylglucosaminylasparagine (the linkage unit of asparagine-linked glycoproteins) in LYSOSOMES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aspartylglucosaminuria</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspartylglycosaminuria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054882</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Antley-Bixler Syndrome phenotype with normal genitalia and normal steroidogenesis, and associated with autosomal dominant mutations in FGFR2,  the gene for FIBROBLAST GROWTH FACTOR RECEPTOR 2.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antley-Bixler Syndrome Phenotype</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Antley-Bixler Syndrome phenotype with normal genitalia and normal steroidogenesis, and associated with autosomal dominant mutations in FGFR2,  the gene for FIBROBLAST GROWTH FACTOR RECEPTOR 2.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>POR Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antley-Bixler Syndrome with Disordered Steroidogenesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Antley-Bixler Syndrome phenotype with normal genitalia and normal steroidogenesis, and associated with autosomal dominant mutations in FGFR2,  the gene for FIBROBLAST GROWTH FACTOR RECEPTOR 2.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antley-Bixler Syndrome, Autosomal Dominant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multisynostotic Osteodysgenesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054909</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of primitive invertebrate animals that exemplify a simple body organization. Trichoplax adhaerens is considered a key species for early metazoan evolution.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Placozoa</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A phylum of primitive invertebrate animals that exemplify a simple body organization. Trichoplax adhaerens is considered a key species for early metazoan evolution.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trichoplax</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054969</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Disorders of the AUTONOMIC NERVOUS SYSTEM occurring as a primary condition. Manifestations can involve any or all body systems but commonly affect the BLOOD PRESSURE and HEART RATE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Primary Dysautonomias</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dysautonomia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054970</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A degenerative disease of the AUTONOMIC NERVOUS SYSTEM that is characterized by idiopathic ORTHOSTATIC HYPOTENSION and a greatly reduced level of CATECHOLAMINES. No other neurological deficits are present.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pure Autonomic Failure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bradbury-Eggleston Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054971</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Symptoms of cerebral hypoperfusion or autonomic overaction which develop while the subject is standing, but are relieved on recumbency. Types of this include NEUROCARDIOGENIC SYNCOPE; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; and neurogenic ORTHOSTATIC HYPOTENSION. (From Noseworthy, JH., Neurological Therapeutics Principles and Practice, 2007, p2575-2576)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Orthostatic Intolerance</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054972</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A syndrome of ORTHOSTATIC INTOLERANCE combined with excessive upright TACHYCARDIA, and usually without associated ORTHOSTATIC HYPOTENSION. All variants have in common an excessively reduced venous return to the heart (central HYPOVOLEMIA) while upright.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Postural Orthostatic Tachycardia Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Postural Tachycardia Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054973</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>PEComas of the falciform ligament / ligamentum teres.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Perivascular Epithelioid Cell Neoplasms</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PEComas</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Perivascular Epithelioid Cell Tumors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neoplasms, Perivascular Epithelioid Cell</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>PEComas of the falciform ligament / ligamentum teres.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clear-Cell Sugar Tumors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>PEComas of the falciform ligament / ligamentum teres.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clear-Cell Myomelanocytic Tumors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CCMMT</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054974</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>STRIATED MUSCLE cell components which anchor the MYOFIBRILS from the Z-bands to the SARCOLEMMA and EXTRACELLULAR MATRIX. Costameric proteins include the proteins of FOCAL ADHESIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Costameres</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Costamere</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054975</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A pleiotropic disorder of human development that comprises hypothalamic HAMARTOMA; central and postaxial POLYDACTYLY; bifid EPIGLOTTIS; ANAL ATRESIA; and renal and other abnormalities. This disorder is associated with FRAMESHIFT MUTATIONS in the GLI3 gene which encodes the GLI3 protein, a KRUPPEL-LIKE TRANSCRIPTION FACTORS family member.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pallister-Hall Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hypothalamic Hamartoblastoma, Hypopituitarism, Imperforate Anus, and Postaxial Polydactyly</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054976</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A framework through which the United Kingdom's National Health Service organizations are accountable for continually improving the quality of their services and safeguarding high standards of care by creating an environment in which excellence in clinical care will flourish.  (Scally and Donaldson, BMJ (4 July 1998): 61-65)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clinical Governance</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054988</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of interstitial lung diseases with no known etiology. There are several entities with varying patterns of inflammation and fibrosis. They are classified by their distinct clinical-radiological-pathological features and prognosis. They include IDIOPATHIC PULMONARY FIBROSIS; CRYPTOGENIC ORGANIZING PNEUMONIA; and others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Idiopathic Interstitial Pneumonias</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Idiopathic Interstitial Pneumonia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054989</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A chronic, acquired, idiopathic, progressive eruption of the skin that occurs in the context of RENAL FAILURE. It is sometimes accompanied by systemic fibrosis. The pathogenesis seems to be multifactorial, with postulated involvement of circulating fibrocytes. There is a strong association between this disorder and the use of gadolinium-based contrast agents.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nephrogenic Fibrosing Dermopathy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nephrogenic Systemic Fibrosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054990</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A common interstitial lung disease of unknown etiology, usually occurring between 50-70 years of age. Clinically, it is characterized by an insidious onset of breathlessness with exertion and a nonproductive cough, leading to progressive DYSPNEA. Pathological features show scant interstitial inflammation, patchy collagen fibrosis, prominent fibroblast proliferation foci, and microscopic honeycomb change.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Idiopathic Pulmonary Fibrosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cryptogenic Fibrosing Alveolitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Usual Interstitial Pneumonia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054991</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Bacterial vaccines prepared from non-pathogenic, autologous bacteria of human origin. In Eastern Europe they are used in humans to treat chronic inflammatory disorders that are resistant to standard treatments. Worldwide they have veterinary use in all types of infectious disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Autovaccines</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Autogenous Vaccines</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D054992</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The interfaces between T-CELLS and ANTIGEN-PRESENTING CELLS. Supramolecular organization of proteins takes place at these synapses involving various types of immune cells. Immunological synapses can have several functions including LYMPHOCYTE ACTIVATION; enhancing, balancing, or terminating signaling; or directing cytokine secretion.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immunological Synapses</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Synapses, Immunological</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055008</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A diffuse parenchymal lung disease caused by accumulation of inhaled CARBON or coal dust. The disease can progress from asymptomatic anthracosis to massive lung fibrosis. This lung lesion usually occurs in coal miners, but can be seen in urban dwellers and tobacco smokers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anthracosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Coal Worker's Pneumoconiosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pneumoconiosis, Coal Worker's</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Black Lung</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Coal Miner's Lung</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Black Lung Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Coalworker's Pneumoconiosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055009</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of spondylosis involving the INTERVERTEBRAL DISK, including both the annulus and the nucleus of the disk. It is usually the consequence of normal aging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spondylosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A form of spondylosis involving the INTERVERTEBRAL DISK, including both the annulus and the nucleus of the disk. It is usually the consequence of normal aging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thoracic Spondylosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A form of spondylosis involving the INTERVERTEBRAL DISK, including both the annulus and the nucleus of the disk. It is usually the consequence of normal aging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spondylosis Deformans</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A form of spondylosis involving the INTERVERTEBRAL DISK, including both the annulus and the nucleus of the disk. It is usually the consequence of normal aging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cervical Spondylosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A form of spondylosis involving the INTERVERTEBRAL DISK, including both the annulus and the nucleus of the disk. It is usually the consequence of normal aging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lumbarsacral Spondylosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055010</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A pathological condition that is characterized by a host of cranial symptoms, such as headaches, abnormal functions of the eyes and the ears, and psychological and mental disorders. This syndrome usually appears after neck injuries, inflammation, or neoplasm.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Posterior Cervical Sympathetic Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Syndrome of Barre-Lieou</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Barre-Lieou Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055011</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Removal of tissue by vaporization, abrasion, or destruction. Methods used include heating tissue by hot liquids or microwave thermal heating, freezing (CRYOABLATION), chemical ablation, and photoablation with LASERS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ablation Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055012</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cell to cell variation in gene expression caused by chromosomal position effects.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromosomal Position Effects</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chromosomal Position Effect</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell to cell variation in gene expression caused by chromosomal position effects.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Position Effect Variegation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055013</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A degenerative joint disease involving the SPINE. It is characterized by progressive deterioration of the spinal articular cartilage (CARTILAGE, ARTICULAR), usually with hardening of the subchondral bone and outgrowth of bone spurs (OSTEOPHYTE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Osteoarthritis, Spine</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal Osteoarthritis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spine Osteoarthritis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A degenerative joint disease involving the SPINE. It is characterized by progressive deterioration of the spinal articular cartilage (CARTILAGE, ARTICULAR), usually with hardening of the subchondral bone and outgrowth of bone spurs (OSTEOPHYTE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lumbar Osteoarthritis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteoarthritis, Lumbar</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055014</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The parent cells that give rise to both cells of the GRANULOCYTE lineage and cells of the monocyte/macrophage lineage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Granulocyte-Macrophage Progenitor Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Granulocyte-Macrophage Progenitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Progenitor Cells, Granulocyte-Macrophage</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Granulocyte-Macrophage Progenitor Cell</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The parent cells that give rise to both cells of the GRANULOCYTE lineage and cells of the monocyte/macrophage lineage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Granulocyte-Macrophage Colony Forming Units</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GM-CFU</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CFU-GM</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055015</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The parent cells that give rise to both cells of the MEGAKARYOCYTE and the ERYTHROCYTE lineages.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Megakaryocyte-Erythroid Progenitor Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Megakaryocyte-Erythroid Progenitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Megakaryocyte-Erythrocyte Progenitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055016</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The parent cells that give rise to cells in the MEGAKARYOCYTE lineage, and ultimately BLOOD PLATELETS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Megakaryocyte Progenitor Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Megakaryocyte Progenitor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Megakaryocyte Progenitors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The parent cells that give rise to cells in the MEGAKARYOCYTE lineage, and ultimately BLOOD PLATELETS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Promegakaryocytes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The parent cells that give rise to cells in the MEGAKARYOCYTE lineage, and ultimately BLOOD PLATELETS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Megakaryoblasts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Megakaryoblast</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055017</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Parent cells in the lineage that gives rise to MONOCYTES and MACROPHAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Monocyte-Macrophage Precursor Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Parent cells in the lineage that gives rise to MONOCYTES and MACROPHAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Promonocytes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Promonocyte</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Parent cells in the lineage that gives rise to MONOCYTES and MACROPHAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Monoblasts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Monoblast</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Parent cells in the lineage that gives rise to MONOCYTES and MACROPHAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Monocyte-Macrophage Progenitor Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055018</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Blood forming cells of the ENDOTHELIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hemangioblasts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hemangioblast</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Blood forming cells of the ENDOTHELIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hemogenic Endothelial Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hemogenic Endothelium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055028</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A method for comparing two sets of chromosomal DNA by analyzing differences in the copy number and location of specific sequences. It is used to look for large sequence changes such as deletions, duplications, amplifications, or translocations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Comparative Genomic Hybridization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Comparative Genome Hybridization</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A method for comparing two sets of chromosomal DNA by analyzing differences in the copy number and location of specific sequences. It is used to look for large sequence changes such as deletions, duplications, amplifications, or translocations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Array-Based Comparative Genomic Hybridization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Array Comparative Genomic Hybridization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055029</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Copies of nucleic acid sequence that are arranged in opposing orientation. They may lie adjacent to each other (tandem) or be separated by some sequence that is not part of the repeat (hyphenated). They may be true palindromic repeats, i.e. read the same backwards as forward, or  complementary which reads as the base complement in the opposite orientation. Complementary inverted repeats have the potential to form hairpin loop or stem-loop structures which results in cruciform structures (such as CRUCIFORM DNA) when the complementary inverted repeats occur in double stranded regions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inverted Repeat Sequences</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inverted Repeat Sequence</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Copies of nucleic acid sequence that are arranged in opposing orientation. They may lie adjacent to each other (tandem) or be separated by some sequence that is not part of the repeat (hyphenated). They may be true palindromic repeats, i.e. read the same backwards as forward, or  complementary which reads as the base complement in the opposite orientation. Complementary inverted repeats have the potential to form hairpin loop or stem-loop structures which results in cruciform structures (such as CRUCIFORM DNA) when the complementary inverted repeats occur in double stranded regions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inverted Tandem Repeats</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Copies of nucleic acid sequence that are arranged in opposing orientation. They may lie adjacent to each other (tandem) or be separated by some sequence that is not part of the repeat (hyphenated). They may be true palindromic repeats, i.e. read the same backwards as forward, or  complementary which reads as the base complement in the opposite orientation. Complementary inverted repeats have the potential to form hairpin loop or stem-loop structures which results in cruciform structures (such as CRUCIFORM DNA) when the complementary inverted repeats occur in double stranded regions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stem-Loop Sequence</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Copies of nucleic acid sequence that are arranged in opposing orientation. They may lie adjacent to each other (tandem) or be separated by some sequence that is not part of the repeat (hyphenated). They may be true palindromic repeats, i.e. read the same backwards as forward, or  complementary which reads as the base complement in the opposite orientation. Complementary inverted repeats have the potential to form hairpin loop or stem-loop structures which results in cruciform structures (such as CRUCIFORM DNA) when the complementary inverted repeats occur in double stranded regions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hairpin Loop Sequence</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Copies of nucleic acid sequence that are arranged in opposing orientation. They may lie adjacent to each other (tandem) or be separated by some sequence that is not part of the repeat (hyphenated). They may be true palindromic repeats, i.e. read the same backwards as forward, or  complementary which reads as the base complement in the opposite orientation. Complementary inverted repeats have the potential to form hairpin loop or stem-loop structures which results in cruciform structures (such as CRUCIFORM DNA) when the complementary inverted repeats occur in double stranded regions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Palindromic Repeat Sequences</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sequence Palindromes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055030</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>People who take drugs for a non-therapeutic or non-medical effect. The drugs may be legal or illegal, but their use often results in adverse medical, legal, or social consequences for the users.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Users</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Drug Abusers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>People who take drugs for a non-therapeutic or non-medical effect. The drugs may be legal or illegal, but their use often results in adverse medical, legal, or social consequences for the users.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Addicts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055031</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of ischemia-reperfusion injury occurring in the early period following transplantation. Significant pathophysiological changes in MITOCHONDRIA are the main cause of the dysfunction. It is most often seen in the transplanted lung, liver, or kidney and can lead to GRAFT REJECTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Primary Graft Dysfunction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055032</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A tomographic technique for obtaining 3-dimensional images with transmission electron microscopy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electron Microscope Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tomography, Electron Microscope</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>EM Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tomography, Electron</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electron Microtomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electron Tomography</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A tomographic technique for obtaining 3-dimensional images with transmission electron microscopy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transmission Electron Microscopy Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transmission Electron Microtomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TEM Tomography</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A tomographic technique for obtaining 3-dimensional images with transmission electron microscopy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>STEM Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Scanning Transmission Electron Microscopy Tomography</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055034</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Any of a group of bone disorders involving one or more ossification centers (EPIPHYSES). It is characterized by degeneration or NECROSIS followed by revascularization and reossification. Osteochondrosis often occurs in children causing varying degrees of discomfort or pain. There are many eponymic types for specific affected areas, such as tarsal navicular (Kohler disease) and tibial tuberosity (Osgood-Schlatter disease).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Osteochondrosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Any of a group of bone disorders involving one or more ossification centers (EPIPHYSES). It is characterized by degeneration or NECROSIS followed by revascularization and reossification. Osteochondrosis often occurs in children causing varying degrees of discomfort or pain. There are many eponymic types for specific affected areas, such as tarsal navicular (Kohler disease) and tibial tuberosity (Osgood-Schlatter disease).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Osgood-Schlatter Disease</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Any of a group of bone disorders involving one or more ossification centers (EPIPHYSES). It is characterized by degeneration or NECROSIS followed by revascularization and reossification. Osteochondrosis often occurs in children causing varying degrees of discomfort or pain. There are many eponymic types for specific affected areas, such as tarsal navicular (Kohler disease) and tibial tuberosity (Osgood-Schlatter disease).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Koehler Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Navicular Osteochondrosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Koehler's Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055035</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A bone disorder involving ossification centers (EPIPHYSES) of the VERTEBRAL COLUMN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spinal Osteochondrosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteochondrosis of Spine</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055036</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rarer variant of campomelic dysplasia. The characteristics match campomelic dysplasia except that long bone curvature is not present (acampomelia).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Campomelic Dysplasia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Camptomelic Dysplasia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A rarer variant of campomelic dysplasia. The characteristics match campomelic dysplasia except that long bone curvature is not present (acampomelia).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acampomelic Campomelic Dysplasia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055048</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The discipline concerned with using the combination of conventional (allopathic) medicine and ALTERNATIVE MEDICINE to address the biological, psychological, social, and spiritual aspects of health and illness.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Integrative Medicine</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055049</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ability of organisms to sense and adapt to high concentrations of salt in their growth environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salt-Tolerance</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Saline-Tolerance</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The ability of organisms to sense and adapt to high concentrations of salt in their growth environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salt-Adaption</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055050</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A diet which is devoid of GLUTENS from WHEAT; BARLEY; RYE; and other wheat-related varieties. The diet is designed to reduce exposure to those proteins in gluten that trigger INFLAMMATION of the small intestinal mucosa in patients with CELIAC DISEASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diet, Gluten-Free</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gluten-Free Diet</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055051</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Plants that have adapted to or require a high concentration of salt.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salt-Tolerant Plants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Saline-Resistant Plants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Salt-Resistant Plants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Saline-Tolerant Plants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plants, Salt-Tolerant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Plants that have adapted to or require a high concentration of salt.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Halophytes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Halophilic Plants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Halophytic Plants</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Plants that have adapted to or require a high concentration of salt.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salt-Adapted Plants</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055052</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Adhesive tape with the mechanical strength to resist stretching. It is applied to the skin to support, stabilize, and restrict movement to aid healing and/or prevent injuries of MUSCULOSKELETAL SYSTEM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Athletic Tape</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orthotic Tape</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055053</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Non-ionizing electromagnetic energy in the frequency range of 100 gigahertz to 10 terahertz which spans from the mid-INFRARED RAYS frequency to the high-frequency edge of the MICROWAVES band.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Terahertz Radiation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>THz Radiation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>T-Rays</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055068</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Spectrum analysis of absorbed or emitted TERAHERTZ RADIATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Terahertz Spectroscopy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055069</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The visualization of internal structure using TERAHERTZ RADIATION technologies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Terahertz Imaging</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055070</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of strength-building exercise program that requires the body muscle to exert a force against some form of resistance, such as weight, stretch bands, water, or immovable objects. Resistance exercise is a combination of static and dynamic contractions involving shortening and lengthening of skeletal muscles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Resistance Training</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Strength Training</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of strength-building exercise program that requires the body muscle to exert a force against some form of resistance, such as weight, stretch bands, water, or immovable objects. Resistance exercise is a combination of static and dynamic contractions involving shortening and lengthening of skeletal muscles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weight-Lifting Strengthening Program</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Weight-Lifting Exercise Program</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of strength-building exercise program that requires the body muscle to exert a force against some form of resistance, such as weight, stretch bands, water, or immovable objects. Resistance exercise is a combination of static and dynamic contractions involving shortening and lengthening of skeletal muscles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weight-Bearing Strengthening Program</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Weight-Bearing Exercise Program</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055088</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Procedures performed on people to identify those who have NEOPLASMS or PRENEOPLASTIC CONDITIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Early Detection of Cancer</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Procedures performed on people to identify those who have NEOPLASMS or PRENEOPLASTIC CONDITIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cancer Screening</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Procedures performed on people to identify those who have NEOPLASMS or PRENEOPLASTIC CONDITIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cancer Screening Tests</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Procedures performed on people to identify those who have NEOPLASMS or PRENEOPLASTIC CONDITIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Early Diagnosis of Cancer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055089</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A congenital or acquired condition of underdeveloped or degeneration of CARTILAGE in the TRACHEA and the BRONCHI. This results in a floppy non-rigid airway making patency difficult to maintain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tracheobronchomalacia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chondromalacia of Trachea and Bronchi</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055090</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A congenital or acquired condition of underdeveloped or degeneration of CARTILAGE in the TRACHEA. This results in a floppy tracheal wall making patency difficult to maintain. It is characterized by wheezing and difficult breathing.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tracheomalacia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chondromalacia of Trachea</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055091</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A congenital or acquired condition of underdeveloped or degeneration of CARTILAGE in the BRONCHI. This results in a floppy bronchial wall making patency difficult to maintain. It is characterized by wheezing and difficult breathing.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bronchomalacia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chondromalacia of Bronchi</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055092</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A congenital or acquired condition of underdeveloped or degeneration of CARTILAGE in the LARYNX. This results in a floppy laryngeal wall making patency difficult to maintain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laryngomalacia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chondromalacia of Larynx</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055093</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Degradation or wasting of the PERIODONTIUM tissues that may involve the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, or the PERIODONTAL LIGAMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Periodontal Atrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Atrophy of Periodontium</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Degradation or wasting of the PERIODONTIUM tissues that may involve the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, or the PERIODONTAL LIGAMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gingivo-Osseous Atrophy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055094</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An approach or process of practicing oral health care that requires the judicious integration of systematic assessments of clinical relevant scientific evidence, relating to the patient's oral and medical condition and history, with the dentist's clinical expertise and the patient's treatment needs and preferences. (from J Am Dent Assoc 134: 689, 2003)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Evidence-Based Dentistry</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dentistry, Evidence-Based</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055095</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specialized field of physics and engineering involved in studying the behavior and properties of light and the technology of analyzing, generating, transmitting, and manipulating ELECTROMAGNETIC RADIATION in the visible, infrared, and ultraviolet range.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optics and Photonics</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specialized field of physics and engineering involved in studying the behavior and properties of light and the technology of analyzing, generating, transmitting, and manipulating ELECTROMAGNETIC RADIATION in the visible, infrared, and ultraviolet range.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photonics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055096</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific collection of optical components configured to detect, analyze, or manipulate light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optical Devices</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Components</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific collection of optical components configured to detect, analyze, or manipulate light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optical System</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055097</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Treatment of pain, drug addictions, or other ailments by stimulating the various points on the external ear (EAR AURICLES). It is based on the ancient Chinese practices of EAR ACUPUNCTURE, but sometimes magnets and other modes of stimulation are used.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Auriculotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055098</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Secretory cells of the ductless glands. They secrete HORMONES directly into the blood circulation (internal secretion) to be carried to the target cells. The secreted chemicals can be PEPTIDES; STEROIDS; NEUROPEPTIDES; or BIOGENIC AMINES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endocrine Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055099</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specialized NEURONS that produce hormones, such as NEUROPEPTIDES or BIOGENIC AMINES. They generally are in the NERVOUS SYSTEM, such as HYPOTHALAMUS, but can be found in other organs or systems. These neurons contain dense neurosecretory granules and PROPROTEIN CONVERTASES allowing the rapidly release of NEUROHORMONES into the blood circulation upon stimulation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neuroendocrine Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endocrine Neurons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055100</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Thin strands of transparent material, usually glass, that are used for transmitting light waves over long distances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optical Fibers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fiber Optic Cables</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055101</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Measurable parameters of semen related to male fertility (e.g., SPERM COUNT; SPERM MOTILITY, volume, concentration, morphology, and viability).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Semen Analysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Semen Quality Analysis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Measurable parameters of semen related to male fertility (e.g., SPERM COUNT; SPERM MOTILITY, volume, concentration, morphology, and viability).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Semen Quality</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055103</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Technique for treating DEHYDRATION and WATER-ELECTROLYTE IMBALANCE by subcutaneous infusion of REHYDRATION SOLUTIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hypodermoclysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Subcutaneous Hydration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Subcutaneous Fluid Administration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055104</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The administration of liquid medication or nutrients under the skin, usually over minutes or hours.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infusions, Subcutaneous</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Subcutaneous Infusions</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055105</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The measurement around the body at the level of the ABDOMEN and just above the hip bone. The measurement is usually taken immediately after exhalation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Waist Circumference</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055106</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An analysis comparing the allele frequencies of all available (or a whole GENOME representative set of) polymorphic markers in unrelated patients with a specific symptom or disease condition, and those of healthy controls to identify markers associated with a specific disease or condition.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genome-Wide Association Study</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genome Wide Association Scan</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genome Wide Association Studies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GWA Study</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Whole Genome Association Analysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Whole Genome Association Study</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genome Wide Association Analysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genome Wide Association Study</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055107</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An induced skin pigment (MELANIN) darkening after exposure to SUNLIGHT or ULTRAVIOLET RAYS. The degree of tanning depends on the intensity and duration of UV exposure, and genetic factors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Suntan</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055108</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Exposing oneself to SUNLIGHT or ULTRAVIOLET RAYS for the purpose of getting a SUNTAN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sunbathing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Exposing oneself to SUNLIGHT or ULTRAVIOLET RAYS for the purpose of getting a SUNTAN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Suntanning</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055109</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An alternative to the ankle-brachial index.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ankle Brachial Index</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ankle-Brachial Index</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An alternative to the ankle-brachial index.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Toe Brachial Index</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Toe-Brachial Index</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055110</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques used to determine the age of materials, based on the content and half-lives of the RADIOACTIVE ISOTOPES they contain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radiometric Dating</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques used to determine the age of materials, based on the content and half-lives of the RADIOACTIVE ISOTOPES they contain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radiocarbon Dating</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Radio-Carbon Dating</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carbon Dating</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055111</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A condition of persistent pain and discomfort in the BACK and the LEG following lumbar surgery, often seen in patients enrolled in pain centers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Failed Back Surgery Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055112</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An accumulation of PUS in the uterine cavity (UTERUS). Pyometra generally indicates the presence of infections.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pyometra</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055113</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chronic inflammation and loss of PERIODONTIUM that is associated with the amount of DENTAL PLAQUE or DENTAL CALCULUS present. Chronic periodontitis occurs mostly in adults and was called adult periodontitis, but this disease can appear in young people.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chronic Periodontitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adult Periodontitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055114</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>X-RAY COMPUTERIZED TOMOGRAPHY with resolution in the micrometer range.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>X-Ray Microtomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MicroCT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Ray Micro-CAT Scans</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Ray Micro-Computed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Xray MicroCT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Ray Micro-CT Scans</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Ray Microcomputed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-ray MicroCT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Xray Micro-CT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microcomputed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Ray Micro-CT</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055115</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The hardening or polymerization of bonding agents (DENTAL CEMENTS) via exposure to light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Light-Curing of Dental Adhesives</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Light-Curing of Dental Resins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Bonding, Light-Cured</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Light-Curing of Dental Cements</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055116</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The hardening or polymerization of bonding agents (DENTAL CEMENTS) via chemical reactions, usually involving two components. This type of dental bonding uses a self-cure or dual-cure system.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Self-Curing of Dental Resins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Bonding, Chemically-Cured</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Bonding, Self-Cured</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chemical-Curing of Dental Adhesives</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The hardening or polymerization of bonding agents (DENTAL CEMENTS) via chemical reactions, usually involving two components. This type of dental bonding uses a self-cure or dual-cure system.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dual-Curing of Resin Cements</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Bonding, Dual-Cure</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055117</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Light sources used to activate polymerization of light-cured DENTAL CEMENTS and DENTAL RESINS. Degree of cure and bond strength depends on exposure time, wavelength, and intensity of the curing light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Curing Lights, Dental</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Curing Lights</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Light sources used to activate polymerization of light-cured DENTAL CEMENTS and DENTAL RESINS. Degree of cure and bond strength depends on exposure time, wavelength, and intensity of the curing light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plasma Arc Dental Curing Lights</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Light sources used to activate polymerization of light-cured DENTAL CEMENTS and DENTAL RESINS. Degree of cure and bond strength depends on exposure time, wavelength, and intensity of the curing light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Halogen Dental Curing Lights</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Light sources used to activate polymerization of light-cured DENTAL CEMENTS and DENTAL RESINS. Degree of cure and bond strength depends on exposure time, wavelength, and intensity of the curing light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>LED Dental Curing Lights</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055118</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The duration of time from initiation to discontinuation of drug therapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medication Adherence</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medication Compliance</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The duration of time from initiation to discontinuation of drug therapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medication Nonadherence</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medication Non-Compliance</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medication Noncompliance</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medication Non-Adherence</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The duration of time from initiation to discontinuation of drug therapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medication Persistence</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055119</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Numerical expression indicating the measure of stiffness in a material. It is defined by the ratio of stress in a unit area of substance to the resulting deformation (strain). This allows the behavior of a material under load (such as bone) to be calculated.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Elastic Modulus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Young's Modulus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Modulus of Elasticity</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Young Modulus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055133</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of flagellated fungi, formerly the order Blastocladiales under CHYTRIDIOMYCOTA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blastocladiomycota</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A phylum of flagellated fungi, formerly the order Blastocladiales under CHYTRIDIOMYCOTA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blastocladiales</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055134</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of aquatic fungi in the phylum BLASTOCLADIOMYCOTA. It is abundant in warmer climates and exhibits true alternation of generations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Allomyces</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055135</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of fungi in the phylum BLASTOCLADIOMYCOTA. They exhibit complex life cycles and are parasitic on the larvae of MOSQUITOES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coelomomyces</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055136</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of anaerobic fungi found in the stomachs of RUMINANTS. These fungi lack mitochondria and reproduce through zoospores.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neocallimastigomycota</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055137</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of fungi that are mutualistic symbionts and form ARBUSCULAR MYCORRHIZAE with PLANT ROOTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glomeromycota</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055139</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ability of the BRAIN to suppress neuronal responses to external sensory inputs, such as auditory and visual stimuli. Sensory filtering (or gating) allows humans to block out irrelevant, meaningless, or redundant stimuli.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sensory Gating</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sensory Filtering</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The ability of the BRAIN to suppress neuronal responses to external sensory inputs, such as auditory and visual stimuli. Sensory filtering (or gating) allows humans to block out irrelevant, meaningless, or redundant stimuli.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sensorimotor Gating</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The ability of the BRAIN to suppress neuronal responses to external sensory inputs, such as auditory and visual stimuli. Sensory filtering (or gating) allows humans to block out irrelevant, meaningless, or redundant stimuli.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acoustic Startle Gating</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Startle Gating</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055153</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A particular zone of tissue composed of a specialized microenvironment where stem cells are retained in a undifferentiated, self-renewable state.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stem Cell Niche</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stem Cell Microenvironment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055154</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Difficulty and/or pain in PHONATION or speaking.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dysphonia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phonation Disorders</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Difficulty and/or pain in PHONATION or speaking.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spastic Dysphonia, Neurologic Adducter</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neurologic Adducter Spastic Dysphonia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Difficulty and/or pain in PHONATION or speaking.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spastic Dysphonia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Difficulty and/or pain in PHONATION or speaking.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hyperkinetic Dysphonia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Difficulty and/or pain in PHONATION or speaking.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Tremor Dysphonia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055155</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of fungi in the phylum ASCOMYCOTA that are important plant pathogens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ophiostomatales</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055156</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of fungi in the family Ophiostomataceae, order OPHIOSTOMATALES. Several species are the source of Dutch elm disease, which is spread by the elm bark beetle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ophiostoma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055157</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous yeast in the family Dipodascaceae, order SACCHAROMYCETALES. It is characterized by asci which have persistent walls and by smooth-walled ascospores. Anamorphs are in the genus GEOTRICHUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dipodascus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055158</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of muscles attached to the SOFT PALATE (or velum) and the PHARYNX. They include the superior constrictor, the PALATOPHARYNGEUS, the levator veli palatini muscle, and the muscularis uvulae. This sphincter is situated between the oral and nasal cavities. A competent velopharyngeal sphincter is essential for normal speech and swallowing.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Velopharyngeal Sphincter</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Palatopharyngeal Sphincter</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055159</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous yeast in the family Endomycetaceae, order SACCHAROMYCETALES. They have been described as ascus-bearing parasites of basidiocarps, the fruiting bodies of BASIDIOMYCOTA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endomyces</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055160</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous soil yeast in the family Lipomycetaceae, order SACCHAROMYCETALES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lipomyces</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055161</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of CAVES, mines, or other subterranean environments in treatment of diseases. Speleotherapy is used in some Central and Eastern European countries to treat CHRONIC OBSTRUCTIVE AIRWAY DISEASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Speleotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055162</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The facilitation of biochemical reactions with the aid of naturally occurring catalysts such as ENZYMES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biocatalysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055163</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous yeast in the family Metschnikowiaceae, order SACCHAROMYCETALES. Its antifungal activity is used to inhibit postharvest decay of fruit.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metschnikowia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055164</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Procedures that stimulate nerve elongation over a period of time. They are used in repairing nerve tissue.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nerve Expansion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nerve Stretching</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nerve Elongation Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nerve Lengthening</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055165</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. Debaryomyces hansenni is a salt-tolerant marine species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Debaromyces</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. Debaryomyces hansenni is a salt-tolerant marine species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Debaromyces hansenii</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055166</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hepatic stellate cells that have differentiated into myofibroblast-like cells in response to liver injury.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hepatic Stellate Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hepatic stellate cells that have differentiated into myofibroblast-like cells in response to liver injury.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ito Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055167</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. It has been implicated in wine spoilage. Anamorphic forms are found in the genus BRETTANOMYCES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dekkera</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055168</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The anamorphic form of the yeast DEKKERA. It is implicated as a spoilage microorganism in wines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brettanomyces</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055169</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. Species in the genus are plant pathogens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eremothecium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055170</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The formation of a nitrogen-fixing cell mass on PLANT ROOTS following symbiotic infection by nitrogen-fixing bacteria such as RHIZOBIUM or FRANKIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Root Nodulation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nodulation, Plant Root</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055171</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hyaline cartilages in the nose. There are five major nasal cartilages including two lateral, two alar, and one septal.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nasal Cartilages</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hyaline cartilages in the nose. There are five major nasal cartilages including two lateral, two alar, and one septal.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lateral Nasal Cartilages</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hyaline cartilages in the nose. There are five major nasal cartilages including two lateral, two alar, and one septal.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Septal Nasal Cartilage</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hyaline cartilages in the nose. There are five major nasal cartilages including two lateral, two alar, and one septal.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alar Nasal Cartilages</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055172</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An unpaired thin ploughshare-shaped facial bone. It is situated in the median plane of the SKULL. The vomer forms the posterior and inferior border of the NASAL SEPTUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vomer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055191</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Abnormally slow pace of regaining CONSCIOUSNESS after general anesthesia (ANESTHESIA, GENERAL) usually given during surgical procedures. This condition is characterized by persistent somnolence.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Delayed Emergence from Anesthesia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Delayed Awakening, Post-Anesthesia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Delayed Return of Consciousness</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Delayed Recovery from Anesthesia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Delayed Regaining of Consciousness</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Delayed Awakening from Anesthesia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Delayed Awakening, Post-Procedural</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055211</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The inner portion of a retinal rod or a cone photoreceptor cell, situated between the PHOTORECEPTOR CONNECTING CILIUM and the synapse with the adjacent neurons (RETINAL BIPOLAR CELLS; RETINAL HORIZONTAL CELLS). The inner segment contains the cell body, the nucleus, the mitochondria, and apparatus for protein synthesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinal Photoreceptor Cell Inner Segment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinal Photoreceptor Inner Segment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinal Inner Segment</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The inner portion of a retinal rod or a cone photoreceptor cell, situated between the PHOTORECEPTOR CONNECTING CILIUM and the synapse with the adjacent neurons (RETINAL BIPOLAR CELLS; RETINAL HORIZONTAL CELLS). The inner segment contains the cell body, the nucleus, the mitochondria, and apparatus for protein synthesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rod Cell Inner Segment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rod Inner Segment</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The inner portion of a retinal rod or a cone photoreceptor cell, situated between the PHOTORECEPTOR CONNECTING CILIUM and the synapse with the adjacent neurons (RETINAL BIPOLAR CELLS; RETINAL HORIZONTAL CELLS). The inner segment contains the cell body, the nucleus, the mitochondria, and apparatus for protein synthesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cone Cell Inner Segment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cone Inner Segment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055212</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The bridge between the inner and the outer segments of a retinal rod or a cone photoreceptor cell. Through it, proteins synthesized in the inner segment are transported to the outer segment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photoreceptor Connecting Cilium</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Connecting Cilium of Photoreceptor Cell</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Photoreceptor Connecting Cilia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Connecting Cilium of Photoreceptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Photoreceptor Cell Connecting Cilium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055213</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The single layer of pigment-containing epithelial cells in the RETINA, situated closely to the tips (outer segments) of the RETINAL PHOTORECEPTOR CELLS. These epithelial cells perform essential functions for the photoreceptor cells, such as in nutrient transport, phagocytosis of the shed photoreceptor membranes, and ensuring retinal attachment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinal Pigment Epithelium</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Epithelium, Retinal Pigment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055214</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The light sensitive outer portion of a retinal rod or a cone photoreceptor cell. The outer segment contains a stack of disk membranes laden with photoreceptive pigments (RETINAL PIGMENTS). The outer segment is connected to the inner segment by a PHOTORECEPTOR CONNECTING CILIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinal Photoreceptor Cell Outer Segment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinal Photoreceptor Outer Segment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinal Outer Segment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055231</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of LINCOMYCIN-related glycosides that contain a pyrrolidine ring linked via an amide-bond to a pyranose moiety. Individual members of this family are defined by the arrangement of specific constituent groups on the lyncomycin molecule. Many lincosamides are ANTIBIOTICS produced by a variety STREPTOMYCES species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lincosamides</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055232</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Protein domains that are enriched in PROLINE. The cyclical nature of proline causes the peptide bonds it forms to have a limited degree of conformational mobility. Therefore the presence of multiple prolines in close proximity to each other can convey a distinct conformational arrangement to a peptide chain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proline-Rich Protein Domains</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Protein domains that are enriched in PROLINE. The cyclical nature of proline causes the peptide bonds it forms to have a limited degree of conformational mobility. Therefore the presence of multiple prolines in close proximity to each other can convey a distinct conformational arrangement to a peptide chain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proline-Rich Peptide Domains</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055233</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cornified Envelope Proline-Rich Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Proline-Rich Cornified Envelope Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pancornulins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 1A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cornifin-A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Proline-Rich Protein IA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>19 kDa Pancornulin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 1B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cornifin-B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Proline-Rich Protein IB</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>14.9 kDa Pancornulin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 2A</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 4</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 2C</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 2D</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 2E</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 2F</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 2G</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cornifin beta</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Esophagin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>22 kDa Pancornulin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cornifins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of low molcular-weight proteins that contain PROLINE-RICH PROTEIN DOMAINS. Members of this family play a role in the formation of an insoluble cornified envelope beneath the plasma membrane of stratified squamous epithelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Proline-Rich Protein 2B</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055252</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Extracellular membrane vesicles generated by the shedding of CELL MEMBRANES blebs. Microparticles originating from PLATELETS; ENDOTHELIAL CELLS; and other cell types circulate in the peripheral blood and through the MICROVASCULATURE where larger cells cannot, functioning as active effectors in a variety of vascular processes such as INFLAMMATION; HEMOSTASIS; angiogenesis; and vascular reactivity. Increased levels are found following stimulation of bleb formation under normal or pathological conditions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell-Derived Microparticles</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ectosomes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microparticles, Cell-Derived</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Membrane Microparticles</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Extracellular membrane vesicles generated by the shedding of CELL MEMBRANES blebs. Microparticles originating from PLATELETS; ENDOTHELIAL CELLS; and other cell types circulate in the peripheral blood and through the MICROVASCULATURE where larger cells cannot, functioning as active effectors in a variety of vascular processes such as INFLAMMATION; HEMOSTASIS; angiogenesis; and vascular reactivity. Increased levels are found following stimulation of bleb formation under normal or pathological conditions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Circulating Cell-Derived Microparticles</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055253</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Function of the human eye that is used in bright illumination or in daylight (at photopic intensities). Photopic vision is performed by the three types of RETINAL CONE PHOTORECEPTORS with varied peak absorption wavelengths in the color spectrum (from violet to red, 400 - 700 nm).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Color Vision</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Photopic Vision</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Daylight Vision</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055254</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Function of the human eye that is used in dim illumination (scotopic intensities) or at nighttime. Scotopic vision is performed by RETINAL ROD PHOTORECEPTORS with high sensitivity to light and peak absorption wavelength at 507 nm near the blue end of the spectrum.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Night Vision</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Scotopic Vision</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rod Vision</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055255</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The function of the eye that is used in the intermediate level of illumination (mesopic intensities) where both the RETINAL ROD PHOTORECEPTORS and the RETINAL CONE PHOTORECEPTORS are active in processing light input simultaneously.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mesopic Vision</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055256</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The amount time between exposure to an infectious agent and becoming symptomatic.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infectious Disease Incubation Period</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Incubation Period, Infectious Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055257</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A gel-forming mucin that is predominantly expressed by submucosal glands of airway tissues and the SUBLINGUAL GLAND.  It is one of the principal components of high molecular weight salivary mucin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-5B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mucin-5 Subtype B, Tracheobronchial</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>High Molecular Weight Salivary Mucin MG1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055258</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Reciprocal action of two vertebrate photoreceptor cells (RODS AND CONES). Rod-cone interaction occurs during MESOPIC VISION in which both rods and cones are active in light transduction to the VISUAL CORTEX. Such interaction can influence visual sensitivity and luminous efficiency.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rod-Cone Interaction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055260</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>GENETIC PROCESSES involved in establishing immunity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immunogenetic Processes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055261</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>GENETIC PHENOMENA characterizing IMMUNITY and the immune response.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immunogenetic Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immunogenetic Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immunogenetic Phenomenon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055262</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A gel-forming mucin found predominantly in SMALL INTESTINE and variety of mucous membrane-containing organs. It provides a protective, lubricating barrier against particles and infectious agents.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intestinal Mucin-2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055263</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A membrane-bound mucin subtype that is primarily found in INTESTINAL MUCOSA. Two closely-related subtypes of this protein have been identified in humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mucin 3</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A membrane-bound mucin subtype that is primarily found in INTESTINAL MUCOSA. Two closely-related subtypes of this protein have been identified in humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-3B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mucin 3B</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A membrane-bound mucin subtype that is primarily found in INTESTINAL MUCOSA. Two closely-related subtypes of this protein have been identified in humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-3A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mucin 3A</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055264</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A transmembrane mucin that is found in a broad variety of epithelial tissue. Mucin-4 may play a role in regulating cellular adhesion and in cell surface signaling from the ERBB-2 RECEPTOR PROTEIN-TYROSINE KINASE. Mucin-4 is a heterodimer of alpha and beta chains. The alpha and beta chains result from the proteolytic cleavage of a precursor protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-4</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A transmembrane mucin that is found in a broad variety of epithelial tissue. Mucin-4 may play a role in regulating cellular adhesion and in cell surface signaling from the ERBB-2 RECEPTOR PROTEIN-TYROSINE KINASE. Mucin-4 is a heterodimer of alpha and beta chains. The alpha and beta chains result from the proteolytic cleavage of a precursor protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-4 beta Chain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ASGP-2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ascites Sialoglycoprotein 2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A transmembrane mucin that is found in a broad variety of epithelial tissue. Mucin-4 may play a role in regulating cellular adhesion and in cell surface signaling from the ERBB-2 RECEPTOR PROTEIN-TYROSINE KINASE. Mucin-4 is a heterodimer of alpha and beta chains. The alpha and beta chains result from the proteolytic cleavage of a precursor protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-4 alpha chain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ASGP-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ascites Sialoglycoprotein 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055271</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A gel-forming mucin that is primarily found on the surface of gastric epithelium and in the RESPIRATORY TRACT. Mucin 5AC was originally identified as two distinct proteins, however a single gene encodes the protein which gives rise to the mucin 5A and mucin 5C variants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin 5AC</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A gel-forming mucin that is primarily found on the surface of gastric epithelium and in the RESPIRATORY TRACT. Mucin 5AC was originally identified as two distinct proteins, however a single gene encodes the protein which gives rise to the mucin 5A and mucin 5C variants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin 5C</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A gel-forming mucin that is primarily found on the surface of gastric epithelium and in the RESPIRATORY TRACT. Mucin 5AC was originally identified as two distinct proteins, however a single gene encodes the protein which gives rise to the mucin 5A and mucin 5C variants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin 5A</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055272</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A gel-forming mucin that is predominantly associated with the gastric epithelium.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mucin-6</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055273</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of proline-rich proteins that constitute the majority of the protein component of SALIVA. Salivary proline-rich proteins occur as acidic, basic and glycosylated basic proteins. They perform a variety of functions such as adhering to the acquired ENAMEL PELLICLE, acting as lubricants and precipitating TANNINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salivary Proline-Rich Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of proline-rich proteins that constitute the majority of the protein component of SALIVA. Salivary proline-rich proteins occur as acidic, basic and glycosylated basic proteins. They perform a variety of functions such as adhering to the acquired ENAMEL PELLICLE, acting as lubricants and precipitating TANNINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salivary Basic Proline-Rich Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of proline-rich proteins that constitute the majority of the protein component of SALIVA. Salivary proline-rich proteins occur as acidic, basic and glycosylated basic proteins. They perform a variety of functions such as adhering to the acquired ENAMEL PELLICLE, acting as lubricants and precipitating TANNINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salivary Acidic Proline-Rich Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of proline-rich proteins that constitute the majority of the protein component of SALIVA. Salivary proline-rich proteins occur as acidic, basic and glycosylated basic proteins. They perform a variety of functions such as adhering to the acquired ENAMEL PELLICLE, acting as lubricants and precipitating TANNINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salivary Glycosylated-Basic Proline-Rich Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055291</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of alpha-amylase ISOENZYMES that are secreted into SALIVA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salivary alpha-Amylases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055292</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of alpha-amylase ISOENZYMES that are secreted into PANCREATIC JUICE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pancreatic alpha-Amylases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055293</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An extracellular receptor specific for UROKINASE-TYPE PLASMINOGEN ACTIVATOR. It is attached to the cell membrane via a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE and plays a role in the co-localization of urokinase-type plasminogen activator with PLASMINOGEN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Urokinase Plasminogen Activator</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD87 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plasminogen Activator Receptor, Urokinase Type</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plasminogen Activator, Urokinase Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plasminogen Activator, Urokinase Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptor, Urokinase Plasminogen Activator</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>U-PA Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Upar Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urokinase Plasminogen Activator Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urokinase-Type Plasminogen Activator Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD87</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptor, Pro-Urokinase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055312</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cytastin subtype found at high levels in the SKIN and in BLOOD CELLS. Cystatin A incorporates into the cornified cell envelope of stratified squamous epithelial cells and may play a role in bacteriostatic properties of skin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystatin A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stefin A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Epidermal SH-Protease Inhibitor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055313</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An intracellular cystatin subtype that is found in a broad variety of cell types. It is a cytosolic enzyme inhibitor that protects the cell against the proteolytic action of lysosomal enzymes such as CATHEPSINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystatin B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stefin B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Liver Thiol Proteinase Inhibitor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055314</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>One or more types of plant seed proteins providing the large amounts of AMINO ACIDS utilized in GERMINATION and SEEDLING growth. As seeds are the major food source from AGRICULTURAL CROPS, seed storage proteins are a major source of DIETARY PROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Seed Storage Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055315</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Prolamins of OATS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prolamins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prolamin Protein, Plant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Prolamins of OATS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Avenins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Avenin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055316</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An extracellular cystatin subtype that is abundantly expressed in bodily fluids. It may play a role in the inhibition of interstitial CYSTEINE PROTEASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystatin C</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>gamma-Trace</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Post-gamma-Globulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuroendocrine Basic Polypeptide</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055317</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A way of providing health care that is guided by a thoughtful integration of the best available scientific knowledge with clinical expertise. This approach allows the practitioner to critically assess research data, clinical guidelines, and other information resources in order to correctly identify the clinical problem, apply the most high-quality intervention, and re-evaluate the outcome for future improvement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Evidence-Based Practice</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A way of providing health care that is guided by a thoughtful integration of the best available scientific knowledge with clinical expertise. This approach allows the practitioner to critically assess research data, clinical guidelines, and other information resources in order to correctly identify the clinical problem, apply the most high-quality intervention, and re-evaluate the outcome for future improvement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Evidence-Based Health Care</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055318</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A way of providing nursing care that is guided by the integration of the best available scientific knowledge with nursing expertise. This approach requires nurses to critically assess relevant scientific data or research evidence, and to implement high-quality interventions for their nursing practice.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Evidence-Based Nursing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nursing, Evidence-Based</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055319</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Type species of the yeast TORULASPORA which is used commercially in the making of wheat beers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Torulaspora</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Type species of the yeast TORULASPORA which is used commercially in the making of wheat beers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Torulaspora delbrueckii</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055320</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous yeast in the family Saccharomycetaceae, order SACCHAROMYCETALES. Many species show mycocinogenic activity against other yeasts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Williopsis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055321</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of the ascomycetous yeast in the family Saccharomycodaceae, order SACCHAROMYCETALES, that contributes to the spontaneous fermentation of cider. Anamorphic forms are in the genus KLOECKERA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hanseniaspora</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055322</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A mitosporic fungal genus used in the fermentation of wine. Teleomorphs are in the genus HANSENIASPORA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kloeckera</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055323</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous mold in the family Trichocomaceae, order EUROTIALES. Byssochlamys species are responsible for spoilage and degradation of fruit and fruit juices. Anamorphs are found in the genus PAECILOMYCES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Byssochlamys</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055324</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of endophytic, ascomycetous mold in the family Trichocomaceae, order EUROTIALES. Anamorphic forms are in the genus PENICILLIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eupenicillium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055325</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous fungi in the family Trichocomaceae, order EUROTIALES. Health effects, allergenicity, and toxicity of Eurotium are closely related to its anamorph ASPERGILLUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eurotium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055326</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous fungi in the family Trichocomaceae, order EUROTIALES. Some species can cause opportunistic infections in humans, similar to its anamorph ASPERGILLUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neosartorya</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055327</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of thermophilic, ascomycetous fungi in the family Trichocomaceae, order EUROTIALES. Anamorphic forms are in the genus PAECILOMYCES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thermoascus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A genus of thermophilic, ascomycetous fungi in the family Trichocomaceae, order EUROTIALES. Anamorphic forms are in the genus PAECILOMYCES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thermoascus aurantiacus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055328</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The anamorphic form of the fungus EPICHLOE. Many Neotyphodium species produce ERGOT ALKALOIDS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neotyphodium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055329</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous fungi in the family Clavicipitaceae, order HYPOCREALES, which are fungal symbionts of grasses. Anamorphic forms are in the genus NEOTYPHODIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Epichloe</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055330</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous fungi in the family Nectriaceae, order HYPOCREALES. They are found as saprophytes on decaying wood or parasites of trees. Anamorphs include FUSARIUM and Cylindrocarpon.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nectria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055331</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A mixed epithelial and myoepithelial neoplasm usually encountered within the breast. It is a multinodular lesion presenting with a bicellular pattern of proliferating epithelial and myoepithelial cells, which are regularly distributed in the glandular structures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenomyoepithelioma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055332</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cystatin subtype that has a diverse tissue distribution, target specificity, and functions as an endogenous inhibitor of lysosomal cysteine proteases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystatin M</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin E</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin-6</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CST6 Cystatin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055333</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of closely-related cystatins found in SALIVA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salivary Cystatins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of closely-related cystatins found in SALIVA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SD-Type Cystatins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of closely-related cystatins found in SALIVA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystatin SA2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of closely-related cystatins found in SALIVA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystatin-SN</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin-SA-I</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin-1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of closely-related cystatins found in SALIVA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystatin S</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Salivary Gland Acidic Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin-4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Salivary Acidic Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acid Protein (Submandibular Gland)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin S, Salivary Gland</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of closely-related cystatins found in SALIVA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystatin SA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin-S5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cystatin-2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055351</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Nerve cells of the RETINA in the pathway of transmitting light signals to the CENTRAL NERVOUS SYSTEM. They include the outer layer of PHOTORECEPTOR CELLS, the intermediate layer of RETINAL BIPOLAR CELLS and AMACRINE CELLS, and the internal layer of RETINAL GANGLION CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinal Neurons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055352</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of HALOBACTERIACEAE which are chemoorganotrophic and strictly aerobic. They have been isolated from multiple hypersaline environments that vary widely in chemical and physical properties.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Halorubrum</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055353</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-negative, moderately halophilic bacteria in the family HALOMONADACEAE. They are chemoorganotrophic and grow optimally in media containing 8-10% salt.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromohalobacter</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055354</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Vesicles secreted from MULTIVESICULAR BODIES into the extracellular environment when the multivesicular bodies fuse with the PLASMA MEMBRANE. Multivesicular bodies are formed from ENDOSOMES when they accumulate vesicles (sometimes referred to as "intraluminal vesicles") from inward budding of the endosome membrane.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Exosomes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055355</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Photosensitive proteins in the membranes of PHOTORECEPTOR CELLS such as the rods and the cones. Opsins have varied light absorption properties and are members of the G-PROTEIN-COUPLED RECEPTORS family. Their ligands are VITAMIN A-based chromophores.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Opsins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Opsin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055356</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Procedures used for the targeted destruction of the mucous membrane lining of the uterine cavity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endometrial Ablation Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endometrial Ablation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endometrial Ablation Technics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055357</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of embolizing agents to block the arterial blood supply to parts or all of the UTERUS. The procedures are done to control bleeding or to cause destruction of uterine tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uterine Artery Embolization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055358</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Photosensitive proteins expressed in the CONE PHOTORECEPTOR CELLS. They are the protein components of cone photopigments. Cone opsins are classified by their peak absorption wavelengths.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cone Opsins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cone Opsin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Photosensitive proteins expressed in the CONE PHOTORECEPTOR CELLS. They are the protein components of cone photopigments. Cone opsins are classified by their peak absorption wavelengths.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Green-Sensitive Cone Opsins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Middle Wavelength-Sensitive Cone Opsins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cone Opsins, Middle Wavelength-Sensitive</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Photosensitive proteins expressed in the CONE PHOTORECEPTOR CELLS. They are the protein components of cone photopigments. Cone opsins are classified by their peak absorption wavelengths.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Red-Sensitive Cone Opsins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Long Wavelength-Sensitive Cone Opsins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cone Opsins, Long Wavelength-Sensitive</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Photosensitive proteins expressed in the CONE PHOTORECEPTOR CELLS. They are the protein components of cone photopigments. Cone opsins are classified by their peak absorption wavelengths.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blue-Sensitive Cone Opsins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Short Wavelength-Sensitive Cone Opsins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cone Opsins, Short Wavelength-Sensitive</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055359</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Substances that do not retain an electrostatic charge.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antistatic Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anti-Static Agents</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Substances that do not retain an electrostatic charge.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antistatic Materials</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anti-Static Material</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055360</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Licensed physicians trained in OSTEOPATHIC MEDICINE. An osteopathic physician, also known as D.O. (Doctor of Osteopathy), is able to perform surgery and prescribe medications.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Osteopathic Physicians</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteopath</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteopaths</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Doctor of Osteopathy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteopathic Physician</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055361</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The statistical manipulation of hierarchically and non-hierarchically nested data. It includes clustered data, such as a sample of subjects within a group of schools. Prevalent in the social, behavioral sciences, and biomedical sciences,  both linear and nonlinear regression models are applied.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multilevel Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055362</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of saprobic mushrooms in the family Bolbitiaceae that grow in grass, dung, garden mulch, or in woods.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Agrocybe</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055363</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of mushrooms in the family Cortinariaceae. When ingested, species of Cortinarius cause delayed acute RENAL FAILURE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cortinarius</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055364</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ectomycorrhizae basidiomycetous fungi in the family Cortinariaceae. Some species are poisonous.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hebeloma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055365</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of saprophytic fungi in the family Nidulariaceae. They look like small bird's nests complete with eggs. The eggs are small capsules known as peridioles, which contain the spores.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyathus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055366</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ion flow that effects the POSTSYNAPTIC POTENTIAL.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Synaptic Potentials</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Synaptic Potential</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The ion flow that effects the POSTSYNAPTIC POTENTIAL.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Postsynaptic Potentials</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The ion flow that effects the POSTSYNAPTIC POTENTIAL.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Postsynaptic Current</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055367</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of edible mushrooms in the family Pluteaceae. They have pink gills and a volva at the stem base, and species can be confused with those of the poisonous genus AMANITA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Volvariella</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055368</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of basidiomycetous mushroom in the family Strophariaceae, exhibiting a bipolar mating system.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pholiota</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055369</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subthreshold depolarizing postsynaptic potential generated at the NEUROMUSCULAR JUNCTION from a spontaneous release of neurotransmitters.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Miniature Postsynaptic Potentials</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subthreshold depolarizing postsynaptic potential generated at the NEUROMUSCULAR JUNCTION from a spontaneous release of neurotransmitters.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spontaneous Postsynaptic Potentials</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subthreshold depolarizing postsynaptic potential generated at the NEUROMUSCULAR JUNCTION from a spontaneous release of neurotransmitters.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Miniature End Plate Potentials</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Miniature End Plate Potential</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spontaneous End Plate Potentials</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MEPPS</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055370</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lung Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pulmonary Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lung Injuries</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Damage to any compartment of the lung caused by physical, chemical, or biological agents which characteristically elicit inflammatory reaction. These inflammatory reactions can either be acute and dominated by NEUTROPHILS, or chronic and dominated by LYMPHOCYTES and MACROPHAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chronic Lung Injury</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055371</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acute Lung Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lung Injury, Acute</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055372</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>AMP-Activated Protein Kinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AMP-Activated Protein Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5'-AMP-Activated Protein Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AMP-Activated Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>AMP-Activated Protein Kinase beta Subunits</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AMP-Activated Protein Kinase beta Subunit</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>AMP-Activated Protein Kinase gamma Subunits</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AMP-Activated Protein Kinase gamma Subunit</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Intracellular signaling protein kinases that play a signaling role in the regulation of cellular energy metabolism. Their activity largely depends upon the concentration of cellular AMP which is increased under conditions of low energy or metabolic stress. AMP-activated protein kinases modify enzymes involved in LIPID METABOLISM, which in turn provide substrates needed to convert AMP into ATP.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>AMP-Activated Protein Kinase alpha Subunits</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AMP-Activated Protein Kinase alpha Subunit</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055391</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of small mushrooms in the family Strophariaceae. Some species are known for their hallucinogenic properties.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Psilocybe</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055392</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of root and butt rot fungi in the family Tricholomataceae that produce rhizomorphs and are facultatively parasitic. Many species are pathogenic to trees causing Armillaria root disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Armillaria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055393</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of mushrooms in the family Tricholomataceae, whose species are characterized by a slimy cap (FRUITING BODIES, FUNGAL).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Flammulina</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A genus of mushrooms in the family Tricholomataceae, whose species are characterized by a slimy cap (FRUITING BODIES, FUNGAL).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Flammulina velutipes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Enoki Mushroom</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Enokitake</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055394</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of metalloproteases that are related to the DROSOPHILA protein tolloid, which is a gene product necessary for dorsal-ventral patterning in early Drosophila embryogenesis. Many members of the group may play a significant role in intercellular signaling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tolloid-Like Metalloproteinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tolloid-Like Enzymes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tolloid Metalloproteases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tolloid Metalloproteinase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055395</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A bone morphogenetic protein family member that includes an active tolloid-like metalloproteinase domain. The metalloproteinase activity of bone morphogenetic protein 1 is specific for the removal of the C-propeptide of PROCOLLAGEN and may act as a regulator of EXTRACELLULAR MATRIX deposition. Alternative splicing of MRNA for bone morphogenetic protein 1 results in the production of several PROTEIN ISOFORMS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Morphogenetic Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Procollagen C-Endopeptidase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055396</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A potent osteoinductive protein that plays a critical role in the differentiation of osteoprogenitor cells into OSTEOBLASTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Morphogenetic Protein 2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055397</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Lung damage that is caused by the adverse effects of PULMONARY VENTILATOR usage. The high frequency and tidal volumes produced by a mechanical ventilator can cause alveolar disruption and PULMONARY EDEMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ventilator-Induced Lung Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lung Injury, Ventilator-Induced</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055398</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A bone morphogenetic protein that is found at high concentrations in a purified osteoinductive protein fraction from BONE. Bone morphogenetic protein 3 is referred to as osteogenin, however it may play a role in variety of developmental processes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Morphogenetic Protein 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteogenin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055399</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of white-spored mushrooms in the family Tricholomataceae. They form symbiotic partnerships (MYCORRHIZAE) with trees.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laccaria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055411</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large family of cell regulatory proteins which are structurally related to TRANSFORMING GROWTH FACTOR BETA. The superfamily is subdivided into at least three related protein families: BONE MORPHOGENETIC PROTEINS; GROWTH DIFFERENTIATION FACTORS; and TRANSFORMING GROWTH FACTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>TGF-beta Superfamily Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transforming Growth Factor beta Superfamily Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055412</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of BONE MORPHOGENETIC PROTEIN-related proteins that are primarily involved in regulation of CELL DIFFERENTIATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055413</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A growth differentiation factor that is closely-related in structure to BONE MORPHOGENETIC PROTEIN 3. Growth differentiation factor 10 is found at high levels in BONE, however it plays an additional roles in regulating EMBRYONIC DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factor 10</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Morphogenetic Protein 3B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-10</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>BMP-3b</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055414</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Imaging blood flow to the MYOCARDIUM by following the distribution of radioactively labeled tracers injected into the blood stream.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Myocardial Perfusion Imaging</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Imaging blood flow to the MYOCARDIUM by following the distribution of radioactively labeled tracers injected into the blood stream.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Myocardial Scintigraphy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Scintigraphy, Myocardial</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055415</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A bone morphogenetic protein that is a potent inducer of bone formation. It also functions as a regulator of MESODERM formation during EMBRYONIC DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Morphogenetic Protein 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Morphogenetic Protein 2B</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055416</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A way of providing emergency medical care that is guided by a thoughtful integration of the best available scientific knowledge with clinical expertise in EMERGENCY MEDICINE. This approach allows the practitioner to critically assess research data, clinical guidelines, and other information resources in order to correctly identify the clinical problem, apply the most high-quality intervention, and re-evaluate the outcome for future improvement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Evidence-Based Emergency Medicine</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Emergency Medicine, Evidence-Based</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055417</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A bone morphogenetic protein that may play a role in CARTILAGE formation. It is a potent regulator of the growth of CHONDROCYTES and the synthesis of cartilage matrix proteins. Evidence for its role in cartilage formation can be seen in MICE, where genetic mutations that cause loss of bone morphogenetic protein 5 function result in the formation of small malformed ears.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Morphogenetic Protein 5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>BMP-5</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055418</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A bone morphogenetic protein that is a potent inducer of BONE formation. It plays additional roles in regulating CELL DIFFERENTIATION of non-osteoblastic cell types and epithelial-mesenchymal interactions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Morphogenetic Protein 6</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>BMP-6</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055419</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Morphogenetic Protein 7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteogenic Protein-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>BMP-7</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055420</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Imaging blood flow to specific organs or areas of the body by following the distribution of radioactively labeled tracers injected in to the blood stream.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Perfusion Imaging</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Imaging blood flow to specific organs or areas of the body by following the distribution of radioactively labeled tracers injected in to the blood stream.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Perfusion Scintigraphy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055422</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Flaps within the VEINS that allow the blood to flow only in one direction. They are usually in the medium size veins that carry blood to the heart against gravity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Venous Valves</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055423</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A course of food intake that is high in FATS and low in CARBOHYDRATES. This diet provides sufficient PROTEINS for growth but insufficient amount of carbohydrates for the energy needs of the body. A ketogenic diet generates 80-90% of caloric requirements from fats and the remainder from proteins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ketogenic Diet</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055424</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Timing the acquisition of imaging data to specific points in the cardiac cycle to minimize image blurring and other motion artifacts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiac-Gated Imaging Techniques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Timing the acquisition of imaging data to specific points in the cardiac cycle to minimize image blurring and other motion artifacts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>EKG-Triggered Imaging Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055425</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Timing the acquisition of imaging data to specific points in the breathing cycle to minimize image blurring and other motion artifacts. The images are used diagnostically and also interventionally to coordinate radiation treatment beam on/off cycles to protect healthy tissues when they move into the beam field during different times in the breathing cycle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Respiratory-Gated Imaging Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gated Imaging Techniques, Respiratory</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055426</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Tomography using single-photon emitting RADIONUCLIDES to create images that are captured in times corresponding to various points in the cardiac cycle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac-Gated SPECT Imaging</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac-Gated SPECT</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055427</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A growth differentiation factor that plays a regulatory role as a paracrine factor for a diverse array of cell types during EMBRYONIC DEVELOPMENT and in the adult tissues. Growth differentiation factor 2 is also a potent regulator of CHONDROGENESIS and was previously referred to as bone morphogenetic protein 9.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factor 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>BMP-9</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Morphogenetic Protein 9</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055428</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A growth differentiation factor that plays a role in early CHONDROGENESIS and joint formation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factor 5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cartilage-Derived Morphogenetic Protein-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cartilage-Derived Morphogenetic Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CDMP-1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055429</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A bone morphogenetic protein that plays an essential role in the regulation of ovarian folliculogenesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factor 9</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-9</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055430</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A protein that plays a role in GRANULOSA CELLS where it regulates folliculogenesis. Mutations in the gene for bone morphogenetic protein 15 are linked to reproductive abnormalities such as PREMATURE OVARIAN FAILURE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Morphogenetic Protein 15</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Growth Differentiation Factor 9B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-9-Related Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-9B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>BMP-15</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-9 Related Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055431</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A growth differentiation factor that plays a role in the neural differentiation, specifically in the retinal development of the EYE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factor 6</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-6</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055432</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The study of metabolite patterns in biological samples and correlation with xenobiotic challenge and disease states. The word was coined by Nicholson in 1999.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metabolomics</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The study of metabolite patterns in biological samples and correlation with xenobiotic challenge and disease states. The word was coined by Nicholson in 1999.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metabonomics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055433</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of tiny mushrooms in the family Tricholomataceae. They help break down the decaying organic matter of the forest floor.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Marasmius</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055434</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A paleotropical genus of fungi in the family Tricholomataceae. They are obligate symbionts of termites.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Termitomyces</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055435</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A growth differentiation factor that is a potent inhibitor of SKELETAL MUSCLE growth. It may play a role in the regulation of MYOGENESIS and in muscle maintenance during adulthood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Myostatin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Growth Differentiation Factor 8</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-8</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055436</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A growth differentiation factor that is secreted in response to cell stress and in response to MACROPHAGE ACTIVATION. In addition growth differentiation factor 15 demonstrates a diverse array of biological properties including the induction of cartilage formation, the inhibition of hematopoietic progenitor proliferation, and the induction of neuronal migration.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factor 15</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Macrophage Inhibitory Cytokine 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostate Differentiation Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-15</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055438</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemical reactions or functions, enzymatic activities, and metabolic pathways of living things.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biochemical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biochemical Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055439</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large genus of gilled mushrooms in the family Tricholomataceae. They are most often found in mountain and northern forests.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tricholoma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055441</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of basiodiomycetous fungi in the family Coriolaceae. Members are known for infesting wood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Poria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055442</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A measurement of all the metabolites of a sample of cells or tissue.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metabolome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A measurement of all the metabolites of a sample of cells or tissue.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metabolic Profile</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055451</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A growth differentiation factor that may play a role in maintaining the undifferentiated state of PLURIPOTENT STEM CELLS by inhibiting the actions of BONE MORPHOGENETIC PROTEINS. Differentiation factor 3 is also considered a nodal signaling ligand that influences the genesis of left-right asymmetry.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factor 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055452</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A growth differentiation factor that plays a role in the genesis of left-right asymmetry during vertebrate development. Evidence for this role is seen in MICE where loss of growth differentiation factor 1 function results in right-left isomerism of visceral organs. In HUMANS heterozygous loss of growth differentiation factor 1 function has been associated with CONGENITAL HEART DEFECTS and TRANSPOSITION OF GREAT VESSELS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Differentiation Factor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GDF-1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055453</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of fungi, order POLYPORALES, found on decaying wood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coriolaceae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of fungi, order POLYPORALES, found on decaying wood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ceriporiopsis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of fungi, order POLYPORALES, found on decaying wood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fomitopsis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of fungi, order POLYPORALES, found on decaying wood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bjerkandera</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of fungi, order POLYPORALES, found on decaying wood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fomes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055454</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of fungi in the family Coriolaceae.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trametes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055456</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Members of the transforming growth factor superfamily that play a role in pattern formation and differentiation during the pregastrulation and GASTRULATION stages of chordate development. Several nodal signaling ligands are specifically involved in the genesis of left-right asymmetry during development. The protein group is named after a critical region of the vertebrate embryo PRIMITIVE STREAK referred to as HENSEN'S NODE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nodal Signaling Ligands</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nodal Signaling Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055457</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The founding member of the nodal signaling ligand family of proteins. Nodal protein was originally discovered in the region of the mouse embryo primitive streak referred to as HENSEN'S NODE. It is expressed asymmetrically on the left side in chordates and plays a critical role in the genesis of left-right asymmetry during vertebrate development.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nodal Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055458</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Signaling ligands that act in opposition to NODAL PROTEIN. During vertebrate development they regulate the degree of left-right asymmetry by controlling the spatiotemporal influence of NODAL PROTEIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Left-Right Determination Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lefty Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Left-Right Determination Factor Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Signaling ligands that act in opposition to NODAL PROTEIN. During vertebrate development they regulate the degree of left-right asymmetry by controlling the spatiotemporal influence of NODAL PROTEIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Left-Right Determination Factor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Left-Right Determination, Factor B</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Signaling ligands that act in opposition to NODAL PROTEIN. During vertebrate development they regulate the degree of left-right asymmetry by controlling the spatiotemporal influence of NODAL PROTEIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Left-Right Determination Factor 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Left-Right Determination Factor A</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055459</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The passive movement of molecules exceeding the rate expected by simple diffusion. No energy is expended in the process. It is achieved by the introduction of passively diffusing molecules to an enviroment or path that is more favorable to the movement of those molecules.  Examples of facilitated diffusion are passive transport of hydrophilic substances across a lipid membrane through hydrophilic pores that traverse the membrane, and the sliding of a DNA BINDING PROTEIN along a strand of DNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Facilitated Diffusion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055471</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The movement of molecules from one location to another as effected by temperature changes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thermal Diffusion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thermodiffusion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055491</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of brown-rot fungi in the family Coriolaceae. The biologically active ingredients of its species have potential pharmaceutical value.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antrodia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055492</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of basidiomyceteous fungi in the family POLYPORACEAE found mostly on living trees or dead wood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polyporus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055493</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A spiral thickening of the fibrous lining of the cochlear wall. Spiral ligament secures the membranous COCHLEAR DUCT to the bony spiral canal of the COCHLEA. Its spiral ligament fibrocytes function in conjunction with the STRIA VASCULARIS to mediate cochlear ion homeostasis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spiral Ligament of Cochlea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spiral Ligament</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055494</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of basidiomyceteous fungi in the family POLYPORACEAE. The species all contain bright orange, bracket-like fruiting bodies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pycnoporus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055495</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Formation of NEURONS which involves the differentiation and division of STEM CELLS in which one or both of the daughter cells become neurons.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neurogenesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055496</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Loss or absence of normal intestinal function due to nerve damage or birth defects. It is characterized by the inability to control the elimination of stool from the body.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neurogenic Bowel</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055498</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Objects of precious metal usually containing gems and worn to enhance personal appearance. Health concerns include possible contamination from lead content or bacteria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Jewelry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055499</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infections resulting from the use of catheters. Proper aseptic technique, site of catheter placement, material composition, and virulence of the organism are all factors that can influence possible infection.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Catheter-Related Infections</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055500</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The human ability to adapt in the face of tragedy, trauma, adversity, hardship, and ongoing significant life stressors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Resilience, Psychological</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055501</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T-LYMPHOCYTES and MACROPHAGES. It is seen predominantly in children with systemic onset JUVENILE IDIOPATHIC ARTHRITIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Macrophage Activation Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055502</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Procedures undertaken to prevent or reduce the incidence or progression of disease, in individuals with EARLY DIAGNOSIS of disease, or known DISEASE SUSCEPTIBILITY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Secondary Prevention</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Procedures undertaken to prevent or reduce the incidence or progression of disease, in individuals with EARLY DIAGNOSIS of disease, or known DISEASE SUSCEPTIBILITY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Early Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055503</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Multimerization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protein Multimer Assembly</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Heteromultimerizaton</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Trimerization</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Dimerization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055504</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A structurally-related group of signaling proteins that are phosphorylated by the INSULIN RECEPTOR PROTEIN-TYROSINE KINASE. The proteins share in common an N-terminal PHOSPHOLIPID-binding domain, a phosphotyrosine-binding domain that interacts with the phosphorylated INSULIN RECEPTOR, and a C-terminal TYROSINE-rich domain. Upon tyrosine phosphorylation insulin receptor substrate proteins interact with specific SH2 DOMAIN-containing proteins that are involved in insulin receptor signaling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin Receptor Substrate Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IRS Signaling Adaptor Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A structurally-related group of signaling proteins that are phosphorylated by the INSULIN RECEPTOR PROTEIN-TYROSINE KINASE. The proteins share in common an N-terminal PHOSPHOLIPID-binding domain, a phosphotyrosine-binding domain that interacts with the phosphorylated INSULIN RECEPTOR, and a C-terminal TYROSINE-rich domain. Upon tyrosine phosphorylation insulin receptor substrate proteins interact with specific SH2 DOMAIN-containing proteins that are involved in insulin receptor signaling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin Receptor Substrate-2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin Receptor Substrate-2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A structurally-related group of signaling proteins that are phosphorylated by the INSULIN RECEPTOR PROTEIN-TYROSINE KINASE. The proteins share in common an N-terminal PHOSPHOLIPID-binding domain, a phosphotyrosine-binding domain that interacts with the phosphorylated INSULIN RECEPTOR, and a C-terminal TYROSINE-rich domain. Upon tyrosine phosphorylation insulin receptor substrate proteins interact with specific SH2 DOMAIN-containing proteins that are involved in insulin receptor signaling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin Receptor Substrate-4 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin Receptor Substrate-4</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A structurally-related group of signaling proteins that are phosphorylated by the INSULIN RECEPTOR PROTEIN-TYROSINE KINASE. The proteins share in common an N-terminal PHOSPHOLIPID-binding domain, a phosphotyrosine-binding domain that interacts with the phosphorylated INSULIN RECEPTOR, and a C-terminal TYROSINE-rich domain. Upon tyrosine phosphorylation insulin receptor substrate proteins interact with specific SH2 DOMAIN-containing proteins that are involved in insulin receptor signaling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin Receptor Substrate-1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin Receptor Substrate-1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A structurally-related group of signaling proteins that are phosphorylated by the INSULIN RECEPTOR PROTEIN-TYROSINE KINASE. The proteins share in common an N-terminal PHOSPHOLIPID-binding domain, a phosphotyrosine-binding domain that interacts with the phosphorylated INSULIN RECEPTOR, and a C-terminal TYROSINE-rich domain. Upon tyrosine phosphorylation insulin receptor substrate proteins interact with specific SH2 DOMAIN-containing proteins that are involved in insulin receptor signaling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin Receptor Substrate-3 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin Receptor Substrate-3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055511</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of secreted proteins found associated with the EXTRACELLULAR MATRIX and cell surface receptors. They are believed to play a role in modulating the effects of a variety of GROWTH FACTORS and PROTEASES at the cell membrane extracellular matrix. The CCN protein family is named after three protypical members; CYSTEINE-RICH PROTEIN 61; CONNECTIVE TISSUE GROWTH FACTOR; and NEPHROBLASTOMA OVEREXPRESSED PROTEIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CCN Intercellular Signaling Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Matricellular CCN Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CCN Family Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055512</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Measures aimed at providing appropriate supportive and rehabilitative services to minimize morbidity and maximize quality of life after a long-term disease or injury is present.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tertiary Prevention</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055513</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A CCN protein family member that regulates a variety of extracellular functions including CELL ADHESION; CELL MIGRATION; and EXTRACELLULAR MATRIX synthesis. It is found in hypertrophic CHONDROCYTES where it may play a role in CHONDROGENESIS and endochondral ossification.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Connective Tissue Growth Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hypertrophic Chondrocyte-Specific Protein 24</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IGF-Binding Protein-Related Protein-2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IGFBP-rP2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin-Like Growth Factor Binding Protein 8</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CCN2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IGFBP-8</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055514</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A CCN protein family member found at high levels in NEPHROBLASTOMA cells. It is found both intracellularly and in the EXTRACELLULAR MATRIX and may play a role in the regulation of CELL PROLIFERATION and EXTRACELLULAR MATRIX synthesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nephroblastoma Overexpressed Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NOVH Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nephroblastoma Overexpressed Gene Product</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CCN3 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IGFBP9 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055515</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A CCN protein family member that regulates a variety of extracellular functions including CELL ADHESION; CELL MIGRATION; and EXTRACELLULAR MATRIX synthesis. It may play an important role in the development of branched CAPILLARIES during EMBRYOGENESIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cysteine-Rich Protein 61</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IGFBP10 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CYR61 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CCN1 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055516</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A major class of water-soluble seed storage proteins. Many proteins from this class are major PLANT ALLERGENS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>2S Albumins, Plant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>2S Storage Albumins, Plant</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055517</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>snRNP Core Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sm Nuclear Antigens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein Core Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sm Core Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein-Associated Protein B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein B</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein-Associated Protein B1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein Polypeptide B'</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein-Associated Protein N</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SNRPN Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SNRPN</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein-Associated Protein D1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>snRNP Core Protein D1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SmD Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SmD Autoantigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein D1 Polypeptide 16kDa</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein Sm D1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein-Associated Protein D2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein D2 Polypeptide 16.5kDa</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein Sm D2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein-Associated Protein D3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein D3 Polypeptide 18kDa</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein-Associated Protein F</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein Polypeptide F</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein Polypeptide E</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein-Associated Protein E</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The protein components that constitute the common core of small nuclear ribonucleoprotein particles. These proteins are commonly referred as Sm nuclear antigens due to their antigenic nature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Nuclear Ribonucleoprotein-Associated Protein B2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein Polypeptide B2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Nuclear Ribonucleoprotein Polypeptide B''</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055519</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Plant proteins that mediate LIGHT SIGNAL TRANSDUCTION. They are involved in PHOTOTROPISM and other light adaption responses during plant growth and development . They include the phototropins, phytochromes (PHYTOCHROME), and members of the ubiquitous cryptochrome family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photoreceptors, Plant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plant Photoreceptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055531</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Small, punctate nuclear structures found in close proximity to COILED BODIES. They are enriched with SMN COMPLEX PROTEINS and may play a role in the processing of SMALL NUCLEAR RIBONUCLEOPROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gemini of Coiled Bodies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GEMS Cell Nucleus Structures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055532</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SMN Complex Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Survival of Motor Neuron Complex Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gem-Associated Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gemin5 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin-5 Protein</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gemin6 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin-6 Protein</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gemin2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Survival of Motor Neuron Protein-Interacting Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin-2 Protein</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gemin8 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin-8 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>FAM51A1 Protein</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SMN Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Survival of Motor Neuron Complex</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gemin4 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin-4 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Component of Gems 4 Protein</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex of proteins that assemble the SNRNP CORE PROTEINS into a core structure that surrounds a highly conserved RNA sequence found in SMALL NUCLEAR RNA. They are found localized in the GEMINI OF COILED BODIES and in the CYTOPLASM. The SMN complex is named after the Survival of Motor Neuron Complex Protein 1, which is a critical component of the complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gemin7 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin-7 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055533</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A SMN complex protein that is essential for the function of the SMN protein complex. In humans the protein is encoded by a single gene found near the inversion telomere of a large inverted region of CHROMOSOME 5. Mutations in the gene coding for survival of motor neuron 1 protein may result in SPINAL MUSCULAR ATROPHIES OF CHILDHOOD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Survival of Motor Neuron 1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Survival Motor Neuron Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Survival of Motor Neuron 1, Telomeric Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SMN Protein (Spinal Muscular Atrophy)</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055534</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An X-linked recessive form of spinal muscular atrophy. It is due to a mutation of the gene encoding the ANDROGEN RECEPTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bulbo-Spinal Atrophy, X-Linked</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal And Bulbar Muscular Atrophy, X-Linked 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Linked Bulbo-Spinal Atrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-linked Bulbospinal Muscular Atrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bulbospinal Muscular Atrophy, X-linked</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kennedy Spinal and Bulbar Muscular Atrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal and Bulbar Muscular Atrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kennedy Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kennedy Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055535</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An unexplained illness which is characterized by skin manifestations including non-healing lesions, itching, and the appearance of fibers. There appears to be a strong association with LYME DISEASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Morgellons Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Morgellons</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Morgellons Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Morgellon's</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055536</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An adjunctive treatment for PARTIAL EPILEPSY and refractory DEPRESSION that delivers electrical impulses to the brain via the VAGUS NERVE. A battery implanted under the skin supplies the energy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vagus Nerve Stimulation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vagal Nerve Stimulation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055537</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The conversion of absorbed light energy into molecular signals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Light Signal Transduction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phototransduction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Signal Transduction, Light</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055538</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A hereditary disorder characterized by reduced or absent DELTA-GLOBIN thus effecting the level of HEMOGLOBIN A2, a minor component of adult hemoglobin monitored in the diagnosis of BETA-THALASSEMIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>delta-Thalassemia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055539</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Portable electronics device for storing and playing audio and or media files.  Uses MPEG-4 standard.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>MP3-Player</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Portable electronics device for storing and playing audio and or media files.  Uses MPEG-4 standard.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>i-POD</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>iPOD</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055540</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A SMN complex protein that is closely-related to SURVIVAL OF MOTOR NEURON 1 PROTEIN. In humans, the protein is encoded by an often duplicated gene found near the inversion centromere of a large inverted region of CHROMOSOME 5.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Survival of Motor Neuron 2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Survival of Motor Neuron 3, Centromeric Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Survival Motor Neuron Protein 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Survival of Motor Neuron 2, Centromeric Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055541</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A multifunctional protein that is both a DEAD-box RNA helicase and a component  of the SMN protein complex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DEAD Box Protein 20</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DEAD Box Protein DP 103</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin3 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DDX20 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gemin-3 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055542</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Members of the alpha-globin family. In humans, they are encoded in a gene cluster on CHROMOSOME 16. They include zeta-globin and alpha-globin. There are also pseudogenes of zeta (theta-zeta) and alpha (theta-alpha) in the cluster. Adult HEMOGLOBIN is comprised of 2 alpha-globin chains and 2 beta-globin chains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>alpha-Globins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha-Globin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Members of the alpha-globin family. In humans, they are encoded in a gene cluster on CHROMOSOME 16. They include zeta-globin and alpha-globin. There are also pseudogenes of zeta (theta-zeta) and alpha (theta-alpha) in the cluster. Adult HEMOGLOBIN is comprised of 2 alpha-globin chains and 2 beta-globin chains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>alpha-1 Globin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha 1-globin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Members of the alpha-globin family. In humans, they are encoded in a gene cluster on CHROMOSOME 16. They include zeta-globin and alpha-globin. There are also pseudogenes of zeta (theta-zeta) and alpha (theta-alpha) in the cluster. Adult HEMOGLOBIN is comprised of 2 alpha-globin chains and 2 beta-globin chains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>alpha-2 Globin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055543</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A member of the alpha-globin family. In humans, zeta-globin is encoded in the alpha-globin gene cluster located on CHROMOSOME 16. Two zeta-globin chains combine with two EPSILON GLOBIN chains to form the embryonic HEMOGLOBIN Gower 1.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>zeta-Globins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>zeta-Globin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055544</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Members of the beta-globin family. In humans, they are encoded in a gene cluster on CHROMOSOME 11. They include epsilon-globin, gamma-globin, delta-globin and beta-globin. There is also a pseudogene of beta (theta-beta) in the gene cluster. Adult HEMOGLOBIN is comprised of two ALPHA-GLOBIN chains and two beta-globin chains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>beta-Globins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Non-alpha Globin Chain, Unspecified</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>beta-Globin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055545</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of gamma-globin encoded by the G gamma globin gene on CHROMOSOME 11.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>gamma-Globins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>gamma-Globin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of gamma-globin encoded by the G gamma globin gene on CHROMOSOME 11.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>A gamma-Globin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of gamma-globin encoded by the G gamma globin gene on CHROMOSOME 11.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G gamma-Globin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055546</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A member of the beta-globin family. In humans, delta-globin is encoded in the beta-globin gene cluster located on CHROMOSOME 11. Two delta-globin chains along with two alpha-globin chains form HEMOGLOBIN A2 which makes up about 3% of the HEMOGLOBIN in adults.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>delta-Globins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>delta-Globin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055547</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A member of the beta-globin family. In humans, epsilon-globin is encoded in the beta-globin gene cluster located on CHROMOSOME 11. Two epsilon-globin chains combine with two ZETA-GLOBIN chains to form the embryonic hemoglobin Gower I or two epsilon-globin chains combine with two ALPHA-2 GLOBIN chains to form the embryonic hemoglobin Gower II.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>epsilon-Globins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>epsilon-Globin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055548</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The contribution to barometric PRESSURE of gaseous substance in equilibrium with its solid or liquid phase.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vapor Pressure</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055549</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Organic compounds that have a relatively high VAPOR PRESSURE at room temperature.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Volatile Organic Compounds</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055550</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ability of a protein to retain its structural conformation or its activity when subjected to physical or chemical manipulations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Stability</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055551</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subfamily of small heat-shock proteins that function as molecular chaperones that aid in refolding of non-native proteins. They play a protective role that increases cellular survival during times of stress.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HSP27 Heat-Shock Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HSP27 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HSP27 Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Heat Shock Protein beta-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Heat-Shock Protein 27</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Heat-Shock Proteins 27</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055552</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A branch of internal medicine concerned with the diagnosis and treatment of INFECTIOUS DISEASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infectious Disease Medicine</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Infectious Diseases Specialty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Infectious Disease Specialty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055553</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that cannot be sold legally without a prescription.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prescription Drugs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055554</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The PROTEIN SUBUNITS that comprise multimeric HEMOGLOBINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hemoglobin Subunits</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055556</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Irrigation of the nose with saline or irrigation solutions for diagnostic or therapeutic purposes. It is used to remove irritants, allergens, or microorganisms from the nose.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nasal Lavage</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nasal Irrigation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055571</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A series of sequential intracellular steps involved in the transport of proteins (such as hormones and enzymes) from the site of synthesis to outside the cell. The pathway involves membrane-bound compartments through which the newly synthesized proteins undergo POST-TRANSLATIONAL MODIFICATIONS, packaging, storage, or transportation to the PLASMA MEMBRANE for secretion.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Secretory Pathway</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Secretion Process</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Secretory Process</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Secretion Pathway</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055572</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Amidohydrolases that are specific for the cleavage of the N-acyl linkage of CERAMIDES. Ceramidases are classified as acidic, neutral or basic according to the optimal pH with which they function.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ceramidases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ceramidase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>N-Acylsphingosine Amidohydrolase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acylsphingosine Deacylase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055573</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A ceramidase subtype that is active at acid pH. It plays an important role in sphingolipid degradation by catalyzing the lysosomal hydrolysis of ceramide to sphingosine and free fatty acid. Inherited deficiency of acid ceramidase activity results in FARBER LIPOGRANULOMATOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acid Ceramidase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055574</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A ceramidase subtype that is active at alkaline pH. It is found at high levels within the SMALL INTESTINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alkaline Ceramidase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055576</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A ceramidase subtype that is active at neutral pH. It is found at high levels within the SMALL INTESTINE and in the BRAIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neutral Ceramidase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055577</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A sphingolipidosis subtype that is characterized by the histological appearance of granulomatous deposits in tissues. It results from the accumulation of CERAMIDES in various tissues due to an inherited deficiency of ACID CERAMIDASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Farber Lipogranulomatosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Farber Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acid Ceramidase Deficiency</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055580</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Aggregates of matter in outer space, such as stars, planets, comets, etc. and the properties and processes they undergo.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Astronomical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astronomic Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astronomical Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astronomic Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astronomic Phenomenon</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Aggregates of matter in outer space, such as stars, planets, comets, etc. and the properties and processes they undergo.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Astrophysical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astrophysical Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astrophysical Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055585</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The entities of matter and energy, and the processes, principles, properties, and relationships describing their nature and interactions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physical Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physical Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055586</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The forces and principles of action of matter and energy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physical Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055587</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Aggregates of matter in outer space.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Astronomical Objects</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astronomic Objects</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055588</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The behavior and interactions of matter and energy in outer space.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Astronomical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astronomical Process</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astronomic Process</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Astronomic Processes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055589</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An inflammatory disease and serious complication of PANCREAS TRANSPLANTATION. It is caused by a premature activation of pancreatic proenzymes leading to autodigestion of the gland and can be attributed to immunological or nonimmunological causes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pancreatitis, Graft</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Graft Pancreatitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055590</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Phenomena involving magnets, electric currents through conductors and the electric and magnetic fields thus produced, as in electric motors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electromagnetic Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electromagnetic Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electromagnetic Concepts</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Phenomena involving magnets, electric currents through conductors and the electric and magnetic fields thus produced, as in electric motors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrical Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrical Concepts</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Phenomena involving magnets, electric currents through conductors and the electric and magnetic fields thus produced, as in electric motors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electromagnetics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055592</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The physical characteristics and processes of biological systems.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biophysical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biophysical Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biophysical Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055593</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The inanimate matter of Earth, the structures and properties of this matter, and the processes that affect it.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Geological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Geological Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Geological Concepts</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The inanimate matter of Earth, the structures and properties of this matter, and the processes that affect it.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Geophysical Phenomena</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055594</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Events and activities of the Earth and its structures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Geological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Geological Process</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Events and activities of the Earth and its structures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Geophysical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Geophysical Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055595</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The properties and processes of materials that affect their behavior under force.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mechanical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mechanical Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mechanical Phenomenon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055596</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The behaviors of materials under force.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mechanical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mechanical Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055597</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physical forces and actions in living things.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biophysical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biophysical Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055598</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The composition, conformation, and properties of atoms and molecules, and their reaction and interaction processes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chemical Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chemical Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055599</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The reactions and interactions of atoms and molecules, the changes in their structure and composition, and associated energy changes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chemical Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055601</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The conformation, properties, reaction processes, and the properties of the reactions of carbon compounds.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Chemistry Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Organic Chemistry Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Organic Chemistry Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055602</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The reactions, changes in structure and composition, the properties of the reactions of carbon compounds, and the associated energy changes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Chemistry Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Organic Chemistry Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055605</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The physical phenomena describing the structure and properties of atoms and molecules, and their reaction and interaction processes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physicochemical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physical Chemistry Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physicochemical Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physical Chemistry Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physicochemical Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055606</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physical reactions involved in the formation of or changes in the structure of atoms and molecules and their interactions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physicochemical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physicochemical Process</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physical Chemistry Process</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physical Chemistry Processes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055607</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Receptors that are specifically found on the surface of NATURAL KILLER CELLS. They play an important role in regulating the cellular component of INNATE IMMUNITY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Natural Killer Cell</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Natural Killer Cell Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK Cell Receptors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Receptors that are specifically found on the surface of NATURAL KILLER CELLS. They play an important role in regulating the cellular component of INNATE IMMUNITY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Killer Cell Activating Receptors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Receptors that are specifically found on the surface of NATURAL KILLER CELLS. They play an important role in regulating the cellular component of INNATE IMMUNITY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Killer Cell Inhibitory Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055608</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Large aggregates of CELESTIAL STARS; COSMIC DUST; and gas. (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Galaxies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Galaxy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055609</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Large bodies consisting of self-luminous gas held together by their own gravity.  (From McGraw Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stars, Celestial</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055610</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A major histocompatibily complex class I-like protein that plays a unique role in the presentation of lipid ANTIGENS to NATURAL KILLER T-CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antigens, CD1d</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD1d Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055611</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific natural killer T-cell subtype that expresses an invariant T-cell receptor alpha-chain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Killer T-Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKT Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Natural Killer T-Cell</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKT Cell</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific natural killer T-cell subtype that expresses an invariant T-cell receptor alpha-chain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Invariant Natural Killer T-Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>iNKT Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055612</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Mononuclear leukocytes that have be expanded in CELL CULTURE and activated by co-culturing with cells that express CYTOKINES such as INTERLEUKIN-2 to produce large numbers of highly cytotoxic cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cytokine-Induced Killer Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CIK Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Mononuclear leukocytes that have be expanded in CELL CULTURE and activated by co-culturing with cells that express CYTOKINES such as INTERLEUKIN-2 to produce large numbers of highly cytotoxic cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lymphocyte-Activated Killer Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lymphocyte-Activated Killer Cell</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055613</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A number of small lung lesions characterized by small round masses of 2- to 3-mm in diameter. They are usually detected by chest CT scans (COMPUTED TOMOGRAPHY, X-RAY). Such nodules can be associated with metastases of malignancies inside or outside the lung, benign granulomas, or other lesions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multiple Pulmonary Nodules</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055615</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Apparatus and instruments that generate and operate with ELECTRICITY, and their electrical components.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrical Equipment and Supplies</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Apparatus and instruments that generate and operate with ELECTRICITY, and their electrical components.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electronic Equipment and Supplies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055616</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Manufacturing technology for making microscopic devices in the micrometer range (typically 1-100 micrometers), such as integrated circuits or MEMS. The process usually involves replication and parallel fabrication of hundreds or millions of identical structures using various thin film deposition techniques and carried out in environmentally-controlled clean rooms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microtechnology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Micromachining</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Micromanufacturing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microfabrication</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055617</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>MEMS designed specifically to interact with biological samples.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Micro-Electrical-Mechanical Systems</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MEMS</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Micro-Electro-Mechanical Systems</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>MEMS designed specifically to interact with biological samples.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>BioMEMS</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055618</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Instruments and apparatus for radiation applications and their components and associated expendables.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radiation Equipment and Supplies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055620</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>LIGHT, it's processes and properties, and the characteristics of materials interacting with it.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optical Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055621</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Behavior of LIGHT and its interactions with itself and materials.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optical Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055622</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inflammation of the extraocular muscle of the eye. It is characterized by swelling which can lead to ischemia, fibrosis, or ORBITAL PSEUDOTUMOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Orbital Myositis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Myositis, Orbital</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055623</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>White or pink lesions on the arms, hands, face, or scalp that arise from sun-induced DNA DAMAGE to KERATINOCYTES in exposed areas. They are considered precursor lesions to superficial SQUAMOUS CELL CARCINOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Keratosis, Actinic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Actinic Keratosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055624</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Methicillin-Resistant Staphylococcus aureus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MRSA</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055627</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A 46-kD stimulatory receptor found on resting and activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Cytotoxicity Triggering Receptor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKp46 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Natural Killer Cell p46-Related Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK-p46 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD335</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD335 Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055628</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A 30 kDa stimulatory receptor found on resting and activated NATURAL KILLER CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Cytotoxicity Triggering Receptor 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD337</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK-p30 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD337 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKp30 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p30 Natural Killer Cell Receptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055629</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A 44-kD stimulatory receptor found on activated NATURAL KILLER CELLS. It has specificity for VIRAL HEMAGGLUTININS that are expressed on infected cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Cytotoxicity Triggering Receptor 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD336 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p44 Natural Killer Cell Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK-p44 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD336</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKp44 Receptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055630</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Structurally-related receptors that are typically found on NATURAL KILLER CELLS. They are considered lectin-like proteins in that they share sequence homology with the carbohydrate binding domains of C-TYPE LECTINS. They differ from classical C-type lectins, however, in that they appear to lack CALCIUM-binding domains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, NK Cell Lectin-Like</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Natural Killer Cell Lectin-Like Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptors, Killer Cell Lectin-Like</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK Cell Lectin-Like Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055632</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The metabolism of drugs and their mechanisms of action.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pharmacological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pharmacologic Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pharmacologic Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055633</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The characteristic properties and processes involved in IMMUNITY and an organism's immune response.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immune System Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immune System Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immune System Phenomenon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055635</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Mechanisms of action and interactions of the components of the IMMUNE SYSTEM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immune System Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immune System Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055636</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of natural killer cell receptors that perform an important role in the recognition of tumor cells by NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Natural Cytotoxicity Triggering</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Natural Cytotoxicity Triggering Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055639</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physiological functions characteristic of plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plant Physiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055641</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Numeric or quantitative entities, descriptions, properties, relationships, operations, and events.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mathematical Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055646</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Protein factors released from one species of YEAST that are selectively toxic to another species of yeast.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Killer Factors, Yeast</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Toxin, Yeast</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Yeast Killer Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Factor, Yeast</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055647</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Laboratory rats that have been produced from a genetically manipulated rat EGG or rat EMBRYO, MAMMALIAN. They contain genes from another species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rats, Transgenic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rat, Transgenic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transgenic Rats</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055648</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cellular functions, mechanisms, and activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Physiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055650</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly-49 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Natural Killer Cell Lectin-Like Receptor Subfamily A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49 Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A, Member 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49B Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A, Member 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49C Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A, Member 8</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49H Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A, Member 5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49E Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A, Member 6</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49F Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A, Member 7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49G Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49A Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly-49A Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An inhibitory subclass of NK cell lectin-like receptors that interacts with CLASS I MAJOR HISTOCOMPATIBILITY ANTIGENS and prevents the activation of NK CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily A, Member 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ly49D Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055651</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of NK cell lectin-like receptors that includes both inhibitory and stimulatory members.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily B</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of NK cell lectin-like receptors that includes both inhibitory and stimulatory members.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily B, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptors, NKR-P1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKR-P1 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKR-P1 Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD161</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD161 Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055652</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with THROMBOCYTOPENIA, enlarged platelets, and prolonged bleeding time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gray Platelet Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Grey Platelet Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A rare, inherited platelet disorder characterized by a selective deficiency in the number and contents of platelet alpha-granules. It is associated with THROMBOCYTOPENIA, enlarged platelets, and prolonged bleeding time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Platelet alpha-Granule Deficiency</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055653</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of LYNCH SYNDROME II associated with cutaneous SEBACEOUS GLAND NEOPLASMS. Muir-Torre syndrome is also associated with other visceral malignant diseases include colorectal, endometrial, urological, and upper gastrointestinal neoplasms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Muir-Torre Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055654</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of NK cell lectin-like receptors that associates with members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D to form heterodimeric receptors for HLA-E antigen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily C</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily C</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Natural Killer Cell Lectin-Like Receptor Subfamily C</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of NK cell lectin-like receptors that associates with members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D to form heterodimeric receptors for HLA-E antigen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily C, Member 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2C Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2-C Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily C, Member 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK Cell Receptor C</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of NK cell lectin-like receptors that associates with members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D to form heterodimeric receptors for HLA-E antigen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily C, Member 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK Cell Receptor F</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2-F Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily C, Member 4</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of NK cell lectin-like receptors that associates with members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D to form heterodimeric receptors for HLA-E antigen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily C, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2B Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2A Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily C, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK Cell Receptor A</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of NK cell lectin-like receptors that associates with members of NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D to form heterodimeric receptors for HLA-E antigen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily C, Member 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2-E Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK Cell Receptor E</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2E Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily C, Member 3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055655</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An activating NK cell lectin-like receptor subfamily that regulates immune responses to INFECTION and NEOPLASMS. Members of this subfamily generally occur as homodimers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily K</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily K</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An activating NK cell lectin-like receptor subfamily that regulates immune responses to INFECTION and NEOPLASMS. Members of this subfamily generally occur as homodimers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NK Cell Lectin-Like Receptor Subfamily K, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2D Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NK Cell Receptor D</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NKG2-D Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD314 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Killer Cell Lectin-Like Receptor Subfamily K, Member 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055656</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Directions written for the obtaining and use of PHARMACEUTICAL PREPARATIONS; MEDICAL DEVICES; corrective LENSES; and a variety of other medical remedies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prescriptions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Directions written for the obtaining and use of PHARMACEUTICAL PREPARATIONS; MEDICAL DEVICES; corrective LENSES; and a variety of other medical remedies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prescriptions, Non-Drug</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prescriptions, Nondrug</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055664</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The utilization of an electrical current to measure, analyze, or alter chemicals or chemical reactions in solution, cells, or tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrochemical Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrochemical Technics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055665</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A severe, rapidly fatal reaction occurring most commonly in children following an infectious illness. It is characterized by large, rapidly spreading skin hemorrhages, fever, or shock. Purpura fulminans often accompanies or is triggered by DISSEMINATED INTRAVASCULAR COAGULATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purpura Fulminans</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055666</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Lipopeptides with an cationic peptide scaffold.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lipopeptides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Lipopeptides with an cationic peptide scaffold.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anionic Lipopeptides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anionic Lipopeptide</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Lipopeptides with an cationic peptide scaffold.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cationic Lipopeptides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cationic Lipopeptide</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055667</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of facultatively anaerobic, gram-positive bacteria in the family ACTINOMYCETACEAE, order ACTINOMYCETALES. They are obligate parasites of the PHARYNX in humans and farm animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Arcanobacterium</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Archanobacterium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055668</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemical reactions effected by light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photochemical Processes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055669</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Ecological and environmental entities, characteristics, properties, relationships and processes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ecological and Environmental Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ecological and Environmental Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055670</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Medical practice or discipline that is based on the knowledge, cultures, and beliefs of the people of KOREA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medicine, Korean Traditional</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traditional Medicine, Korea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Korean Traditional Medicine</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055672</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An electric charge accumulated on an object. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Static Electricity</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An electric charge accumulated on an object. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrostatics</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An electric charge accumulated on an object. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Static Charge</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055673</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Autosomal recessive syndrome characterized by hypogenesis or agenesis of CORPUS CALLOSUM. Clinical features include MENTAL RETARDATION; CRANIOFACIAL ABNORMALITIES; digital malformations, and growth retardation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acrocallosal Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055675</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Viscoelastic solutions that are injected into JOINTS in order to alleviate symptoms of joint-related disorders such as OSTEOARTHRITIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viscosupplements</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Viscosupplement</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055676</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A therapeutic treatment typically involving INTRA-ARTICULAR INJECTIONS of HYALURONIC ACID and related compounds. The procedure is commonly used in the treatment of OSTEOARTHRITIS with the therapeutic goal to restore the viscoelasticity of SYNOVIAL FLUID, decrease pain, improve mobility and restore the natural protective functions of hyaluronan in the joint.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viscosupplementation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055677</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A condition of metabolic imbalance that is caused by complications of initially feeding a severely malnourished patient too aggressively. Usually occurring within the first 5 days of refeeding, this syndrome is characterized by WATER-ELECTROLYTE IMBALANCE; GLUCOSE INTOLERANCE; CARDIAC ARRHYTHMIAS; and DIARRHEA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Refeeding Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055679</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physiological functions, activities, and interactions of microorganisms, including ARCHAEA; BACTERIA; RICKETTSIA; VIRUSES; FUNGI; and others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microbiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microbiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055681</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Biological activities of viruses and their interactions with the cells they infect.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Virus Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Viral Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Virus Physiological Process</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Viral Physiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055682</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Substances that display the physical properties of ELASTICITY and VISCOSITY. The dual-nature of these substances causes them to resist applied forces in a time-dependent manner.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viscoelastic Substances</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Substances that display the physical properties of ELASTICITY and VISCOSITY. The dual-nature of these substances causes them to resist applied forces in a time-dependent manner.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viscoelastic Solutions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Substances that display the physical properties of ELASTICITY and VISCOSITY. The dual-nature of these substances causes them to resist applied forces in a time-dependent manner.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viscoelastic Foams</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055683</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The functions, behavior, and activities of bacteria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bacterial Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bacterial Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055685</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The anamorphic form of the fungus MAGNAPORTHE GRISEA and the most important pathogen of rice worldwide. It causes rice blast which prevents maturation of the rice grains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pyricularia grisea</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055686</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A measurement of OXYGEN uptake in a sitting, resting person (resting oxygen consumption), varying with age, sex, race, and other factors. In normal adult men, one MET is approximately 3.5 ml O2/kg/min of body weight. Oxygen uptake during activities or work can be measured in METs which can be use to determine health status and exercise prescription.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metabolic Equivalent</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055687</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Properties, and processes of the MUSCULOSKELETAL SYSTEM and the NERVOUS SYSTEM or their parts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Musculoskeletal and Neural Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Musculoskeletal and Neural Physiological Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Musculoskeletal and Neural Physiology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Musculoskeletal and Neural Physiological Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055688</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Properties and processes of the DIGESTIVE SYSTEM and DENTITION as a whole or of any of its parts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Digestive System and Oral Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Digestive System and Oral Physiological Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Digestive System and Oral Physiological Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Digestive System and Oral Physiology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055690</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Functions and activities of DENTITION as a whole.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dental Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Physiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055691</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Ecosystem and environmental activities, functions, or events.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ecological and Environmental Processes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055694</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Biological activities and function of  the whole organism in human, animal, microorgansims, and plants, and of the biosphere.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055695</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of COMPUTER COMMUNICATION NETWORKS to store and transmit medical PRESCRIPTIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electronic Prescribing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>E-Prescribing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The use of COMPUTER COMMUNICATION NETWORKS to store and transmit medical PRESCRIPTIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electronic Transmission of Prescriptions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The use of COMPUTER COMMUNICATION NETWORKS to store and transmit medical PRESCRIPTIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electronic Prescriptions</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>E-Prescriptions</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055696</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process by which the nature and meaning of olfactory stimuli, such as odors, are recognized and interpreted by the brain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Olfactory Perception</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055697</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process by which the nature and meaning of gustatory stimuli are recognized and interpreted by the brain. The four basic classes of taste perception are salty, sweet, bitter, and sour.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Taste Perception</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gustatory Perception</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055698</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process by which the nature and meaning of tactile stimuli are recognized and interpreted by the brain, such as realizing the characteristics or name of an object being touched.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Touch Perception</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tactile Perception</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055699</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Areas set apart as burial grounds.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cemeteries</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055700</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Reducing a dead body to ashes by burning or incineration.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cremation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Reducing a dead body to ashes by burning or incineration.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cremains</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055702</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Functions and activities of the URINARY TRACT as a whole or of any of its parts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Urinary Tract Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urinary Tract Physiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055703</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physiological processes, factors, properties and characteristics pertaining to REPRODUCTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reproductive Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reproductive Physiological Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reproductive Physiologic Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reproductive Physiological Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055704</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physiological activities and functions that pertain to REPRODUCTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reproductive Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reproductive Physiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055705</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The functions and activities of living organisms that support life in single- or multi-cellular organisms from their origin through the progression of life.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055724</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The electrical properties, characteristics of living organisms, and the processes of organisms or their parts that are involved in generating and responding to electrical charges.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrophysiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrophysiological Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrophysiological Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrophysiologic Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrophysiologic Phenomena</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055725</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The functions and activities of living organisms or their parts involved in generating and responding to electrical charges .</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrophysiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrophysiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055726</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The republic consists of islands that are located in the mid-Atlantic Ocean about 300 miles off the west coast of Africa. The archipelago includes 10 islands and 5 islets, divided into the windward (Barlavento) and leeward (Sotavento) groups. The capital is Praia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cape Verde</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Republic of Cape Verde</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055728</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Primary Myelofibrosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Marrow Fibrosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Myelosis, Nonleukemic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Myelofibrosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Myeloid Metaplasia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Myelosclerosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Agnogenic Myeloid Metaplasia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fibrosis, Bone Marrow</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055731</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The study of the structure, biosynthesis, and function of CARBOHYDRATES and GLYCOSYLATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carbohydrate Biochemistry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055732</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infections of the respiratory tract with fungi of the genus ASPERGILLUS. Infections may result in allergic reaction (ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS), colonization in pulmonary cavities as fungus balls (MYCETOMA), or lead to invasion of the lung parenchyma (INVASIVE PULMONARY ASPERGILLOSIS).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pulmonary Aspergillosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lung Aspergillosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Infections of the respiratory tract with fungi of the genus ASPERGILLUS. Infections may result in allergic reaction (ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS), colonization in pulmonary cavities as fungus balls (MYCETOMA), or lead to invasion of the lung parenchyma (INVASIVE PULMONARY ASPERGILLOSIS).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bronchopulmonary Aspergillosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspergillosis, Bronchopulmonary</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bronchopulmonary Aspergilloses</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspergilloses, Bronchopulmonary</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055744</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Lung infections with the invasive forms of ASPERGILLUS, usually after surgery, transplantation, prolonged NEUTROPENIA or treatment with high-doses of CORTICOSTEROIDS. Invasive pulmonary aspergillosis can progress to CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS or hematogenous spread to other organs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Invasive Pulmonary Aspergillosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pulmonary Aspergillosis - Invasive</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Lung infections with the invasive forms of ASPERGILLUS, usually after surgery, transplantation, prolonged NEUTROPENIA or treatment with high-doses of CORTICOSTEROIDS. Invasive pulmonary aspergillosis can progress to CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS or hematogenous spread to other organs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chronic Necrotizing Pulmonary Aspergillosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Lung infections with the invasive forms of ASPERGILLUS, usually after surgery, transplantation, prolonged NEUTROPENIA or treatment with high-doses of CORTICOSTEROIDS. Invasive pulmonary aspergillosis can progress to CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS or hematogenous spread to other organs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Allergic Bronchopulmonary Mycosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055745</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The small airways branching off the TERTIARY BRONCHI. Terminal bronchioles lead into several orders of respiratory bronchioles which in turn lead into alveolar ducts and then into PULMONARY ALVEOLI.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bronchioles</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bronchiole</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The small airways branching off the TERTIARY BRONCHI. Terminal bronchioles lead into several orders of respiratory bronchioles which in turn lead into alveolar ducts and then into PULMONARY ALVEOLI.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Respiratory Bronchioles</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The small airways branching off the TERTIARY BRONCHI. Terminal bronchioles lead into several orders of respiratory bronchioles which in turn lead into alveolar ducts and then into PULMONARY ALVEOLI.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Terminal Bronchioles</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055746</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cell-surface molecules that exhibit lineage-restricted patterns of expression during EMBRYONIC DEVELOPMENT. The antigens are useful markers in the identification of EMBRYONIC STEM CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stage-Specific Embryonic Antigens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SSEA Antigens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stage-Specific Embryonic Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055747</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large family of structurally-related transcription factors that were originally discovered based upon their close sequence homology to an HMG-box domain found in SEX-DETERMINING REGION Y PROTEIN. Many SOX transcription factors play important roles in regulating CELL DIFFERENTIATION. The numerous members of this family are organized in several subgroups according to structural identities found within the proteins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SRY (Sex Determining Region Y)-Box Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX Family of Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX Transcription Factor Family</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055748</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional activators.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOXB1 Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Group B1 SOX Transcription Factors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional activators.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX3 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-3 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SRY (Sex Determining Region Y)-Box 3 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional activators.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX2 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-2 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional activators.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX1 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SRY (Sex Determining Region Y)-Box 1 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-1 Transcription Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055749</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional repressors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOXB2 Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Group B2 Sox Transcription Factors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional repressors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX21 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-21 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SRY (Sex Determining Region Y)-Box 21 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of SOX transcription factors that are expressed in neuronal tissue where they may play a role in the regulation of CELL DIFFERENTIATION. Members of this subclass are generally considered to be transcriptional repressors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX14 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SRY (Sex Determining Region Y)-Box 14 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-14 Transcription Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055750</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of parasitic OOMYCETES in the family Peronosporaceae that is the causative agent of late blight of potato.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phytophthora infestans</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055751</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of the group have been found expressed in developing neuronal tissue, LYMPHOCYTES, and during EMBRYONIC DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOXC Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Group C SOX Transcription Factors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of the group have been found expressed in developing neuronal tissue, LYMPHOCYTES, and during EMBRYONIC DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX4 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-4 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of the group have been found expressed in developing neuronal tissue, LYMPHOCYTES, and during EMBRYONIC DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX12 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-12 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of the group have been found expressed in developing neuronal tissue, LYMPHOCYTES, and during EMBRYONIC DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX11 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-11 Transcription Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055752</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Cell Lung Carcinoma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oat Cell Carcinoma of Lung</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oat Cell Lung Cancer</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carcinoma, Small Cell Lung</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Cell Lung Cancer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055754</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The CHEMICAL PROCESSES that occur within the cells, tissues, or an organism and related temporal, spatial, qualitative, and quantitative concepts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metabolic Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metabolism Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metabolism Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metabolic Concepts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metabolic Phenomenon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055755</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of closely-related SOX transcription factors. In addition to a conserved HMG-BOX DOMAIN, members of this group contain a leucine zipper motif which mediates protein DIMERIZATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOXD Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Group D SOX Transcription Factors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. In addition to a conserved HMG-BOX DOMAIN, members of this group contain a leucine zipper motif which mediates protein DIMERIZATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX13 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-13 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. In addition to a conserved HMG-BOX DOMAIN, members of this group contain a leucine zipper motif which mediates protein DIMERIZATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX5 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-5 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. In addition to a conserved HMG-BOX DOMAIN, members of this group contain a leucine zipper motif which mediates protein DIMERIZATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX6 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-6 Transcription Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055756</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Primary or secondary neoplasm in the ARACHNOID or SUBARACHNOID SPACE. It appears as a diffuse fibrotic thickening of the MENINGES associated with variable degrees of inflammation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Meningeal Carcinomatosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carcinomatous Meningitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Leptomeningeal Carcinomatosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055757</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of this subfamily have been implicated in regulating the differentiation of OLIGODENDROCYTES during neural crest formation and in CHONDROGENESIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOXE Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Group E SOX Transcription Factors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of this subfamily have been implicated in regulating the differentiation of OLIGODENDROCYTES during neural crest formation and in CHONDROGENESIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX8 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX8 Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-8 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of this subfamily have been implicated in regulating the differentiation of OLIGODENDROCYTES during neural crest formation and in CHONDROGENESIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX10 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-10 Transcription Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055758</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A SOXE transcription factor that plays a critical role in regulating CHONDROGENESIS; OSTEOGENESIS; and male sex determination. Loss of function of the SOX9  transcription factor due to genetic mutations is a cause of CAMPOMELIC DYSPLASIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX9 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-9 Transcription Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055760</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of this subclass are expressed in VASCULAR ENDOTHELIAL CELLS and may play a role in vasculogenesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOXF Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Group F SOX Transcription Factors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of this subclass are expressed in VASCULAR ENDOTHELIAL CELLS and may play a role in vasculogenesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX18 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-18 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of this subclass are expressed in VASCULAR ENDOTHELIAL CELLS and may play a role in vasculogenesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX7 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-7 Transcription Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of closely-related SOX transcription factors. Members of this subclass are expressed in VASCULAR ENDOTHELIAL CELLS and may play a role in vasculogenesis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>SOX17 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SOX-17 Transcription Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055761</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of pathologic syndromes found in avian species caused by RETICULOENDOTHELIOSIS VIRUS. The distinct syndromes include non-neoplastic runting, acute neoplastic disease, and chronic neoplastic disease. Humans and mammals appear resistant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reticuloendotheliosis, Avian</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Avian Reticuloendotheliosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055762</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Any of six membrane-covered openings between the CRANIAL SUTURES in the incompletely ossified skull of the fetus or newborn infant. The fontanelles normally close sometime after birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cranial Fontanelles</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Fontanel</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Any of six membrane-covered openings between the CRANIAL SUTURES in the incompletely ossified skull of the fetus or newborn infant. The fontanelles normally close sometime after birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Posterior Fontanelle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Posterior Fontanel</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Any of six membrane-covered openings between the CRANIAL SUTURES in the incompletely ossified skull of the fetus or newborn infant. The fontanelles normally close sometime after birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mastoid Fontanelle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mastoid Fontanel</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Any of six membrane-covered openings between the CRANIAL SUTURES in the incompletely ossified skull of the fetus or newborn infant. The fontanelles normally close sometime after birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sphenoidal Fontanelle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sphenoidal Fontanel</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Any of six membrane-covered openings between the CRANIAL SUTURES in the incompletely ossified skull of the fetus or newborn infant. The fontanelles normally close sometime after birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anterior Fontanelle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anterior Fontanel</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055764</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Single-celled, aquatic endoparasitic worms that are currently considered belonging to the phylum CNIDARIA. They have a complex life cycle and parasitize a wide range of hosts including FISHES; ANNELIDA; and BRYOZOA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Myxozoa</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Single-celled, aquatic endoparasitic worms that are currently considered belonging to the phylum CNIDARIA. They have a complex life cycle and parasitize a wide range of hosts including FISHES; ANNELIDA; and BRYOZOA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Myxosporea</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Single-celled, aquatic endoparasitic worms that are currently considered belonging to the phylum CNIDARIA. They have a complex life cycle and parasitize a wide range of hosts including FISHES; ANNELIDA; and BRYOZOA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Malacosporea</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055765</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of signaling adaptor proteins that contain SRC HOMOLOGY DOMAINS. Many members of this family are involved in transmitting signals from CELL SURFACE RECEPTORS to MITOGEN-ACTIVATED PROTEIN KINASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Shc Signaling Adaptor Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Shc Family Adapter Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Shc Adaptor Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of signaling adaptor proteins that contain SRC HOMOLOGY DOMAINS. Many members of this family are involved in transmitting signals from CELL SURFACE RECEPTORS to MITOGEN-ACTIVATED PROTEIN KINASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Src Homology 2 Domain-Containing, Transforming Protein 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Src Homology 2 Domain-Containing-Transforming Protein C3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SHC3 (Src Homology 2 Domain-Containing) Protein</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of signaling adaptor proteins that contain SRC HOMOLOGY DOMAINS. Many members of this family are involved in transmitting signals from CELL SURFACE RECEPTORS to MITOGEN-ACTIVATED PROTEIN KINASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Src Homology 2 Domain-Containing, Transforming Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Src Homology 2 Domain-Containing-Transforming Protein C1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SHC1 (Src Homology 2 Domain-Containing) Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SHC (Src Homology 2 Domain-Containing) Transforming Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SHC-Transforming Protein 1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of signaling adaptor proteins that contain SRC HOMOLOGY DOMAINS. Many members of this family are involved in transmitting signals from CELL SURFACE RECEPTORS to MITOGEN-ACTIVATED PROTEIN KINASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Src Homology 2 Domain-Containing, Transforming Protein 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SHC2 (Src Homology 2 Domain-Containing) Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Src Homology 2 Domain-Containing-Transforming Protein C2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SHC (Src Homology 2 Domain-Containing) Transforming Protein 2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055766</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of MYXOSPOREA that causes whirling disease in salmonids.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Myxobolus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A species of MYXOSPOREA that causes whirling disease in salmonids.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Myxobolus Cerebralis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055767</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins that are chemically bound to a substrate material which renders their location fixed. The immobilization of proteins allows their use in chemical reactions without being diluted by solvent.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immobilized Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055768</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that contain two halogenated benzene rings linked via an OXYGEN atom. Many polybrominated diphenyl ethers are used as FLAME RETARDANTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Halogenated Diphenyl Ethers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that contain two halogenated benzene rings linked via an OXYGEN atom. Many polybrominated diphenyl ethers are used as FLAME RETARDANTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chlorinated Diphenyl Ethers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PCDEs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PCDE Compounds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that contain two halogenated benzene rings linked via an OXYGEN atom. Many polybrominated diphenyl ethers are used as FLAME RETARDANTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Iodinated Diphenyl Ethers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that contain two halogenated benzene rings linked via an OXYGEN atom. Many polybrominated diphenyl ethers are used as FLAME RETARDANTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brominated Diphenyl Ethers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PBDEs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Polybrominated Diphenyl Ethers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PBDE Compounds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that contain two halogenated benzene rings linked via an OXYGEN atom. Many polybrominated diphenyl ethers are used as FLAME RETARDANTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fluorinated Diphenyl Ethers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055770</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Injection of ANALGESICS; LOCAL ANESTHETICS; or NARCOTICS into the PLEURAL CAVITY between the two pleural membranes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Interpleural Analgesia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intrapleural Analgesia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055771</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A republic  located south of HUNGARY, west of ROMANIA and BULGARIA, and part of the former YUGOSLAVIA. The capital is Belgrade.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serbia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055772</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pollution prevention through the design of effective chemical products that have low or no toxicity and use of chemical processes that reduce or eliminate the use and generation of hazardous substances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Green Chemistry Technology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Environmentally Friendly Chemistry Technology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sustainable Chemistry Technology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Environmentally Friendly Chemical Technology</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Pollution prevention through the design of effective chemical products that have low or no toxicity and use of chemical processes that reduce or eliminate the use and generation of hazardous substances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Green Chemical Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Environmentally Friendly Chemical Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055785</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gene Knockdown Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knockdown</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock-Down</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock-Down Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock Down</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock Down Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055786</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques to alter a gene sequence that result in an inactivated gene, or one in which the expression can be inactivated at a chosen time during development to study the loss of function of a gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gene Knockout Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knockout</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock-Out Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock Out</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock Out Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055787</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Former state in north central Germany. Formally abolished March 1, 1947. Kingdom established 1701.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prussia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055805</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physical management of the patient while they are being moved or lifted, or during rehabilitation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Moving and Lifting Patients</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Repositioning</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Moving and Lifting</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Lifting</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Moving</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Physical management of the patient while they are being moved or lifted, or during rehabilitation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Patient Handling</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055806</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The finer blood vessels of the vasculature that are generally less than 100 microns in internal diameter.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microvessels</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The finer blood vessels of the vasculature that are generally less than 100 microns in internal diameter.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microvasculature</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microvascular Network</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055807</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Course of conduct directed at a specific person that involves repeated (two or more occasions) visual or physical proximity, nonconsensual communication, or verbal, written, or implied threats, or a combination thereof, that would cause a reasonable person fear.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stalking</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055808</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process of finding chemicals for potential therapeutic use.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Discovery</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The process of finding chemicals for potential therapeutic use.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Prospecting</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055809</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Coordinate set of non-specific behavioral responses to non-psychiatric illness. These may include loss of APPETITE or LIBIDO; disinterest in ACTIVITIES OF DAILY LIVING; or withdrawal from social interaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Illness Behavior</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sickness Behavior</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055810</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A sampling methodology using small sample sizes when conducting surveys in small geographical or population-based areas or lots.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lot Quality Assurance Sampling</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>LQAS</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055811</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A quantitative measure of the frequency on average with which articles in a journal have been cited in a given period of time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Journal Impact Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055812</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Collaborative process of research involving researchers and community representatives.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Community-Based Participatory Research</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055813</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Skills and knowledge required for assessment and treatment of traumatic, environmental, and medical emergencies in remote geographic or wilderness environments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wilderness Medicine</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055814</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Environment un-modified by human activity. Areas in which natural processes operate without human interference.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wilderness</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055815</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A person between 19 and 24 years of age.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Young Adult</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055816</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Moving oneself through space while confused or otherwise cognitively impaired. Patterns include akathisia, exhibiting neuroleptic-induced pacing and restlessness; exit seekers who are often newly admitted institution residents who try to open locked exit doors; self-stimulators who perform other activities such as turning doorknobs, in addition to continuous pacing; and modelers who shadow other pacers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wandering Behavior</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055817</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Delivery of nursing services via remote telecommunications.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Telenursing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055818</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Public-Private Section Cooperation</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Public-Private Sector Partnerships</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Public-Private Partnerships</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Public-Private Section Cooperation</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Public-Private Sector Cooperation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Public-Private Cooperation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055819</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Buildings or  ships used for quarantine detention.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hospitals, Isolation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Buildings or  ships used for quarantine detention.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stations, Quarantine</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Buildings or  ships used for quarantine detention.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lazarettos</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055820</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>City in Orleans Parish (county), largest city in state of LOUISIANA. It is located between the Mississippi River and Lake Pontchartrain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>New Orleans</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055821</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Works that consist of literary and oral genre expressing meaning via symbolism and following formal or informal patterns.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Poetry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055823</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Collections of recipes or instructions for preparation of food and organization of meals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cookbooks</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recipe Books</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cookbook</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Collections of recipes or instructions for preparation of food and organization of meals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recipes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055824</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Works that consist of lists of drugs or collections of recipes, formulas, and prescriptions for the compounding of medicinal preparations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Formularies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055825</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Component of the NATIONAL INSTITUTES OF HEALTH.  It supports and conducts research, both basic and clinical, on the normal and diseases nervous system. It was established in 1950.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>National Institute of Neurological Disorders and Stroke</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NINDS</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>National Institute of Neurological Disorders and Stroke (U.S.)</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055826</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Multinational coalition military operation initiated in October 2001 to counter terrorism and bring security to AFGHANISTAN in collaboration with Afghan forces.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Afghan Campaign 2001-</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Operation Enduring Freedom</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Afghan War, 2001-</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055827</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The properties and relationships and biological processes that characterize the nature and function of the SKIN and its appendages.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Integumentary System Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Integumentary System Physiology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Integumentary System Physiological Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Integumentary System Physiological Phenomenon Concepts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055847</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hereditary nonpolyposis colorectal neoplasms associated with other malignancies, more commonly of ovarian or uterine origin. When also associated with SEBACEOUS GLAND NEOPLASMS, it is called MUIR-TORRE SYNDROME.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lynch Syndrome II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lynch Cancer Family Syndrome II</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055848</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Facilities that convert NUCLEAR ENERGY into electrical energy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Power Plants</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055864</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Prolonged dry periods in natural climate cycle. They are slow-onset phenomena caused by rainfall deficit combined with other predisposing factors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Droughts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Drought</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055865</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A progressive advance or delay of bedtime until the desired bedtime is achieved.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sleep Phase Chronotherapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A progressive advance or delay of bedtime until the desired bedtime is achieved.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phase Advance Chronotherapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A progressive advance or delay of bedtime until the desired bedtime is achieved.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phase Delay Chronotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055866</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sudden slips on a fault, and the resulting ground shaking and radiated seismic energy caused by the slips, or by volcanic or magmatic activity, or other sudden stress changes in the earth.  Faults are fractures along which the blocks of EARTH crust on either side have moved relative to one another parallel to the fracture.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Earthquakes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055867</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A tropical cyclone in which the maximum sustained surface wind speed ranges from 34 kt (39 mph or 63 km/hr) to 63 kt (73 mph or 118 km/hr).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclonic Storms</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cyclone</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cyclones</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A tropical cyclone in which the maximum sustained surface wind speed ranges from 34 kt (39 mph or 63 km/hr) to 63 kt (73 mph or 118 km/hr).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Typhoons</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Typhoon</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A tropical cyclone in which the maximum sustained surface wind speed ranges from 34 kt (39 mph or 63 km/hr) to 63 kt (73 mph or 118 km/hr).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hurricanes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hurricane</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A tropical cyclone in which the maximum sustained surface wind speed ranges from 34 kt (39 mph or 63 km/hr) to 63 kt (73 mph or 118 km/hr).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tropical Storm</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055868</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sudden onset water phenomena with different speed of occurrence. These include flash floods, seasonal river floods, and coastal floods, associated with CYCLONIC STORMS; TIDALWAVES; and storm surges.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Floods</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Sudden onset water phenomena with different speed of occurrence. These include flash floods, seasonal river floods, and coastal floods, associated with CYCLONIC STORMS; TIDALWAVES; and storm surges.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Flooding, Catastrophic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Catastrophic Flooding</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055869</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rotating column of air extending from a thunderstorm to the ground.  Tornadoes generally produce damage paths of 100 yards wide or less, with path lengths of a couple miles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tornadoes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tornado</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055870</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The adaptation of drug administration to the known variations in biological RHYTHMICITY, such as CIRCADIAN RHYTHMS. The treatment is aimed at supporting normal rhythms, or modifying the timing of therapy to achieve maximal efficacy and minimal adverse effect.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Chronotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055871</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Water waves caused by the gravitational interactions between the EARTH; MOON; and SUN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tidal Waves</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Earth Tides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ocean Tides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tidalwaves</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055872</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A health care system's ability to rapidly mobilize to meet an increased demand, to rapidly expand beyond normal services levels to meet the increased demand in the event of large-scale DISASTERS or public health emergencies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Surge Capacity</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055873</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Below normal weather temperatures that may lead to serious health problems. Extreme cold is a dangerous situation that can bring on health emergencies in susceptible people.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Extreme Cold</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055874</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>High temperature weather exceeding the average and of several weeks duration. Extreme heat is a dangerous situation that can bring on health emergencies in susceptible people.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Extreme Heat</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055875</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Mass of snow and/or ice falling down a mountain or incline.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Avalanches</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Avalanche</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055876</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Downslope movements of mud.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Landslides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Downslope movements of mud.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rockslides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Downslope movements of mud.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mudslides</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055877</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Monitoring of information sources of potential value in detecting an emerging epidemic, whether naturally occurring or the result of bioterrorism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biosurveillance</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055879</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques used to add in exogenous gene sequence such as mutated genes; REPORTER GENES, to study mechanisms of gene expression; or regulatory control sequences, to study effects of temporal changes to GENE EXPRESSION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gene Knock-In Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock In Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock-In</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Knock In</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055881</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A multidisciplinary field of research and practice studying the periodicity of biological systems and the application of principles of chronobiology to various therapeutic strategies. Aging, biological rhythms, and cyclic phenomena are included. Statistical, computer-aided mathematical procedures are used to describe, in mathematical terminology, various biological functions over time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chronobiology Discipline</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055882</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A benign skin lesion characterized by a zone of depigmentation surrounding the nevus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nevus, Halo</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Leukoderma Acquisitum Centrifugum of Sutton</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nevi, Halo</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055883</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Loss of functional integrity of man-made structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Structure Collapse</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Structure Failure</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Loss of functional integrity of man-made structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Levee Collapse</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Levee Failure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dike Failure</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Loss of functional integrity of man-made structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dam Collapse</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Loss of functional integrity of man-made structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bridge Failure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bridge Collapse</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Loss of functional integrity of man-made structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Building Collapse</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055884</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Non-deliberate uncontrolled release of a chemical from its containment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemical Hazard Release</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Incidents, Chemical</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hazrad Release, Chemical</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Non-deliberate uncontrolled release of a chemical from its containment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Accidents, Chemical</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accidental Release, Chemical</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055885</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Uncontrolled release of biological material from its containment. This either threatens to, or does, cause exposure to a biological hazard. Such an incident may occur accidentally or deliberately.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biohazard Release</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Uncontrolled release of biological material from its containment. This either threatens to, or does, cause exposure to a biological hazard. Such an incident may occur accidentally or deliberately.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Accidents, Biological</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accidents, Biohazard</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accidental Release, Biological</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Uncontrolled release of biological material from its containment. This either threatens to, or does, cause exposure to a biological hazard. Such an incident may occur accidentally or deliberately.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Incidents, Biological</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055904</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The science of studying the characteristics of the atmosphere such as its temperature, density, winds, clouds, precipitation, and other atmospheric phenomena and aiming to account for the weather in terms of external influences and the basic laws of physics. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Meteorology</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The science of studying the characteristics of the atmosphere such as its temperature, density, winds, clouds, precipitation, and other atmospheric phenomena and aiming to account for the weather in terms of external influences and the basic laws of physics. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Climatology</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The science of studying the characteristics of the atmosphere such as its temperature, density, winds, clouds, precipitation, and other atmospheric phenomena and aiming to account for the weather in terms of external influences and the basic laws of physics. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biometeorology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055905</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>ANTHRAX outbreak  that occurred in 1979 and was associated with a research facility in Sverdlovsk, in the Ural mountain region of central RUSSIA.  Most victims worked or lived in a narrow zone extending from the facility. The zone of anthrax-caused livestock mortality paralleled the northerly wind that prevailed shortly before the outbreak. It was concluded that an escape of ANTHRAX caused outbreak.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sverdlovsk Accidental Release</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055906</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>1976 accidental release of DIOXINS from a manufacturing facility in Seveso, ITALY following an equipment failure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Seveso Accidental Release</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055907</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Characteristic events occurring in the ATMOSPHERE during the interactions and transformation of various atmospheric components and conditions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Climatic Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Climatic Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055908</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>1984 accident in Bhopal, INDIA at a PESTICIDES facility, resulting when WATER entered a storage tank containing ISOCYANATES. The following accidental chemical release and uncontrolled reaction resulted in several thousand deaths.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bhopal Accidental Release</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bhopal Chemical Accident</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055909</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The magnetic stimulation of specific target tissues or areas of the body for therapeutic purposes via the application of magnetic fields generated by MAGNETS or ELECTROMAGNETS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Magnetic Field Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Magnetic Stimulation Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055910</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Antibodies that are chemically bound to a substrate material which renders their location fixed.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antibodies, Immobilized</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immobilized Antibodies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055927</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Instructions on preparation of specific food for eating.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cookbooks as Topic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Instructions on preparation of specific food for eating.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recipes as Topic</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055928</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Biological activities and functions of the SKIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Skin Physiological Processes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Skin Physiological Process</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055944</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Membrane-bound prokaryotic organelles of magnetotactic bacteria that contain chains of MAGNETITE crystals which orient the bacteria to geomagnetic fields.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Magnetosomes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055947</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Loeys-Dietz Syndrome with aortic aneurysm or dissection.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Loeys-Dietz Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Loeys-Dietz Syndrome with aortic aneurysm or dissection.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Loeys-Dietz Aortic Aneurysm Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055948</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sarcopenia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055949</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pregnancy complication where fetal blood vessels, normally inside the umbilical cord, are left unprotected and cross FETAL MEMBRANES. It is associated with antepartum bleeding and FETAL DEATH and STILLBIRTH due to exsanguination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vasa Previa</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vasa Praevia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055951</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Components of the usual diet that may provide health benefits beyond basic nutrients. Examples of functional foods include soy, nuts, chocolate, and cranberries (From NCCAM Backgrounder, March 2004, p3). Soy, for example, provides not only protein but also PHYTOESTROGENS (isoflavones), which help reduce total blood cholesterol by lowering LDL CHOLESTEROL.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Functional Food</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055952</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A condition consisting of inflammatory eye disease usually presenting as interstitial KERATITIS, vestibuloauditory dysfunction, and large- to medium-vessel vasculitis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cogan Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cogans Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cogan's Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055953</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A primary systemic vasculitis of small- and some medium-sized vessels. It is characterized by a tropism for kidneys and lungs, positive association with anti-neutrophil cytoplasmic antibodies (ANCA), and a paucity of immunoglobulin deposits in vessel walls.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microscopic Polyangiitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055954</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Loss of CORNEAL ENDOTHELIUM usually following intraocular surgery (e.g., cataract surgery) or due to FUCHS' ENDOTHELIAL DYSTROPHY; ANGLE-CLOSURE GLAUCOMA; IRITIS; or aging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Corneal Endothelial Cell Loss</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endothelial Cell Loss, Corneal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Corneal Endothelial Cell Damage</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055955</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare disorder consisting of microangiopathy of brain, retina, and inner ear ARTERIOLES. It is characterized by the clinical triad of encephalopathy, BRANCH RETINAL ARTERY OCCLUSION and VERTIGO/hearing loss.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Susac Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Susac's Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinocochleocerebral Vasculopathy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055956</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of presenile DEMENTIA characterized by cortical dementia, NEUROFIBRILLARY TANGLES without SENILE PLAQUES, Fahr's type CALCINOSIS, and ATROPHY in frontotemporal or TEMPORAL LOBE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diffuse Neurofibrillary Tangles with Calcification</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kosaka-Shibayama Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055958</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A chronic PELVIC PAIN characterized by pain deep in the buttock that may radiate to posterior aspects of the leg. It is caused by the piriformis muscle compressing or irritating the SCIATIC NERVE due to trauma, hypertrophy, inflammation or anatomic variations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Piriformis Muscle Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Piriformis syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055959</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Degenerative changes in the INTERVERTEBRAL DISC due to aging or structural damage, especially to the vertebral end-plates.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intervertebral Disc Degeneration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intervertebral Disk Degeneration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Disk Degeneration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Disk Degradation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Disc Degeneration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Disc Degradation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Degenerative changes in the INTERVERTEBRAL DISC due to aging or structural damage, especially to the vertebral end-plates.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Degenerative Intervertebral Discs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Degenerative Intervertebral Disks</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055963</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Asthmatic adverse reaction (e.g., BRONCHOCONSTRICTION) to conventional NSAIDS including aspirin use.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Asthma, Aspirin-Induced</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Asthma, NSAID-induced</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspirin-Induced Asthma Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspirin Induced Asthma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspirin-Induced Asthma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055964</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An apraxia characterized by the affected limb having involuntary, autonomous, and purposeful behaviors that are perceived as being controlled by an external force. Often the affected limb interferes with the actions of the normal limb. Symptoms develop from lesions in the CORPUS CALLOSUM or medial frontal cortex, stroke, infarction, and neurodegenerative diseases (e.g., CREUTZFELDT-JAKOB SYNDROME, corticobasal degeneration).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alien Hand Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anarchic Hand Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055966</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Fluid collected from nipple by gentle aspiration. The fluid contains cells and extracellular fluid from the breast ductal epithelium.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nipple Aspirate Fluid</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055984</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A stream of low-energy ELECTRONS produced in cathode ray tubes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathode Ray Tube</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cathode Ray Tubes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A stream of low-energy ELECTRONS produced in cathode ray tubes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathode Rays</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A stream of low-energy ELECTRONS produced in cathode ray tubes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathode Ray Tube Display</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055985</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Latent Tuberculosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Latent Tuberculosis Infection</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055986</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The signs of life that may be monitored or measured, namely pulse rate, respiratory rate, body temperature, and blood pressure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vital Signs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055988</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A branch arising from the internal iliac artery in females, that supplies blood to the uterus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uterine Artery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055989</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A CATHETER-delivered implant used for closing abnormal holes in the cardiovascular system, especially HEART SEPTAL DEFECTS; or passageways intentionally made during cardiovascular surgical procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Septal Occluder Device</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Septal Occluder</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A CATHETER-delivered implant used for closing abnormal holes in the cardiovascular system, especially HEART SEPTAL DEFECTS; or passageways intentionally made during cardiovascular surgical procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Helex Septal Occluder</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gore-Helex Septal Occluder</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A CATHETER-delivered implant used for closing abnormal holes in the cardiovascular system, especially HEART SEPTAL DEFECTS; or passageways intentionally made during cardiovascular surgical procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Amplatzer Septal Occluder</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amplatzer Occluder</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amplatzer Occluder Device</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amplatzer Septal Occluder Device</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A CATHETER-delivered implant used for closing abnormal holes in the cardiovascular system, especially HEART SEPTAL DEFECTS; or passageways intentionally made during cardiovascular surgical procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CardioSeal Septal Occluder</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CardioSeal Occluder</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055990</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Underestimation of risk and overestimation of benefit by subjects participating in medical research.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Therapeutic Misconception</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Underestimation of risk and overestimation of benefit by subjects participating in medical research.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Therapeutic Misestimation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055991</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Patient-maintained records of individual health history in electronic form.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Health Records, Personal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Personal Health Records</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Patient-maintained records of individual health history in electronic form.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Personal Medical Records</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Patient-maintained records of individual health history in electronic form.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Personal Electronic Health Records</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Patient-maintained records of individual health history in electronic form.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Computerized Patient Records</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Records, Computerized</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055993</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The forms of the PLANT GERM CELLS at the final stage of GAMETOGENESIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Germ Cells, Plant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plant Germ Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The forms of the PLANT GERM CELLS at the final stage of GAMETOGENESIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Generative Cells, Plant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The forms of the PLANT GERM CELLS at the final stage of GAMETOGENESIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gametes, Plant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plant Gametes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The forms of the PLANT GERM CELLS at the final stage of GAMETOGENESIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gametophytes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D055994</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The study of the physical, chemical, hydrological, and biological aspects of fresh water bodies. (EPA Terms of Environment: Glossary, Abbreviations and Acronyms [Internet] US Environmental Protection Agency [cited 2008 Sep 25] available from http://www.epa.gov/OCEPAterms/aterms.html)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Limnology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056004</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A computer simulation developed to study the motion of molecules over a period of time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molecular Dynamics Simulation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Molecular Dynamics Simulations</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A computer simulation developed to study the motion of molecules over a period of time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molecular Dynamics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056005</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of LEPROSY classified by the World Health Organization for the purpose of treatment, based on clinical manifestations and skin smear results. Patients with paucibacillary leprosy have fewer than six skin lesions with no causative agent MYCOBACTERIUM LEPRAE on any slit-skin smear testing. Paucibacillary leprosy encompasses indeterminate, borderline tuberculoid, and tuberculoid leprosy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leprosy, Paucibacillary</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Paucibacillary Leprosy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Borderline Tuberculoid</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Indeterminate Tuberculoid</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056006</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of LEPROSY classified by the World Health Organization for the purpose of treatment, based on clinical manifestations and skin smear results. Patients with multibacillary leprosy have six or more lesions with or without positive skin smear results for the causative agent MYCOBACTERIUM LEPRAE. Multibacillary leprosy encompasses borderline lepromatous, midborderline, and lepromatous leprosy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leprosy, Multibacillary</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Borderline Lepromatous</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Midborderline Lepromatous</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multibacillary Leprosy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056044</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The measurement and recording of MOTOR ACTIVITY to assess rest/activity cycles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Actigraphy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056084</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The relative likelihood that an organism will survive and pass on its genes to the next generation in comparison to organisms with a different gene or genotype. It is a mathematically calculable ratio determined from the average number of offspring contributed to a population by a particular genotype during one generation compared to the average number of offspring contributed by competing genotypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genetic Fitness</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The relative likelihood that an organism will survive and pass on its genes to the next generation in comparison to organisms with a different gene or genotype. It is a mathematically calculable ratio determined from the average number of offspring contributed to a population by a particular genotype during one generation compared to the average number of offspring contributed by competing genotypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reproductive Fitness</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The relative likelihood that an organism will survive and pass on its genes to the next generation in comparison to organisms with a different gene or genotype. It is a mathematically calculable ratio determined from the average number of offspring contributed to a population by a particular genotype during one generation compared to the average number of offspring contributed by competing genotypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Darwinian Fitness</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056104</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A sudden CARDIAC ARRHYTHMIA (e.g., VENTRICULAR FIBRILLATION) caused by a blunt, non-penetrating impact to the precordial region of chest wall. Commotio cordis often results in sudden death without prompt cardiopulmonary defibrillation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Commotio Cordis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac Concussion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056124</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An intermittent and self-limiting headache disorder in individuals with CEREBROSPINAL FLUID SHUNTS emplaced for the treatment of HYDROCEPHALUS. The symptoms of headache, vomiting, and cranial neuropathies are associated with intermittent obstruction of the shunt.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Slit Ventricle Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056126</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A surgical procedure in which an undescended testicle is sutured inside the SCROTUM in male infants or children to correct CRYPTORCHIDISM. Orchiopexy is also performed to treat TESTICULAR TORSION in adults and adolescents.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Orchiopexy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orchidopexy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A surgical procedure in which an undescended testicle is sutured inside the SCROTUM in male infants or children to correct CRYPTORCHIDISM. Orchiopexy is also performed to treat TESTICULAR TORSION in adults and adolescents.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laparoscopic Orchiopexy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056127</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The study of aquatic life inhabiting bodies of water, including growth, morphology, physiology, genetics, distribution, and interactions with other organisms and the environment. It includes MARINE HYDROBIOLOGY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hydrobiology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aquatic Biology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aquatic Ecology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056128</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Obesity due to excessive deposition of INTRA-ABDOMINAL FAT in the abdominal VISCERA and OMENTUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Obesity, Abdominal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Central Obesity</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Obesity due to excessive deposition of INTRA-ABDOMINAL FAT in the abdominal VISCERA and OMENTUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Obesity, Visceral</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Visceral Obesity</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056130</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process of germ cell development in plants, from the primordial PLANT GERM CELLS to the mature haploid PLANT GAMETES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gametogenesis, Plant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plant Gametogenesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The process of germ cell development in plants, from the primordial PLANT GERM CELLS to the mature haploid PLANT GAMETES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Spermatogenesis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spermatogenesis, Plant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The process of germ cell development in plants, from the primordial PLANT GERM CELLS to the mature haploid PLANT GAMETES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microsporogenesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The process of germ cell development in plants, from the primordial PLANT GERM CELLS to the mature haploid PLANT GAMETES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antheridiogenesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The process of germ cell development in plants, from the primordial PLANT GERM CELLS to the mature haploid PLANT GAMETES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Megasporogenesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056144</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A recess on each side in the wall of the HYPOPHARYNX.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pyriform Sinus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Piriform Sinus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Piriform Fossa</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Piriform Recess</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056145</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The study of life and ECOLOGIC SYSTEMS in bodies of FRESHWATER.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Freshwater Biology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fresh Water Biology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056146</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Disjoining the limbs or other parts of a corpse, often in association with criminal acts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Corpse Dismemberment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cadaver Dismemberment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056147</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A treatment strategy that uses the movement of the horse as a treatment tool for the rider who has physical, developmental or other limitations (e.g., cerebral palsy). Typically, a hippotherapy session involves a team of a health professional (e.g., occupational therapist), a horse handler, and the rider. The rhythm of the horse's movement is thought to challenge and influence the rider in improving balance, muscle symmetry, gross motor functions, etc.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Equine-Assisted Therapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A treatment strategy that uses the movement of the horse as a treatment tool for the rider who has physical, developmental or other limitations (e.g., cerebral palsy). Typically, a hippotherapy session involves a team of a health professional (e.g., occupational therapist), a horse handler, and the rider. The rhythm of the horse's movement is thought to challenge and influence the rider in improving balance, muscle symmetry, gross motor functions, etc.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hippotherapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A treatment strategy that uses the movement of the horse as a treatment tool for the rider who has physical, developmental or other limitations (e.g., cerebral palsy). Typically, a hippotherapy session involves a team of a health professional (e.g., occupational therapist), a horse handler, and the rider. The rhythm of the horse's movement is thought to challenge and influence the rider in improving balance, muscle symmetry, gross motor functions, etc.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recreational Horseback Riding Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Horseback Riding Therapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A treatment strategy that uses the movement of the horse as a treatment tool for the rider who has physical, developmental or other limitations (e.g., cerebral palsy). Typically, a hippotherapy session involves a team of a health professional (e.g., occupational therapist), a horse handler, and the rider. The rhythm of the horse's movement is thought to challenge and influence the rider in improving balance, muscle symmetry, gross motor functions, etc.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Equine-Assisted Psychotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056148</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A chromatography technique in which the stationary phase is composed of a non-polar substance with a polar mobile phase, in contrast to normal-phase chromatography in which the stationary phase is a polar substance with a non-polar mobile phase.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromatography, Reverse-Phase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reverse-Phase Chromatography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reversed-Phase Chromatography</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A chromatography technique in which the stationary phase is composed of a non-polar substance with a polar mobile phase, in contrast to normal-phase chromatography in which the stationary phase is a polar substance with a non-polar mobile phase.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromatography, Reversed-Phase Liquid</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reversed-Phase Liquid Chromatography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reverse-Phase Liquid Chromatography</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056149</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Recording the locations and measurements of electrical activity in the EPICARDIUM by placing electrodes on the surface of the heart to analyze the patterns of activation and to locate arrhythmogenic sites.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Epicardial Mapping</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recording the locations and measurements of electrical activity in the EPICARDIUM by placing electrodes on the surface of the heart to analyze the patterns of activation and to locate arrhythmogenic sites.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Percutaneous Epicardial Mapping</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056150</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare skin eruption that is characterized by acute, extensive formation of sterile pustules, fever, and peripheral blood LEUKOCYTOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acute Generalized Exanthematous Pustulosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pustulosis, Exanthematous, Acute Generalized</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A rare skin eruption that is characterized by acute, extensive formation of sterile pustules, fever, and peripheral blood LEUKOCYTOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acute Localized Exanthematous Pustulosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pustulosis, Exanthematous, Acute Localized</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056151</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The structural changes seen in the asthmatic airways, including increased SMOOTH MUSCLE mass, deposition of EXTRACELLULAR MATRIX components, and thickening of the epithelial reticular BASEMENT MEMBRANE. Asthmatic airway remodeling is often associated with airway function decline (e.g., airflow limitation, persistent airway hyper-responsiveness, and allergic airway inflammation).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Airway Remodeling</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Airway Wall Remodelling</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Airway Remodelling</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The structural changes seen in the asthmatic airways, including increased SMOOTH MUSCLE mass, deposition of EXTRACELLULAR MATRIX components, and thickening of the epithelial reticular BASEMENT MEMBRANE. Asthmatic airway remodeling is often associated with airway function decline (e.g., airflow limitation, persistent airway hyper-responsiveness, and allergic airway inflammation).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Airway Remodeling</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Airway Remodelling</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The structural changes seen in the asthmatic airways, including increased SMOOTH MUSCLE mass, deposition of EXTRACELLULAR MATRIX components, and thickening of the epithelial reticular BASEMENT MEMBRANE. Asthmatic airway remodeling is often associated with airway function decline (e.g., airflow limitation, persistent airway hyper-responsiveness, and allergic airway inflammation).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Asthmatic Airway Remodeling</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Asthmatic Airway Wall Remodeling</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Asthmatic Airway Wall Remodelling</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Asthmatic Airway Remodelling</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056152</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The number of times an organism breathes with the lungs (RESPIRATION) per unit time, usually per minute.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Respiratory Rate</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Respiration Rate</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056164</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Systematic discussions and teaching relating to patient care.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Teaching Rounds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Systematic discussions and teaching relating to patient care.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Grand Rounds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Systematic discussions and teaching relating to patient care.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Morning Rounds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Systematic discussions and teaching relating to patient care.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Attending Rounds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Systematic discussions and teaching relating to patient care.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Morning Report</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056185</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Strains of PRIMATE T-LYMPHOTROPIC VIRUS 3 isolated from diverse primate species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Simian T-lymphotropic virus 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>STLV-3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>STLV-L</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Simian T-lymphotropic virus-L</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056186</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The genomic analysis of assemblages of organisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metagenomics</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Environmental Genomics</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Population Genomics</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Community Genomics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056187</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A strain of PRIMATE T-LYMPHOTROPIC VIRUS 3 that is genetically similar to STLV-3.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Human T-lymphotropic virus 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HTLV-3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056189</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The specificity of a virus for infecting a particular type of cell or tissue.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viral Tropism</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tropism, Viral</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056224</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The structural parts of the VIRION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viral Structures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Virus Structures</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The structural parts of the VIRION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viral Components</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Virus Components</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056226</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The parts of bacteria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bacterial Structures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056228</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A mechanism of communicating one's own sensory system information about a task, movement or skill.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Feedback, Sensory</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A mechanism of communicating one's own sensory system information about a task, movement or skill.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proprioceptive Feedback</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A mechanism of communicating one's own sensory system information about a task, movement or skill.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Visual Feedback</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A mechanism of communicating one's own sensory system information about a task, movement or skill.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Audio Feedback</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A mechanism of communicating one's own sensory system information about a task, movement or skill.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sensorimotor Feedback</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056229</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The parts of fungi.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fungal Structures</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The parts of fungi.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fungal Components</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056245</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A enzyme complex involved in the remodeling of  NUCLEOSOMES. The complex is comprised of at least seven subunits and includes both histone deacetylase and ATPase activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mi-2 Nucleosome Remodeling and Deacetylase Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NuRD Histone Deacetylase Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nucleosome Remodeling and Deacetylase Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NuRD Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Histone Deacetylase Complex MI-2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Histone Deacetylase Complex NuRD</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056246</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The branch of chemistry dealing with detection (qualitative) and determination (quantitative) of substances. (Grant &amp; Hackh's Chemical Dictionary, 5th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemistry, Analytic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Analytic Chemistry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056264</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A multisubunit enzyme complex that regulates GENETIC TRANSCRIPTION by deacetylating the HISTONE residues of NUCLEOSOMES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sin3 Histone Deacetylase and Corepressor Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SIN3 Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SIN3 Histone Deacetylase Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sin3-Histone Deacetylase (HDAC) Corepressor Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SIN-3 Histone Deacetylase Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sin3 Corepressor Complex</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056265</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The inter- and intra-relationships between various microorganisms. This can include both positive (like SYMBIOSIS) and negative (like ANTIBIOSIS) interactions. Examples include virus - bacteria and bacteria - bacteria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microbial Interactions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The inter- and intra-relationships between various microorganisms. This can include both positive (like SYMBIOSIS) and negative (like ANTIBIOSIS) interactions. Examples include virus - bacteria and bacteria - bacteria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cooperative Behavior, Microbial</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The inter- and intra-relationships between various microorganisms. This can include both positive (like SYMBIOSIS) and negative (like ANTIBIOSIS) interactions. Examples include virus - bacteria and bacteria - bacteria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Competitive Behavior, Microbial</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056266</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An autosomal dominant skin disease characterized by transient and variable noninflammatory ERYTHEMA and hyperkeratosis. It has been associated with mutations in the genes that code for CONNEXINS.  Erythrokeratodermia variabilis inherited in an autosomal recessive fashion has also been reported. Affected individuals often develop PALMOPLANTAR KERATODERMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Erythrokeratodermia Variabilis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Erythrokeratodermia Figurata Variabilis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mendes De Costa Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Erythro et Keratodermia Variabilis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An autosomal dominant skin disease characterized by transient and variable noninflammatory ERYTHEMA and hyperkeratosis. It has been associated with mutations in the genes that code for CONNEXINS.  Erythrokeratodermia variabilis inherited in an autosomal recessive fashion has also been reported. Affected individuals often develop PALMOPLANTAR KERATODERMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Greither Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transgrediens et Progrediens Palmoplantar Keratoderma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056267</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A generalized or disseminated form of pagetoid reticulosis. Some authors consider it to be a primary cutaneous aggressive epidermotrophic CD8+ T-Cell lymphoma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pagetoid Reticulosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Woringer Kolopp Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Woringer-Kolopp Disease</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A generalized or disseminated form of pagetoid reticulosis. Some authors consider it to be a primary cutaneous aggressive epidermotrophic CD8+ T-Cell lymphoma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ketron-Goodman Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056284</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A histone deacetylase subtype that is found along with HISTONE DEACETYLASE 2; RETINOBLASTOMA-BINDING PROTEIN 4; and RETINOBLASTOMA-BINDING PROTEIN 7 as core components of histone deacetylase complexes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Histone Deacetylase 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HDAC1 Histone Deacetylase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RPD3L1 Histone Deacetylase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056285</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella bacillispora.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cryptococcus gattii</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cryptococcus neoformans var. gattii</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056286</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of endogenous regulatory proteins that associate with RETINOBLASTOMA PROTEIN via a specific high-affinity binding domain. Members of this family of proteins are often found associated with histone-modifying enzymes and protein complexes that regulate gene expression.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoblastoma Binding Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RBBP Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinoblastoma Protein Binding Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056304</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An inward slant of the thigh in which the knees are close together and the ankles far apart. Genu valgum can develop due to skeletal and joint dysplasias (e.g., OSTEOARTHRITIS; HURLER SYNDROME); and malnutrition (e.g., RICKETS; FLUORIDE POISONING).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genu Valgum</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Knock Knee</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genu Valga</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056305</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An outward slant of the thigh in which the knees are wide apart and the ankles close together. Genu varum can develop due to skeletal and joint dysplasia (e.g., OSTEOARTHRITIS; Blount's disease); and malnutrition (e.g., RICKETS; FLUORIDE POISONING).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genu Varum</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genu Varus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bow Leg</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056324</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The tracing of neural or muscle fibers by diffusion tensor imaging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diffusion Tensor Imaging</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The tracing of neural or muscle fibers by diffusion tensor imaging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diffusion Tractography</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056325</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Substances used to identify the location and to characterize the types of NEURAL PATHWAYS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neuronal Tract-Tracers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuroanatomical Tract-Tracing Markers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056344</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Executive Function</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Executive Control</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056345</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ability to attribute mental states (e.g., beliefs, desires, feelings, intentions, thoughts, etc.) to self and to others, allowing an individual to understand and infer behavior on the basis of the mental states. Difference or deficit in theory of mind is associated with ASPERGER SYNDROME; AUTISTIC DISORDER; and SCHIZOPHRENIA, etc.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Theory of Mind</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mentalizing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056346</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Incision through the midline of the STERNUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sternotomy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Incision through the midline of the STERNUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Median Sternotomy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056347</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods used to label and follow the course of NEURAL PATHWAYS by AXONAL TRANSPORT of injected NEURONAL TRACT-TRACERS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neuroanatomical Tract-Tracing Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuron Pathway Tracing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuronal Pathway Tracing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuroanatomical Tract-Tracing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056348</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ability to understand and manage emotions and to use emotional knowledge to enhance thought and deal effectively with tasks. Components of emotional intelligence include empathy, self-motivation, self-awareness, self-regulation, and social skill. Emotional intelligence is a measurement of one's ability to socialize or relate to others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Emotional Intelligence</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The ability to understand and manage emotions and to use emotional knowledge to enhance thought and deal effectively with tasks. Components of emotional intelligence include empathy, self-motivation, self-awareness, self-regulation, and social skill. Emotional intelligence is a measurement of one's ability to socialize or relate to others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Social Intelligence</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056352</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Individuals who have developed skills, physical stamina and strength or participants in SPORTS or other physical activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Athletes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056364</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Benign, congenital, neuroepithelial cysts that are typically filled with a viscous mucus. They usually arise in the anterior portion of the THIRD VENTRICLE between the fornices.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Colloid Cysts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056384</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subcategory of chaperonins found in MITOCHONDRIA; CHLOROPLASTS; and BACTERIA. Group I chaperonins form into a barrel-shaped macromolecular structure that is enclosed by a separate lid-like protein component.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Group I Chaperonins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type I Chaperonins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056385</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subcategory of chaperonins found in ARCHAEA and the CYTOSOL of eukaryotic cells. Group II chaperonins form a barrel-shaped macromolecular structure that is distinct from GROUP I CHAPERONINS in that it does not utilize a separate lid like structure to enclose proteins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Group II Chaperonins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type II Chaperonins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Group II Chaparonins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056404</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin Containing TCP-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cytosolic Molecular Chaperone CCT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing t-Complex Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin CCT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cytosolic Chaperonin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, beta Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, delta Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CCT delta Subunit</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, zeta2 Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 6B</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, eta Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 7</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, gamma Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 3</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, theta Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 8</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, zeta1 Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 6A</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, alpha Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Testis Complex Polypeptide 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>t-Complex Polypeptide 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>t-Complex Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin-Containing T-Complex Polypeptide 1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group II chaperonin found in eukaryotic CYTOSOL. It is comprised of eight subunits with each subunit encoded by a separate gene. This chaperonin is named after one of its subunits which is a T-COMPLEX REGION-encoded polypeptide.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chaperonin CCT, epsilon Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chaperonin Containing TCP1, Subunit 5</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056405</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Group II chaperonins found in species of ARCHAEA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thermosomes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thermosome Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thermosome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056424</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Excision of part of the skull. This procedure is used to treat elevated intracranial pressure that is unresponsive to conventional treatment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Decompressive Craniectomy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056426</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specific regions that are mapped within a GENOME. Genetic loci are usually identified with a shorthand notation that indicates the chromosome number and the position of a specific band along the P or Q arm of the chromosome where they are found. For example the locus 6p21 is found within band 21 of the P-arm of CHROMOSOME 6. Many well known genetic loci are also known by common names that are associated with a genetic function or HEREDITARY DISEASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genetic Loci</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genetic Locus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056427</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A 20 cM region of mouse chromosome 17 that is represented by a least two HAPLOTYPES. One of the haplotypes is referred to as the t-haplotype and contains an unusual array of mutations that affect embryonic development and male fertility. The t-haplotype is maintained in the gene pool by the presence of unusual features that prevent its recombination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>t-Complex Genome Region</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>t-Complex Region</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 20 cM region of mouse chromosome 17 that is represented by a least two HAPLOTYPES. One of the haplotypes is referred to as the t-haplotype and contains an unusual array of mutations that affect embryonic development and male fertility. The t-haplotype is maintained in the gene pool by the presence of unusual features that prevent its recombination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mouse t-Haplotype</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056444</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Dyneins that are responsible for ciliary and flagellar beating.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Axonemal Dyneins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056445</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Dyneins that are responsible for intracellular transport, MITOSIS, cell polarization, and movement within the cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cytoplasmic Dyneins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056446</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The posture of an individual supported by the knees and chest resting on a table.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Knee-Chest Position</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056447</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of live animal as a means of therapy</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Animal Assisted Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Animal Facilitated Therapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The use of live animal as a means of therapy</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pet Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pet Facilitated Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056448</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Fields of science encompassing studies and research from the disciplines of PHYSICS; CHEMISTRY; BIOLOGICAL SCIENCES; and MATHEMATICS; that are related to the planet EARTH. Subfields include atmospheric chemistry; CLIMATOLOGY; ENVIRONMENTAL SCIENCES; GEOGRAPHY; GEOLOGY; geophysics; METEOROLOGY; OCEANOGRAPHY; PALEONTOLOGY; mineralogy; and seismology.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Earth Sciences</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Geoscience</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Geosciences</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Earth Science</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056449</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of GRAM-POSITIVE BACTERIA in the class Bacilli, phylum Firmacutes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bacillales</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056450</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of GRAM-POSITIVE ENDOSPORE-FORMING RODS, in the family Alicyclobacillaceae, containing a unique lipid in their membranes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alicyclobacillus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056464</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A histone deacetylase subtype that is found along with HISTONE DEACETYLASE 1; RETINOBLASTOMA-BINDING PROTEIN 4; and RETINOBLASTOMA-BINDING PROTEIN 7 as core components of histone deacetylase complexes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Histone Deacetylase 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HDAC2 Histone Deacetylase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056465</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A ubiquitously expressed regulatory protein that contains a retinoblastoma protein binding domain and an AT-rich interactive domain. The protein may play a role in recruiting HISTONE DEACETYLASES to the site of RETINOBLASTOMA PROTEIN-containing transcriptional repressor complexes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoblastoma-Binding Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AT-Rich Interactive Domain 4A (RBP1-Like) Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RBBP1 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056466</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Histone Demethylases</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Histone Arginine Demethylases</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Enzymes that catalyse the removal of methyl groups from LYSINE or ARGININE residues found on HISTONES. Many histone demethylases generally function through an oxidoreductive mechanism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Histone Lysine Demethylases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056484</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of histone demethylases that share a conserved Jumonji C domain. The enzymes function via an iron-dependent dioxygenase mechanism that couples the conversion of 2-oxoglutarate to succinate to the hydroxylation of N-methyl groups.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Jumonji Domain-Containing Histone Demethylases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>JmjC Domain-Containing Histone Demethylases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056485</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A retinoblastoma binding protein that is also a member of the Jumonji-domain histone demethylases. It has demethylation activity towards specific LYSINE residues found on HISTONE H3.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoblastoma-Binding Protein 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RBBP2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Jumonji Domain-Containing Protein 1A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Jumonji, AT Rich Interactive Domain 1A</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056486</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>INFLAMMATION of the LIVER due to hepatocellular toxicity, caused by drug metabolites and chemicals from the environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug-Induced Liver Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Drug-Induced Liver Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Liver Injury, Drug-Induced</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>INFLAMMATION of the LIVER due to hepatocellular toxicity, caused by drug metabolites and chemicals from the environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hepatitis, Drug-Induced</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>INFLAMMATION of the LIVER due to hepatocellular toxicity, caused by drug metabolites and chemicals from the environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hepatitis, Toxic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Toxic Hepatitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056487</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Liver disease lasting six months or more, caused by an adverse drug effect.  The adverse effect may result from a direct toxic effect of a drug or metabolite, or an idiosyncratic response to a drug or metabolite.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug-Induced Liver Injury, Chronic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Liver Injury, Drug-Induced, Chronic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chronic Drug-Induced Liver Injury</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Liver disease lasting six months or more, caused by an adverse drug effect.  The adverse effect may result from a direct toxic effect of a drug or metabolite, or an idiosyncratic response to a drug or metabolite.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hepatitis, Chronic, Drug-Induced</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hepatitis, Chronic, Drug-Related</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056488</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins involved in the assembly and disassembly of HISTONES into NUCLEOSOMES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Histone Chaperones</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056489</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of histone molecular chaperones that play roles in sperm CHROMATIN decondensation and CHROMATIN ASSEMBLY in fertilized eggs. They were originally discovered in XENOPUS egg extracts as histone-binding factors that mediate nucleosome formation in vitro.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nucleoplasmins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nucleoplasmin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056490</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A histone chaperone that facilitates nucleosome assembly by mediating the formation of the histone octamer and its transfer to DNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nucleosome Assembly Protein 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056504</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A histone chaperone protein that plays a role in the deposition of NUCLEOSOMES on newly synthesized DNA. It is comprised of three different subunits of 48, 60, and 150 kDa molecular size. The 48 kDa subunit, RETINOBLASTOMA-BINDING PROTEIN 4, is also a component of several other protein complexes involved in chromatin remodeling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromatin Assembly Factor-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chromatin Assembly Complex-1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A histone chaperone protein that plays a role in the deposition of NUCLEOSOMES on newly synthesized DNA. It is comprised of three different subunits of 48, 60, and 150 kDa molecular size. The 48 kDa subunit, RETINOBLASTOMA-BINDING PROTEIN 4, is also a component of several other protein complexes involved in chromatin remodeling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromatin Assembly Complex-1, p150 Subunit</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A histone chaperone protein that plays a role in the deposition of NUCLEOSOMES on newly synthesized DNA. It is comprised of three different subunits of 48, 60, and 150 kDa molecular size. The 48 kDa subunit, RETINOBLASTOMA-BINDING PROTEIN 4, is also a component of several other protein complexes involved in chromatin remodeling.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromatin Assembly Complex-1, p60 Subunit</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056505</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A retinoblastoma-binding protein that is involved in CHROMATIN REMODELING, histone deacetylation, and transcription repression. Although initially discovered as a retinoblastoma binding protein it has an affinity for core HISTONES and is a subunit of chromatin assembly factor-1 where it plays a role in the deposition of NUCLEOSOMES on newly synthesized DNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoblastoma-Binding Protein 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nucleosome-Remodeling Factor Subunit RBAP48</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinoblastoma p48-Binding Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RbAp48 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RBBP4 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chromatin Assembly Factor 1 Subunit C</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p48 Subunit, Chromatin Assembly Factor-1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056506</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-positive, endospore-forming, thermophilic bacteria in the family BACILLACEAE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Geobacillus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056507</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of GRAM-POSITIVE ENDOSPORE-FORMING RODS in the family Paenibacillaceae.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Paenibacillus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056508</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A medical specialty concerned with the diagnosis and treatment of SLEEP DISORDERS and their causes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sleep Medicine Specialty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056509</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-positive bacteria in the family Thermoactinomycetaceae, that can cause FARMER'S LUNG.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thermoactinomyces</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056510</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The tabular notation of the count per position of each potential residue as observed from an aligned set of sequences.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Position-Specific Scoring Matrices</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Position-Specific Weight Matrix</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Position-Specific Scoring Matrix</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Position-Specific Weight Matrices</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Position Weight Matrices</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Position Weight Matrix</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The tabular notation of the count per position of each potential residue as observed from an aligned set of sequences.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sequence Logo</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sequence Logos</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The tabular notation of the count per position of each potential residue as observed from an aligned set of sequences.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Position Frequency Matrices</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056511</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of soluble metal binding proteins that are involved in the intracellular transport of specific metal ions and their transfer to the appropriate metalloprotein precursor.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metallochaperones</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metallochaperone</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056524</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A retinoblastoma-binding protein that is found as a subunit of protein complexes involved in the acetylation of newly synthesized histones. Although initially discovered as a retinoblastoma binding protein, it also has an affinity for core HISTONES and plays a role in recruiting core histone proteins to the active site of the acetyltransferase enzyme complexes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoblastoma-Binding Protein 7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RBBP7 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinoblastoma-Associated Protein 46</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RbAp46 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056545</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of histone deacetylases that are NAD-dependent. Several members of the SIRTUINS family are included in this subclass.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Group III Histone Deacetylases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NAD-Dependent Histone Deacetylases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sir2-like Deacetylases</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of histone deacetylases that are NAD-dependent. Several members of the SIRTUINS family are included in this subclass.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sirtuin Histone Deacetylases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056546</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of GRAM-POSITIVE BACTERIA in the class Bacilli, that have the ability to ferment sugars to lactic acid. They are widespread in nature and commonly used to produce fermented foods.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lactobacillales</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056547</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The pyramidal cell layer (stratum pyramidale) of the HIPPOCAMPUS CA1 FIELD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CA1 Region, Hippocampal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cornu Ammonis 1 Area</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hippocampus CA1 Field</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Regio Superior of Hippocampus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA1 Field of Hippocampus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hippocampal Sector CA1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The pyramidal cell layer (stratum pyramidale) of the HIPPOCAMPUS CA1 FIELD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CA1 Pyramidal Cell Area</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA1 Stratum Pyramidale</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA1 Pyramidal Cell Layer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056564</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A sirtuin family member found primarily in the CELL NUCLEUS. It is an NAD-dependent deacetylase with specificity towards HISTONES and a variety of proteins involved in gene regulation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sirtuin 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Silent Mating Type Information Regulation 2 Homolog 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056565</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A sirtuin family member found primarily in the CYTOPLASM. It is a multifunctional enzyme that contains a NAD-dependent deacetylase activity that is specific for HISTONES and a mono-ADP-ribosyltransferase activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sirtuin 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Silent Mating Type Information Regulation 2 Homolog 2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056566</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A sirtuin family member found primarily in MITOCHONDRIA. It is a multifunctional enzyme that contains a NAD-dependent deacetylase activity that is specific for HISTONES and a mono-ADP-ribosyltransferase activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sirtuin 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Silent Mating Type Information Regulation 2 Homolog 3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056567</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of gram-positive lactic acid-producing bacteria in the order LACTOBACILLALES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aerococcaceae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056568</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of gram-positive, lactic acid-producing bacteria in the order LACTOBACILLALES. It includes both high-pressure-loving species (piezophiles) found in the deep ocean and Antarctic species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carnobacteriaceae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056569</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote></ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Enterococcaceae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote></ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tetragenococcus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056570</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-positive cocci in the family AEROCOCCACEAE, occurring as airborne saprophytes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aerococcus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056571</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cards on which a message may be written or printed for mailing without an envelope.  Art &amp; Architectural Thesaurus Online www.getty.edu/research/conducting_research/vocabularies/aat/ accessed 12/18/2008</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Postcards</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056572</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that inhibit HISTONE DEACETYLASES.  This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Histone Deacetylase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Histone Deacetylase Inhibitor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HDAC Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056573</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-positive bacteria in the family CARNOBACTERIACEAE. They are tolerant to freezing/thawing and high pressure and able to grow at low temperatures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carnobacterium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056584</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of gram-positive bacteria in the order LACTOBACILLALES. Lactic acid is the main product of their carbohydrate metabolism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leuconostocaceae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of gram-positive bacteria in the order LACTOBACILLALES. Lactic acid is the main product of their carbohydrate metabolism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weisella</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056585</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of GRAM-POSITIVE COCCI in the family LEUCONOSTOCACEAE. It is the primary bacteria involved in carrying out malolactic conversion in winemaking.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oenococcus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056586</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Respiratory syndrome characterized by the appearance of a new pulmonary infiltrate on chest x-ray, accompanied by symptoms of fever, cough, chest pain, tachypnea, or DYSPNEA, often seen in patients with SICKLE CELL ANEMIA. Multiple factors (e.g., infection, and pulmonary FAT EMBOLISM) may contribute to the development of the syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acute Chest Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056587</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of rare autosomal dominant diseases, commonly characterized by atypical URTICARIA (hives) with systemic symptoms that develop into end-organ damage. The atypical hives do not involve T-cell or autoantibody. Cryopyrin-associated periodic syndrome includes three previously distinct disorders: Familial cold autoinflammatory syndrome; Muckle-Wells Syndrome; and CINCA Syndrome, that are now considered to represent a disease continuum, all caused by NLRP3 protein mutations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cryopyrin-Associated Periodic Syndromes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cryopyrinopathy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of rare autosomal dominant diseases, commonly characterized by atypical URTICARIA (hives) with systemic symptoms that develop into end-organ damage. The atypical hives do not involve T-cell or autoantibody. Cryopyrin-associated periodic syndrome includes three previously distinct disorders: Familial cold autoinflammatory syndrome; Muckle-Wells Syndrome; and CINCA Syndrome, that are now considered to represent a disease continuum, all caused by NLRP3 protein mutations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Familial Cold Autoinflammatory Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Familial Cold Urticaria</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of rare autosomal dominant diseases, commonly characterized by atypical URTICARIA (hives) with systemic symptoms that develop into end-organ damage. The atypical hives do not involve T-cell or autoantibody. Cryopyrin-associated periodic syndrome includes three previously distinct disorders: Familial cold autoinflammatory syndrome; Muckle-Wells Syndrome; and CINCA Syndrome, that are now considered to represent a disease continuum, all caused by NLRP3 protein mutations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Muckle-Wells Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urticaria-Deafness-Amyloidosis Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urticaria, Deafness and Amyloidosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of rare autosomal dominant diseases, commonly characterized by atypical URTICARIA (hives) with systemic symptoms that develop into end-organ damage. The atypical hives do not involve T-cell or autoantibody. Cryopyrin-associated periodic syndrome includes three previously distinct disorders: Familial cold autoinflammatory syndrome; Muckle-Wells Syndrome; and CINCA Syndrome, that are now considered to represent a disease continuum, all caused by NLRP3 protein mutations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chronic Infantile Neurological, Cutaneous, and Articular Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CINCA Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NOMID</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IOMID</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multisystem Inflammatory Disease, Neonatal-Onset</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neonatal Onset Multisystem Inflammatory Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chronic, Infantile, Neurological, Cutaneous, Articular Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Infantile Onset Multisystem Inflammatory Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056604</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Exudate from seeds of the grape plant Vitis vinifera, composed of oils and secondary plant metabolites (BIOFLAVONOIDS and polyphenols) credited with important medicinal properties.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Grape Seed Extract</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056624</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An endodontic procedure performed to encourage continued physiological development and formation of TOOTH APEX.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Apexification</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An endodontic procedure performed to encourage continued physiological development and formation of TOOTH APEX.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Apexogenesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056625</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Nutritive tissue of the seeds of flowering plants that surrounds the EMBRYOS. It is produced by a parallel process of fertilization in which a second male gamete from the pollen grain fuses with two female nuclei within the embryo sac. The endosperm varies in ploidy and contains reserves of starch, oils, and proteins, making it an important source of human nutrition.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endosperm</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056626</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cluster of FLOWERS (as opposed to a solitary flower) arranged on a main stem of a plant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inflorescence</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A cluster of FLOWERS (as opposed to a solitary flower) arranged on a main stem of a plant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tassel</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A cluster of FLOWERS (as opposed to a solitary flower) arranged on a main stem of a plant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Flower Head</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A cluster of FLOWERS (as opposed to a solitary flower) arranged on a main stem of a plant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inflorescence Types</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056627</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Disorder characterized by a wide range of structural changes in PERITONEUM, resulting from fibrogenic or inflammatory processes. Peritoneal fibrosis is a common complication in patients receiving PERITONEAL DIALYSIS and contributes to its gradual decrease in efficiency.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peritoneal Fibrosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peritoneal Fibrosing Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Disorder characterized by a wide range of structural changes in PERITONEUM, resulting from fibrogenic or inflammatory processes. Peritoneal fibrosis is a common complication in patients receiving PERITONEAL DIALYSIS and contributes to its gradual decrease in efficiency.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peritoneal Sclerosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Disorder characterized by a wide range of structural changes in PERITONEUM, resulting from fibrogenic or inflammatory processes. Peritoneal fibrosis is a common complication in patients receiving PERITONEAL DIALYSIS and contributes to its gradual decrease in efficiency.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Encapsulating Peritoneal Sclerosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056629</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of invertebrate RNA viruses in the order Picornavirales.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dicistroviridae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of invertebrate RNA viruses in the order Picornavirales.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cripavirus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of invertebrate RNA viruses in the order Picornavirales.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Israeli acute paralysis virus of bees</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056630</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The management and maintenance of colonies of honeybees.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Beekeeping</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Apiculture</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056631</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A disorder of unknown cause affecting honeybees, whereby a colony rapidly loses its adult bee population. ISRAELI ACUTE PARALYSIS VIRUS OF BEES may have a role in the disorder.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Colony Collapse</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A disorder of unknown cause affecting honeybees, whereby a colony rapidly loses its adult bee population. ISRAELI ACUTE PARALYSIS VIRUS OF BEES may have a role in the disorder.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Colony Collapse Disorder</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bee Colony Collapse</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056646</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A lysosomal papain-related cysteine proteinase that is expressed in a broad variety of cell types.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathepsin F</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056647</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Systemic Vasculitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056648</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ANCA-Associated Vasculitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pauci-Immune Vasculitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ANCA-Associated Vasculitides</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056649</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A serine protease found in the azurophil granules of NEUTROPHILS. It has an enzyme specificity similar to that of chymotrypsin C.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathepsin G</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056650</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Complex pain syndrome with unknown etiology, characterized by constant or intermittent generalized vulva pain (Generalized vulvodynia) or localized burning sensations in the VESTIBULE area when pressure is applied (Vestibulodynia, or Vulvar Vestibulitis Syndrome). Typically, vulvar tissue with vulvodynia appears normal without infection or skin disease. Vulvodynia impacts negatively on a woman's quality of life as it interferes with sexual and daily activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vulvodynia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Complex pain syndrome with unknown etiology, characterized by constant or intermittent generalized vulva pain (Generalized vulvodynia) or localized burning sensations in the VESTIBULE area when pressure is applied (Vestibulodynia, or Vulvar Vestibulitis Syndrome). Typically, vulvar tissue with vulvodynia appears normal without infection or skin disease. Vulvodynia impacts negatively on a woman's quality of life as it interferes with sexual and daily activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vestibulodynia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Complex pain syndrome with unknown etiology, characterized by constant or intermittent generalized vulva pain (Generalized vulvodynia) or localized burning sensations in the VESTIBULE area when pressure is applied (Vestibulodynia, or Vulvar Vestibulitis Syndrome). Typically, vulvar tissue with vulvodynia appears normal without infection or skin disease. Vulvodynia impacts negatively on a woman's quality of life as it interferes with sexual and daily activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Generalized Vulvodynia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056651</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The pyramidal cell layer (stratum pyramidale) of the HIPPOCAMPUS CA2 FIELD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CA2 Region, Hippocampal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cornu Ammonis 2 Area</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hippocampus CA2 Field</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA2 Field of Hippocampus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hippocampal Sector CA2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The pyramidal cell layer (stratum pyramidale) of the HIPPOCAMPUS CA2 FIELD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CA2 Pyramidal Cell Area</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA2 Stratum Pyramidale</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA2 Pyramidal Cell Layer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056653</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Necrotizing VASCULITIS of small and medium size vessels, developing as a complication in RHEUMATOID ARTHRITIS patients. It is characterized by peripheral vascular lesions, cutaneous ULCERS, peripheral GANGRENE, and MONONEURITIS MULTIPLEX.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rheumatoid Vasculitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056654</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The pyramidal cell layer (stratum pyramidale) of the HIPPOCAMPUS CA3 FIELD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CA3 Region, Hippocampal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Regio Inferior of Hippocampus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hippocampal Sector CA3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hippocampus CA3 Field</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA3 Field of Hippocampus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cornu Ammonis 3 Area</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The pyramidal cell layer (stratum pyramidale) of the HIPPOCAMPUS CA3 FIELD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CA3 Pyramidal Cell Area</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA3 Stratum Pyramidale</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CA3 Pyramidal Cell Layer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056655</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An ubiquitously-expressed lysosomal cysteine protease that is involved in protein processing. The enzyme has both endopeptidase and aminopeptidase activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathepsin H</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056656</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Microdevices that combine microfluidics technology with electrical and/or mechanical functions for analyzing very small fluid volumes. They consist of microchannels etched into substrates made of silicon, glass, or polymer using processes similar to photolithography. The test fluids in the channels can then interact with different elements such as electrodes, photodetectors, chemical sensors, pumps, and valves.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lab-On-A-Chip Devices</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Microdevices that combine microfluidics technology with electrical and/or mechanical functions for analyzing very small fluid volumes. They consist of microchannels etched into substrates made of silicon, glass, or polymer using processes similar to photolithography. The test fluids in the channels can then interact with different elements such as electrodes, photodetectors, chemical sensors, pumps, and valves.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microchip Analytical Devices</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Microdevices that combine microfluidics technology with electrical and/or mechanical functions for analyzing very small fluid volumes. They consist of microchannels etched into substrates made of silicon, glass, or polymer using processes similar to photolithography. The test fluids in the channels can then interact with different elements such as electrodes, photodetectors, chemical sensors, pumps, and valves.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nanochip Analytical Devices</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056657</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cysteine protease that is highly expressed in OSTEOCLASTS and plays an essential role in BONE RESORPTION as a potent EXTRACELLULAR MATRIX-degrading enzyme.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathepsin K</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056660</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hereditary inflammation conditions, characterized by recurrent episodes of systemic inflammation. Common symptoms include recurrent fever, rash, arthritis, fatigue, and secondary AMYLOIDOSIS. Hereditary autoinflammatory diseases are associated with mutations in genes involved in regulation of normal inflammatory process and are not caused by AUTOANTIBODIES, or antigen specific T-LYMPHOCYTES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hereditary Autoinflammatory Diseases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hereditary Recurrent Fevers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hereditary Autoinflammation Diseases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hereditary Periodic Fever Syndromes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056661</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A member of the family PARVOVIRIDAE, subfamily PARVOVIRINAE, originally isolated from human nasopharyngeal aspirates in patients with respiratory disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Human bocavirus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056662</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of MAMMALS that feeds using their trunks. It contains one family, the Elephantidae, comprised of two living genera of ELEPHANTS plus the extinct MAMMOTHS and MASTODONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proboscidea Mammal</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056663</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A ubiquitously-expressed cysteine peptidase that exhibits carboxypeptidase activity.  It is highly expressed in a variety of immune cell types and may play a role in inflammatory processes and immune responses.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathepsin Z</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cathepsin P</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056664</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cysteine endopeptidase found in NATURAL KILLER CELLS and CYTOTOXIC T-LYMPHOCYTES.  It may have a specific function in the mechanism or regulation of cytolytic activity of immune cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathepsin W</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lymphopain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056665</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An extinct genus of large mammals in the family Elephantidae that fed by grazing on low vegetation. Most died out at the end of the last ice age.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mammoths</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammuthus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An extinct genus of large mammals in the family Elephantidae that fed by grazing on low vegetation. Most died out at the end of the last ice age.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Woolly Mammoth</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammuthus primigenius</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056666</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An extinct genus of large mammals in the family Mammutidae, that fed by browsing on tall plants. Eurasian species died out three million years ago, but some specimens of the American Mastodon survived the last Ice Age.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mastodons</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammut</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An extinct genus of large mammals in the family Mammutidae, that fed by browsing on tall plants. Eurasian species died out three million years ago, but some specimens of the American Mastodon survived the last Ice Age.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>American Mastodon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammut americanum</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056667</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Electronic identification of a human based on attributes of the face.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biometric Identification</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biometric Authentication</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Electronic identification of a human based on attributes of the face.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Automated Facial Recognition</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056668</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A ubiquitously-expressed cysteine protease that plays an enzymatic role in POST-TRANSLATIONAL PROTEIN PROCESSING of proteins within SECRETORY GRANULES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cathepsin L</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056669</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Substances that induce LACTATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Galactogogues</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Galactagogues</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056684</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare condition characterized by the presence of yellow nails, LYMPHEDEMA, and/or PLEURAL EFFUSION with respiratory tract involvement. Abnormal lymphatic network may play a role in its etiology. Occasionally inherited, yellow nail syndrome mostly is sporadic without apparent family history.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Yellow Nail Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056685</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare congenital disorder with multiple anomalies including: characteristic dysmorphic craniofacial features, musculoskeletal abnormalities, neurocognitive delay, and high prevalence of cancer. Germline mutations in H-Ras protein can cause Costello syndrome. Costello syndrome shows early phenotypic overlap with other disorders that involve MAP KINASE SIGNALING SYSTEM (e.g., NOONAN SYNDROME and cardiofaciocutaneous syndrome).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Costello Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Faciocutaneoskeletal Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056686</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A virus whose host is the amoeba Acanthamoeba polyphaga. Mimivirus is a putative pathogen of human PNEUMONIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mimiviridae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A virus whose host is the amoeba Acanthamoeba polyphaga. Mimivirus is a putative pathogen of human PNEUMONIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mimivirus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acanthamoeba polyphaga mimivirus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056687</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The practice of prescribing or using a drug outside the scope of the drug's official approved label as designated by a regulatory agency concerning the treatment of a particular disease or condition.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Off-Label Use</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Unlabeled Indication</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Off-Label Prescribing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056689</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Strains of Escherichia coli that preferentially grow and persist within the urinary tract. They exhibit certain virulence factors and strategies that cause urinary tract infections.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uropathogenic Escherichia coli</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056690</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A hypothalamic hormone that is synthesized as a precursor protein which is cleaved into two peptides. In addition to stimulating PROLACTIN release the peptides bind to specific G-PROTEIN-COUPLED RECEPTORS found at locations within the BRAIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prolactin-Releasing Hormone</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prolactin-Releasing Peptide</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A hypothalamic hormone that is synthesized as a precursor protein which is cleaved into two peptides. In addition to stimulating PROLACTIN release the peptides bind to specific G-PROTEIN-COUPLED RECEPTORS found at locations within the BRAIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prolactin-Releasing Peptide PrRP20</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PrRP20</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A hypothalamic hormone that is synthesized as a precursor protein which is cleaved into two peptides. In addition to stimulating PROLACTIN release the peptides bind to specific G-PROTEIN-COUPLED RECEPTORS found at locations within the BRAIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prolactin-Releasing Peptide PrRP31</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PrRP31</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056692</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Non-digestible food ingredients mostly of a carbohydrate base that improve human health by selectively stimulating the growth and/or activity of existing bacteria in the colon.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prebiotics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056693</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Autosomal recessive metabolic disorder caused by mutations in PROPIONYL-COA CARBOXYLASE genes that result in dysfunction of branch chain amino acids and of the metabolism of certain fatty acids. Neonatal clinical onset is characterized by severe metabolic acidemia accompanied by hyperammonemia, HYPERGLYCEMIA, lethargy, vomiting, HYPOTONIA; and HEPATOMEGALY. Survivors of the neonatal onset propionic acidemia often show developmental retardation, and intolerance to dietary proteins. Late-onset form of the disease shows mild mental and/or developmental retardation, sometimes without metabolic acidemia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Propionic Acidemia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ketotic Glycinemia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Propionyl-CoA Carboxylase Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PCC Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Propionicacidemia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glycinemia, Ketotic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ketotic Hyperglycinemia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Autosomal recessive metabolic disorder caused by mutations in PROPIONYL-COA CARBOXYLASE genes that result in dysfunction of branch chain amino acids and of the metabolism of certain fatty acids. Neonatal clinical onset is characterized by severe metabolic acidemia accompanied by hyperammonemia, HYPERGLYCEMIA, lethargy, vomiting, HYPOTONIA; and HEPATOMEGALY. Survivors of the neonatal onset propionic acidemia often show developmental retardation, and intolerance to dietary proteins. Late-onset form of the disease shows mild mental and/or developmental retardation, sometimes without metabolic acidemia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Propionicaciduria</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Propionic Aciduria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056704</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adaptive Immunity</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adoptive Immunity</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immunity, Adaptive</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acquired Immunity</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Protection from an infectious disease agent that is mediated by B- and T- LYMPHOCYTES following exposure to specific antigen, and characterized by IMMUNOLOGIC MEMORY. It can result from either previous infection with that agent or vaccination (IMMUNITY, ACTIVE), or transfer of antibody or lymphocytes from an immune donor (IMMUNIZATION, PASSIVE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adaptive Immune Response</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056705</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The medical use of honey bee products such as BEE VENOM; HONEY; bee pollen; PROPOLIS; and royal jelly.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Apitherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056724</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Antibody-mediated immune response. Humoral immunity is brought about by ANTIBODY FORMATION, resulting from TH2 CELLS activating B-LYMPHOCYTES, followed by COMPLEMENT ACTIVATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immunity, Humoral</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Antibody-mediated immune response. Humoral immunity is brought about by ANTIBODY FORMATION, resulting from TH2 CELLS activating B-LYMPHOCYTES, followed by COMPLEMENT ACTIVATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Humoral Immune Response</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056725</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of von Willebrand disease that results from a partial deficiency of VON WILLEBRAND FACTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>von Willebrand Disease, Type 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>von Willebrand Disease, Type I</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 1 von Willebrand Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type I von Willebrand Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056726</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The determination of genes suspected to be associated with specific traits, metabolic pathways, or diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genetic Association Studies</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The determination of genes suspected to be associated with specific traits, metabolic pathways, or diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genotype-Phenotype Associations</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genotype-Phenotype Correlation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genotype-Phenotype Correlations</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genotype-Phenotype Association</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The determination of genes suspected to be associated with specific traits, metabolic pathways, or diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Candidate Gene Analysis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The determination of genes suspected to be associated with specific traits, metabolic pathways, or diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Candidate Gene Identification</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Candidate Gene Association Study</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gene Discovery</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Candidate Gene Association Studies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056727</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An animal or plant species likely to become endangered within the foreseeable future.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endangered Species</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An animal or plant species likely to become endangered within the foreseeable future.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Threatened Species</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056728</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of von Willebrand disease that results from qualitative deficiencies of VON WILLEBRAND FACTOR. The subtype is divided into several variants with each variant having a distinctive pattern of PLATELET-interaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>von Willebrand Disease, Type 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>von Willebrand Disease, Type II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 2 von Willebrand Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type II von Willebrand Disease</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subtype of von Willebrand disease that results from qualitative deficiencies of VON WILLEBRAND FACTOR. The subtype is divided into several variants with each variant having a distinctive pattern of PLATELET-interaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>von Willebrand Disease, Type 2N</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type IIN von Willebrand Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>von Willebrand Disease, Type IIN</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 2N von Willebrand Disease</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subtype of von Willebrand disease that results from qualitative deficiencies of VON WILLEBRAND FACTOR. The subtype is divided into several variants with each variant having a distinctive pattern of PLATELET-interaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>von Willebrand Disease, Type 2M</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type IIM von Willebrand Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>von Willebrand Disease, Type IIM</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 2M von Willebrand Disease</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subtype of von Willebrand disease that results from qualitative deficiencies of VON WILLEBRAND FACTOR. The subtype is divided into several variants with each variant having a distinctive pattern of PLATELET-interaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>von Willebrand Disease, Type 2A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type IIA von Willebrand Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>von Willebrand Disease, Type IIA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 2A von Willebrand Disease</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subtype of von Willebrand disease that results from qualitative deficiencies of VON WILLEBRAND FACTOR. The subtype is divided into several variants with each variant having a distinctive pattern of PLATELET-interaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>von Willebrand Disease, Type 2B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type IIB von Willebrand Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>von Willebrand Disease, Type IIB</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 2B von Willebrand Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056729</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of von Willebrand disease that results from a total or near total deficiency of VON WILLEBRAND FACTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>von Willebrand Disease, Type 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 3 VWD</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Von Willebrand Disease, Severe Form</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 3 Von Willebrand's Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056730</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Genetically and clinically heterogeneous disorder characterized by low birth weight, postnatal growth retardation, facial dysmorphism, bilateral body asymmetry, and clinodactyly of the fifth fingers. Alterations in GENETIC IMPRINTING are involved. Hypomethylation of IGF2/H19 locus near an imprinting center region of chromosome 11p15 plays a role in a subset of Silver-Russell syndrome. Hypermethylation of the same chromosomal region, on the other hand, can cause BECKWITH-WIEDEMANN SYNDROME. Maternal UNIPARENTAL DISOMY for chromosome 7 is known to play a role in its etiology.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Silver-Russell Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Silver-Russell Dwarfism</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Russell Silver Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Silver Russell Dwarfism</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056731</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive syndrome, characterized by a milder set of clinical features with prolonged survival, compared to Donohue syndrome. Mutations in the same INSULIN RECEPTOR, mostly in the non-binding domain, result in Rabson-Mendenhall syndrome (allelic heterogeneity). Clinical features include insulin-resistant DIABETES MELLITUS, often with ACANTHOSIS NIGRICANS; DIABETIC KETOACIDOSIS; HYPERTRICHOSIS; and dysmorphisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Donohue Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Leprechaunism</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Rare autosomal recessive syndrome, characterized by a milder set of clinical features with prolonged survival, compared to Donohue syndrome. Mutations in the same INSULIN RECEPTOR, mostly in the non-binding domain, result in Rabson-Mendenhall syndrome (allelic heterogeneity). Clinical features include insulin-resistant DIABETES MELLITUS, often with ACANTHOSIS NIGRICANS; DIABETIC KETOACIDOSIS; HYPERTRICHOSIS; and dysmorphisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rabson-Mendenhall Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mendenhall Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056732</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive disorder of metabolism due to mutations in the prolidase gene. It is characterized by recurrent lower extremity skin ulcers, recurrent infections, and FACIES, often with INTELLECTUAL DISABILITY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prolidase Deficiency</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056733</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Carney Complex, Type 1</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carney Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NAME Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>LAMB Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Myxoma, Spotty Pigmentation, and Endocrine Overactivity</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carney Myxoma-Endocrine Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carney Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Carney Complex, Type 1</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carney Complex, Type 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carney Complex, Type II</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Carney Complex, Type 1</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carney Complex, Type 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carney Complex, Type I</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056734</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal dominant disorder of the hair shaft. The clinical features of the disease include HYPOTRICHOSIS, dry, and/or brittle hair, with varying degrees of ALOPECIA. Mutations in the hair-specific keratin genes KRTHB1, KRTHB3, or KRTHB6 are associated with monilethrix. Autosomal recessive monilethrix with limited HYPOTRICHOSIS are also known. Mutations in Dsg4, Liph, and P2ry5 protein genes are associated with the recessive form of monilethrix.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Monilethrix</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nodose Hair</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056735</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Autoimmune lymphoproliferative syndrome due to mutations in CASPASE 8 gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Autoimmune Lymphoproliferative Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Canale Smith Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Autoimmune lymphoproliferative syndrome due to mutations in CASPASE 8 gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Autoimmune Lymphoproliferative Syndrome Type 2B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Caspase 8 Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Caspase-8 Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Autoimmune Lymphoproliferative Syndrome Type 2B (ALPS2B)</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Autoimmune lymphoproliferative syndrome due to mutations in CASPASE 8 gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056736</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Removal of a drug from the market due to a problem occurring in the manufacture or distribution of the product.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Recalls</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Drug Recall</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056737</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Removal of a drug from the market due to the identification of an intrinsic property of the drug that results in a serious risk to public health.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Safety-Based Drug Withdrawals</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Drug Withdrawals Due to Safety</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Safety-Based Drug Withdrawal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Drug Withdrawal Due to Safety</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056738</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Protection conferred on a host by inoculation with one strain or component of a microorganism that prevents infection when later challenged with a similar strain. Most commonly the microorganism is a virus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cross Protection</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056739</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A small space in the skull between the MAXILLA and the SPHENOID BONE, medial to the pterygomaxillary fissure, and connecting to the NASAL CAVITY via the sphenopalatine foramen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pterygopalatine Fossa</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056740</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A prominent projection of the ulna that that articulates with the humerus and forms the outer protuberance of the ELBOW JOINT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Olecranon Process</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Olecranon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056741</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin subtype that is specific for CYCLIN-DEPENDENT KINASE 4 and CYCLIN-DEPENDENT KINASE 6. Unlike most cyclins, cyclin D expression is not cyclical, but rather it is expressed in response to proliferative signals. Cyclin D may therefore play a role in cellular responses to mitogenic signals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin D</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type D Cyclins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type D Cyclin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056742</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin D subtype which is regulated by GATA4 TRANSCRIPTION FACTOR. Experiments using KNOCKOUT MICE suggest a role for cyclin D2 in granulosa cell proliferation and gonadal development.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin D2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056743</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A broadly expressed type D cyclin. Experiments using KNOCKOUT MICE suggest a role for cyclin D3 in LYMPHOCYTE development.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin D3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056744</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin B subtype that colocalizes with MICROTUBULES during INTERPHASE and is transported into the CELL NUCLEUS at the end of the G2 PHASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin B1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056745</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin subtype that binds to the CYCLIN-DEPENDENT KINASE 3 and CYCLIN-DEPENDENT KINASE 8. Cyclin C plays a dual role as a transcriptional regulator and a G1 phase CELL CYCLE regulator.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin C</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type C Cyclins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type C Cyclin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056746</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin subtype that is found associated with CYCLIN-DEPENDENT KINASE 5; cyclin G associated kinase, and PROTEIN PHOSPHATASE 2.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin G</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056747</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immunomodulation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immunomodulatory Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056748</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin subtype that is found as a component of a heterotrimeric complex containing cyclin-dependent kinase 7 and CDK-activating kinase assembly factor. The complex plays a role in cellular proliferation by phosphorylating several CYCLIN DEPENDENT KINASES at specific regulatory threonine sites.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin H</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056749</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin subtype that is found abundantly in post-mitotic tissues. In contrast to the classical cyclins, its level does not fluctuate during the cell cycle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin I</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056750</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin A subtype primarily found in male GERM CELLS. It may play a role in the passage of SPERMATOCYTES into meiosis I.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin A1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056751</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A widely-expressed cyclin A subtype that functions during the G1/S and G2/M transitions of the CELL CYCLE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin A2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056765</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin B subtype that colocalizes with GOLGI APPARATUS during INTERPHASE and is transported into the CELL NUCLEUS at the end of the G2 PHASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin B2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056766</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin G subtype that is constitutively expressed throughout the cell cycle. Cyclin G1 is considered a major transcriptional target of TUMOR SUPPRESSOR PROTEIN P53 and is highly induced in response to DNA damage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin G1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056767</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An unusual cyclin subtype that is found highly expressed in terminally differentiated cells. Unlike conventional cyclins increased expression of cyclin G2 is believed to cause a withdrawal of cells from the CELL CYCLE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin G2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056768</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive disorder of INTERMEDIATE FILAMENT PROTEINS. The disease is caused by mutations in the gene that codes gigaxonin protein. The mutations result in disorganization of axonal NEUROFILAMENT PROTEINS, formation of the characteristic giant axons, and progressive neuropathy. The clinical features of the disease include early-onset progressive peripheral motor and sensory neuropathies often associated with central nervous system involvement (INTELLECTUAL DISABILITY, seizures, DYSMETRIA, and CONGENITAL NYSTAGMUS).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Giant Axonal Neuropathy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Giant Axonal Neuropathy (GAN)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Giant Axonal Neuropathy 1 (GAN1)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Giant Axonal Neuropathy 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuropathy, Giant Axonal</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056769</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive disease characterized by multiple organ dysfunction. The key clinical features include retinal degeneration (NYSTAGMUS, PATHOLOGIC; RETINITIS PIGMENTOSA; and eventual blindness), childhood obesity, sensorineural hearing loss, and normal mental development. Endocrinologic complications include TYPE 2 DIABETES MELLITUS; HYPERINSULINEMIA; ACANTHOSIS NIGRICANS; HYPOTHYROIDISM; and progressive renal and hepatic failures. The disease is caused by mutations in the ALMS1 gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alstrom Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Alstrom's Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056770</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive disease with variable expressions. Clinical features of the disease include variable ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL; bamboo hair (trichorrhexis invaginata); and ATOPIC DERMATITIS. The disease is caused by mutations in the SPINK5 gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Netherton Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Netherton Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056771</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The element in plants that contains the female GAMETOPHYTES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ovule</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The element in plants that contains the female GAMETOPHYTES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Female Gametophytes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Megagametophyte</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The element in plants that contains the female GAMETOPHYTES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Megaspores, Plant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The element in plants that contains the female GAMETOPHYTES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Female Gametes, Plant</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056784</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Autosomal recessive disease characterized by the slow progress rarefaction of white matter with childhood-onset. More severe infancy-onset forms are also known.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leukoencephalopathies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>White Matter Diseases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Leukoencephalopathy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Autosomal recessive disease characterized by the slow progress rarefaction of white matter with childhood-onset. More severe infancy-onset forms are also known.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leukoencephalopathy with Vanishing White Matter</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Childhood Ataxia with Diffuse Central Nervous System Hypomyelination</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056785</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Medical practice indigenous to the peoples of Mongolia, developed over many years according to their culture, beliefs, and traditions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medicine, Mongolian Traditional</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mongolian Medicine</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mongolian Folk Medicine</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056804</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hydrocarbon-rich byproducts from the non-fossilized BIOMASS that are combusted to generate energy as opposed to fossilized hydrocarbon deposits (FOSSIL FUELS).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biofuels</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biofuel</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hydrocarbon-rich byproducts from the non-fossilized BIOMASS that are combusted to generate energy as opposed to fossilized hydrocarbon deposits (FOSSIL FUELS).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biofuel Oils</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hydrocarbon-rich byproducts from the non-fossilized BIOMASS that are combusted to generate energy as opposed to fossilized hydrocarbon deposits (FOSSIL FUELS).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biogas</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hydrocarbon-rich byproducts from the non-fossilized BIOMASS that are combusted to generate energy as opposed to fossilized hydrocarbon deposits (FOSSIL FUELS).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biodiesel</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056805</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Devices used to assess the level of consciousness especially during anesthesia. They measure brain activity level based on the EEG.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Consciousness Monitors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Devices used to assess the level of consciousness especially during anesthesia. They measure brain activity level based on the EEG.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Index of Consciousness-View Monitor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Devices used to assess the level of consciousness especially during anesthesia. They measure brain activity level based on the EEG.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bispectral Index Monitor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Devices used to assess the level of consciousness especially during anesthesia. They measure brain activity level based on the EEG.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cerebral State Index Monitor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056806</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare congenital metabolism disorders of the urea cycle. The disorders are due to mutations that result in complete (neonatal onset) or partial (childhood or adult onset) inactivity of an enzyme, involved in the urea cycle. Neonatal onset results in clinical features that include irritability, vomiting, lethargy, seizures, NEONATAL HYPOTONIA; RESPIRATORY ALKALOSIS; HYPERAMMONEMIA; coma, and death. Survivors of the neonatal onset and childhood/adult onset disorders share common risks for ENCEPHALOPATHIES, METABOLIC, INBORN; and RESPIRATORY ALKALOSIS due to HYPERAMMONEMIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Urea Cycle Disorders, Inborn</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urea Cycle Disorders</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inborn Urea Cycle Disorder</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056807</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive disorder of the urea cycle which leads to the accumulation of argininosuccinic acid in body fluids and severe HYPERAMMONEMIA. Clinical features of the neonatal onset of the disorder include poor feeding, vomiting, lethargy, seizures, tachypnea, coma, and death. Later onset results in milder set of clinical features including vomiting, failure to thrive, irritability, behavioral problems, or psychomotor retardation. Mutations in the ARGININOSUCCINATE LYASE gene cause the disorder.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Argininosuccinic Aciduria</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Argininosuccinate Acidemia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Argininosuccinate Lyase Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urea Cycle Disorder, Arginino Succinase Type</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Argininosuccinicaciduria</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ASA Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ASL Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inborn Error of Urea Synthesis, Arginino Succinic Type</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Arginino Succinase Deficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Argininosuccinic Acid Lyase Deficiency</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056808</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The application of STATISTICS to biological systems and organisms involving the retrieval or collection, analysis, reduction, and interpretation of qualitative and quantitative data.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biostatistics</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biological Statistics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056809</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Large flat epithelial cells that line the PULMONARY ALVEOLI and are involved in PULMONARY GAS EXCHANGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pneumocytes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pneumocyte</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Large flat epithelial cells that line the PULMONARY ALVEOLI and are involved in PULMONARY GAS EXCHANGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Type-II Pneumocytes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 2 Pneumocytes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Large flat epithelial cells that line the PULMONARY ALVEOLI and are involved in PULMONARY GAS EXCHANGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Type-I Pneumocytes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 1 Pneumocytes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056810</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A pesticide or chemical agent that kills mites and ticks. This is a large class that includes carbamates, formamides, organochlorines, organophosphates, etc, that act as antibiotics or growth regulators.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acaricides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Miticide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mite Control Agent</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056811</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cellular response to environmental insults that cause disruptions in PROTEIN FOLDING and/or accumulation of defectively folded protein in the ENDOPLASMIC RETICULUM. It consists of a group of regulatory cascades that are triggered as a response to altered levels of calcium and/or the redox state of the endoplasmic reticulum. Persistent activation of the unfolded protein response leads to the induction of APOPTOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Unfolded Protein Response</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056824</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Spontaneous DEEP VEIN THROMBOSIS of an upper extremity vein, mostly AXILLARY VEIN; and SUBCLAVIAN VEIN. It is frequently precipitated by repetitive physical activity often in young, healthy adults.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Upper Extremity Deep Vein Thrombosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Spontaneous DEEP VEIN THROMBOSIS of an upper extremity vein, mostly AXILLARY VEIN; and SUBCLAVIAN VEIN. It is frequently precipitated by repetitive physical activity often in young, healthy adults.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Upper Extremity Deep Vein Thrombosis, Secondary</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Central Venous Catheter Thrombosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Spontaneous DEEP VEIN THROMBOSIS of an upper extremity vein, mostly AXILLARY VEIN; and SUBCLAVIAN VEIN. It is frequently precipitated by repetitive physical activity often in young, healthy adults.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Upper Extremity Deep Vein Thrombosis, Primary</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Paget-Schroetter Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Exercise-Induced Upper Extremity Deep Vein Thrombosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Idiopathic Upper Extremity Deep Vein Thrombosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Effort-Induced Upper Extremity Deep Vein Thrombosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Effort-Related Upper Extremity Deep Vein Thrombosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056825</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A thyroid hormone transport protein found in serum. It binds about 75% of circulating THYROXINE and 70% of circulating TRIIODOTHYRONINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thyroxine-Binding Globulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Serpin A7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thyropexin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056826</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The techniques used to select and/or place only one embryo from FERTILIZATION IN VITRO into the uterine cavity to establish a singleton pregnancy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Single Embryo Transfer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056827</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A set of protein subcomplexes involved in PROTEIN SORTING of UBIQUITINATED PROTEINS into intraluminal vesicles of MULTIVESICULAR BODIES and in membrane scission during formation of intraluminal vesicles, during the final step of CYTOKINESIS, and during the budding of enveloped viruses. The ESCRT machinery is comprised of the protein products of Class E vacuolar protein sorting genes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endosomal Sorting Complexes Required for Transport</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ESCRT Machinery</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ESCRT Complexes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endosomal Sorting Complex Required for Transport</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endosomal Sorting Complex Required for Transport Machinery</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A set of protein subcomplexes involved in PROTEIN SORTING of UBIQUITINATED PROTEINS into intraluminal vesicles of MULTIVESICULAR BODIES and in membrane scission during formation of intraluminal vesicles, during the final step of CYTOKINESIS, and during the budding of enveloped viruses. The ESCRT machinery is comprised of the protein products of Class E vacuolar protein sorting genes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endosomal Sorting Complex Required for Transport III</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ESCRT III</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A set of protein subcomplexes involved in PROTEIN SORTING of UBIQUITINATED PROTEINS into intraluminal vesicles of MULTIVESICULAR BODIES and in membrane scission during formation of intraluminal vesicles, during the final step of CYTOKINESIS, and during the budding of enveloped viruses. The ESCRT machinery is comprised of the protein products of Class E vacuolar protein sorting genes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endosomal Sorting Complex Required for Transport I</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ESCRT I</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A set of protein subcomplexes involved in PROTEIN SORTING of UBIQUITINATED PROTEINS into intraluminal vesicles of MULTIVESICULAR BODIES and in membrane scission during formation of intraluminal vesicles, during the final step of CYTOKINESIS, and during the budding of enveloped viruses. The ESCRT machinery is comprised of the protein products of Class E vacuolar protein sorting genes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endosomal Sorting Complex Required for Transport II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ESCRT II</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056828</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of hereditary angioedema that occurs in women and is precipitated or worsened by high ESTROGEN levels. It is associated with mutations in the gene for FACTOR XII that result in its increased activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hereditary Angioedema Type III</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Estrogen-Sensitive Hereditary Angioedema</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056829</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Forms of hereditary angioedema that occur due to mutations in the gene for COMPLEMENT C1 INHIBITOR PROTEIN. Type I hereditary angioedema is associated with reduced serum levels of complement C1 inhibitor protein. Type II hereditary angioedema is associated with the production of a non-functional complement C1 inhibitor protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hereditary Angioedema Types I and II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Angioedema, Hereditary, Types I and II</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Forms of hereditary angioedema that occur due to mutations in the gene for COMPLEMENT C1 INHIBITOR PROTEIN. Type I hereditary angioedema is associated with reduced serum levels of complement C1 inhibitor protein. Type II hereditary angioedema is associated with the production of a non-functional complement C1 inhibitor protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hereditary Angioedema Type II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Angioedema, Hereditary, Type II</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Forms of hereditary angioedema that occur due to mutations in the gene for COMPLEMENT C1 INHIBITOR PROTEIN. Type I hereditary angioedema is associated with reduced serum levels of complement C1 inhibitor protein. Type II hereditary angioedema is associated with the production of a non-functional complement C1 inhibitor protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hereditary Angioedema Type I</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Angioedema, Hereditary, Type I</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056830</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Mutations in the tafazzin gene are associated with X-Linked Isolated Noncompaction of the Left Ventricular Myocardium. BARTH SYNDROME is an allelic disorder.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Isolated Noncompaction of the Ventricular Myocardium</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Isolated Non-compaction of the Ventricular Myocardium</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Mutations in the tafazzin gene are associated with X-Linked Isolated Noncompaction of the Left Ventricular Myocardium. BARTH SYNDROME is an allelic disorder.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Noncompaction of the Left Ventricular Myocardium, Autosomal Dominant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Mutations in the tafazzin gene are associated with X-Linked Isolated Noncompaction of the Left Ventricular Myocardium. BARTH SYNDROME is an allelic disorder.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Isolated Noncompaction of the Left Ventricular Myocardium, X-Linked</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056831</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Neutral or negatively charged ligands bonded to metal cations or neutral atoms. The number of ligand atoms to which the metal center is directly bonded is the metal cation's coordination number, and this number is always greater than the regular valence or oxidation number of the metal. A coordination complex can be negative, neutral, or positively charged.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coordination Complexes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metal Complexes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056833</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Central Serous Chorioretinopathy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Central Serous Retinopathy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056844</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A severe pain in the lower back radiating to the groin, scrotum, and labia which is most commonly caused by a kidney stone (RENAL CALCULUS) passing through the URETER or by other urinary track blockage. It is often associated with nausea, vomiting, fever, restlessness, dull pain, frequent urination, and HEMATURIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Renal Colic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acute Renal Colic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ureteral Colic</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056846</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The autosomal recessive form of Weill-Marchesani syndrome is associated with Fibrillin gene mutations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weill-Marchesani Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Weill Marchesani Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spherophakia Brachymorphia Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Marchesani-Weill Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mesodermal Dysmorphodystrophy, Congenital</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The autosomal recessive form of Weill-Marchesani syndrome is associated with Fibrillin gene mutations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weill-Marchesani Syndrome, Autosomal Dominant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The autosomal recessive form of Weill-Marchesani syndrome is associated with Fibrillin gene mutations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weill-Marchesani Syndrome, Autosomal Recessive</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056849</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin-dependent kinase that forms a complex with CYCLIN C and is active during the G1 PHASE of the CELL CYCLE. It plays a role in the transition from G1 to S PHASE and in transcriptional regulation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin-Dependent Kinase 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cdk3 Protein Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Division Protein Kinase 3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056850</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A CYCLIN C dependent kinase that is an important component of the mediator complex. The enzyme is activated by its interaction with CYCLIN C and plays a role in transcriptional regulation by phosphorylating RNA POLYMERASE II.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin-Dependent Kinase 8</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Division Protein Kinase 8</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cdk8 Cyclin-Dependent Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cdk8 Protein Kinase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056864</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Medicines that are stocked behind the counter of a pharmacy which require the attention or counsel of a pharmacist before being dispensed or handed over to a consumer or patient.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Behind-the-Counter Drugs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056865</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A device used to predict or determine the ideal body weight of an individual.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ideal Body Weight</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ideal Body Mass</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Normal Body Weight</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A device used to predict or determine the ideal body weight of an individual.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ideal Body Weight Formula</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A device used to predict or determine the ideal body weight of an individual.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ideal Body Weight Chart</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056885</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>c-Kit positive cells intercalated between the autonomic nerves and the smooth muscle layers of smooth muscle organs including the bladder, blood vessels, lymphatics, prostate, fallopian tube, uterus, gallbladder, and kidney. They play similar roles to the INTERSTITIAL CELLS OF CAJAL of the gastrointestinal tract.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Interstitial Cells of Cajal</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>c-Kit positive cells intercalated between the autonomic nerves and the smooth muscle layers of smooth muscle organs including the bladder, blood vessels, lymphatics, prostate, fallopian tube, uterus, gallbladder, and kidney. They play similar roles to the INTERSTITIAL CELLS OF CAJAL of the gastrointestinal tract.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Interstitial Cell of Cajal-Like Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056886</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An injury in which the damage is located on the opposite side of the primary impact site. A blow to the back of head which results in contrecoup injury to the frontal lobes of the brain is the most common type.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Contrecoup Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Contre-coup Injury</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056887</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Prolapse of vaginal apex post hysterectomy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pelvic Organ Prolapse</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urogenital Prolapse</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Prolapse of vaginal apex post hysterectomy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vaginal Vault Prolapse</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056888</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Moving a patient into a specific position or POSTURE to facilitate examination, surgery, or for therapeutic purposes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Patient Positioning</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056889</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare congenital X-linked disorder of lipid metabolism. Barth syndrome is transmitted in an X-linked recessive pattern. The syndrome is characterized by muscular weakness, growth retardation, DILATED CARDIOMYOPATHY, variable NEUTROPENIA, 3-methylglutaconic aciduria (type II) and decreases in mitochondrial CARDIOLIPIN level. Other biochemical and morphological mitochondrial abnormalities also exist.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Barth Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MGA Type 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MGA type II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>3-methylglutaconicaciduria type 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>3-methylglutaconicaciduria type II</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056890</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>One of the three domains of life (the others being BACTERIA and ARCHAEA), also called Eukarya. These are organisms whose cells are enclosed in membranes and possess a nucleus. They comprise almost all multicellular and many unicellular organisms, and are traditionally divided into groups (sometimes called kingdoms) including ANIMALS; PLANTS; FUNGI; and various algae and other taxa that were previously part of the old kingdom Protista.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eukaryota</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eukarya</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eucarya</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eukaryotes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056891</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specific states or life cycle stages of organisms. These include post-embryonic stages of insects, symbiotic relationships between organisms, and reproductive elements such as spores.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organism Forms</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056892</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large protein complex which acts as a signaling adaptor protein that allows communication between the various regulatory and functional components of GENETIC TRANSCRIPTION including DNA POLYMERASE II; GENERAL TRANSCRIPTION FACTORS; and TRANSCRIPTION FACTORS that are bound to upstream ENHANCER ELEMENTS. The mediator complex was originally studied in YEAST where at least 21 subunits were identified. Many of the yeast subunits are homologs to proteins in higher organisms that are found associated with specific nuclear receptors such as THYROID HORMONE RECEPTORS and VITAMIN D RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mediator Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mediator Transcription Complex</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A large protein complex which acts as a signaling adaptor protein that allows communication between the various regulatory and functional components of GENETIC TRANSCRIPTION including DNA POLYMERASE II; GENERAL TRANSCRIPTION FACTORS; and TRANSCRIPTION FACTORS that are bound to upstream ENHANCER ELEMENTS. The mediator complex was originally studied in YEAST where at least 21 subunits were identified. Many of the yeast subunits are homologs to proteins in higher organisms that are found associated with specific nuclear receptors such as THYROID HORMONE RECEPTORS and VITAMIN D RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thyroid Hormone-Associated Protein Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TRAP (Thyroid Hormone Associated Protein) Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TR-Associated Protein (TRAP) Complex</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A large protein complex which acts as a signaling adaptor protein that allows communication between the various regulatory and functional components of GENETIC TRANSCRIPTION including DNA POLYMERASE II; GENERAL TRANSCRIPTION FACTORS; and TRANSCRIPTION FACTORS that are bound to upstream ENHANCER ELEMENTS. The mediator complex was originally studied in YEAST where at least 21 subunits were identified. Many of the yeast subunits are homologs to proteins in higher organisms that are found associated with specific nuclear receptors such as THYROID HORMONE RECEPTORS and VITAMIN D RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mediator-Like Complexes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mediator-Like Complex</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056893</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of three related eukaryotic phyla whose members possess an alveolar membrane system, consisting of flattened membrane-bound sacs lying beneath the outer cell membrane.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alveolata</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056894</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A supergroup (some say phylum) of ameboid EUKARYOTES, comprising ARCHAMOEBAE; LOBOSEA; and MYCETOZOA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Amoebozoa</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056895</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of AMOEBOZOA comprising two distinct groups with the ability to form fruiting bodies: DICTYOSTELIIDA (dictyostelid cellular slime molds) and MYXOMYCETES (plasmodial slime molds).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mycetozoa</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eumycetozoa</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056896</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group (some say infraphylum) of AMOEBOZOA that lack mitochondria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Archamoebae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056897</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of stalked, sessile, single-celled EUKARYOTES. They are considered the transitional link between the flagellated protozoa and the SPONGES, the most primitive metazoans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Choanoflagellata</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Choanozoa</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Choanoflagellates</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Choanoflagellida</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056898</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large group of flagellated EUKARYOTES found in both free-living and parasitic forms. The flagella are present in pairs and contain unique paraxonemal rods.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Euglenozoa</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A large group of flagellated EUKARYOTES found in both free-living and parasitic forms. The flagella are present in pairs and contain unique paraxonemal rods.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diplonemida</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056899</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of EUKARYOTES found in the gut of termites and other insects that live on LIGNIN. MITOCHONDRIA and GOLGI APPARATUS are absent from oxymonads.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oxymonadida</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oxymonads</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056900</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group (or phylum) of flagellated, anaerobic EUKARYOTES that are endosymbionts of animals. They lack mitochondria but contain small energy-producing hydrogenosomes. The group is comprised of two major classes: HYPERMASTIGIA and TRICHOMONADIDA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Parabasalidea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Parabasalia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Parabasalids</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056901</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large supergroup of mostly amoeboid EUKARYOTES whose three main subgroups are CERCOZOA; FORAMINIFERA; and HAPLOSPORIDA. Nearly all of the species possess MITOCHONDRIA and historically many were considered ANIMALS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rhizaria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056902</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Components of medical instrumentation used for physiological evaluation of patients, that signal when a threshold value is reached.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clinical Alarms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Components of medical instrumentation used for physiological evaluation of patients, that signal when a threshold value is reached.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physiologic Monitor Alarms</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056905</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The specific sequence of DNA where CHROMOSOME BREAKS have occurred.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromosome Breakpoints</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chromosome Breakpoint</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Breakpoint, Chromosome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The specific sequence of DNA where CHROMOSOME BREAKS have occurred.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromosome Breakpoint Sequence</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056906</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cyclin subtype that is found associated with CYCLIN-DEPENDENT KINASE 9. Unlike traditional cyclins, which regulate the CELL CYCLE, type T cyclins appear to regulate transcription and are components of positive transcriptional elongation factor B.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin T</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type T Cyclins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type T Cyclin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A cyclin subtype that is found associated with CYCLIN-DEPENDENT KINASE 9. Unlike traditional cyclins, which regulate the CELL CYCLE, type T cyclins appear to regulate transcription and are components of positive transcriptional elongation factor B.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin T3</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A cyclin subtype that is found associated with CYCLIN-DEPENDENT KINASE 9. Unlike traditional cyclins, which regulate the CELL CYCLE, type T cyclins appear to regulate transcription and are components of positive transcriptional elongation factor B.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin T2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A cyclin subtype that is found associated with CYCLIN-DEPENDENT KINASE 9. Unlike traditional cyclins, which regulate the CELL CYCLE, type T cyclins appear to regulate transcription and are components of positive transcriptional elongation factor B.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyclin T1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056907</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of amoeboid and flagellate EUKARYOTES in the supergroup RHIZARIA. They feed by means of threadlike pseudopods.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cercozoa</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056908</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of amoeboid EUKARYOTES characterized by reticulating pseudopods and a complex life cycle with an alternation of generations. Most are less than 1mm in size and found in marine or brackish water.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Foraminifera</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Foraminiferida</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Forams</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056909</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of EUKARYOTES that are parasites of plants. Life cycle stages include zoospores and plasmodia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plasmodiophorida</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plasmodiophoromycetes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plasmodiophorids</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of EUKARYOTES that are parasites of plants. Life cycle stages include zoospores and plasmodia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polymyxa</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group of EUKARYOTES that are parasites of plants. Life cycle stages include zoospores and plasmodia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plasmodiophora</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056910</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The capital is Seoul. The country, established September 9, 1948, is located on the southern part of the Korean Peninsula. Its northern border is shared  with the Democratic People's Republic of Korea.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Republic of Korea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>South Korea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Korea, Republic of</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056911</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A country located on the Korean Peninsula whose capital is Pyongyang. The country was established September 9, 1948.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Democratic People's Republic of Korea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>North Korea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Korea, Democratic People's Republic of</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056912</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A disorder associated with three or more of the following: eating until feeling uncomfortably full;  eating large amounts of food when not physically hungry; eating much more rapidly than normal;  eating alone due to embarrassment; feeling of disgust, DEPRESSION, or guilt after overeating. Criteria includes occurrence on average, at least 2 days a week for 6 months.  The binge eating is not associated with the regular use of inappropriate compensatory behavior (i.e. purging, excessive exercise, etc.) and does not co-occur exclusively with BULIMIA NERVOSA or ANOREXIA NERVOSA. (From DSM-IV, 1994)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Binge-Eating Disorder</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056913</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A mediator complex subunit that is believed to play a key role in the coactivation of nuclear receptor-activated transcription by the mediator complex. It interacts with a variety of nuclear receptors including RETINOIC ACID RECEPTORS; THYROID HORMONE RECEPTORS; VITAMIN D RECEPTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; ESTROGEN RECEPTORS; and GLUCOCORTICOID RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mediator Complex Subunit 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mediator of RNA Polymerase II Transcription Subunit 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p53 Regulatory Protein RB18A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peroxisome Proliferator-Activated Receptor Binding Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PPAR-Binding Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RB18A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thyroid Receptor Interacting Protein 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TR-Associated Protein P220</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TRAP220</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TRIP2 (Thyroid Receptor Interacting Protein 2)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vitamin D Receptor-Interacting Protein Complex Component DRIP205</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DRIP205</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thyroid Hormone Receptor Associated Protein 220</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056914</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Contiguous large-scale (1000-400,000 basepairs) differences in the genomic DNA between individuals, due to SEQUENCE DELETION; SEQUENCE INSERTION; or SEQUENCE INVERSION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genomic Structural Variation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genome Structural Variation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genomic Structural Variants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genome Structural Variants</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056915</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Stretches of genomic DNA that exist in different multiples between individuals. Many copy number variations have been associated with susceptibility or resistance to disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA Copy Number Variations</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Copy Number Variation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Copy Number Variants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Copy Number Variants, DNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Copy Number Variation, DNA</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Stretches of genomic DNA that exist in different multiples between individuals. Many copy number variations have been associated with susceptibility or resistance to disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA Copy Number Polymorphisms</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Copy Number Polymorphism</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Copy Number Polymorphisms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Stretches of genomic DNA that exist in different multiples between individuals. Many copy number variations have been associated with susceptibility or resistance to disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA Copy Number Changes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Copy Number Change</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Copy Number Changes, DNA</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056916</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Low-copy (2-50) repetitive DNA elements that are highly homologous and range in size from 1000 to 400,000 base pairs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Segmental Duplications, Genomic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Segmental Duplications</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Low-copy (2-50) repetitive DNA elements that are highly homologous and range in size from 1000 to 400,000 base pairs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Duplicons</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Low-copy (2-50) repetitive DNA elements that are highly homologous and range in size from 1000 to 400,000 base pairs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Low-Copy Repeats</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Low-Copy Repeats, DNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Low-Copy Repeat Sequences</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056918</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins that enhance gene expression when associated with ligand bound activated NUCLEAR RECEPTORS. The coactivators may act through an enzymatic process that affects the rate of transcription or the structure of chromatin. Alternatively nuclear receptor coactivators can function as adaptor proteins that bring nuclear receptors into close proximity with transcriptional complexes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Coactivators</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056919</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of flagellated EUKARYOTES that live in the intestines of several invertebrate and vertebrate species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retortamonadidae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retortamonadida</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retortamonads</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of flagellated EUKARYOTES that live in the intestines of several invertebrate and vertebrate species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chilomastix</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of flagellated EUKARYOTES that live in the intestines of several invertebrate and vertebrate species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retortamonas</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056920</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A nuclear receptor coactivator with specificity for ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and THYROID HORMONE RECEPTORS. It contains a histone acetyltransferase activity that may play a role in the transcriptional activation of chromatin regions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Coactivator 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor Coactivator-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Steroid Receptor Coactivator 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056921</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A nuclear receptor coactivator with specificity for ESTROGEN RECEPTORS and PROGESTERONE RECEPTORS. It contains a histone acetyltransferase activity that may play a role in CHROMATIN REMODELING during the process of nuclear receptor-induced transcription. The coactivator has been found at elevated levels in certain HORMONE-DEPENDENT NEOPLASMS such as those found in BREAST CANCER.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Coactivator 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thyroid Hormone Receptor Activator Molecule 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptor-Associated Coactivator 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Steroid Receptor Coactivator 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amplified in Breast Cancer-1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor Coactivator-3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056925</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A broad category of proteins that regulate the CIRCADIAN RHYTHM of an organism. Included here are proteins that transmit intracellular and intercellular signals in a chronological manner along with proteins that sense light and time-dependent changes in the environment such as the PHOTOPERIOD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Circadian Rhythm Signaling Peptides and Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Clock Proteins and Peptides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A broad category of proteins that regulate the CIRCADIAN RHYTHM of an organism. Included here are proteins that transmit intracellular and intercellular signals in a chronological manner along with proteins that sense light and time-dependent changes in the environment such as the PHOTOPERIOD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Circadian Rhythm Signaling Peptides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A broad category of proteins that regulate the CIRCADIAN RHYTHM of an organism. Included here are proteins that transmit intracellular and intercellular signals in a chronological manner along with proteins that sense light and time-dependent changes in the environment such as the PHOTOPERIOD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Circadian Rhythm Signaling Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056926</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Basic helix-loop-helix (bHLH) domain-containing proteins that contain intrinsic HISTONE ACETYLTRANSFERASE activity and play important roles in CIRCADIAN RHYTHM regulation.  Clock proteins combine with Arntl proteins to form heterodimeric transcription factors that are specific for E-BOX ELEMENTS and stimulate the transcription of several E-box genes that are involved in cyclical regulation.  This transcriptional activation also sets into motion a time-dependent feedback loop which in turn down-regulates the expression of clock proteins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CLOCK Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Locomotor Output Cycles Kaput Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CLOCK Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056928</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Analysis of the oscillations observed in an x-ray absorption spectrum that begin just above the absorption edge (i.e. the point on the spectrum where the amount of x-ray absorption suddenly increases) to determine or evaluate the chemical structure of the absorbing surface.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>X-Ray Absorption Spectroscopy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Analysis of the oscillations observed in an x-ray absorption spectrum that begin just above the absorption edge (i.e. the point on the spectrum where the amount of x-ray absorption suddenly increases) to determine or evaluate the chemical structure of the absorbing surface.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Near Edge X-Ray Absorption Fine Structure Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Ray Absorption Near Edge Structure Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>XANES Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Ray Absorption Near-Edge Structure Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Near-Edge X-Ray Absorption Fine Structure Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NEXAFS Spectroscopy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056929</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Familial pseudoaldosteronism characterized by autosomal dominant inheritance of hypertension with HYPOKALEMIA; ALKALOSIS; RENIN and ALDOSTERONE level decreases. It is caused by mutations in EPITHELIAL SODIUM CHANNEL beta and gamma subunits. Different mutations in the same EPITHELIAL SODIUM CHANNEL subunits can cause PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Liddle Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pseudoaldosteronism</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056930</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Basic helix-loop-helix (bHLH) domain-containing proteins that play important roles in CIRCADIAN RHYTHM regulation. They combine with CLOCK PROTEINS to form heterodimeric transcription factors that are specific for E-BOX ELEMENTS and stimulate the transcription of several E-box genes that are involved in cyclical regulation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>ARNTL Transcription Factors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brain and Muscle ARNT-like Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aryl Hydrocarbon Receptor Nuclear Translocator-like Transcription Factors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Basic helix-loop-helix (bHLH) domain-containing proteins that play important roles in CIRCADIAN RHYTHM regulation. They combine with CLOCK PROTEINS to form heterodimeric transcription factors that are specific for E-BOX ELEMENTS and stimulate the transcription of several E-box genes that are involved in cyclical regulation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aryl Hydrocarbon Receptor Nuclear Translocator-like 2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ARNTL2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>BMAL2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Member of PAS Protein 9</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MOP9 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brain and Muscle ARNT-like 2 Protein</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Basic helix-loop-helix (bHLH) domain-containing proteins that play important roles in CIRCADIAN RHYTHM regulation. They combine with CLOCK PROTEINS to form heterodimeric transcription factors that are specific for E-BOX ELEMENTS and stimulate the transcription of several E-box genes that are involved in cyclical regulation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aryl Hydrocarbon Receptor Nuclear Translocator-like 1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>BMAL1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ARNTL1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Member of PAS Protein 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MOP3 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aryl Hydrocarbon Receptor Nuclear Translocator-like Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brain and muscle ARNT-like 1 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056931</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Flavoproteins that function as circadian rhythm signaling proteins in ANIMALS and as blue-light photoreceptors in PLANTS. They are structurally-related to DNA PHOTOLYASES and it is believed that both classes of proteins may have originated from an earlier protein that played a role in protecting primitive organisms from the cyclical exposure to UV LIGHT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cryptochromes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cryptochrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cryptochrome Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056945</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A human liver tumor cell line used to study a variety of liver-specific metabolic functions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hep G2 Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HepG2 Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hep G2 Cell Line</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hepatoblastoma G2 Cell Line</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Line, Hep G2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Line, Hepatoblastoma G2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056947</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Therapeutic replacement or supplementation of defective or missing enzymes to alleviate the effects of enzyme deficiency (e.g., GLUCOSYLCERAMIDASE replacement for GAUCHER DISEASE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Enzyme Replacement Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056948</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgery performed to repair or correct the skeletal anomalies of the jaw and its associated dental and facial structures (e.g. CLEFT PALATE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Orthognathic Surgical Procedures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056949</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Blue-light receptors that regulate a range of physiological responses in PLANTS. Examples include: PHOTOTROPISM, light-induced stomatal opening, and CHLOROPLAST movements in response to changes in light intensity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phototropins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phototropin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056950</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Circadian rhythm signaling proteins that influence circadian clock by interacting with other circadian regulatory proteins and transporting them into the CELL NUCLEUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Period Circadian Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Clock Protein Period</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Period Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Circadian rhythm signaling proteins that influence circadian clock by interacting with other circadian regulatory proteins and transporting them into the CELL NUCLEUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Period Circadian Protein 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Clock Protein Period 2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Circadian rhythm signaling proteins that influence circadian clock by interacting with other circadian regulatory proteins and transporting them into the CELL NUCLEUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Period Circadian Protein 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Clock Protein Period 3</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Circadian rhythm signaling proteins that influence circadian clock by interacting with other circadian regulatory proteins and transporting them into the CELL NUCLEUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Period Circadian Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Pacemaker Protein Rigui</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Clock Protein Period 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056951</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of photoelectron spectroscopy in which a sample is irradiated with a beam of ULTRAVIOLET RAYS and the energies of the resulting photoelectrons are analyzed.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photoelectron Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Photoelectron Emission Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Photoemission Spectroscopy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A form of photoelectron spectroscopy in which a sample is irradiated with a beam of ULTRAVIOLET RAYS and the energies of the resulting photoelectrons are analyzed.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>X-Ray Photoelectron Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electron Spectroscopy for Chemical Analysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Xray Photoelectron Spectroscopy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A form of photoelectron spectroscopy in which a sample is irradiated with a beam of ULTRAVIOLET RAYS and the energies of the resulting photoelectrons are analyzed.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photoelectron Spectrometry</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A form of photoelectron spectroscopy in which a sample is irradiated with a beam of ULTRAVIOLET RAYS and the energies of the resulting photoelectrons are analyzed.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ultraviolet Photoelectron Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ultra-Violet Photoelectron Spectroscopy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056952</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A class of endosymbiont EUKARYOTES, in the group PARABASALIDEA, that are obligate mutualists in the digestive tracts of wood-eating insects. Hypermastigotes produce CELLULASE that breaks down the cellulose in wood so that insects can metabolize it.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hypermastigia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hypermastigotes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A class of endosymbiont EUKARYOTES, in the group PARABASALIDEA, that are obligate mutualists in the digestive tracts of wood-eating insects. Hypermastigotes produce CELLULASE that breaks down the cellulose in wood so that insects can metabolize it.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trichonympha</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056953</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A DNA-binding orphan nuclear receptor that negatively regulates expression of ARNTL TRANSCRIPTION FACTORS and plays a role as a regulatory component of the circadian clock system.  The Nr1d1 nuclear receptor expression is cyclically-regulated by a feedback loop involving its positive regulation by CLOCK PROTEIN; BMAL1 PROTEIN heterodimers and its negative regulation by CRYPTOCHROME and PERIOD PROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 1, Group D, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rev-erb-alpha Nuclear Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>V-erbA-Related Protein EAR-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR1D1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056965</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The administration of substances into the eye with a hypodermic syringe.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Injections, Intraocular</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injections, Intra-Ocular</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The administration of substances into the eye with a hypodermic syringe.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Injections, Periocular</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056966</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A process fundamental to muscle physiology whereby an electrical stimulus or action potential triggers a myocyte to depolarize and contract. This mechanical muscle contraction response is regulated by entry of calcium ions into the cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Excitation Contraction Coupling</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056968</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Bacterial repressor proteins that bind to the LAC OPERON and thereby prevent the synthesis of proteins involved in catabolism of LACTOSE. When lactose levels are high lac repressors undergo an allosteric change that causes their release from the DNA and the resumption of lac operon transcription.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lac Repressors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lac Repressor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>LacI Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056969</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Optical imaging techniques used for recording patterns of electrical activity in tissues by monitoring transmembrane potentials via FLUORESCENCE imaging with voltage-sensitive fluorescent dyes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Voltage-Sensitive Dye Imaging</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Vm Mapping</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transmembrane Potential Optical Mapping</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Transmembrane Potential Mapping</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Mapping, Transmembrane Potential</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Optical imaging techniques used for recording patterns of electrical activity in tissues by monitoring transmembrane potentials via FLUORESCENCE imaging with voltage-sensitive fluorescent dyes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optical Action Potential Mapping</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Mapping, Action Potential</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Action Potential Optical Mapping</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anatomic Electrical Activity Optical Mapping</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optical Mapping, Anatomic Electrical Activity</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056970</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Co-repressor proteins that bind to inactive NUCLEAR RECEPTORS and mediate GENE SILENCING.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Co-Repressor Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Corepressor Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Corepressors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Co-Repressors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Co-repressor proteins that bind to inactive NUCLEAR RECEPTORS and mediate GENE SILENCING.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Co-Repressors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor Corepressors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Co-repressor proteins that bind to inactive NUCLEAR RECEPTORS and mediate GENE SILENCING.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Hormone Receptor Co-Repressors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056971</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A nuclear protein that regulates the expression of genes involved in a diverse array of processes related to metabolism and reproduction. The protein contains three nuclear receptor interaction domains and three repressor domains and is closely-related in structure to NUCLEAR RECEPTOR CO-REPRESSOR 2.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Co-Repressor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RIP140 Repressor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptor Interacting Protein 140</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinoid X Receptor-Interacting Protein 13</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Factor RIP140</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor Co-Repressor RIP140</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056972</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A technique to generate restriction maps from single large DNA molecules by spreading the DNA onto a glass surface, digesting with DNA RESTRICTION ENZYMES, staining with FLUORESCENT DYES, and visualizing the DNA cleavage sites by FLUORESCENCE MICROSCOPY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optical Restriction Mapping</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056973</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Three-dimensional computed tomographic imaging with the added dimension of time, to follow motion during imaging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Four-Dimensional Computed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>4D Computed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>4D CT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Four-Dimensional CAT Scan</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Four-Dimensional CT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Four-Dimensional CT Scan</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>4D CAT Scan</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>4D CT Scan</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056985</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A nuclear co-repressor protein that shows specificity for RETINOIC ACID RECEPTORS and THYROID HORMONE RECEPTORS. The dissociation of this co-repressor from nuclear receptors is generally ligand-dependent, but can also occur by way of its phosphorylation by members of the MAP KINASE SIGNALING SYSTEM. The protein contains two nuclear receptor interaction domains and four repressor domains and is closely-related in structure to NUCLEAR RECEPTOR CO-REPRESSOR 1.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Co-Repressor 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TRAC Co-repressor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>T3 Receptor-associating Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SMRT Co-repressor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056986</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infections with the protozoa of the phylum EUGLENOZOA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Euglenozoa Infections</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056987</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Condition of low SYSTEMIC VASCULAR RESISTANCE that develops secondary to other conditions such as ANAPHYLAXIS; SEPSIS; SURGICAL SHOCK; and SEPTIC SHOCK. Vasoplegia that develops during or post surgery (e.g., CARDIOPULMONARY BYPASS) is called postoperative vasoplegic syndrome or vasoplegic syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vasoplegia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Condition of low SYSTEMIC VASCULAR RESISTANCE that develops secondary to other conditions such as ANAPHYLAXIS; SEPSIS; SURGICAL SHOCK; and SEPTIC SHOCK. Vasoplegia that develops during or post surgery (e.g., CARDIOPULMONARY BYPASS) is called postoperative vasoplegic syndrome or vasoplegic syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Postoperative Vasoplegic Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vasoplegic Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Post-operative Vasoplegic Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056988</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anterior Wall Myocardial Infarction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Myocardial Infarction, Anterior Wall</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anterolateral Myocardial Infarction</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anteroseptal Myocardial Infarction</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>MYOCARDIAL INFARCTION in which the anterior wall of the heart is involved. Anterior wall myocardial infarction is often caused by occlusion of the left anterior descending coronary artery. It can be categorized as anteroseptal or anterolateral wall myocardial infarction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acute Anterior Wall Myocardial Infarction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056989</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>MYOCARDIAL INFARCTION in which the inferior wall of the heart is involved. It is often caused by occlusion of the right coronary artery.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inferior Wall Myocardial Infarction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Myocardial Infarction, Inferior Wall</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Diaphragmatic Myocardial Infarction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inferior Myocardial Infarction</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>MYOCARDIAL INFARCTION in which the inferior wall of the heart is involved. It is often caused by occlusion of the right coronary artery.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acute Inferior Myocardial Infarction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D056990</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The prevention of infection or disease following exposure to a pathogen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Post-Exposure Prophylaxis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Post-Exposure Prevention</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057005</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The application of engineering principles and methods to living organisms or biological systems.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bioengineering</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bio-Engineering</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biological Engineering</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bio engineering</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057026</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Induced Pluripotent Stem Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IPS Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fibroblast-Derived Induced Pluripotent Stem Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fibroblast-Derived IPS Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057045</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>GASTROESOPHAGEAL REFLUX wherein the retrograde flow passes through the UPPER ESOPHAGEAL SPHINCTER</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laryngopharyngeal Reflux</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>GASTROESOPHAGEAL REFLUX wherein the retrograde flow passes through the UPPER ESOPHAGEAL SPHINCTER</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gastric Aspiration</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>GASTROESOPHAGEAL REFLUX wherein the retrograde flow passes through the UPPER ESOPHAGEAL SPHINCTER</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Regurgitation, Gastric</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057048</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sugar-rich liquid produced in plant glands called nectaries. It is either produced in flowers or other plant structures, providing a source of attraction for pollinating insects and animals, as well as being a nutrient source to animal mutualists which provide protection of plants against herbivores.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Nectar</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nectar</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057049</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thrombotic Microangiopathies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057050</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of cell surface receptors that were originally identified by their structural homology to neurotropic TYROSINE KINASES and referred to as orphan receptors because the associated ligand and signaling pathways were unknown. Evidence for the functionality of these proteins has been established by experiments showing that disruption of the orphan receptor genes results in developmental defects.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptor Tyrosine Kinase-like Orphan Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ROR Tyrosine Kinase Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neurotrophic Tyrosine Kinase, Receptor-related Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NTRKR Receptors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of cell surface receptors that were originally identified by their structural homology to neurotropic TYROSINE KINASES and referred to as orphan receptors because the associated ligand and signaling pathways were unknown. Evidence for the functionality of these proteins has been established by experiments showing that disruption of the orphan receptor genes results in developmental defects.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptor Tyrosine Kinase-like Orphan Receptor 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ROR2 Tyrosine Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of cell surface receptors that were originally identified by their structural homology to neurotropic TYROSINE KINASES and referred to as orphan receptors because the associated ligand and signaling pathways were unknown. Evidence for the functionality of these proteins has been established by experiments showing that disruption of the orphan receptor genes results in developmental defects.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptor Tyrosine Kinase-like Orphan Receptor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ROR1 Tyrosine Kinase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057051</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The removal of a product from the marketplace, usually due a design defect or for marketing reasons.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Product Recalls and Withdrawals</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The removal of a product from the marketplace, usually due a design defect or for marketing reasons.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Product Recalls</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The removal of a product from the marketplace, usually due a design defect or for marketing reasons.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Product Withdrawals</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Market Withdrawals</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057052</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Removal of a MEDICAL DEVICE from the market due to a problem occurring in the manufacture or distribution of the product.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medical Device Recalls</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Removal of a MEDICAL DEVICE from the market due to a problem occurring in the manufacture or distribution of the product.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biomedical Device Recalls</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057053</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Removal of a MEDICAL DEVICE from the market due to the identification of an intrinsic property of the device that results in a serious risk to public health.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Safety-Based Medical Device Withdrawals</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medical Device Safety Withdrawals</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Removal of a MEDICAL DEVICE from the market due to the identification of an intrinsic property of the device that results in a serious risk to public health.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biomedical Device Safety Withdrawals</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Safety-Based Biomedical Device Withdrawals</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057054</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of molecularly targeted imaging probes to localize and/or monitor biochemical and cellular processes via various imaging modalities that include RADIONUCLIDE IMAGING; ULTRASONOGRAPHY; MAGNETIC RESONANCE IMAGING; fluorescence imaging; and MICROSCOPY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molecular Imaging</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057055</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of peptide hydrolases that depend on an ASPARTIC ACID residue for their activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aspartic Acid Proteases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspartic Proteinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspartyl Proteinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspartic Acid Proteinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aspartyl Proteases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057056</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of peptide hydrolases that depend on a CYSTEINE residue for their activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cysteine Proteases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cysteine Proteinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cysteine Proteinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cysteine Protease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057057</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Peptide hydrolases that contain at the active site a SERINE residue involved in catalysis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serine Proteases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Serine Proteinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Serine Proteinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Serine Protease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Serine Protein Hydrolases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057065</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endoproteases that contain proteolytic core domains and ATPase-containing regulatory domains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>ATP-Dependent Endopeptidases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ATP-Dependent Endoproteases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endoprotease, ATP-Dependent</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ATP-Dependent Endoprotease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057066</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of GLAUCOMA in which chronic optic nerve damage and loss of vision normally attributable to buildup of intraocular pressure occurs despite prevailing conditions of normal intraocular pressure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Low Tension Glaucoma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Normal Tension Glaucoma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057068</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Fractures around joint replacement prosthetics or implants. They can occur intraoperatively or postoperatively.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Periprosthetic Fractures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fractures, Periprosthetic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Fractures around joint replacement prosthetics or implants. They can occur intraoperatively or postoperatively.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peri-Implant Fractures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057069</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process of gaining approval by a government regulatory agency for DIAGNOSTIC REAGENTS AND TEST KITS. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diagnostic Test Approval</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The process of gaining approval by a government regulatory agency for DIAGNOSTIC REAGENTS AND TEST KITS. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>In Vitro Diagnostic Device Approval</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057070</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A supernumerary rib developing from an abnormal enlargement of the costal element of the C7 vertebra. This anomaly is found in 1-2% of the population and can put pressure on adjacent structures causing CERVICAL RIB SYNDROME; THORACIC OUTLET SYNDROME; or other conditions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cervical Rib</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057071</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The articulation between the articular surface of the PATELLA and the patellar surface of the FEMUR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Patellofemoral Joint</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patellofemoral Articulation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Femoropatellar Articulation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057072</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Fractures of the articular surface of a bone.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intra-Articular Fractures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intraarticular Fractures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057073</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A highly purified recombinant glycoprotein form of human THYROID-STIMULATING HORMONE, produced by recombinant DNA technology comprising two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites, and a beta subunit of 118 residues containing one N-linked glycosylation site. The amino acid sequence of thyrotropin alfa is identical to that of human pituitary thyroid stimulating hormone.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thyrotropin Alfa</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recombinant Human TSH</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>rhTSH</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A highly purified recombinant glycoprotein form of human THYROID-STIMULATING HORMONE, produced by recombinant DNA technology comprising two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites, and a beta subunit of 118 residues containing one N-linked glycosylation site. The amino acid sequence of thyrotropin alfa is identical to that of human pituitary thyroid stimulating hormone.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thyrogen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genzyme Brand of Thyrotropin Alfa</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057074</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Release of a virus from the host cell following VIRUS ASSEMBLY and maturation. Egress can occur by host cell lysis, EXOCYTOSIS, or budding through the plasma membrane.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Virus Release</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Virus Egress</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Release of a virus from the host cell following VIRUS ASSEMBLY and maturation. Egress can occur by host cell lysis, EXOCYTOSIS, or budding through the plasma membrane.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Virus Budding</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057075</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sensitive detection methods using enzymes to indirectly measure substances that would normally be difficult to quantitate.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Enzyme Assays</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Enzymatic Assays</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Sensitive detection methods using enzymes to indirectly measure substances that would normally be difficult to quantitate.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Indirect Enzyme Assays</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Indirect Enzymatic Assays</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057077</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of mite that is a parasite of honeybees.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Varroidae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A species of mite that is a parasite of honeybees.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Varroa destructor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Honeybee Mite</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A species of mite that is a parasite of honeybees.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Varroa</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057078</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of CRUSTACEA comprising the tongue worms which are obligatory parasites of reptiles, birds, and mammals including humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pentastomida</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tongue Worms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of CRUSTACEA comprising the tongue worms which are obligatory parasites of reptiles, birds, and mammals including humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Linguatula serrata</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057079</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of orangutans in the family HOMINIDAE, comprising two species. Among the PRIMATES, the orangutan is second in size only to the gorilla (GORILLA GORILLA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pongo</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orangutans</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057080</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of orangutan, family HOMINIDAE, found in the forests on the island of Sumatra.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pongo abelii</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sumatran Orangutan</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pongo pygmaeus abelii</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orangutan, Sumatran</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pongo pygmaeus abeli</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057085</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Loss of the tooth substance by chemical or mechanical processes</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tooth Wear</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Wear</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057086</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of focused, high-frequency sound waves to destroy tissue. It is sometimes used in conjunction with but is distinct from INTERVENTIONAL ULTRASONOGRAPHY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>High-Intensity Focused Ultrasound Ablation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057087</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Treatment modality for DENTAL CARIES that uses manual excavation method and GLASS IONOMER CEMENTS. Because of its noninvasiveness and no need for expensive equipment and anesthesia it is promoted as an approach in places where dental care is not readily available.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dental Atraumatic Restorative Treatment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Atraumatic Restorative Treatment, Dental</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057088</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Benign DERMATOSIS caused by a loss of dermal ELASTIC TISSUE resulting in localized sac-like areas of flaccid skin. It can be either primary (idiopathic) or secondary to other skin conditions, PENICILLAMINE use, or premature birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anetoderma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Benign DERMATOSIS caused by a loss of dermal ELASTIC TISSUE resulting in localized sac-like areas of flaccid skin. It can be either primary (idiopathic) or secondary to other skin conditions, PENICILLAMINE use, or premature birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anetoderma, Secondary</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Benign DERMATOSIS caused by a loss of dermal ELASTIC TISSUE resulting in localized sac-like areas of flaccid skin. It can be either primary (idiopathic) or secondary to other skin conditions, PENICILLAMINE use, or premature birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anetoderma, Primary</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057089</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subspecialty of pathology concerned with the molecular basis (e.g., mutations) of various diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pathology, Molecular</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subspecialty of pathology concerned with the molecular basis (e.g., mutations) of various diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diagnostic Molecular Pathology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Molecular Diagnostics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057090</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare malignant neoplasm of the sweat glands. It most often develops as a form of degenerative progression from a benign ECCRINE POROMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eccrine Porocarcinoma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Malignant Eccrine Poroma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057091</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Benign adnexal neoplasm whose glandular secretion does not release part of the secreting cell. The malignant counterpart of an eccrine poroma is called an ECCRINE POROCARCINOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Poroma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Benign adnexal neoplasm whose glandular secretion does not release part of the secreting cell. The malignant counterpart of an eccrine poroma is called an ECCRINE POROCARCINOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hidracanthoma Simplex</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Benign adnexal neoplasm whose glandular secretion does not release part of the secreting cell. The malignant counterpart of an eccrine poroma is called an ECCRINE POROCARCINOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Apocrine Poroma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Benign adnexal neoplasm whose glandular secretion does not release part of the secreting cell. The malignant counterpart of an eccrine poroma is called an ECCRINE POROCARCINOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eccrine Poroma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057092</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Geographic Atrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dry Macular Degeneration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057093</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A broad category of receptor-like proteins that may play a role in transcriptional-regulation in the CELL NUCLEUS. Many of these proteins are similar in structure to known NUCLEAR RECEPTORS but appear to lack a functional ligand-binding domain, while in other cases the specific ligands have yet to be identified.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Orphan Nuclear Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057094</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A DNA-binding orphan nuclear receptor that positively regulates expression of ARNTL TRANSCRIPTION FACTORS and is a regulatory component of the circadian clock system. The protein also has a role in neuron cell survival and differentiation in that loss of function mutations of its gene result in the mouse phenotype referred to as the STAGGERER MOUSE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 1, Group F, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor ROR-alpha</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinoid-Related Orphan Receptor-alpha</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR1F1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RAR-Related Orphan Receptor A</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A DNA-binding orphan nuclear receptor that positively regulates expression of ARNTL TRANSCRIPTION FACTORS and is a regulatory component of the circadian clock system. The protein also has a role in neuron cell survival and differentiation in that loss of function mutations of its gene result in the mouse phenotype referred to as the STAGGERER MOUSE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoid-Related Orphan Receptor-alpha4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor RZR-alpha</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A DNA-binding orphan nuclear receptor that positively regulates expression of ARNTL TRANSCRIPTION FACTORS and is a regulatory component of the circadian clock system. The protein also has a role in neuron cell survival and differentiation in that loss of function mutations of its gene result in the mouse phenotype referred to as the STAGGERER MOUSE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoid-Related Orphan Receptor-alpha3</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A DNA-binding orphan nuclear receptor that positively regulates expression of ARNTL TRANSCRIPTION FACTORS and is a regulatory component of the circadian clock system. The protein also has a role in neuron cell survival and differentiation in that loss of function mutations of its gene result in the mouse phenotype referred to as the STAGGERER MOUSE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoid-Related Orphan Receptor-alpha1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A DNA-binding orphan nuclear receptor that positively regulates expression of ARNTL TRANSCRIPTION FACTORS and is a regulatory component of the circadian clock system. The protein also has a role in neuron cell survival and differentiation in that loss of function mutations of its gene result in the mouse phenotype referred to as the STAGGERER MOUSE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinoid-Related Orphan Receptor-alpha2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057095</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An orphan nuclear receptor that is expressed at high levels in neuronal tissues, the RETINA; EPIDIDYMIS; and VAS DEFERENS. The receptor is believed to play a role in regulating a variety of functions including the processing of sensory information, the differentiation of PHOTORECEPTOR CELLS and the CIRCADIAN RHYTHM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 1, Group F, Member 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinoid-related Orphan Receptor-beta</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RAR-related Orphan Receptor B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RAR-related Orphan Receptor-B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR1F2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor RZR-beta</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057096</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A condition caused by ingestion of shellfish contaminated with toxins from Dinophysis species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Shellfish Poisoning</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A condition caused by ingestion of shellfish contaminated with toxins from Dinophysis species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Paralytic Shellfish Poisoning</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A condition caused by ingestion of shellfish contaminated with toxins from Dinophysis species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neurotoxic Shellfish Poisoning</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A condition caused by ingestion of shellfish contaminated with toxins from Dinophysis species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Amnesic Shellfish Poisoning</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A condition caused by ingestion of shellfish contaminated with toxins from Dinophysis species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diarrhetic Shellfish Poisoning</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057097</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A colloquial term for a harmful algal bloom in which DINOFLAGELLATES accumulate rapidly forming dense patches and often discolor the water (but not always red). Some red tides are associated with the build up of natural toxins and some with the depletion of dissolved oxygen. They are unrelated to EARTH TIDES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Harmful Algal Bloom</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A colloquial term for a harmful algal bloom in which DINOFLAGELLATES accumulate rapidly forming dense patches and often discolor the water (but not always red). Some red tides are associated with the build up of natural toxins and some with the depletion of dissolved oxygen. They are unrelated to EARTH TIDES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Red Tide</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057105</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An orphan nuclear receptor that is closely related to members of the thyroid-steroid receptor gene family. It was originally indentified in NERVE CELLS and may play a role in mediation of NERVE GROWTH FACTOR-induced CELL DIFFERENTIATION. However, several other functions have been attributed to this protein including the positive and negative regulation of APOPTOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 4, Group A, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nerve Growth Factor-inducible B Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NGFI-B Orphan Nuclear Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR4A1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nur77 Orphan Nuclear Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor NGFI-B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor NR4A1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor TR3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TR3 Orphan Nuclear Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Early Response Protein NAK1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor HMR</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057106</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An orphan nuclear receptor that is closely related to members of the thyroid-steroid receptor family. It was originally identified in NERVE CELLS, however it may play regulatory roles in a variety of other tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 4, Group A, Member 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuron-derived Orphan Receptor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Translocated in Extraskeletal Chondrosarcoma Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR4A3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor TEC</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mitogen Induced Nuclear Orphan Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Hormone Receptor NOR-1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057107</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A DNA-binding orphan nuclear receptor that has specificity for directly repeated (DR) AGGTCA sequences. It binds DNA as either as a homodimer or as a heterodimer with the closely-related orphan nuclear receptor NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 2. The protein was originally identified as a PROSTATE-specific protein and is involved in the regulation of variety of cellular processes, including CELL DIFFERENTIATION; CELL PROLIFERATION; and APOPTOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 2, Group C, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor TR2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor TR2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TR2-11 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR2C1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor NR2C1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057108</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Asymmetries in the topography and refractive index of the corneal surface that affect visual acuity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Corneal Wavefront Aberration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057109</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A technique of diagnostic imaging of RETINA or CORNEA of the human eye involving the measurement and interpretation of polarizing ELECTROMAGNETIC WAVES such as radio or light waves. It is helpful in the diagnosis of GLAUCOMA; MACULAR DEGENERATION; and other retinal disorders.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Scanning Laser Polarimetry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057111</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A surgical procedure or KERATOPLASTY involving selective stripping and replacement of diseased host DESCEMET MEMBRANE and CORNEAL ENDOTHELIUM with a suitable and healthy donor posterior lamella. The advantage to this procedure is that the normal corneal surface of the recipient is retained, thereby avoiding corneal surface incisions and sutures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Descemet Stripping Endothelial Keratoplasty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057112</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A puncture or hole through the CORNEAL STROMA resulting from various diseases or trauma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Corneal Perforation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057125</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An orphan nuclear receptor that has specificity for hormone response elements found in the promoters of target genes. It binds DNA either as a homodimer or as heterodimer with the closely-related orphan nuclear receptor NUCLEAR RECEPTOR SUBFAMILY 2, GROUP C, MEMBER 1. The protein was originally identified as a TESTES-specific protein and is involved in the regulation of variety of cellular processes, including CELL DIFFERENTIATION; CELL PROLIFERATION; and APOPTOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 2, Group C, Member 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TR4 Nuclear Hormone Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TAK1 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR2C2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor TR4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Testicular Receptor 4</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057126</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An orphan nuclear receptor that is found at high levels in BRAIN tissue. The protein is believed to play a role in development and maintenance of NEURONS, particularly dopaminergic neurons.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 4, Group A, Member 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor-Related Factor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nurr1 Nuclear Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor Nurr1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR4A2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nur-Related Factor 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057127</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of antibodies consisting only of the variable regions of the heavy and light chains, connected by a small linker peptide. They are less immunogenic than complete immunoglobulin and thus have potential therapeutic use.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Single-Chain Antibodies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Single-Chain Variable Fragment Antibody</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Single-Chain Variable Fragment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ScFv Antibodies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Single-Chain Fv</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Single-Chain Fv Antibody</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Single-Chain Variable Fragment Antibodies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Single-Chain Variable Fragments</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057128</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of an aberrometer to measure eye tissue imperfections or  abnormalities based on the way light passes through the eye which affects the ability of the eye to focus properly.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aberrometry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057129</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A grouping of three closely linked conditions: iris nevus (or Cogan-Reese) syndrome, Chandler Syndrome, and essential (progressive) iris atrophy. The most common features of this syndrome are the movement of endothelial cells off the cornea onto the iris leading to corneal swelling, distortion of the iris, and variable degrees of distortion of the pupil. The abnormal cell movement plugs fluid outflow channels of the eye causing GLAUCOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Iridocorneal Endothelial Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A grouping of three closely linked conditions: iris nevus (or Cogan-Reese) syndrome, Chandler Syndrome, and essential (progressive) iris atrophy. The most common features of this syndrome are the movement of endothelial cells off the cornea onto the iris leading to corneal swelling, distortion of the iris, and variable degrees of distortion of the pupil. The abnormal cell movement plugs fluid outflow channels of the eye causing GLAUCOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chandler Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dystrophy Endothelial Cornea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Iris Atrophy with Corneal Edema and Glaucoma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chandler's Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057130</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare degenerative inherited eye disease that appears at birth or in the first few months of life that results in a loss of vision. Not to be confused with LEBER HEREDITARY OPTIC NEUROPATHY, the disease is thought to be caused by abnormal development of PHOTORECEPTOR CELLS in the RETINA, or by the extremely premature degeneration of retinal cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leber Congenital Amaurosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057131</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods used by pathogenic organisms to evade a host's immune system.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immune Evasion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057132</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Thymus-specific isoform of retinoid-related orphan receptor gamma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 1, Group F, Member 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor RZR-gamma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor NR1F3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RAR-related Orphan Receptor C</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ROR-C Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ROR-gamma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR1F3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Orphan Nuclear Receptor ROR-gamma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Thymus-specific isoform of retinoid-related orphan receptor gamma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Orphan Nuclear Receptor ROR-gammaT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RORgammaT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ROR-gammat</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057133</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Substances which reduce or eliminate dentinal sensitivity or the pain associated with a source of stimulus (such as touch, heat, or cold) at the orifice of exposed dentinal tubules causing the movement of tubular fluid that in turn stimulates tooth nerve receptors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dentin Desensitizing Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057134</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antibodies, Neutralizing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neutralizing Antibodies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neutralizing Antibody</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antibody, Neutralizing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057135</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of RETINAL DEGENERATION in which abnormal CHOROIDAL NEOVASCULARIZATION occurs under the RETINA and MACULA LUTEA, causing bleeding and leaking of fluid. This leads to bulging and or lifting of the macula and the distortion or destruction of central vision.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wet Macular Degeneration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057136</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An orphan nuclear receptor expressed mainly in the GERM CELLS of GONADS. It functions as a transcription factor that binds to a direct repeat of the sequence AGGTCA and may play a role in the regulation of EMBRYOGENESIS and germ cell differentiation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nuclear Receptor Subfamily 6, Group A, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuronal Cell Nuclear Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinoid Receptor Related Testis Specific Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinoid Receptor-Related Testis-Associated Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Germ Cell Nuclear Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR6A1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057137</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An orphan nuclear receptor that is implicated in regulation of steroidogenic pathways. It is unlike most orphan nuclear receptors in that it appears to lack an essential DNA-binding domain and instead acts as a transcriptional co-repressor. Mutations in the gene Dax-1 cause congenital adrenal hypoplasia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DAX-1 Orphan Nuclear Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor 0B1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor NR0B1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor Subfamily 0, Group B, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DSS-AHC Critical Region on the X Chromosome, Gene 1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nuclear Receptor DAX-1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057138</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The expelling of bacteria from the body. Important routes include the respiratory tract, genital tract, and intestinal tract.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bacterial Shedding</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057139</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Submicron-sized fibers with diameters typically between 50 and 500 nanometers. The very small dimension of these fibers can generate a high surface area to volume ratio, which makes them potential candidates for various biomedical and other applications.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nanofibers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057140</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Prepared food that is ready to eat or partially prepared food that has a final preparation time of a few minutes or less.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fast Foods</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Convenience Foods</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Prepared food that is ready to eat or partially prepared food that has a final preparation time of a few minutes or less.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ready-Prepared Foods</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ready-To-Eat Meals</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Meals, Ready-To-Eat</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057141</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Food that has been prepared and stored in a way to prevent spoilage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Food, Preserved</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Food that has been prepared and stored in a way to prevent spoilage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Food, Dried</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Food that has been prepared and stored in a way to prevent spoilage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Food, Canned</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057145</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Nanometer range spherical cores of particular semiconductor compounds surrounded by an ultrathin metal shell that is commonly made of gold or silver. This configuration gives the nanoshells highly tunable optical properties. They have potential in biomedicine for diagnosis and therapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nanoshells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metal Nanoshells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057146</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endosomes containing intraluminal vesicles which are formed by the inward budding of the endosome membrane. Multivesicular bodies (MVBs) may fuse with other organelles such as LYSOSOMES or fuse back with the PLASMA MEMBRANE releasing their contents by EXOCYTOSIS. The MVB intraluminal vesicles released into the extracellular environment are known as EXOSOMES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multivesicular Bodies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endosomal Carrier Vesicles</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multi-Vesicular Bodies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057147</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Free-standing or supported light weight meshwork fabric made of cotton, silk, polyester or other material having openings too small to allow entry of mosquitoes or other insects, thereby protecting against INSECT BITES; INSECT STINGS, and insect-borne diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mosquito Nets</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mosquito Netting</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Free-standing or supported light weight meshwork fabric made of cotton, silk, polyester or other material having openings too small to allow entry of mosquitoes or other insects, thereby protecting against INSECT BITES; INSECT STINGS, and insect-borne diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Portable Mosquito Net</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Free-standing or supported light weight meshwork fabric made of cotton, silk, polyester or other material having openings too small to allow entry of mosquitoes or other insects, thereby protecting against INSECT BITES; INSECT STINGS, and insect-borne diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mosquito Bednet</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057148</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Lightweight meshwork fabric made of cotton, silk, polyester, nylon (polyamides), or other material impregnated with insecticide, having openings too small to allow entry of mosquitoes or other insects, thereby offering protection against insect bite and insect-borne diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insecticide-Treated Bednets</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Treated Mosquito Net</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057149</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins covalently modified with UBIQUITINS or UBIQUITIN-LIKE PROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ubiquitinated Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057165</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Disorders caused by dysfunctions in PROTEIN FOLDING and degradation or clearance of misfolded proteins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proteostasis Deficiencies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Proteostasis Dysfunctions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Disorders caused by dysfunctions in PROTEIN FOLDING and degradation or clearance of misfolded proteins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Misfolding Disorders</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protein Folding Disorders</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protein Misfolding Diseases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protein Folding Diseases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057166</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>High-Throughput Screening Assays</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>High-Throughput Screening Methods</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>High-Throughput Biological Assays</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>High-Throughput Chemical Assays</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057167</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large family of transmembrane proteins found in TIGHT JUNCTIONS. They take part in the formation of paracellular barriers and pores that regulate paracellular permeability.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Claudins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Claudin Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057168</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A chemical process for separating the components of a liquid mixture by boiling and collecting condensed vapors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Distillation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057169</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A technique that induces the processing of disturbing memories and experiences, by stimulating neural mechanisms that are similar to those activated during REM sleep. The technique consists of eye movements following side-to-side movements of the index and middle fingers, or the alternate tapping of the hands on the knees. This procedure triggers the processing of information, thus facilitating the connection of neural networks.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eye Movement Desensitization Reprocessing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>EMDR</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eye Movement Desensitization and Processing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057170</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The application of discoveries generated by laboratory research and preclinical studies to the development of clinical trials and studies in humans. A second area of translational research concerns enhancing the adoption of best practices.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Translational Medical Research</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Translational Research, Medical</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Translational Research</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Translational Medical Science</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Translational Medicine</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057171</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Public Law No: 111-5, enacted February 2009, makes supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>American Recovery and Reinvestment Act</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Public Law 111-5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PL 111-5</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Public Law No: 111-5, enacted February 2009, makes supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>TAA Health Coverage Improvement Act of 2009</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Public Law No: 111-5, enacted February 2009, makes supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medicare and Medicaid Health Information Technology for Economic and Clinical Health Act</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>M-HITECH Act</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Public Law No: 111-5, enacted February 2009, makes supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Health Information Technology for Economic and Clinical Health Act</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Public Law No: 111-5, enacted February 2009, makes supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, and State and local fiscal stabilization, for fiscal year ending September 30, 2009.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Health Insurance Assistance for the Unemployed Act of 2009</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HITECH Act</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057172</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Severe economic downturn that lasts several years.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Economic Recession</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recession, Economic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Severe economic downturn that lasts several years.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Economic Depression</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057173</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The enhancement of physical, cognitive, emotional and social skills so an individual may participate in chosen activities. Recreational modalities are used in designed intervention strategies, incorporating individual's interests to make the therapy process meaningful and relevant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recreation Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recreational Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057174</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Frontotemporal Lobar Degeneration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>FTLD</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Heterogeneous group of neurodegenerative disorders characterized by frontal and temporal lobe atrophy associated with neuronal loss, gliosis, and dementia. Patients exhibit progressive changes in social, behavioral, and/or language function. Multiple subtypes or forms are recognized based on presence or absence of TAU PROTEIN inclusions. FTLD includes three clinical syndromes: FRONTOTEMPORAL DEMENTIA, semantic dementia, and PRIMARY PROGRESSIVE NONFLUENT APHASIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Semantic Dementia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057175</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Single or multi-sheet notices made to attract attention to events, activities, causes, goods, or services. They are for display, usually in a public place and are chiefly pictorial.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Posters as Topic</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057176</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Treatment of seriously ill using unapproved techniques, devices, and substances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Compassionate Use Trials</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Expanded Access Trials</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Treatment of seriously ill using unapproved techniques, devices, and substances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Humanitarian Device Exemption</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Treatment of seriously ill using unapproved techniques, devices, and substances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Compassionate Use</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057177</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Diseases characterized by the presence of abnormally phosphorylated, ubiquitinated, and cleaved DNA-binding protein TDP-43 in affected brain and spinal cord. Inclusions of the pathologic protein in neurons and glia, without the presence of AMYLOID, is the major feature of these conditions, thus making these proteinopathies distinct from most other neurogenerative disorders in which protein misfolding leads to brain amyloidosis. Both frontotemporal lobar degeneration and AMYOTROPHIC LATERAL SCLEROSIS exhibit this common method of pathogenesis and thus they may represent two extremes of a continuous clinicopathological spectrum of one disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>TDP-43 Proteinopathies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057178</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of frontotemporal lobar degeneration and a progressive form of dementia characterized by motor speech impairment and AGRAMMATISM, with relative sparing of single word comprehension and semantic memory.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Primary Progressive Nonfluent Aphasia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Progressive Nonfluent Aphasia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Non-fluent Primary Progressive Aphasia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PPA Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057179</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Evidence-based nursing, midwifery and healthcare grounded in research and scholarship. Practitioners include nurse practitioners, clinical nurse specialists, nurse anesthetists, and nurse midwives.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Advanced Practice Nursing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057180</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Frontotemporal Dementia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Frontotemporal Lobe Dementia (FLDEM)</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multiple System Tauopathy with Presenile Dementia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Frontotemporal Dementia with Parkinsonism</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dementia, Frontotemporal, with Parkinsonism</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Frontotemporal Dementia, Ubiquitin-Positive</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dementia, Hereditary Dysphasic Disinhibition</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057181</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sensation of enjoyment or gratification.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pleasure</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057182</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of the GENETIC VARIATION of known functions or phenotypes to correlate the causal effects of those functions or phenotypes with a disease outcome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mendelian Randomization Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057184</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Patterns of practice in nursing related to provision of services including diagnosis and treatment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nurse's Practice Patterns</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Patterns of practice in nursing related to provision of services including diagnosis and treatment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nurse-Led Clinics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057185</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Usual level of physical activity that is less than 30 minutes of moderate-intensity activity on most days of the week.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sedentary Lifestyle</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057186</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Conduct and synthesis of systematic research comparing interventions and strategies to prevent, diagnose, treat, and monitor health conditions. The purpose of this research is to inform patients, providers, and decision-makers, responding to their expressed needs, about which interventions are most effective for which patients under specific circumstances. (hhs.gov/recovery/programs/cer/draftdefinition.html accessed 6/12/2009)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Comparative Effectiveness Research</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057187</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>To continue to live in one's home safely, independently, and comfortably in a familiar environment..</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Independent Living</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>To continue to live in one's home safely, independently, and comfortably in a familiar environment..</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aging in Place</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057188</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Description of pattern of recurrent functions or procedures frequently found in organizational processes, such as notification, decision, and action.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Workflow</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Work Flow</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057189</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Aid for consistent recording of data such as tasks completed and observations noted.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Checklist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057190</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Response showing selective inattention to complex stimuli.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stroop Test</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Response showing selective inattention to complex stimuli.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stroop Paradigm</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Response showing selective inattention to complex stimuli.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stroop Effect</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057191</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Organizational development including enhancement of management structures, processes and procedures, within organizations and among different organizations and sectors to meet present and future needs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Capacity Building</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057192</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Series of ocean waves produced by geologic events  or underwater LANDSLIDES. These waves can travel at speeds averaging 450 (and up to 600) miles per hour in the open ocean.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tsunamis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tsunami</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057193</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Travel to another country for the purpose of medical treatment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medical Tourism</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057194</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Strategy for the analysis of RANDOMIZED CONTROLLED TRIALS AS TOPIC that compares patients in the groups to which they were originally randomly assigned.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intention to Treat Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057205</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Controlled operations of analytic or diagnostic processes, or systems by mechanical or electronic devices.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Automation, Laboratory</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057207</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Devices used to protect and restrain infant and child automotive passengers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Child Restraint Systems</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Devices used to protect and restrain infant and child automotive passengers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Child Safety Seats</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057208</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An  American National Standards Institute-accredited organization working on specifications to support development and advancement of clinical and administrative standards for healthcare.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Health Level Seven</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Health Level Seven (Organization)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Health Level 7</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057209</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Team of hospital doctors and nurses who respond immediately to patients suffering cardiac arrest.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hospital Rapid Response Team</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Team of hospital doctors and nurses who respond immediately to patients suffering cardiac arrest.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Code Team</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac Crash Team</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Team of hospital doctors and nurses who respond immediately to patients suffering cardiac arrest.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rapid Response Team</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057210</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Excessive period of time between onset of disease and identification.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Delayed Diagnosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Excessive period of time between onset of disease and identification.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Late Diagnosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057211</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Use of technology that allows organizations to deliver news to a desktop computer or other INTERNET device.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Webcasts as Topic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Use of technology that allows organizations to deliver news to a desktop computer or other INTERNET device.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Streaming Video as Topic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Use of technology that allows organizations to deliver news to a desktop computer or other INTERNET device.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Podcasts as Topic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Use of technology that allows organizations to deliver news to a desktop computer or other INTERNET device.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RSS as Topic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Really Simple Syndication as Topic</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057212</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Expectation of real uncertainty on the part of the investigator regarding the comparative therapeutic merits of each arm in a trial.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Therapeutic Equipoise</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057213</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Books printed before 1501.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Incunabula</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057214</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A sultanate comprised at various times of parts of EUROPE, ASIA, and AFRICA. Its period extends generally from 1301 to 1922.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ottoman Empire</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057215</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Preoccupations with appearance or self-image causing significant distress or impairment in important areas of functioning.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Body Dysmorphic Disorders</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Body Image Disfunction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Body Image Disorders</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057216</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Conditional probability of exposure to a treatment given observed covariates.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Propensity Score</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057217</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Increase in the level of production of goods and services.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Economic Development</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Development, Economic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Increase in the level of production of goods and services.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Economic Growth</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057218</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Contents of such an online personal journal established on the INTERNET.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blogging</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Contents of such an online personal journal established on the INTERNET.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Twitter Messaging</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Contents of such an online personal journal established on the INTERNET.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blog</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057219</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Process by which unwanted microbial, plant or animal materials or organisms accumulate on man-made surfaces.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biofouling</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057220</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Degree to which individuals have the capacity to obtain, process, and understand basic health information and services needed to make appropriate health decisions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Health Literacy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057221</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 1 and neuraminidase 2. It is endemic in both human and pig populations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Influenza A Virus, H1N2 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>H1N2 Virus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057225</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Use of sophisticated tools to parse, organize, and examine textual information.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Data Mining</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Use of sophisticated tools to parse, organize, and examine textual information.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Text Mining</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057226</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>How information is gathered in personal, academic or work environments and the resources used.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Information Seeking Behavior</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057227</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Female-associated sex-specific social roles and behaviors unrelated to biologic function.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Femininity</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057228</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Male-associated sex-specific social roles and behaviors unrelated to biologic function.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Masculinity</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057229</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Persons who have a history of physical or psychological dependence on ETHANOL.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alcoholics</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Persons who have a history of physical or psychological dependence on ETHANOL.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Skid Row Alcoholics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057230</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Concentration or quantity that is derived from the smallest measure that can be detected with reasonable certainty for a given analytical procedure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Limit of Detection</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Limits of Detection</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057231</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Any significant change in measures of climate (such as temperature, precipitation, or wind) lasting for an extended period (decades or longer). It may result from natural factors such as changes in the sun's intensity, natural processes within the climate system such as changes in ocean circulation, or human activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Climate Change</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057232</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Increase in the temperature of the atmosphere near the Earth's surface and in the troposphere, which can contribute to changes in global climate patterns.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Global Warming</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057233</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Machine readable patient or equipment identification device using radio frequency from 125 kHz to 5.8 Ghz.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radio Frequency Identification Device</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RFID</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Machine readable patient or equipment identification device using radio frequency from 125 kHz to 5.8 Ghz.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radio Frequency Identification</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057234</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The period before a surgical operation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Preoperative Period</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057235</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A dual monarchy formed in 1867. It included AUSTRIA; HUNGARY; CZECHOSLOVAKIA; Moravia, Bukovina, Transylvania, Carniola, Kustenland, Dalmatia, CROATIA; Fiume, and Galicia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Austria-Hungary</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Habsburg Empire</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Austro-Hungarian Empire</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057236</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The specialty devoted to the medical aspects of travel. It excludes study tours.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Travel Medicine</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medicine, Emporiatric</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The specialty devoted to the medical aspects of travel. It excludes study tours.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Emporiatrics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057237</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Persons who have committed a crime but have not yet been convicted of the offense.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Criminals</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Persons who have committed a crime but have not yet been convicted of the offense.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Offenders</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057238</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Graphic displays of height and weight showing development over time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Growth Charts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Growth Charts as Topic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Graphic displays of height and weight showing development over time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reference Growth Curves</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057239</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Earlier than planned termination of clinical trials.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Early Termination of Clinical Trials</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057240</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Individual's expression of desirability or value  of one course of action, outcome, or selection in contrast to others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Patient Preference</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057265</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A DNA-methyltransferase that catalyzes the transfer of a methyl group from S-ADENOSYLMETHIONINE to the exocyclic NH2 group at the 4 position of CYTOSINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Site-Specific DNA-Methyltransferase (Cytosine-N(4)-Specific)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>N(4)-Cytosine-Specific DNA Methylase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057285</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Therapeutic approach tailoring therapy for genetically defined subgroups of patients.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Individualized Medicine</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Personalized Medicine</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057286</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Media that facilitate transportability of pertinent information concerning patient's illness across varied providers and geographic locations. Some versions include direct linkages to online consumer health information that is relevant to the health conditions and treatments related to a specific patient.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electronic Health Records</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electronic Medical Record</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electronic Medical Records</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electronic Health Record</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057345</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The deletion and reinsertion of a segment of a nucleic acid sequence in the same place, but flipped in an opposite orientation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sequence Inversion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inverted Sequence</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inversion, Sequence</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057386</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Software used to locate data or information stored in machine-readable form  locally or at a distance such as an INTERNET site.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Search Engine</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057405</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>News delivered to a desktop computer or other INTERNET device.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Webcasts</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>News delivered to a desktop computer or other INTERNET device.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Streaming Video</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>News delivered to a desktop computer or other INTERNET device.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Podcasts</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>News delivered to a desktop computer or other INTERNET device.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RSS</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Really Simple Syndication</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057445</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The state of failure to complete the process of GERMINATION of an intact viable seed, due to intrinsic physical, molecular, genetic, or physiological parameters under otherwise favourable prevailing conditions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Seed Dormancy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057446</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The motion of fluids, especially noncompressible liquids, under the influence of internal and external forces.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hydrodynamics</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fluid Dynamics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057465</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The inactivation or blocking of alternate carbon sources or their genes in favor the preferred carbon source.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Catabolite Repression</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The inactivation or blocking of alternate carbon sources or their genes in favor the preferred carbon source.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carbon Catabolite Repression</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057466</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Nonsteroidal agents which block the action or downregulate the synthesis of ANDROGENS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nonsteroidal Anti-Androgens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nonsteroidal Antiandrogens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AntiAndrogens, Nonsteroidal</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057486</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The cycle by which the element carbon is exchanged between organic matter and the earth's physical environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carbon Cycle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carbon Flux</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The cycle by which the element carbon is exchanged between organic matter and the earth's physical environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carbon Fixation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057487</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The parenteral use of enzymes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Enzyme Therapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The parenteral use of enzymes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Systemic Enzyme Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Enzymotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057488</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Artificial device such as an externally-worn camera attached to a stimulator on the RETINA, OPTIC NERVE, or VISUAL CORTEX, intended to restore or amplify vision.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Visual Prosthesis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retinal Prosthesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Artificial device such as an externally-worn camera attached to a stimulator on the RETINA, OPTIC NERVE, or VISUAL CORTEX, intended to restore or amplify vision.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bionic Eye</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057505</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Vascular filters or occlusive devices that provide mechanical protection of the distal end organ from blood clots or EMBOLISM-causing debri dislodged during ENDOVASCULAR PROCEDURES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Embolic Protection Devices</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Emboli Protection Devices</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Embolism Protection Devices</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Vascular filters or occlusive devices that provide mechanical protection of the distal end organ from blood clots or EMBOLISM-causing debri dislodged during ENDOVASCULAR PROCEDURES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Embolic Protection Filters</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057506</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Paired sense organs connected to the anterior segments of ARTHROPODS that help them navigate through the environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Arthropod Antennae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Arthropod Antenna</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antennae, Arthropod</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Paired sense organs connected to the anterior segments of ARTHROPODS that help them navigate through the environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insect Antennae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insect Antenna</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antennae, Insect</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057507</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Strains of mice arising from a parental inbred stock that was subsequently used to produce substrains of knockout and other mutant mice with targeted mutations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mice, 129 Strain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>129 Mouse</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>129 Strain Mice</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mouse, 129</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bar Harbor 129 Mice</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bar Harbor 129 Mouse</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mice, 129</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mice, Strain 129</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>129 Mice</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>129 Strain Mouse</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057508</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of gram-negative bacteria that causes disease in plants. It is found commonly in the environment and is an opportunistic pathogen in humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Burkholderia cenocepacia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057509</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A hemoflagellate parasite affecting domestic and wild animals, as well as humans and invertebrates. Though it induces an immune response, it is non-pathogenic in humans and other vertebrates. It is cross-reactive with TRYPANOSOMA CRUZI and can thus cause false positives for CHAGAS DISEASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trypanosoma rangeli</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057510</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Minimally invasive procedures, diagnostic or therapeutic, performed within the BLOOD VESSELS. They may be perfomed via ANGIOSCOPY; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTERVENTIONAL RADIOGRAPHY; or INTERVENTIONAL ULTRASONOGRAPHY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endovascular Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intravascular Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endovascular Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intravascular Procedures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057545</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A perceived attribute that is deeply discrediting and is considered to be a violation of social norms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Social Stigma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stigma, Social</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057565</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Lack of emotion or emotional expression; a disorder of motivation that persists over time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Apathy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057566</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Method for obtaining information through verbal responses, written or oral, from subjects.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Self Report</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057567</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Information learned before age 12 and less subject to disruption than intermediate memory.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Memory, Long-Term</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Memory, Longterm</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Information learned before age 12 and less subject to disruption than intermediate memory.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Memory, Remote</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Remote Memory</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057585</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of gram-negative, facultatively anaerobic bacteria that is found in domestic and wild animals including birds, and fish. In humans it causes GASTROENTERITIS in young children and some adults.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aeromonas caviae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057586</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specialized ophthalmic technique used in the surgical repair and or treatment of disorders that include retinal tears or detachment; MACULAR HOLES; hereditary retinal disease; AIDS-related retinal infections; ocular tumors; MACULAR DEGENERATION; DIABETIC RETINOPATHY; and UVEITIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vitreoretinal Surgery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057605</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Procedures performed with an ENDOSCOPE passing through a natural opening in the body such as the mouth, nose, urethra, or anus and along their natural body pathways; and then through an internal incision in the wall of the tubular structure or organ such as the stomach, bladder, or intestines, thus avoiding any external incisions through the skin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Orifice Endoscopic Surgery</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Procedures performed with an ENDOSCOPE passing through a natural opening in the body such as the mouth, nose, urethra, or anus and along their natural body pathways; and then through an internal incision in the wall of the tubular structure or organ such as the stomach, bladder, or intestines, thus avoiding any external incisions through the skin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Orifice Transluminal Endoscopy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Procedures performed with an ENDOSCOPE passing through a natural opening in the body such as the mouth, nose, urethra, or anus and along their natural body pathways; and then through an internal incision in the wall of the tubular structure or organ such as the stomach, bladder, or intestines, thus avoiding any external incisions through the skin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Orifice Transluminal Endoscopic Surgery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057625</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A nonlinear electrophoretic technique used to separate a variety of ionic compounds, ranging from small metal ions to large molecules like proteins. Unlike "linear" zone electrophoresis in which separating solute bands continually spread by diffusion or dispersion, isotachophoresis forms self-sharpening, adjacent zones of substantially pure solute whose concentrations often exceed several mgs/ml. In isotachophoresis a multianalyte sample is introduced between the leading electrolyte and the terminating electrolyte where the sample ions have lower electrophoretic mobilities than the leading ion but larger than the terminating ion. (From "Isotachophoresis" on the AES Web Site [Internet]. Madison, WI: The American Electrophoresis Society; c2000-2008 [cited 2009 Aug 20]. Available from http://www.aesociety.org/areas/isotachophoresis.php)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Isotachophoresis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Displacement Electrophoresis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057645</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Thick triangular muscle in the SHOULDER whose function is to abduct, flex, and extend the arm. It is a common site of INTRAMUSCULAR INJECTIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Deltoid Muscle</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057646</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Intracellular step that follows VIRUS INTERNALIZATION during which the viral nucleic acid and CAPSID are separated.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Virus Uncoating</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Viral Uncoating</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057665</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Formerly known as Rhynchelytrum repens, a member of the perennial grass family native to South Africa, widely distributed and known by different common names. It is used as a diabetes cure in folk medicine and actively studied for its hypoglycemic properties.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Melinis repens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rhynchelytrum repens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tricholaena rosea nees</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rose Natal Grass</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Saccharum repens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tricholaena repens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Natal Grass</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rhynchelytrum roseum</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057666</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote></ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Research Support, American Recovery and Reinvestment Act</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057667</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The injuries caused by conducted energy weapons such as stun guns, shock batons, and cattle prods.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Conducted Energy Weapon Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stun Gun Injuries</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The injuries caused by conducted energy weapons such as stun guns, shock batons, and cattle prods.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>TASER Injuries</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057668</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Medical, pre-operative, and post-operative organizational approaches that support patients who refuse allogeneic BLOOD TRANSFUSIONS or blood products for personal reasons, religious beliefs, or fear of bloodborne infections. Preparations for AUTOLOGOUS BLOOD TRANSFUSIONS may be a component of some programs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bloodless Medical and Surgical Procedures</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Medical, pre-operative, and post-operative organizational approaches that support patients who refuse allogeneic BLOOD TRANSFUSIONS or blood products for personal reasons, religious beliefs, or fear of bloodborne infections. Preparations for AUTOLOGOUS BLOOD TRANSFUSIONS may be a component of some programs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bloodless Medicine and Surgery Programs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057685</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A plant growing in a location where it is not wanted, often competing with cultivated plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Weeds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A plant growing in a location where it is not wanted, often competing with cultivated plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Invasive Weeds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A plant growing in a location where it is not wanted, often competing with cultivated plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Perennial Weeds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A plant growing in a location where it is not wanted, often competing with cultivated plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Parasitic Weeds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A plant growing in a location where it is not wanted, often competing with cultivated plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Annual Weeds</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A plant growing in a location where it is not wanted, often competing with cultivated plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Noxious Weeds</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057686</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The mechanisms by which a cell becomes internalized in another. The host cell may engulf another as do PHAGOCYTIC CELLS, or the host cell may be invaded by another cell (ENTOSIS), or internalization processes may involve the cooperation of both the host cell and the cell being internalized. Viable cells may remain in non-phagocytic cells (EMPERIPOLESIS), undergo cell division, pass through and then out of the host cell (TRANSCELLULAR CELL MIGRATION), or trigger APOPTOSIS of the invaded cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell-in-Cell Formation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057687</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The movement of one cell within another cell (non-phagocytic).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Emperipolesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057688</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The movement of one cell into, through, and out of another cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcellular Cell Migration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057689</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>For publications noted as supported by US Government.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Research Support, U.S. Government</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057691</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The processes by which one cell actively invades and becomes internalized within another cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Entosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057705</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The passage of BLOOD CELLS across the layer of ENDOTHELIAL CELLS, i.e., the ENDOTHELIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transendothelial and Transepithelial Migration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transepithelial and Transendothelial Migration</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The passage of BLOOD CELLS across the layer of ENDOTHELIAL CELLS, i.e., the ENDOTHELIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transendothelial Migration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endothelial Transmigration</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The passage of BLOOD CELLS across the layer of ENDOTHELIAL CELLS, i.e., the ENDOTHELIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transepithelial Migration</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The passage of BLOOD CELLS across the layer of ENDOTHELIAL CELLS, i.e., the ENDOTHELIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diapedesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057725</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Recovery of blood cells lost during surgical procedures for reuse by the same patient. It is used to collect blood cells for AUTOLOGOUS BLOOD TRANSFUSIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Operative Blood Salvage</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recovery of blood cells lost during surgical procedures for reuse by the same patient. It is used to collect blood cells for AUTOLOGOUS BLOOD TRANSFUSIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intraoperative Blood Salvage</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recovery of blood cells lost during surgical procedures for reuse by the same patient. It is used to collect blood cells for AUTOLOGOUS BLOOD TRANSFUSIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Postoperative Blood Salvage</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Post-Operative Blood Salvage</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recovery of blood cells lost during surgical procedures for reuse by the same patient. It is used to collect blood cells for AUTOLOGOUS BLOOD TRANSFUSIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intraoperative Blood Cell Salvage</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057747</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Removal or disruption of DENTAL DEPOSITS and plaque-retentive DENTAL CALCULUS from tooth surfaces and within the periodontal pocket space without deliberate removal of CEMENTUM as done in ROOT PLANING and often in DENTAL SCALING. The goal is to conserve dental cementum to help maintain or re-establish healthy periodontal environment and eliminate PERIODONTITIS by using light instrumentation strokes and nonsurgical techniques (e.g., ultrasonic, laser instruments).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Periodontal Debridement</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nonsurgical Periodontal Debridement</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Removal or disruption of DENTAL DEPOSITS and plaque-retentive DENTAL CALCULUS from tooth surfaces and within the periodontal pocket space without deliberate removal of CEMENTUM as done in ROOT PLANING and often in DENTAL SCALING. The goal is to conserve dental cementum to help maintain or re-establish healthy periodontal environment and eliminate PERIODONTITIS by using light instrumentation strokes and nonsurgical techniques (e.g., ultrasonic, laser instruments).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Periodontal Pocket Debridement</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057748</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The application of medicine, vitamins, extracts, or other bioactive substances for a localized effect via multiple subcutaneous injections or perfusion of substances into the various layers of the skin below the EPIDERMIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mesotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057765</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eosinophilic Esophagitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chronic Esophagitis, Eosinophilic</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057766</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A course or method of action selected to guide and determine present and future decisions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Policy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057767</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Disabling osteochondrodysplasia with OSTEOSCLEROSIS, cone-shaped METAPHYSIS, and shortening of the DIAPHYSIS. It is endemic in parts of Siberia and northern China. Mineral deficiencies (e.g., selenium, iodine), fungal cereal contamination, and water contamination may be contributing factors in its etiology.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kashin-Beck Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057768</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An event experienced by an infant or a child that is characterized by some combination of apnea, color change, change in muscle tone, choking, and gagging.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infantile Apparent Life-Threatening Event</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Idiopathic Apparent Life-Threatening Event</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057769</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A procedure to increase the flow of blood to the MYOCARDIUM by creating transmural channels in the heart wall via the application of laser pulses to epicardial or endocardial surfaces.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transmyocardial Laser Revascularization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Laser Transmyocardial Revascularization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Trans-Myocardial Laser Revascularization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057770</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infantile systemic hyalinosis is additionally characterized by infantile onset painful thickened skin, hyperpigmentation over joints, and increased susceptibility to bone fractures. Early childhood death due to severe diarrhea and recurrent infections are common.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hyalinosis, Systemic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Systemic Hyalinosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hyaline Fibromatosis Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Infantile systemic hyalinosis is additionally characterized by infantile onset painful thickened skin, hyperpigmentation over joints, and increased susceptibility to bone fractures. Early childhood death due to severe diarrhea and recurrent infections are common.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Juvenile Hyaline Fibromatosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fibromatosis Juvenile Hyaline</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hyaline Fibromatosis Juvenile</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fibromatosis Hyalinica Multiplex Juvenilis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Infantile systemic hyalinosis is additionally characterized by infantile onset painful thickened skin, hyperpigmentation over joints, and increased susceptibility to bone fractures. Early childhood death due to severe diarrhea and recurrent infections are common.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infantile Systemic Hyalinosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057771</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A structurally-related family of small proteins that form a stable tertiary fold pattern which is supported by a series of disulfide bonds. The arrangement of disulfide bonds between the CYSTEINE moieties results in a knotted structure which is unique to this family of proteins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cystine-Knot Miniproteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Knottins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Knottin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057772</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Injuries to blood vessels caused by laceration, contusion, puncture, or crush and other types of injuries. Symptoms vary by site and mode of injuries and may include bleeding, bruising, swelling, pain, and numbness. It does not include injuries secondary to pathologic function or diseases such as ATHEROSCLEROSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vascular System Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vascular Injuries</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057773</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cellular proteins and peptides that are induced in response to cold stress. They are found in a broad variety of prokaryotic and eukaryotic organisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cold Shock Proteins and Peptides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cold Stress Proteins and Peptides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cellular proteins and peptides that are induced in response to cold stress. They are found in a broad variety of prokaryotic and eukaryotic organisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cold Shock Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cold Stress Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cellular proteins and peptides that are induced in response to cold stress. They are found in a broad variety of prokaryotic and eukaryotic organisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cold Shock Peptides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cold Stress Peptides</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057774</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Transient reduction in blood pressure levels immediately after exercises that lasts 2-12 hours. The reduction varies but is typically 5-20 mm Hg when compared to pre-exercise levels. It exists both in normotensive and hypertensive individuals and may play a role in excercise related PHYSIOLOGIC ADAPTATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Post-Exercise Hypotension</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Post Exercise Hypotension</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Postexercise Hypotension</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057775</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The application of repeated, brief periods of vascular occlusion at the onset of REPERFUSION to reduce REPERFUSION INJURY that follows a prolonged ischemic event. The techniques are similar to ISCHEMIC PRECONDITIONING but the time of application is after the ischemic event instead of before.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ischemic Postconditioning</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ischemic Post-Conditioning</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057785</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A flexible, tubular device that is used to carry fluids into or from a blood vessel, hollow organ, or body cavity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Catheters</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Catheter</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A flexible, tubular device that is used to carry fluids into or from a blood vessel, hollow organ, or body cavity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cannula</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057786</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that are designed to mimic the 3D structure of a natural peptide or protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peptidomimetics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057787</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of gram-positive bacteria in the family STAPHYLOCOCCACEAE. It is responsible for skin and soft-tissue infections among others, and is part of the normal human skin flora.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Staphylococcus lugdunensis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057788</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of gram-positive bacteria in the family STAPHYLOCOCCACEAE. It is an important opportunistic pathogen in swine.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Staphylococcus hyicus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057789</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of gram-positive bacteria in the family STAPHYLOCOCCACEAE. It is a zoonotic organism and common commensal in dogs, but can cause disease in dogs and other animals. It also can be associated with human disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Staphylococcus intermedius</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057790</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of gram-positive bacteria in the family STAPHYLOCOCCACEAE. It commonly causes urinary tract infections in humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Staphylococcus saprophyticus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057791</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Visualization of the heart structure and cardiac blood flow for diagnostic evaluation or to guide cardiac procedures via techniques including ENDOSCOPY (cardiac endoscopy, sometimes refered to as cardioscopy), RADIONUCLIDE IMAGING; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY; or ULTRASONOGRAPHY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiac Imaging Techniques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Visualization of the heart structure and cardiac blood flow for diagnostic evaluation or to guide cardiac procedures via techniques including ENDOSCOPY (cardiac endoscopy, sometimes refered to as cardioscopy), RADIONUCLIDE IMAGING; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY; or ULTRASONOGRAPHY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intracardiac Imaging Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057792</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Complication of CHOLELITHIASIS characterized by OBSTRUCTIVE JAUNDICE; abdominal pain, and fever.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mirizzi Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mirizzi's Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057805</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Animals kept by humans for companionship and enjoyment, as opposed to DOMESTIC ANIMALS such as livestock or farm animals, which are kept for economic reasons.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pets</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Companion Animals</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057807</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A superfamily of roundworms in the order STRONGYLIDA. It comprises the single family Molineidae and subfamily Nematodirinae.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molineoidae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A superfamily of roundworms in the order STRONGYLIDA. It comprises the single family Molineidae and subfamily Nematodirinae.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molineidae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057808</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of roundworms in the family MOLINIEIDAE, whose species are important gastrointestinal parasites of RUMINANTS, especially CATTLE; SHEEP; and GOATS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nematodirus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057809</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cell line generated from human embryonic kidney cells that were tranformed with human adenovirus type 5.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HEK293 Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Human Kidney Cell Line 293</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HEK 293 Cell Line</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HEK 293 Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057825</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods of comparing two or more samples on the same two-dimensional gel electrophoresis gel.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Two-Dimensional Difference Gel Electrophoresis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>2D-DIGE</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>2-Dimensional Difference Gel Electrophoresis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057826</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Autosomal dominant hereditary maculopathy with childhood-onset accumulation of LIPOFUSION in RETINAL PIGMENT EPITHELIUM. Affected individuals develop progressive central acuity loss, and distorted vision (METAMORPHOPSIA). It is associated with mutations in bestrophin, a chloride channel.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vitelliform Macular Dystrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Best's Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Best Vitelliform Macular Dystrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Best Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Best Macular Dystrophy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Autosomal dominant hereditary maculopathy with childhood-onset accumulation of LIPOFUSION in RETINAL PIGMENT EPITHELIUM. Affected individuals develop progressive central acuity loss, and distorted vision (METAMORPHOPSIA). It is associated with mutations in bestrophin, a chloride channel.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Juvenile-Onset Vitelliform Macular Dystrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vitelliform Macular Dystrophy, Juvenile-Onset</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Autosomal dominant hereditary maculopathy with childhood-onset accumulation of LIPOFUSION in RETINAL PIGMENT EPITHELIUM. Affected individuals develop progressive central acuity loss, and distorted vision (METAMORPHOPSIA). It is associated with mutations in bestrophin, a chloride channel.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adult-Onset Vitelliform Macular Dystrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vitelliform Macular Dystrophy, Adult-Onset</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057828</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Voluntary authorization by a person not of usual legal age for diagnostic or investigative procedures, or for medical and surgical treatment.  (from English A, Shaw FE, McCauley MM, Fishbein DB Pediatrics 121:Suppl Jan 2008 pp S85-7).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Informed Consent By Minors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057829</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Clinical treatments used to change the physiological sexual characteristics of an individual.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sex Reassignment Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gender Reassignment Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sex Change Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gender Change Procedures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057830</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgical treatments used to change the physiological sexual characteristics of an individual.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sex Reassignment Surgery</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sex Change Surgery</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gender Change Surgery</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gender Reassignment Surgery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057831</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A superinfection of the damaged oropharyngeal mucosa by FUSOBACTERIUM NECROPHORUM leading to the secondary septic THROMBOPHLEBITIS of the internal jugular vein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lemierre Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lemierre's Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Postanginal Sepsis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lemierre Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lemierre's Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057832</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Clinical management approach wherein immediate therapy is not provided but there is a period of observation during which periodic tests monitor patient and the progression of the illness.  (Driffield T, Smith PC  Med Decis Making. 2007 Mar-Apr;27(2):178-88)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Watchful Waiting</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057845</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pentosyltransferases that catalyze the reaction between a pyrimidine nucleoside and orthophosphate to form a free pyrimidine and ribose-5-phosphate.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pyrimidine Phosphorylases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pyrimidine Nucleoside Phosphorylase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057846</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Peptides that have the ability to enter cells by crossing the plasma membrane directly, or through uptake by the endocytotic pathway.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell-Penetrating Peptides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peptides, Cell-Penetrating</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057847</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Substances that alter the metabolism of LIPIDS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lipid Regulating Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lipid Regulating Drugs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057849</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The continuous visual field seen by a subject through space and time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optic Flow</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057850</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Organisms with both protandrous and protogynous individuals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hermaphroditic Organisms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Organisms with both protandrous and protogynous individuals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protogynous Organisms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Organisms with both protandrous and protogynous individuals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protandrous Organisms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Organisms with both protandrous and protogynous individuals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dichogamous Organisms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Organisms with both protandrous and protogynous individuals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Heterodichogamous Organisms</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057851</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A breach in the continuity of the posterior chamber of the eyeball.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Posterior Capsular Rupture, Ocular</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057852</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The posterior aspect of the casing that surrounds the natural CRYSTALLINE LENS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Posterior Capsule of the Lens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Posterior Capsule, Lens</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057865</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specific signaling cascades set in motion to defend against or repel pathogens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Immunity</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Specific signaling cascades set in motion to defend against or repel pathogens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Immune System</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Specific signaling cascades set in motion to defend against or repel pathogens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Immune Response</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057866</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The anterior aspect of the casing that surrounds the natural CRYSTALLINE LENS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anterior Capsule of the Lens</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057867</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Postoperative hemorrhage from an endovascular AORTIC ANEURYSM repaired with endoluminal placement of stent grafts (BLOOD VESSEL PROSTHESIS IMPLANTATION).  It is associated with pressurization, expansion, and eventual rupture of the aneurysm.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endoleak</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Perigraft Leak</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057868</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Breakdown of the connection and subsequent leakage of digestive system fluid from a SURGICAL ANASTOMOSIS of digestive system structures. Most common leakages are from breakdown of the sutured lines in gastrointestinal or bowel anastomosis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anastomotic Leak</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anastomotic Leakage</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057872</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Materials used in DENTAL PULP CAPPING or PULPECTOMY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pulp Capping and Pulpectomy Agents</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Materials used in DENTAL PULP CAPPING or PULPECTOMY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pulp Capping Agents</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Materials used in DENTAL PULP CAPPING or PULPECTOMY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pulpectomy Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057873</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An inflammatory process with loss of supporting bone in the tissues surrounding functioning DENTAL IMPLANTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peri-Implantitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Periimplantitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057885</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Polyploidy with three sets of chromosomes. Triploidy in humans are 69XXX, 69XXY, and 69XYY. It is associated with HOLOPROSENCEPHALY; ABNORMALITIES, MULTIPLE; PARTIAL HYDATIDIFORM MOLE; and MISCARRAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Triploidy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Triploid</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057886</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemicals that are used to oxidize pigments and thus effect whitening.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bleaching Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Whitening Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057887</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A malocclusion of the teeth in which maxillary incisor and canine teeth project over the mandiblar teeth. The overlap is measured parallel to the occlusal plane and therefore is called horizontal overlap.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Overbite</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Deep Bite</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Deep-Bite</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A malocclusion of the teeth in which maxillary incisor and canine teeth project over the mandiblar teeth. The overlap is measured parallel to the occlusal plane and therefore is called horizontal overlap.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Overjet, Dental</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A malocclusion of the teeth in which maxillary incisor and canine teeth project over the mandiblar teeth. The overlap is measured parallel to the occlusal plane and therefore is called horizontal overlap.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Incisor Protrusion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057888</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of iridoid compounds that include a glucoside moiety, usually found at the C-1 position.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Iridoid Glucosides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Iridoidglucosides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of iridoid compounds that include a glucoside moiety, usually found at the C-1 position.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Secoiridoid Glucosides</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057889</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of iridoid compounds that include a glycoside moiety, usually found at the C-1 position.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Iridoid Glycosides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Iridoidglycosides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of iridoid compounds that include a glycoside moiety, usually found at the C-1 position.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Secoiridoid Glycosides</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057890</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The systematic study of the global gene expression changes due to EPIGENETIC PROCESSES and not due to DNA base sequence changes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Epigenomics</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The systematic study of the global gene expression changes due to EPIGENETIC PROCESSES and not due to DNA base sequence changes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Epigenetics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057891</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The presence of four sets of chromosomes. It is associated with ABNORMALITIES, MULTIPLE; and MISCARRAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tetraploidy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tetraploid</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057892</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The part of the pelvis, inferior to the pelvic brim, that comprises both the pelvic cavity and the part of the PERINEUM lying inferior to the PELVIC DIAPHRAGM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lesser Pelvis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>True Pelvis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pelvis Minor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057893</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endosseous dental implantation where implants are fitted with an abutment or where an implant with a transmucosal coronal portion is used within 1 week to 2 months.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immediate Dental Implant Loading</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Implant Loading, Immediate</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Endosseous dental implantation where implants are fitted with an abutment or where an implant with a transmucosal coronal portion is used within 1 week to 2 months.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Early Dental Implant Loading</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Implant Loading, Early</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057894</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Marine ridges composed of living CORALS, coral skeletons, calcareous algae, and other organisms, mixed with minerals and organic matter. They are found most commonly in tropical waters and support other animal and plant life.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coral Reefs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057895</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A copy number variation that results in reduced GENE DOSAGE due to any loss-of-function mutation. The loss of heterozygosity is associated with abnormal phenotypes or diseased states because the remaining gene is insufficient.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Haploinsufficiency</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057896</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Linear dermal scars accompanied by epidermal atrophy that affects skin that is subjected to continuous stretching. They usually do not cause any significant medical problems, only cosmetic problems.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Striae Distensae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stretch Marks</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057897</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The instinctive tendency (or ability) to assume a normal position of the body in space when it has been displaced.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reflex, Righting</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Righting Reflex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Righting Response</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057898</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An individual having only one allele at a given locus because of the loss of the other allele through a mutation (e.g., CHROMOSOME DELETION).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hemizygote</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057899</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The engulfment and degradation of cells by other cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cytophagocytosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cytophagy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Phagocytosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Cannibalism</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057900</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The mechanisms by which materials are transported through cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcytosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transcellular Transport</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The mechanisms by which materials are transported through cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcytotic Pathways</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transcellular Pathways</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057905</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Experimentation on STEM CELLS and on the use of stem cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stem Cell Research</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Experimentation on STEM CELLS and on the use of stem cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Embryonic Stem Cell Research</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Experimentation on STEM CELLS and on the use of stem cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adult Stem Cell Research</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057906</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Biological mechanism that controls CIRCADIAN RHYTHM. Circadian clocks exist in the simplest form in cyanobacteria and as more complex systems in fungi, plants, and animals. In humans the system includes photoresponsive RETINAL GANGLION CELLS and the SUPRACHIASMATIC NUCLEUS that acts as the central oscillator.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Circadian Clocks</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Clock System</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Circadian Timing System</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057907</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cytoskeleton specialization at the cytoplasmic side of postsynaptic membrane in SYNAPSES. It is involved in neuronal signaling and NEURONAL PLASTICITY and comprised of GLUTAMATE RECEPTORS; scaffolding molecules (e.g., PSD95, PSD93), and other proteins (e.g., CaCMKII).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Post-Synaptic Density</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Postsynaptic Density Region</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Post-Synaptic Density Region</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Postsynaptic Density</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057908</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A method of tissue ablation and bleeding control that uses ARGON plasma (ionized argon gas) to deliver a current of thermocoagulating energy to the area of tissue to be coagulated.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Argon Plasma Coagulation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Argon Beam Coagulation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057909</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A surgical specialty concerned with correcting conditions related to malposition of the jawbones and other related MAXILLOFACIAL ABNORMALITIES (e.g., CLEFT PALATE; RETROGNATHISM).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Orthognathic Surgery</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A surgical specialty concerned with correcting conditions related to malposition of the jawbones and other related MAXILLOFACIAL ABNORMALITIES (e.g., CLEFT PALATE; RETROGNATHISM).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Maxillofacial Orthognathic Surgery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057910</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The shrinkage of the foreign body encapsulation scar tissue that forms around artificial implants imbedded in body tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Implant Capsular Contracture</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057911</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Angiotensin Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Angiotensin Receptor Blockers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Angiotensin II Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Angiotensin II Receptor Blockers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057912</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Agents that antagonize the ANGIOTENSIN II TYPE 2 RECEPTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Angiotensin II Type 2 Receptor Blockers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 2 Angiotensin Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Type 2 Angiotensin Receptor Blockers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Angiotensin II Type 2 Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057913</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgical procedure to relax the JOINT CAPSULE tissues in a joint that has a reduced range of motion due to CONTRACTURE or TISSUE ADHESIONS or joint deformities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Joint Capsule Release</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Capsular Release</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Surgical procedure to relax the JOINT CAPSULE tissues in a joint that has a reduced range of motion due to CONTRACTURE or TISSUE ADHESIONS or joint deformities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Capsular Contracture Release</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Surgical procedure to relax the JOINT CAPSULE tissues in a joint that has a reduced range of motion due to CONTRACTURE or TISSUE ADHESIONS or joint deformities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Arthroscopic Capsular Release</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057914</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The routing of water to open or closed areas where it is used for agricultural purposes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Agricultural Irrigation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057915</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The practice of replacing one prescribed drug with another that is expected to have the same clinical or psychological effect.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Substitution</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Drug Switching</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Therapeutic Substitution</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The practice of replacing one prescribed drug with another that is expected to have the same clinical or psychological effect.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Generic Substitution</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057916</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 1. This subtype has demonstrated the ability to mutate from a low pathogenic form to a highly pathogenic form in birds. It was responsible for a 1999 outbreak in turkeys in Italy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Influenza A Virus, H7N1 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>H7N1 Virus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057917</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 2. It has been involved in a number of outbreaks in the 21st century on poultry farms and has been isolated a few times in humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Influenza A Virus, H7N2 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>H7N2 Virus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057918</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Materials used as reference points on or implanted in the body to position patients for radiotherapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fiducial Markers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fiducial Targets</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anatomic Fiducials</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Materials used as reference points on or implanted in the body to position patients for radiotherapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Implanted Fiducials</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057919</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The quantity of oxygen consumed by biodegradation of organic materials in a water sample by measuring over a specific time period.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biological Oxygen Demand Analysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biological Oxygen Demand Analyses</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The quantity of oxygen consumed by biodegradation of organic materials in a water sample by measuring over a specific time period.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemical Oxygen Demand Analysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chemical Oxygen Demand Analyses</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The quantity of oxygen consumed by biodegradation of organic materials in a water sample by measuring over a specific time period.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biological Oxygen Demand</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The quantity of oxygen consumed by biodegradation of organic materials in a water sample by measuring over a specific time period.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemical Oxygen Demand</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057920</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 7 and neuraminidase 3. It was first detected in turkeys in Britain in 1963 and there have been several outbreaks on poultry farms since that time. A couple cases of human infections have been reported.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Influenza A Virus, H7N3 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>H7N3 Virus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057921</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 10 and neuraminidase 7. It has been isolated from a variety of wild and domestic animals including ducks, emu, and mink. It was found for the first time in humans in 2004.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Influenza A Virus, H10N7 Subtype</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057925</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A pathologic mechanical process that can lead to hip failure. It is caused by abnormalities of the ACETABULUM and/or femur combined with rigorous hip motion, leading to repetitive collisions that damage the soft tissue structures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Femoracetabular Impingement</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057927</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The thermodynamic interaction between a substance and WATER.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hydrophobic and Hydrophilic Interactions</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hydrophilic and Hydrophobic Interactions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The thermodynamic interaction between a substance and WATER.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hydrophobicity</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The thermodynamic interaction between a substance and WATER.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hydrophobic Interactions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The thermodynamic interaction between a substance and WATER.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hydrophilic Interactions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The thermodynamic interaction between a substance and WATER.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hydrophilicity</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057928</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Insertion of a catheter into the urethra to drain the urine from the bladder at intervals as needed using clean techniques and disposable or cleansed reusable catheters as opposed to using asceptic technique with sterile catheters and disinfecting lubricants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intermittent Urethral Catheterization</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Insertion of a catheter into the urethra to drain the urine from the bladder at intervals as needed using clean techniques and disposable or cleansed reusable catheters as opposed to using asceptic technique with sterile catheters and disinfecting lubricants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Urethral Self-Catheterization</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Insertion of a catheter into the urethra to drain the urine from the bladder at intervals as needed using clean techniques and disposable or cleansed reusable catheters as opposed to using asceptic technique with sterile catheters and disinfecting lubricants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clean Intermittent Catheterization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057929</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Replacement of the ELBOW JOINT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Arthroplasty, Replacement, Elbow</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Total Elbow Replacement</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Elbow Replacement Arthroplasty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057930</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Organic chemistry methodology that mimics the modular nature of various biosynthetic processes. It uses highly reliable and selective reactions designed to "click" i.e., rapidly join small modular units together in high yield, without offensive byproducts. In combination with COMBINATORIAL CHEMISTRY TECHNIQUES, it is used for the synthesis of new compounds and combinatorial libraries.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Click Chemistry</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Click Chemical Techniques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Organic chemistry methodology that mimics the modular nature of various biosynthetic processes. It uses highly reliable and selective reactions designed to "click" i.e., rapidly join small modular units together in high yield, without offensive byproducts. In combination with COMBINATORIAL CHEMISTRY TECHNIQUES, it is used for the synthesis of new compounds and combinatorial libraries.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Click Chemical Reactions</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057945</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The fusion of a male gamete with a female gamete from the same individual animal or plant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Self-Fertilization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057946</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A division of VIRIDIPLANTAE which is equivalent to Charophyceae in some classifications and its parent in others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Charophyceae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Charophytes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A division of VIRIDIPLANTAE which is equivalent to Charophyceae in some classifications and its parent in others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Charales</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stoneworts</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A division of VIRIDIPLANTAE which is equivalent to Charophyceae in some classifications and its parent in others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Charophyta</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057947</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specialized solutions for PARENTERAL NUTRITION. They may contain a variety of MICRONUTRIENTS; VITAMINS; AMINO ACIDS; CARBOHYDRATES; LIPIDS; and SALTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Parenteral Nutrition Solutions</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Specialized solutions for PARENTERAL NUTRITION. They may contain a variety of MICRONUTRIENTS; VITAMINS; AMINO ACIDS; CARBOHYDRATES; LIPIDS; and SALTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intravenous Feeding Solutions</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057948</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A monophyletic group of green plants that includes all land plants (EMBRYOPHYTA) and all green algae (CHLOROPHYTA and STREPTOPHYTA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Viridiplantae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Green Plants</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057949</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of green plants comprising CHAROPHYCEAE (streptophyte green algae) and EMBRYOPHYTA (land plants).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Streptophyta</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057965</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Any of several processes for the permanent or long-term artificial or natural capture or removal and storage of carbon dioxide and other forms of carbon, through biological, chemical or physical processes, in a manner that prevents it from being released into the atmosphere.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carbon Sequestration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Carbon Sink</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Any of several processes for the permanent or long-term artificial or natural capture or removal and storage of carbon dioxide and other forms of carbon, through biological, chemical or physical processes, in a manner that prevents it from being released into the atmosphere.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carbon Sequestration Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057966</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Small organic molecules that act as allosteric activators of the calcium sensing receptor (CaSR) in the PARATHYROID GLANDS and other tissues. They lower the threshold for CaSR activation by extracellular calcium ions and diminish PARATHYROID HORMONE (PTH) release from parathyroid cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Calcimimetic Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057967</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Delivery of drugs into the ventricular system of brain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infusions, Intraventricular</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Delivery of drugs into the ventricular system of brain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infusions, Intracerebroventricular</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057968</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A medicated adhesive patch placed on the skin to deliver a specific dose of medication into the bloodstream.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transdermal Patch</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057970</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Medications administered in a manner that poses more risk than benefit, particularly where safer alternatives exist.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inappropriate Prescribing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Medications administered in a manner that poses more risk than benefit, particularly where safer alternatives exist.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Over Prescribing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Medications administered in a manner that poses more risk than benefit, particularly where safer alternatives exist.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inappropriate Prescriptions</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057971</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A breach in the continuity of the ANTERIOR CHAMBER of the eyeball.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anterior Capsular Rupture, Ocular</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057972</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The back two-thirds of the eye that includes the anterior hyaloid membrane and all of the optical structures behind it: the VITREOUS HUMOR; RETINA; CHOROID; and OPTIC NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Posterior Eye Segment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057973</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>X-linked recessive NEPHROLITHIASIS characterized by HYPERCALCIURIA; HYPOPHOSPHATEMIA; NEPHROCALCINOSIS; and PROTEINURIA. It is associated with mutations in the voltage-gated chloride channel, CLC-5 (Dent Disease I). Another group of mutations associated with this disease is in phosphatidylinositol 4,5-bisphosphate-5-phosphatase gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dent Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dent's Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dents Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D057985</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A broad category of multi-ingredient preparations that are marketed for the relief of upper respiratory symptoms resulting from the COMMON COLD; ALLERGIES; or HUMAN INFLUENZA. While the majority of these medications are available as OVER-THE-COUNTER DRUGS some of them contain ingredients that require them to be sold as PRESCRIPTION DRUGS or as BEHIND-THE COUNTER DRUGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multi-Ingredient Cold, Flu, and Allergy Medications</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cold, Flu, and Allergy Medications, Multi-Ingredient</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A broad category of multi-ingredient preparations that are marketed for the relief of upper respiratory symptoms resulting from the COMMON COLD; ALLERGIES; or HUMAN INFLUENZA. While the majority of these medications are available as OVER-THE-COUNTER DRUGS some of them contain ingredients that require them to be sold as PRESCRIPTION DRUGS or as BEHIND-THE COUNTER DRUGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multi-Ingredient Cold and Flu Medications</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cold and Flu Medications, Multi-Ingredient</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A broad category of multi-ingredient preparations that are marketed for the relief of upper respiratory symptoms resulting from the COMMON COLD; ALLERGIES; or HUMAN INFLUENZA. While the majority of these medications are available as OVER-THE-COUNTER DRUGS some of them contain ingredients that require them to be sold as PRESCRIPTION DRUGS or as BEHIND-THE COUNTER DRUGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multi-Ingredient Flu Medications</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A broad category of multi-ingredient preparations that are marketed for the relief of upper respiratory symptoms resulting from the COMMON COLD; ALLERGIES; or HUMAN INFLUENZA. While the majority of these medications are available as OVER-THE-COUNTER DRUGS some of them contain ingredients that require them to be sold as PRESCRIPTION DRUGS or as BEHIND-THE COUNTER DRUGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multi-Ingredient Allergy Medications</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A broad category of multi-ingredient preparations that are marketed for the relief of upper respiratory symptoms resulting from the COMMON COLD; ALLERGIES; or HUMAN INFLUENZA. While the majority of these medications are available as OVER-THE-COUNTER DRUGS some of them contain ingredients that require them to be sold as PRESCRIPTION DRUGS or as BEHIND-THE COUNTER DRUGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multi-Ingredient Cold Medications</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multi-Ingredient Cold Remedies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058005</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physicians whose practice is not restricted to a specific field of MEDICINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>General Practitioners</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physicians, General Practice</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058006</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Patient-based medical care provided across age and gender or specialty boundaries.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>General Practice</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058007</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Providers of initial care for patients. These PHYSICIANS refer patients when appropriate for secondary or specialist care.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physicians, Primary Care</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Primary Care Physicians</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058008</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An endogenous GAMMARETROVIRUS from the germ line of mice but isolated from humans. It has close similarity to xenotropic MURINE LEUKEMIA VIRUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Xenotropic murine leukemia virus-related virus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>XMRV Virus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Xenotropic MuLV-related virus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058009</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A common name (but used formally) for a group of organisms that are mostly kinds of algae including BACILLARIOPHYTA; OOMYCETES; PHAEOPHYCEAE; and CHRYSOPHYCEAE. They all contain CHLOROPLASTS that are thought to have been derived from the endosymbiosis of ancient RED ALGAE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stramenopiles</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Heterokonts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058010</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A psychological test consisting of true/false items. It is used as a diagnostic screening or clinical assessment of adults who evidence problematic emotional and interpersonal symptoms or who are undergoing PSYCHOTHERAPY or a psychodiagnostic evaluation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Millon Clinical Multiaxial Inventory</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058011</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A statistical tool for detecting and modeling gene-gene interactions. It is a non-parametric and model-free approach.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multifactor Dimensionality Reduction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058012</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>For-profit enterprise with moderate number of employees and generally moderate volume of sales.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Small Business</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microenterprise</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>For-profit enterprise with moderate number of employees and generally moderate volume of sales.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medium-Sized Business</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058013</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Skills and strategies, unrelated to the traits a test is intended to measure, that may increase test takers' scores -- may include the effects of coaching or experience in taking tests. (ERIC Thesaurus)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Test Taking Skills</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Test Wiseness</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Test-Taking</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Test Taking Strategies</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Skills and strategies, unrelated to the traits a test is intended to measure, that may increase test takers' scores -- may include the effects of coaching or experience in taking tests. (ERIC Thesaurus)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Test Preparation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Skills and strategies, unrelated to the traits a test is intended to measure, that may increase test takers' scores -- may include the effects of coaching or experience in taking tests. (ERIC Thesaurus)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Study Skills</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058014</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The concept covering the physical and mental conditions of VETERANS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Veterans Health</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058015</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The transfer of information from experts in the medical and public health fields to patients and the public. The study and use of communication strategies to inform and influence individual and community decisions that enhance health.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Health Communication</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058016</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Management of the organization of HEALTH FACILITIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Health Facility Administration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058017</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgical insertion of BLOOD VESSEL PROSTHESES, or transplanted BLOOD VESSELS, or other biological material to repair injured or diseased blood vessels.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vascular Grafting</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Surgical insertion of BLOOD VESSEL PROSTHESES, or transplanted BLOOD VESSELS, or other biological material to repair injured or diseased blood vessels.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blood Vessel Grafting</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058025</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Programs of study which span the traditional boundaries of academic scholarship.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Interdisciplinary Studies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058027</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subfield of psychiatry that emphasizes the somatic substructure on which mental operations and emotions are based, and the functional or organic disturbances of the central nervous system that give rise to, contribute to, or are associated with mental and emotional disorders. (From Campbell's Psychiatric Dictionary, 8th ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neuropsychiatry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058028</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Detailed account or statement or formal record of the proceedings of a meeting or session. May also document status or progress of an activity or research project.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Research Report</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Detailed account or statement or formal record of the proceedings of a meeting or session. May also document status or progress of an activity or research project.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Investigative Report</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Detailed account or statement or formal record of the proceedings of a meeting or session. May also document status or progress of an activity or research project.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Summary Report</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Detailed account or statement or formal record of the proceedings of a meeting or session. May also document status or progress of an activity or research project.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Progress Report</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Detailed account or statement or formal record of the proceedings of a meeting or session. May also document status or progress of an activity or research project.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Report</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reports</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Detailed account or statement or formal record of the proceedings of a meeting or session. May also document status or progress of an activity or research project.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Field Report</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058045</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cell-like structures that contain the minimum of components necessary for carrying out self-sustaining biosynthetic reactions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Artificial Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Synthetic Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Artificial Cell</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell-like structures that contain the minimum of components necessary for carrying out self-sustaining biosynthetic reactions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protocells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell-like structures that contain the minimum of components necessary for carrying out self-sustaining biosynthetic reactions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Artificial Organelles</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Synthetic Organelles</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058065</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diabetic Cardiomyopathies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058066</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Highly contagious infectious dermatitis with lesions near the interdigital spaces usually in cattle. It causes discomfort and often severe lameness (LAMENESS, ANIMAL). Lesions can be either erosive or proliferative and wart-like with papillary growths and hypertrophied hairs. DICHELOBACTER NODOSUS and TREPONEMA are the most commonly associated causative agents for this mixed bacterial infection disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Digital Dermatitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Papillomatous Digital Dermatitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Digital Papillomatosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Highly contagious infectious dermatitis with lesions near the interdigital spaces usually in cattle. It causes discomfort and often severe lameness (LAMENESS, ANIMAL). Lesions can be either erosive or proliferative and wart-like with papillary growths and hypertrophied hairs. DICHELOBACTER NODOSUS and TREPONEMA are the most commonly associated causative agents for this mixed bacterial infection disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ovine Digital Dermatitis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Highly contagious infectious dermatitis with lesions near the interdigital spaces usually in cattle. It causes discomfort and often severe lameness (LAMENESS, ANIMAL). Lesions can be either erosive or proliferative and wart-like with papillary growths and hypertrophied hairs. DICHELOBACTER NODOSUS and TREPONEMA are the most commonly associated causative agents for this mixed bacterial infection disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bovine Digital Dermatitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bovine Hairy Footwarts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bovine Foot Warts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058067</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Signal and data processing method that uses decomposition of wavelets to approximate, estimate, or compress signals with finite time and frequency domains.  It represents a signal or data in terms of a fast decaying wavelet series from the original prototype wavelet, called the mother wavelet. This mathematical algorithm has been adopted widely in biomedical disciplines for data and signal processing in noise removal and audio/image compression (e.g., EEG and MRI).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wavelet Analysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wavelet Signal Processing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wavelet Transform</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spatiotemporal Wavelet Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058068</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Measurable biological (physiological, biochemical, and anatomical features), behavioral (psychometric pattern) or cognitive markers that are found more often in individuals with a disease than in the general population. Because many endophenotypes are present before the disease onset and in individuals with heritable risk for disease such as unaffected family members, they can be used to help diagnose and search for causative genes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endophenotypes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058069</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neglected Diseases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058070</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Diseases that do not exhibit symptoms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Asymptomatic Diseases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Asymptomatic States</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Presymptomatic Diseases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Asymptomatic Conditions</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pre-Symptomatic Diseases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058086</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A non-taxonomic term for unicellular microscopic algae which are found in both freshwater and marine environments. Some authors consider DIATOMS; CYANOBACTERIA; HAPTOPHYTA; and DINOFLAGELLATES as part of microalgae, even though they are not algae.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microalgae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microphytes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058087</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Haptophyta</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prymnesiophytes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Haptophytes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prymnesiophyceae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Coccolithophorids</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Haptophyceae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Isochrysis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prymnesium</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phaeocystis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pleurochrysis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Emiliania</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A group (or phylum) of unicellular EUKARYOTA (or algae) possessing CHLOROPLASTS and FLAGELLA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pavlova</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058088</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Limb girdle muscular dystrophies due to mutations in the gene for the ALPHA-SARCOGLYCAN or deficiencies in alpha-sarcoglycan due to a mutation in another gene (secondary alpha-sarcoglycanopathy).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sarcoglycanopathies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sarcoglycanopathy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Limb girdle muscular dystrophies due to mutations in the gene for the ALPHA-SARCOGLYCAN or deficiencies in alpha-sarcoglycan due to a mutation in another gene (secondary alpha-sarcoglycanopathy).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alpha-Sarcoglycanopathies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adhalinopathies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058105</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemical reaction in which monomeric components are combined to form POLYMERS (e.g., POLYMETHYLMETHACRYLATE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polymerization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058106</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods to repair breaks in tissue caused by trauma or to close surgical incisions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wound Closure Techniques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods to repair breaks in tissue caused by trauma or to close surgical incisions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Surgical Closure Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058107</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods to repair breaks in abdominal tissues caused by trauma or to close surgical incisions during abdominal surgery.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Abdominal Wound Closure Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Abdominal Wound Closure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Abdominal Closure Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058108</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum or class of freshwater microscopic EUKARYOTA considered to be plants or MICROALGAE. Their CHLOROPLASTS (called cyanelles) are believed to be derived from the direct endosymbiosis of CYANOBACTERIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glaucophyta</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glaucocystophyceae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glaucophyceae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058109</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Evaluation, planning, and use of a range of procedures and airway devices for the maintenance or restoration of a patient's ventilation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Airway Management</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Airway Control</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058110</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs manufactured and sold with the intent to misrepresent its origin, authenticity, chemical composition, and or efficacy.  Counterfeit drugs may contain inappropriate quantities of ingredients not listed on the label or package.  In order to further deceive the consumer, the packaging, container, or labeling, may be inaccurate, incorrect, or fake.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Counterfeit Drugs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fake Drugs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Counterfeit Medicines</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs manufactured and sold with the intent to misrepresent its origin, authenticity, chemical composition, and or efficacy.  Counterfeit drugs may contain inappropriate quantities of ingredients not listed on the label or package.  In order to further deceive the consumer, the packaging, container, or labeling, may be inaccurate, incorrect, or fake.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Counterfeiting</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058112</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of GTP-binding proteins that were initially identified in YEASTS where they were shown to initiate the process of septation and bud formation. Septins form into hetero-oligomeric complexes that are comprised of several distinct septin subunits. These complexes can act as cytoskeletal elements that play important roles in CYTOKINESIS, cytoskeletal reorganization, BIOLOGICAL TRANSPORT, and membrane dynamics.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Septins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058113</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that disintegrate natural waxy exudates such as EAR WAX.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cerumenolytic Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wax Solvent</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cerumen Remover</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cerumenolytic</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058114</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of mostly unicellular, microscopic, freshwater algae that have highly symmetrical and varied shapes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Desmidiales</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Desmids</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058115</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Any chemical species which acts as an electron-pair donor in a chemical bonding reaction with a LEWIS ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lewis Bases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058116</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Any chemical species which accepts an electron-pair from a LEWIS BASE in a chemical bonding reaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lewis Acids</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058117</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Medical devices which substitute for a nervous system function by electrically stimulating the nerves directly and monitoring the response to the electrical stimulation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neural Prostheses</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neural Prosthesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058118</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A transcription factor that takes part in WNT signaling pathway. The activity of the protein is regulated via its interaction with BETA CATENIN. Transcription factor 7-like 2 protein plays an important role in the embryogenesis of the PANCREAS and ISLET CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcription Factor 7-Like 2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TCF7L2 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>T-Cell-Specific Transcription Factor 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>T Cell Factor 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>T Cell Transcription Factor 4</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058119</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of crescent-shaped algae in the family Closteriaceae, order DESMIDIALES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Closterium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058120</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of unicellular streptophyte algae in the family Desmidiaceae, order DESMIDIALES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Micrasterias</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058125</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A transcription factor that takes part in WNT signaling pathway where it may play a role in the differentiation of KERATINOCYTES. The transcriptional activity of this protein is regulated via its interaction with BETA CATENIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcription Factor 7-Like 1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TCF7L1 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TCF-3 Transcription Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HMG Box Transcription Factor 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>T Cell Factor 3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058126</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A historical term for a method of anesthesia that used a combination of preanesthetic medication for sedation, local nerve blocking anesthetic at the surgical site, and NITROUS OXIDE inhalation anesthesia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Balanced Anesthesia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A historical term for a method of anesthesia that used a combination of preanesthetic medication for sedation, local nerve blocking anesthetic at the surgical site, and NITROUS OXIDE inhalation anesthesia.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anoci-Association</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anocithesia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anociassociation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058127</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A basic helix-loop-helix transcription factor that plays a role in determining cell fate during embryogenesis. It forms a heterodimer with TWIST TRANSCRIPTION FACTOR and ACHAETE-SCUTE GENE COMPLEX-related TRANSCRIPTION FACTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcription Factor 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transcription Factor E2-alpha</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immunoglobulin Transcription Factor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>kappa-E2-Binding Factor</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A basic helix-loop-helix transcription factor that plays a role in determining cell fate during embryogenesis. It forms a heterodimer with TWIST TRANSCRIPTION FACTOR and ACHAETE-SCUTE GENE COMPLEX-related TRANSCRIPTION FACTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcription Factor 3, Isoform E12</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>E2A Immunoglobulin Enhancer Binding Factor E12</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pan-2 DNA-Binding Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>E12 Helix-Loop-Helix Protein</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A basic helix-loop-helix transcription factor that plays a role in determining cell fate during embryogenesis. It forms a heterodimer with TWIST TRANSCRIPTION FACTOR and ACHAETE-SCUTE GENE COMPLEX-related TRANSCRIPTION FACTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcription Factor 3, Isoform E47</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>E47 Helix-Loop-Helix Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pan-1 DNA-Binding Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>E2A Immunoglobulin Enhancer Binding Factor E47</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058128</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Strips of elastic material used to apply pressure to body parts to control EDEMA and aid circulation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Compression Bandages</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Elastic Compression Wraps</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Elastic Bandages</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Compression Bandage</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Compression Wraps</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058129</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of freshwater algae possessing unbranched filaments. Sexual reproduction takes place via conjugation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Zygnematales</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058130</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of filamentous algae in the order ZYGNEMATALES, family Zygnemataceae, that possess CHLOROPLASTS that can orient to the direction of light.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mougeotia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058131</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of filamentous algae in the order ZYGNEMATALES, family Zygnemataceae, named for the helical arrangement of its CHLOROPLASTS. It is commonly found in freshwater habitats.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spirogyra</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058145</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genomic region found in DROSOPHILA. The region contains genes encoding BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS that play a critical role in the regulation of pattern formation during EMBRYONIC DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Achaete-Scute Complex Genome Region</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Achaete-Scute Gene Complex</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058165</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Condition with a variable constellation of phenotypes due to deletion polymorphisms at chromosome location 22q11. It encompasses several syndromes with overlapping abnormalities including the DIGEORGE SYNDROME, VELOCARDIOFACIAL SYNDROME, and CONOTRUNCAL AMOMALY FACE SYNDROME. In addition, variable developmental problems and schizoid features are also associated with this syndrome. (From BMC Med Genet. 2009 Feb 25;10:16) Not all deletions at 22q11 result in the 22q11deletion syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>22q11 Deletion Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058185</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Synthesized magnetic particles under 100 nanometers possessing many biomedical applications including DRUG DELIVERY SYSTEMS and CONTRAST AGENTS. The particles are usually coated with a variety of polymeric compounds.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Magnetite Nanoparticles</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058186</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Conditions in which the function of KIDNEYS deteriorates suddenly in a matter of days or even hours. It is characterized by the sudden drop in GLOMERULAR FILTRATION RATE; (GMR).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acute Kidney Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acute Renal Injury</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Conditions in which the function of KIDNEYS deteriorates suddenly in a matter of days or even hours. It is characterized by the sudden drop in GLOMERULAR FILTRATION RATE; (GMR).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kidney Failure, Acute</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acute Renal Failure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Renal Failure, Acute</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acute Kidney Failure</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Conditions in which the function of KIDNEYS deteriorates suddenly in a matter of days or even hours. It is characterized by the sudden drop in GLOMERULAR FILTRATION RATE; (GMR).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Renal Insufficiency, Acute</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acute Renal Insufficiency</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kidney Insufficiency, Acute</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acute Kidney Insufficiency</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058205</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemicals that are used to oxidize pigments in TEETH and thus effect whitening.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tooth Bleaching Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tooth Whitening Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Teeth Bleaching Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Teeth Whitening Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058206</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemicals that are used to oxidize pigments in HAIR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hair Bleaching Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hair Lightening Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058207</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of POST-TRANSLATIONAL PROTEIN MODIFICATION by SMALL UBIQUITIN-RELATED MODIFIER PROTEINS (also known as SUMO proteins).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sumoylation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SUMO-Conjugation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058225</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Accumulations of extracellularly deposited AMYLOID FIBRILS within tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plaque, Amyloid</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amyloid Plaques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plaques, Amyloid</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amyloid Deposits</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Accumulations of extracellularly deposited AMYLOID FIBRILS within tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Senile Plaques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuritic Plaques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058226</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Lesions formed within the walls of ARTERIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plaque, Atherosclerotic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Atherosclerotic Plaques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Atherosclerotic Plaque</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Lesions formed within the walls of ARTERIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fatty Streak, Arterial</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Lesions formed within the walls of ARTERIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fibroatheroma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fibroatheromatous Plaques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Lesions formed within the walls of ARTERIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Atheroma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Atheromatous Plaques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058227</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins that form the core of amyloid fibrils. For example, the core of amyloid A is formed from amyloid A protein, also known as serum amyloid A protein or SAA protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Amyloidogenic Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amyloid Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058228</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A pancreatic beta-cell hormone that is co-secreted with INSULIN. It displays an anorectic effect on nutrient metabolism by inhibiting gastric acid secretion, gastric emptying and postprandial GLUCAGON secretion. Islet amyloid polypeptide can fold into AMYLOID FIBRILS that have been found as a major constituent of pancreatic AMYLOID DEPOSITS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Islet Amyloid Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pancreatic Amylin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IAPP Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulinoma Amyloid Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amlintide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amylin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A pancreatic beta-cell hormone that is co-secreted with INSULIN. It displays an anorectic effect on nutrient metabolism by inhibiting gastric acid secretion, gastric emptying and postprandial GLUCAGON secretion. Islet amyloid polypeptide can fold into AMYLOID FIBRILS that have been found as a major constituent of pancreatic AMYLOID DEPOSITS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Islet Amyloid Polypeptide Precursor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulinoma Amyloid Polypeptide Precursor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IAPP Precursor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058245</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Capacity that enables an individual to cope with and/or recover from the impact of a neural injury or a psychotic episode.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cognitive Reserve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brain Reserve</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058246</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prehypertension</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pre-Hypertension</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058247</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Benign childhood alopecia that improves spontaneously with aging. It is characterized by anagen hairs (misshapen hair bulbs and absent inner and outer root sheaths), thin, and sparse hairs that pulls out easily.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Loose Anagen Hair Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Loose Anagen Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058248</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Procedures for identification and measurement of IMMUNOGLOBULINS in the blood that initiate lysis of bacteria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serum Bactericidal Antibody Assay</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Serum Bactericidal Antibody Assays</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Procedures for identification and measurement of IMMUNOGLOBULINS in the blood that initiate lysis of bacteria.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bactericidal Antibody Assay</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058249</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Autosomal dominant neoplastic syndrome characterised by genodermatosis, lung cysts, spontaneous and recurrent PNEUMOTHORAX; and RENAL CANCER. It is associated with mutations in the folliculin protein gene (FLCN protein).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Birt-Hogg-Dube Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fibrofolliculomas with Trichodiscomas and Acrochordons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058250</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process of repairing broken or worn parts of a PERMANENT DENTAL RESTORATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dental Restoration Repair</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058251</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of FLEAS in the family Pulicidae. It includes the cat flea (Ctenocephalides felis), one of the most common species on earth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ctenocephalides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A genus of FLEAS in the family Pulicidae. It includes the cat flea (Ctenocephalides felis), one of the most common species on earth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ctenocephalides felis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cat Flea</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058252</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cutaneous necrobiotic disorder characterized by firm, yellow plaques or nodules, often in a periorbital distribution. It is often accompanied by an elevated ERYTHROCYTE SEDIMENTATION RATE; LEUKOPENIA; and MONOCLONAL GAMMOPATHY (IgG-kappa type) and systemic involvement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Necrobiotic Xanthogranuloma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058253</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of burrowing flea that requires a human host or other mammal to reproduce.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tunga</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A species of burrowing flea that requires a human host or other mammal to reproduce.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tunga penetrans</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Jigger Flea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sand Flea</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chigoe Flea</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058254</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Bed-like structures for transporting or temporarily holding patients.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stretchers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Litters</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Holding Stretchers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Trolleys</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Bed-like structures for transporting or temporarily holding patients.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wheeled Stretchers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gurneys</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Bed-like structures for transporting or temporarily holding patients.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rescue Stretchers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Bed-like structures for transporting or temporarily holding patients.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ambulance Stretchers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Bed-like structures for transporting or temporarily holding patients.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Emergency Room Stretchers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058255</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Extracellular protease inhibitors that are secreted from FIBROBLASTS. They form a covalent complex with SERINE PROTEASES and can mediate their cellular internalization and degradation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protease Nexins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nexin, Protease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nexin, Protease-Associated</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058256</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Wave-like oscillations of electric potential between parts of the brain recorded by EEG.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brain Waves</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brainwaves</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058257</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sterile covering for footwear used during surgical procedures to protect the surgical site from sources of contamination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Surgical Attire</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Sterile covering for footwear used during surgical procedures to protect the surgical site from sources of contamination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Surgical Gowns</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Sterile covering for footwear used during surgical procedures to protect the surgical site from sources of contamination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Surgical Shoe Covers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058258</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A protease nexin and serpin subtype that is specific for several SERINE PROTEASES including UROKINASE; THROMBIN; TRYPSIN; and PLASMINOGEN ACTIVATORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serpin E2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protease Inhibitor 7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Serpin Peptidase Inhibitor, Clade E</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glia-Derived Nexin 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protease Nexin I</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058260</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The oriental rat flea that is a primary vector for BUBONIC PLAGUE and MURINE TYPHUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Xenopsylla</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The oriental rat flea that is a primary vector for BUBONIC PLAGUE and MURINE TYPHUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Xenopsylla cheopis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oriental Rat Flea</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058261</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of proteins that bind to CELL SURFACE RECEPTORS and alter their specificity, signaling mechanism, or mode of intracellular transport.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptor Activity-Modifying Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptor Activity-Modifying Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RAMP Receptor Accessory Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058262</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A receptor activity-modifying protein that is a subunit of specific G-PROTEIN COUPLED RECEPTORS. The CALCITONIN GENE-RELATED PEPTIDE RECEPTOR is formed from a dimer of this protein and CALCITONIN RECEPTOR-LIKE PROTEIN, while an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptor Activity-Modifying Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Calcitonin-Receptor-Like Receptor Activity-Modifying Protein 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058263</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A receptor activity-modifying protein that heterodimerizes with CALCITONIN RECEPTOR-LIKE PROTEIN to form the ADRENOMEDULLIN RECEPTOR. In addition, an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptor Activity-Modifying Protein 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Calcitonin-Receptor-Like Receptor Activity-Modifying Protein 2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058264</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A receptor activity-modifying protein that heterodimerizes with CALCITONIN RECEPTOR-LIKE PROTEIN to form the ADRENOMEDULLIN RECEPTOR. In addition, an isoform of the ISLET AMYLOID POLYPEPTIDE RECEPTOR is formed from this protein dimerizing with the CALCITONIN RECEPTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptor Activity-Modifying Protein 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Calcitonin-Receptor-Like Receptor Activity-Modifying Protein 3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058265</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>G-protein-coupled cell surface receptors for ADRENOMEDULLIN. They are formed by the heterodimerization of CALCITONIN RECEPTOR-LIKE PROTEIN and either RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 or RECEPTOR ACTIVITY-MODIFYING PROTEIN 3.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Adrenomedullin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenomedullin Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenomedullin Receptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058266</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A technique of measuring the dielectric properties of materials, which vary over a range of frequencies depending on the physical properties of the material.  The technique involves measuring, over a range of frequencies, ELECTRICAL IMPEDANCE and phase shift of an electric field as it passes through the material.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dielectric Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Impedance Spectroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electrochemical Impedance Spectroscopy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058267</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Parasitic attack by members of the order SIPHONAPTERA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Flea Infestations</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058285</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An infestation with the flea TUNGA PENETRANS causing inflammation, pruritus, and pain, in both humans and other mammals. There is a high incidence of secondary infections such as BACTEREMIA and TETANUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tungiasis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058286</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A receptor protein that is associated with RECEPTOR ACTIVITY-MODIFYING PROTEINS.  When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 1 it forms the CALCITONIN GENE-RELATED RECEPTOR. When bound to RECEPTOR ACTIVITY-MODIFYING PROTEIN 2 or RECEPTOR ACTIVITY-MODIFYING PROTEIN 3 it forms the ADRENOMEDULLIN RECEPTOR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Calcitonin Receptor-Like Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Calcitonin Receptor-Like Receptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058287</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>G-protein coupled receptors that are formed through the dimerization of the CALCITONIN RECEPTOR with a RECEPTOR ACTIVITY-MODIFYING PROTEIN. Their affinity for ISLET AMYLOID POLYPEPTIDE is dependent upon which of several receptor activity-modifying protein subtypes they are bound to.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Islet Amyloid Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptor, Amylin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IAPP Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Islet Amyloid Polypeptide Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amylin Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Amylin Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058288</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Metastatic lesion of the UMBILICUS associated with intra-abdominal neoplasms especially of the GASTROINTESTINAL TRACT or OVARY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sister Mary Joseph's Nodule</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sister Joseph's Nodule</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058305</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large family of phosphatidylinositol phosphate-binding proteins that are involved in mediating intracellular transport and sorting of proteins via a variety of endocytic pathways.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sorting Nexins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nexin, Sorting</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058306</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of prostaglandin E receptors that specifically couples to GTP-BINDING PROTEIN ALPHA SUBUNIT, GQ and the subsequently activates TYPE C PHOSPHOLIPASES. Additional evidence has shown that the receptor can act through a calcium-dependent signaling pathway.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Prostaglandin E, EP1 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostaglandin E Receptor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostanoid Receptor EP1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PGE Receptor, EP1 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostaglandin E2 Receptor, EP1 Subtype</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058307</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of prostaglandin E receptors that specifically couples to GS ALPHA GTP-BINDING PROTEIN SUBUNITS and subsequently activates ADENYLATE CYCLASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Prostaglandin E, EP2 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostanoid Receptor EP2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PGE Receptor, EP2 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostaglandin E Receptor 2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058308</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of prostaglandin E receptors that specifically couples to GTP-BINDING PROTEIN ALPHA SUBUNIT, GI and subsequently inhibits ADENYLATE CYCLASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Prostaglandin E, EP3 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostaglandin E Receptor 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostanoid Receptor EP3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PGE Receptor, EP3 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostaglandin E2 Receptor, EP3 Subtype</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058309</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of prostaglandin E receptors that specifically couples to GS ALPHA GTP-BINDING PROTEIN SUBUNITS and subsequently activates ADENYLATE CYCLASE. The receptor may also signal through the activation of PHOSPHATIDYLINOSITOL 3-KINASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Prostaglandin E, EP4 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostaglandin E Receptor 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptor, Prostaglandin EP4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostaglandin EP4 Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostanoid Receptor EP4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PGE Receptor, EP4 Subtype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostaglandin E2 Receptor, EP4 Subtype</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058325</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A suborder of chewing lice, in the order PHTHIRAPTERA, that are ectoparasites of poultry and some mammals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Amblycera</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058326</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A suborder of chewing lice, in the order PHTHIRAPTERA, that are parasites of birds and mammals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ischnocera</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A suborder of chewing lice, in the order PHTHIRAPTERA, that are parasites of birds and mammals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bovicola</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Damalinia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058327</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A complex cardiac surgical procedure done on individuals with univentricular congenital heart malformations to establish sufficient outflow to the systemic circulation. This operation (Norwood procedure stage 1) involves disconnecting the PULMONARY ARTERY from the heart so that the right ventricle can be connected to the AORTA instead, and the creation of an alternative path for the pulmonary blood flow. The new path for arterial blood flow to the lungs is created by a systemic-to-pulmonary arterial shunt such as a MODIFIED BLALOCK-TAUSSIG SHUNT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Norwood Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Norwood Procedure</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex cardiac surgical procedure done on individuals with univentricular congenital heart malformations to establish sufficient outflow to the systemic circulation. This operation (Norwood procedure stage 1) involves disconnecting the PULMONARY ARTERY from the heart so that the right ventricle can be connected to the AORTA instead, and the creation of an alternative path for the pulmonary blood flow. The new path for arterial blood flow to the lungs is created by a systemic-to-pulmonary arterial shunt such as a MODIFIED BLALOCK-TAUSSIG SHUNT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Norwood Operation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stage I Norwood Procedure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stage 1 Norwood Procedure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Norwood Procedure, Stage 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Norwood Procedure, Stage I</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058345</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infections that do not exhibit symptoms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Asymptomatic Infections</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Subclinical Infections</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058365</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An important nosocomial fungal infection with species of the genus CANDIDA, most frequently CANDIDA ALBICANS. Invasive candidiasis occurs when candidiasis goes beyond a superficial infection and manifests as CANDIDEMIA, deep tissue infection, or disseminated disease with deep organ involvement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Candidiasis, Invasive</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058366</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of a BLOOD VESSEL PROSTHESIS to connect the subclavian branch of the aorta to the pulmonary artery.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blalock-Taussig Procedure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Subclavian Pulmonary Artery Shunt</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Blue Baby Operation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Blalock Taussig Shunt</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Blalock-Taussig Operation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The use of a BLOOD VESSEL PROSTHESIS to connect the subclavian branch of the aorta to the pulmonary artery.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Modified Blalock-Taussig Procedure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Modified Blalock-Taussig Shunt</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058385</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of heart valve surgery that involves the repair, replacement, or reconstruction of the annuli of HEART VALVES. It includes shortening the circumference of the annulus to improve valve closing capacity and reinforcing the annulus as a step in more complex valve repairs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiac Valve Annuloplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Valvular Annuloplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Heart Valve Annuloplasty</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of heart valve surgery that involves the repair, replacement, or reconstruction of the annuli of HEART VALVES. It includes shortening the circumference of the annulus to improve valve closing capacity and reinforcing the annulus as a step in more complex valve repairs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiac Valve Annulus Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Heart Valve Annulus Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac Valve Annular Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Heart Valve Annular Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Annular Repair, Cardiac Valve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Annulus Repair, Cardiac Valve</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of heart valve surgery that involves the repair, replacement, or reconstruction of the annuli of HEART VALVES. It includes shortening the circumference of the annulus to improve valve closing capacity and reinforcing the annulus as a step in more complex valve repairs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiac Valve Annular Reduction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac Valve Annulus Shortening</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac Valve Annulus Reduction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Annular Reduction, Cardiac Valve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Annulus Reduction, Cardiac Valve</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058386</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of heart valve surgery that involves the repair, replacement, or reconstruction of the annulus of the MITRAL VALVE. It includes shortening the circumference of the annulus to improve valve closing capacity and reinforcing the annulus as a step in more complex valve repairs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mitral Valve Annuloplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mitral Annuloplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mitral Valve Annulus Repair</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058387</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of invasive candidiasis where species of CANDIDA are present in the blood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Candidemia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058405</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare, aggressive soft tissue sarcoma that primarily affects adolescents and young adults. It is most commonly found in the abdomen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Desmoplastic Small Round Cell Tumor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Desmoplastic Small Round-Cell Tumor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Desmoplastic Small-Cell Tumor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Desmoplastic Small Cell Tumor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058406</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Electrical stimulation of the heart by artificial pacemaker leads placed at sites in the RIGHT ATRIUM and both HEART VENTRICLES to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiac Resynchronization Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Resynchronization Pacing Therapy, Cardiac</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac Resynchronization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiac Resynchronization Pacing Therapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Electrical stimulation of the heart by artificial pacemaker leads placed at sites in the RIGHT ATRIUM and both HEART VENTRICLES to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Atrio-Biventricular Pacing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biventricular Pacing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058407</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Adjustment of BRAIN WAVES from two or more neuronal groups within or across a brain structure (e.g., cortical and limbic brain structures) to become uniform in EEG oscillation patterns in response to a stimulus. It is interpreted as a brain integration sign during many processes such as learning, memory, and perception and involves reciprocal neural connections.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electroencephalography Phase Synchronization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>EEG Phase Synchrony</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phase Synchronization, EEG</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phase Synchrony, EEG</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>EEG Phase Synchronization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electroencephalography Phase Synchrony</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Adjustment of BRAIN WAVES from two or more neuronal groups within or across a brain structure (e.g., cortical and limbic brain structures) to become uniform in EEG oscillation patterns in response to a stimulus. It is interpreted as a brain integration sign during many processes such as learning, memory, and perception and involves reciprocal neural connections.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electroencephalography Phase Desynchronization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phase Desynchrony, EEG</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electroencephalography Phase Desynchrony</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phase Desynchronization, EEG</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>EEG Phase Desynchronization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>EEG Phase Desynchrony</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058408</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods that measure the balance of T-cell cytokines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Th1-Th2 Balance</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Th1-Th2 Cytokine Balance</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods that measure the balance of T-cell cytokines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Th1-Th2 Assays</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058409</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Artificial pacemakers with implantable leads to be placed in the RIGHT ATRIUM and both HEART VENTRICLES. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiac Resynchronization Therapy Devices</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Artificial pacemakers with implantable leads to be placed in the RIGHT ATRIUM and both HEART VENTRICLES. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biventricular Pacemakers, Artificial</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058425</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Vaccines using supra-molecular structures composed of multiple copies of recombinantly expressed viral structural proteins. They are often antigentically indistinguishable from the virus from which they were derived.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vaccines, Virus-Like Particle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Virus-Like Particle Vaccines</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058426</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neointima</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The new and thickened layer of scar tissue that forms on a PROSTHESIS, or as a result of vessel injury especially following ANGIOPLASTY or stent placement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neointima Formation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058427</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Materials that readily absorb moisture from their surroundings.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hygroscopic Agents</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Materials that readily absorb moisture from their surroundings.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Humectants</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Materials that readily absorb moisture from their surroundings.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Desiccants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Drying Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058428</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A non-crystalline form of silicon oxide that has absorptive properties. It is commonly used as a desiccating agent and as a stationary phase for CHROMATOGRAPHY. The fully hydrated form of silica gel has distinct properties and is referred to as SILICIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Silica Gel</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A non-crystalline form of silicon oxide that has absorptive properties. It is commonly used as a desiccating agent and as a stationary phase for CHROMATOGRAPHY. The fully hydrated form of silica gel has distinct properties and is referred to as SILICIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Silochrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058429</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infections with nematodes of the genus GNATHOSTOMA, superfamily THELAZIOIDEA. Gnathostomiasis is a food-borne zoonosis caused by eating undercooked or raw fish or meat.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gnathostomiasis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gnathostoma Infection</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058430</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The portion of the upper rounded extremity fitting into the glenoid cavity of the SCAPULA. (from Stedman, 27th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Humeral Head</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058431</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A plant genus in the family POACEAE. Brachypodium distachyon is a model species for functional genomics studies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brachypodium</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A plant genus in the family POACEAE. Brachypodium distachyon is a model species for functional genomics studies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brachypodium distachyon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058432</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A structure found in plants, fungi, and algae, that produces and contains spores.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sporangia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sporangium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058433</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Devices for generating biological products that use light as the energy source. They are used for controlled BIOMASS production such as growing cyanobacteria, mosses, or algae.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photobioreactors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058436</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The leveraging of collective wisdom within an organization as a catalyst to increase responsiveness and innovation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Knowledge Management</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058437</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Degenerative changes to the RETINA due to HYPERTENSION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hypertensive Retinopathy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058438</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Circulation of water among various ecological systems, in various states, on, above, and below the surface of the earth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Water Cycle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hydrologic Cycle</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058439</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process of embryo initiation in culture from vegetative, non-gametic, sporophytic, or somatic plant cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Somatic Embryogenesis Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plant Somatic Embryogenesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058440</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Nitrate reduction process generally mediated by anaerobic bacteria by which nitrogen available to plants is converted to a gaseous form and lost from the soil or water column. It is a part of the nitrogen cycle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Denitrification</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058441</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The immediate physical zone surrounding plant roots that include the plant roots. It is an area of intense and complex biological activity involving plants, microorganisms, other soil organisms, and the soil.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Rhizosphere</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058442</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Capsule Opacification</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058443</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cognitive and emotional processes encompassing magnification of pain-related stimuli, feelings of helplessness, and a generally pessimistic orientation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Catastrophization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Catastrophizing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cognitive and emotional processes encompassing magnification of pain-related stimuli, feelings of helplessness, and a generally pessimistic orientation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pain Catastrophizing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058445</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Aggressive behavior intended to cause harm or distress using electronic -social media as the means of contact and dissemination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bullying</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Aggressive behavior intended to cause harm or distress using electronic -social media as the means of contact and dissemination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cyberbullying</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058446</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of ion channels that open or close in response to the binding of specific LIGANDS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ligand-Gated Ion Channels</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ligand-Gated Channels</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058447</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A dull or sharp painful sensation associated with the outer or inner structures of the eyeball, having different causes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Eye Pain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058448</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The distribution and abundance of taxa in a biological or ecological community.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biota</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biological Community</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biotic Community</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biocenose</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The distribution and abundance of taxa in a biological or ecological community.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Community Structure, Ecological</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The distribution and abundance of taxa in a biological or ecological community.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ecological Community</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The distribution and abundance of taxa in a biological or ecological community.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Community Composition, Ecological</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058449</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intravitreal Injections</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058450</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A method of stopping internal bleeding or blood flow, or the closure of a wound or body cavity, achieved by applying pressure or introducing an absorbent liquid, gel, or tampon.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endotamponade</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058451</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The reaction of two molecular entities via oxidation usually catalyzed by a transition metal compound and involving dioxygen as the oxidant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oxidative Coupling</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058452</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The distance between the anterior and posterior poles of the eye, measured either by ULTRASONOGRAPHY or by partial coherence interferometry.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Axial Length, Eye</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058453</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The condition of where images are correctly brought to a focus on the retina.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Emmetropia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058456</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of rare, idiopathic, congenital retinal vascular anomalies affecting the retinal capillaries. It is characterized by dilation and tortuosity of retinal vessels and formation of multiple aneurysms, with different degrees of leakage and exudates emanating from the blood vessels.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinal Telangiectasis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Coats Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058457</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A disease of the eye in which the eyelashes abnormally turn inwards toward the eyeball producing constant irritation caused by motion of the lids.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trichiasis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058458</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The circulation of nitrogen in nature, consisting of a cycle of biochemical reactions in which atmospheric nitrogen is compounded, dissolved in rain, and deposited in the soil, where it is assimilated and metabolized by bacteria and plants, eventually returning to the atmosphere by bacterial decomposition of organic matter.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nitrogen Cycle</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058465</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A process facilitated by specialized bacteria involving the oxidation of ammonium to nitrite and nitrate.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nitrification</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058466</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subfamily of ligand-gated ion channel receptors that share a characteristic loop which is formed by a disulfide bond between two CYSTEINE residues. These receptors typically contain five subunits with the cysteine-loop occurring near an N-terminal extracellular domain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cysteine Loop Ligand-Gated Ion Channel Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cys-Loop Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cys-Loop Receptor Superfamily</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058467</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of microscopic ecdysozoan invertebrates, closely related to ARTHROPODS. Members exhibit anabiosis and cryptobiosis, dormant states where metabolic activity is reduced or absent, thus making them tolerant to extreme environmental conditions. They are distributed worldwide and most are semi-aquatic.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tardigrada</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tartigrades</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Water Bears</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058468</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A class of ligand-gated ion channel receptors that have specificity for GLUTAMATE. They are distinct from METABOTROPIC GLUTAMATE RECEPTORS which act through a G-protein-coupled mechanism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Ionotropic Glutamate</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ionotropic Glutamate Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058469</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of purinergic P2 receptors that signal by means of a ligand-gated ion channel. They are comprised of three P2X subunits which can be identical (homotrimeric form) or dissimilar (heterotrimeric form).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2X</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X Purinoceptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X Purinoceptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058470</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of purinergic P2 receptors whose signaling is coupled through a G-PROTEIN signaling mechanism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2Y</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y Purinoceptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y Purinoceptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058471</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An exudate between the RETINA and CHOROID from various sources including the vitreous cavity, SUBARACHNOID SPACE, or abnormal vessels.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Subretinal Fluid</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058472</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of purinergic P2Y receptors that have a preference for ATP and ADP. The activated P2Y1 receptor signals through the G-PROTEIN-coupled activation of PHOSPHOLIPASE C and mobilization of intracellular CALCIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2Y1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y1 Purinoceptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y1 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor P2Y, G-Protein Coupled, 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinoceptor P2Y1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y1 Purinoceptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y1 Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058473</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of purinergic P2Y receptors that have a preference for ATP and UTP. The activated P2Y2 receptor acts through a G-PROTEIN-coupled PHOSPHATIDYLINOSITOL and intracellular CALCIUM SIGNALING pathway.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2Y2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinoreceptor P2U</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y2 Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Puringergic Receptor P2Y, G-Protein Coupled, 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2U Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y2 Purinoceptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058474</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A purinergic P2X neurotransmitter receptor found at sympathetically innervated SMOOTH MUSCLE. It may play a functional role regulating the juxtoglomerular apparatus of the KIDNEY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2X1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X1 Purinoceptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor P2X, Ligand-Gated Ion Channel, 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X1 Purinoceptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X1 Receptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058475</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sheath of the eyeball consisting of fascia extending from the OPTIC NERVE to the corneal limbus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tenon Capsule</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tenon's Capsule</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058476</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A purinergic P2X neurotransmitter receptor involved in sensory signaling of TASTE PERCEPTION, chemoreception, visceral distension and NEUROPATHIC PAIN. The receptor comprises three P2X2 subunits. The P2X2 subunits also have been found associated with P2X3 RECEPTOR subunits in a heterotrimeric receptor variant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2X2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor P2X, Ligand-Gated Ion Channel, 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X2 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X2 Purinoceptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X2 Purinoceptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058477</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A purinergic P2X neurotransmitter receptor involved in sensory signaling of TASTE PERCEPTION, chemoreception, visceral distension, and NEUROPATHIC PAIN. The receptor comprises three P2X3 subunits. The P2X3 subunits are also associated with P2X2 RECEPTOR subunits in a heterotrimeric receptor variant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2X3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X3 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor P2X, Ligand-Gated Ion Channel, 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X3 Purinoceptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058485</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A purinergic P2X neurotransmitter receptor found at high levels in the BRAIN and IMMUNE SYSTEM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2X5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X5 Purinoceptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor P2X, Ligand-Gated Ion Channel, 5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X5 Purinoceptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058486</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A purinergic P2X neurotransmitter receptor that plays a role in pain sensation signaling and regulation of inflammatory processes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2X7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X7 Purinoceptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X7 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor P2X, Ligand-Gated Ion Channel, 7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinoceptor P2Z</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X7 Purinoceptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Z Receptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058487</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The free-swimming larval forms of parasites found in an intermediate host.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cercaria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058488</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Encysted cercaria which house the intermediate stages of trematode parasites in tissues of an intermediate host.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metacercariae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058489</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital conditions in individuals with a female karyotype, in which the development of the gonadal or anatomical sex is atypical.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>46, XX Disorders of Sex Development</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>46,XX DSD</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>46, XX DSD</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>46,XX Disorders of Sex Development</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Congenital conditions in individuals with a female karyotype, in which the development of the gonadal or anatomical sex is atypical.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Female Pseudohermaphroditism</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058490</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital conditions in individuals with a male karyotype, in which the development of the gonadal or anatomical sex is atypical.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>46, XY Disorders of Sex Development</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>46,XY DSD</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>46,XY Disorders of Sex Development</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>46, XY DSD</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Congenital conditions in individuals with a male karyotype, in which the development of the gonadal or anatomical sex is atypical.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Male Pseudohermaphroditism</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058491</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Measurable quantity of bacteria in an object, organism, or organism compartment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bacterial Load</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Measurable quantity of bacteria in an object, organism, or organism compartment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bacterial Count</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bacterial Counts</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Count, Bacterial</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Counts, Bacterial</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058492</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The deliberate and methodical practice of finding new applications for existing drugs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug Repositioning</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058493</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Family of flies in the order DIPTERA, commonly known as flesh flies. They lay their eggs in dead or decaying matter or open wounds.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sarcophagidae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Flesh Fly</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fleshfly</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Flesh Flies</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Family of flies in the order DIPTERA, commonly known as flesh flies. They lay their eggs in dead or decaying matter or open wounds.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sarcophaga</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058494</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive lissencephaly type 2 associated with congenital MUSCULAR DYSTROPHY and eye anomalies (e.g., RETINAL DETACHMENT; CATARACT; MICROPHTHALMOS). It is often associated with additional brain malformations such as HYDROCEPHALY and cerebellar hypoplasia and is the most severe form of the group of related syndromes (alpha-dystroglycanopathies) with common congenital abnormalities in the brain, eye and muscle development.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Walker-Warburg Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Warburg Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chemke Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Rare autosomal recessive lissencephaly type 2 associated with congenital MUSCULAR DYSTROPHY and eye anomalies (e.g., RETINAL DETACHMENT; CATARACT; MICROPHTHALMOS). It is often associated with additional brain malformations such as HYDROCEPHALY and cerebellar hypoplasia and is the most severe form of the group of related syndromes (alpha-dystroglycanopathies) with common congenital abnormalities in the brain, eye and muscle development.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Muscle-Eye-Brain Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MEB (Muscle-Eye-Brain) Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Muscle Eye Brain Disease</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Rare autosomal recessive lissencephaly type 2 associated with congenital MUSCULAR DYSTROPHY and eye anomalies (e.g., RETINAL DETACHMENT; CATARACT; MICROPHTHALMOS). It is often associated with additional brain malformations such as HYDROCEPHALY and cerebellar hypoplasia and is the most severe form of the group of related syndromes (alpha-dystroglycanopathies) with common congenital abnormalities in the brain, eye and muscle development.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>alpha-Dystroglycanopathies</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Rare autosomal recessive lissencephaly type 2 associated with congenital MUSCULAR DYSTROPHY and eye anomalies (e.g., RETINAL DETACHMENT; CATARACT; MICROPHTHALMOS). It is often associated with additional brain malformations such as HYDROCEPHALY and cerebellar hypoplasia and is the most severe form of the group of related syndromes (alpha-dystroglycanopathies) with common congenital abnormalities in the brain, eye and muscle development.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fukuyama Type Congenital Muscular Dystrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fukuyama Congenital Muscular Dystrophy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Muscular Dystrophy, Congenital, Fukuyama Type</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cerebromuscular Dystrophy, Fukuyama Type</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058495</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital or postnatal overgrowth syndrome most often in height and occipitofrontal circumference with variable delayed motor and cognitive development. Other associated features include advanced bone age, seizures, NEONATAL JAUNDICE; HYPOTONIA; and SCOLIOSIS. It is also associated with increased risk of developing neoplasms in adulthood. Mutations in the NSD1 protein and its HAPLOINSUFFICIENCY are associated with the syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sotos Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cerebral Gigantism</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058496</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Complex neurobehavioral disorder characterized by distinctive facial features (FACIES), developmental delay and INTELLECTUAL DISABILITY. Behavioral phenotypes include sleep disturbance, maladaptive, self-injurious and attention-seeking behaviors. The sleep disturbance is linked to an abnormal circadian secretion pattern of MELATONIN. The syndrome is associated with de novo deletion or mutation and HAPLOINSUFFICIENCY of the retinoic acid-induced 1 protein on chromosome 17p11.2.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Smith-Magenis Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058497</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive congenital malformation syndrome characterized by cryptophthalmos, SYNDACTYLY and UROGENITAL ABNORMALITIES. Other anomalies of bone, ear, lung, and nose are common. Mutations on FRAS1 and FREM2 are associated with the syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fraser Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cryptophthalmos with Other Malformations</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cryptophthalmos-Syndactyly Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058498</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Procedures to restore vertebrae to their original shape following vertebral compression fractures by inflating a balloon inserted into the vertebrae, followed by removal of the balloon and injection of BONE CEMENTS to fill the cavity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kyphoplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Balloon Vertebroplasty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058499</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of disorders involving predominantly the posterior portion of the ocular fundus, due to degeneration in the sensory layer of the RETINA; RETINAL PIGMENT EPITHELIUM; BRUCH MEMBRANE; CHOROID; or a combination of these tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retinal Dystrophies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058500</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Membranous appendage of fish and other aquatic organisms used for locomotion or balance.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Animal Fins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058501</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A method of detection of the number of cells in a sample secreting a specific molecule. Wtih this method a population of cells are plated over top of the immunosorbent substrate that captures the secreted molecules.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Enzyme-Linked Immunospot Assay</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ELISPOT</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058502</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare congenital deformity syndrome characterized by a combination of five anomalies as a result of neural tube defect. The five anomalies are a midline supraumbilical abdominal wall defect (e.g., OMPHALOCELE), a lower STERNUM defect, a congenital intracardiac defect, an anterior DIAPHRAGM defect, and a diaphragmatic PERICARDIUM defect (e.g., PERICARDIAL EFFUSION). Variants with incomplete and variable combinations of the defects are known. ECTOPIA CORDIS; CLEFT LIP; and CLEFT PALATE are often associated with the syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pentalogy of Cantrell</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thoracoabdominal Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cantrell's Pentalogy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cantrell Haller Ravitch syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cantrell Pentalogy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058503</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Irregular chlorophyll-bearing mesophyll cells interspersed with air spaces.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mesophyll Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Irregular chlorophyll-bearing mesophyll cells interspersed with air spaces.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Palisade Parenchyma Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Irregular chlorophyll-bearing mesophyll cells interspersed with air spaces.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spongy Mesophyll Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058504</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Subset of helper-effector T-lymphocytes which synthesize and secrete IL-17, IL-17F, and IL-22. These cytokines are involved in host defenses and tissue inflammation in autoimmune diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Th17 Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058506</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A layer of living cells between the bark and hardwood that each year produces additional wood and bark cells, forming concentric growth rings.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cambium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058507</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The properties of a pathogen that makes it capable of infecting one or more specific hosts. The pathogen can include PARASITES as well as VIRUSES; BACTERIA; FUNGI; or PLANTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Host Specificity</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Host Species Specificity</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The properties of a pathogen that makes it capable of infecting one or more specific hosts. The pathogen can include PARASITES as well as VIRUSES; BACTERIA; FUNGI; or PLANTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Host Range</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058525</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A piezoelectric mass-sensing devise sensitive in the nanomolar range.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Quartz Crystal Microbalance Techniques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A piezoelectric mass-sensing devise sensitive in the nanomolar range.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Quartz Crystal Microbalance</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A piezoelectric mass-sensing devise sensitive in the nanomolar range.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Quartz Crystal Microbalance with Dissipation Monitoring</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A piezoelectric mass-sensing devise sensitive in the nanomolar range.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrochemical Quartz Crystal Impedance Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058526</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A strand of primary conductive plant tissue consisting essentially of XYLEM, PHLOEM, and CAMBIUM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Vascular Bundle</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058527</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A primary peripheral T-cell lymphoma in the gastrointestinal tract, most often in the jejunum, associated with a history of CELIAC DISEASE or other gastrointestinal diseases.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Enteropathy-Associated T-Cell Lymphoma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>T-Cell Lymphoma, Enteropathy-Associated</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lymphoma, T-Cell, Enteropathy-Associated</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058529</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital abnormality where one, instead of the usual two, UMBILICAL ARTERY connects the fetus to the placenta.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Single Umbilical Artery</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Two Vessel Cord</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058530</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A plant species and perennial herb of the genus DATURA, family SOLANACEAE, containing poisonous tropane ALKALOIDS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Datura metel</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058531</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital conditions in individuals in which male GONADS develop in a genetic female (female to male sex reversal).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>46, XX Testicular Disorders of Sex Development</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>46, XX Testicular DSD</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Congenital conditions in individuals in which male GONADS develop in a genetic female (female to male sex reversal).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>46, XX Gonadal Sex Reversal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sex Reversal, Gonadal, 46, XX</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gonadal Sex Reversal, 46, XX</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058533</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital conditions of atypical sexual development associated with abnormal sex chromosome constitutions including MONOSOMY; TRISOMY; and MOSAICISM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sex Chromosome Disorders of Sex Development</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sex Chromosome DSD</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058534</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phosphatidylinositol 3-kinase subclass that includes enzymes with a specificity for 1-phosphatidylinositol, 1-phosphatidylinositol 4-phosphate, and 1-phosphatidylinositol 4,5-bisphosphate. Members of this enzyme subclass are activated by cell surface receptors and occur as heterodimers of enzymatic and regulatory subunits.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class I Phosphatidylinositol 3-Kinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Class I Phosphatidylinositol 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol 3-Kinase, Class I</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058535</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A PRENATAL ULTRASONOGRAPHY finding of excessively dense fetal bowel due to MECONIUM buildup.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Echogenic Bowel</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hyperechogenic Bowel</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058536</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Dilation of fetal KIDNEY PELVIS. It is a common PRENATAL ULTRASONOGRAPHY finding with no significant long-term sequelae.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pyelectasis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prenatal Fetal Pyelectasis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fetal Pyelectasis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058537</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Supporting content or information, such as animation, datasets, multimedia files, video, movies, audio files, text files, or software, which is submitted for publication in an online journal or an online edition of a journal. This information may be referenced in the text of the article with a link to the supplementary data provided. CATALOG: do not use</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electronic Supplementary Materials</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Supporting Information</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Supplementary Material</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electronic Supplementary Material</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Supplementary Information</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058538</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phosphatidylinositol 3-kinase that catalyzes the conversion of 1-phosphatidylinositol 4-phosphate into phosphatidylinositol 3,4-bisphosphate.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phosphatidylinositol-4-Phosphate 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>1-Phosphatidylinositol-4-Phosphate 3-Kinase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058539</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phosphatidylinositol 3-kinase that catalyzes the conversion of 1-phosphatidylinositol into 1-phosphatidylinositol 3-phosphate.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phosphatidylinositol 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>1-Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058540</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare genetic disorder characterized by partial or complete absence of the CORPUS CALLOSUM, resulting in infantile spasms, MENTAL RETARDATION, and lesions of the RETINA or OPTIC NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aicardi Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aicardi's Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058541</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of phosphatidylinositol 3-kinases that have specificity for 1-phosphatidylinositol and 1-phosphatidylinositol 4-phosphate. Members of this subclass consist of a single subunit structure and are regulated by RECEPTOR TYROSINE KINASES; CYTOKINE RECEPTORS; and INTEGRINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class II Phosphatidylinositol 3-Kinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol 3-Kinase, Class II</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of phosphatidylinositol 3-kinases that have specificity for 1-phosphatidylinositol and 1-phosphatidylinositol 4-phosphate. Members of this subclass consist of a single subunit structure and are regulated by RECEPTOR TYROSINE KINASES; CYTOKINE RECEPTORS; and INTEGRINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phosphoinositide-3-Kinase, Class II, gamma Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PtdIns-3-Kinase C2 gamma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Class 2, gamma Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol-4-Phosphate 3-Kinase C2 Domain-Containing gamma Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide 3-Kinase-C2-gamma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of phosphatidylinositol 3-kinases that have specificity for 1-phosphatidylinositol and 1-phosphatidylinositol 4-phosphate. Members of this subclass consist of a single subunit structure and are regulated by RECEPTOR TYROSINE KINASES; CYTOKINE RECEPTORS; and INTEGRINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phosphoinositide-3-Kinase, Class II, alpha Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PtdIns-3-Kinase C2 alpha</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Class 2, alpha Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol-4-Phosphate 3-Kinase C2 Domain-Containing alpha Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide 3-Kinase C2alpha</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subclass of phosphatidylinositol 3-kinases that have specificity for 1-phosphatidylinositol and 1-phosphatidylinositol 4-phosphate. Members of this subclass consist of a single subunit structure and are regulated by RECEPTOR TYROSINE KINASES; CYTOKINE RECEPTORS; and INTEGRINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phosphoinositide-3-Kinase, Class II, beta Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PtdIns-3-Kinase C2 beta</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Class 2, beta Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol-4-Phosphate 3-Kinase C2 Domain-Containing beta Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide 3-Kinase-C2-beta</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058542</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgically placed electric conductors through which ELECTRIC STIMULATION of nerve tissue is delivered.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Implantable Neurostimulators</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Implanted Neurostimulators</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Implanted Nerve Stimulation Electrodes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058543</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol 3-Kinase, Class Ia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Class Ia Phosphatidylinositol 3-Kinases</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase, p110beta Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Catalytic, beta Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p110beta Subunit, Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase, p110delta Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Catalytic, delta Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p110delta Subunit, Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase, p85beta Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p85beta Subunit, Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Regulatory Subunit 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Class Ia Phosphatidylinositol 3-kinase, Regulatory, beta Polypeptide</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase, p55alpha Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p55alpha Subunit, Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase, p55gamma Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p55gamma Subunit, Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Regulatory Subunit 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Class Ia Phosphatidylinositol 3-kinase, Regulatory, gamma Polypeptide</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase, p85alpha Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Regulatory Subunit 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p85alpha Subunit, Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha-P85 Subunit, PI-3K</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Class Ia Phosphatidylinositol 3-kinase, Regulatory, alpha Polypeptide</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase, p110alpha Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Catalytic, alpha Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p110alpha Subunit, Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A 50kDa variant protein resulting from alternatively-splicing of the phosphoinositide-3-Kinase, regulatory subunit 1mRNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ia Phosphatidylinositol 3-Kinase, p50alpha Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p50alpha Subunit, Class Ia Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058544</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phosphatidylinositol 3-kinase subclass that includes enzymes formed through the association of a p110gamma catalytic subunit and one of the three regulatory subunits of 84, 87, and 101 kDa in size. This subclass of enzymes is a downstream target of G PROTEIN-COUPLED RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ib Phosphatidylinositol 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Class Ib Phosphatidylinositol 3-Kinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol 3-Kinase, Class Ib</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A phosphatidylinositol 3-kinase subclass that includes enzymes formed through the association of a p110gamma catalytic subunit and one of the three regulatory subunits of 84, 87, and 101 kDa in size. This subclass of enzymes is a downstream target of G PROTEIN-COUPLED RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ib Phosphatidylinositol 3-Kinase, p110gamma Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Catalytic, gamma Polypeptide</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p110gamma Subunit, Class Ib Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A phosphatidylinositol 3-kinase subclass that includes enzymes formed through the association of a p110gamma catalytic subunit and one of the three regulatory subunits of 84, 87, and 101 kDa in size. This subclass of enzymes is a downstream target of G PROTEIN-COUPLED RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ib Phosphatidylinositol 3-Kinase, p87 Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p87 Subunit, Class Ib Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A phosphatidylinositol 3-kinase subclass that includes enzymes formed through the association of a p110gamma catalytic subunit and one of the three regulatory subunits of 84, 87, and 101 kDa in size. This subclass of enzymes is a downstream target of G PROTEIN-COUPLED RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ib Phosphatidylinositol 3-Kinase, p101 Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-Kinase, Regulatory Subunit 5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p101 Subunit, Phosphoinositide-3-Kinase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A phosphatidylinositol 3-kinase subclass that includes enzymes formed through the association of a p110gamma catalytic subunit and one of the three regulatory subunits of 84, 87, and 101 kDa in size. This subclass of enzymes is a downstream target of G PROTEIN-COUPLED RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class Ib Phosphatidylinositol 3-Kinase, p84 Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p84 Subunit, Class Ib Phosphatidylinositol 3-Kinase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058545</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Illicit use of chemicals and products whose vapors can be inhaled to produce a rapid mind-altering effect. Inhalants include aerosols, gases, and volatile solvents that are often inhaled repeatedly to achieve the short-lived intoxicating effect.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inhalant Abuse</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Illicit use of chemicals and products whose vapors can be inhaled to produce a rapid mind-altering effect. Inhalants include aerosols, gases, and volatile solvents that are often inhaled repeatedly to achieve the short-lived intoxicating effect.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glue Sniffing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glue Abuse</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058546</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phosphatidylinositol 3-kinase subclass that includes enzymes whose specificity is limited to 1-phosphatidylinositol. Members of this class play a role in vesicular transport and in the regulation of TOR KINASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class III Phosphatidylinositol 3-Kinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol 3-Kinase, Class III</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A phosphatidylinositol 3-kinase subclass that includes enzymes whose specificity is limited to 1-phosphatidylinositol. Members of this class play a role in vesicular transport and in the regulation of TOR KINASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Class III Phosphatidylinositol 3-Kinase Catalytic Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>VPS34 Sorting Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vacuolar Protein Sorting 34 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vps34 Phosphatidylinositol 3-Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol 3-Kinase p100 Subunit</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058565</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inflammation of CEREBRAL VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cerebral Ventriculitis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Inflammation of CEREBRAL VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infectious Ventriculitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058566</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inflammation of the SACROILIAC JOINT. It is characterized by lower back pain, especially upon walking, fever, UVEITIS; PSORIASIS; and decreased range of motion. Many factors are associated with and cause sacroiliitis including infection; injury to spine, lower back, and pelvis; DEGENERATIVE ARTHRITIS; and pregnancy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sacroiliitis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Inflammation of the SACROILIAC JOINT. It is characterized by lower back pain, especially upon walking, fever, UVEITIS; PSORIASIS; and decreased range of motion. Many factors are associated with and cause sacroiliitis including infection; injury to spine, lower back, and pelvis; DEGENERATIVE ARTHRITIS; and pregnancy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pyogenic Sacroiliitis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Inflammation of the SACROILIAC JOINT. It is characterized by lower back pain, especially upon walking, fever, UVEITIS; PSORIASIS; and decreased range of motion. Many factors are associated with and cause sacroiliitis including infection; injury to spine, lower back, and pelvis; DEGENERATIVE ARTHRITIS; and pregnancy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Septic Sacroiliitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058567</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemical compound used to initiate polymerization of dental resins by the use of DENTAL CURING LIGHTS. It absorbs UV light and undergoes decomposition into free radicals that initiate polymerization process of the resins in the mix. Each photoinitiator has optimum emission spectrum and intensity for proper curing of dental materials.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photoinitiators, Dental</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Resin Photoinitiators, Dental</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058568</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Recurrent cutaneous manifestation of GLUCAGONOMA characterized by necrolytic polycyclic migratory lesions with scaling borders. It is associated with elevated secretion of GLUCAGON by the tumor. Other conditions with elevated serum glucagon levels such as HEPATIC CIRRHOSIS may also result in similar skin lesions, which are referred to as pseudoglucagonoma syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Necrolytic Migratory Erythema</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recurrent cutaneous manifestation of GLUCAGONOMA characterized by necrolytic polycyclic migratory lesions with scaling borders. It is associated with elevated secretion of GLUCAGON by the tumor. Other conditions with elevated serum glucagon levels such as HEPATIC CIRRHOSIS may also result in similar skin lesions, which are referred to as pseudoglucagonoma syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pseudoglucagonoma Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058569</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Replacement for an elbow joint.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Elbow Prosthesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058570</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A serine threonine kinase that controls a wide range of growth-related cellular processes. The protein is referred to as the target of RAPAMYCIN due to the discovery that TACROLIMUS (commonly known as rapamycin) forms an inhibitory complex with TACROLIMUS BINDING PROTEIN 1A that blocks the action of its enzymatic activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>TOR Serine-Threonine Kinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>FKBP12-Rapamycin Associated Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>FKBP12-Rapamycin Complex-Associated Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mechanistic Target of Rapamycin Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TOR Kinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>mTOR Serine-Threonine Kinases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RAFT-1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rapamycin Target Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Target of Rapamycin Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>FK506 Binding Protein 12-Rapamycin Associated Protein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>mTOR Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058571</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A 150 kDa protein serine-threonine kinase that is found as a regulatory subunit of the class III phosphatidylinositol 3-kinases. The protein is believed to play an important role in the regulation of vesicular trafficking with the cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vacuolar Sorting Protein VPS15</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Class III Phosphatidylinositol 3-Kinase, p150 Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vps15 Protein Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphoinositide-3-kinase, Regulatory Subunit 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vacuolar Protein Sorting 15</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>VPS15 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Class III Phosphatidylinositol 3-Kinase Regulatory Subunit</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphatidylinositol 3-Kinase, Regulatory Subunit, Polypeptide 4, p150</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058572</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A measure of the total greenhouse gas emissions produced by an individual, organization, event, or product. It is measured in units of equivalent kilograms of CARBON DIOXIDE generated in a given time frame.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carbon Footprint</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058573</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Agents that improve the ability to carry out activities such as athletics, mental endurance, work, and resistance to stress. The substances can include PRESCRIPTION DRUGS; DIETARY SUPPLEMENTS; phytochemicals; and ILLICIT DRUGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Performance-Enhancing Substances</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Agents that improve the ability to carry out activities such as athletics, mental endurance, work, and resistance to stress. The substances can include PRESCRIPTION DRUGS; DIETARY SUPPLEMENTS; phytochemicals; and ILLICIT DRUGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Performance-Enhancing Drugs</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Agents that improve the ability to carry out activities such as athletics, mental endurance, work, and resistance to stress. The substances can include PRESCRIPTION DRUGS; DIETARY SUPPLEMENTS; phytochemicals; and ILLICIT DRUGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Performance-Enhancing Effect</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Performance-Enhancing Effects</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058574</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A highly glycosylated and sulfated phosphoprotein that is found almost exclusively in mineralized connective tissues. It is an extracellular matrix protein that binds to hydroxyapatite through polyglutamic acid sequences and mediates cell attachment through an RGD sequence.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Integrin-Binding Sialoprotein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Sialoprotein 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Sialoprotein II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Sialoprotein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058575</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A small leucine-rich proteoglycan that interacts with FIBRILLAR COLLAGENS and modifies the EXTRACELLULAR MATRIX structure of CONNECTIVE TISSUE. Decorin has also been shown to play additional roles in the regulation of cellular responses to GROWTH FACTORS. The protein contains a single glycosaminoglycan chain and is similar in structure to BIGLYCAN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Decorin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Proteoglycan II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DSPG-II</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058578</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A small leucine-rich proteoglycan found in a variety of tissues including CAPILLARY ENDOTHELIUM; SKELETAL MUSCLE; CARTILAGE; BONE; and TENDONS. The protein contains two glycosaminoglycan chains and is similar in structure to DECORIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biglycan</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Proteoglycan S1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Proteoglycan I</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058579</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of high molecular weight chondroitin sulfate proteoglycans that form aggregates with HYALURONIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hyalectins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058580</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A hyalectin family member that is expressed in neuronal tissue and plays a role in neuronal CELL ADHESION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neurocan</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chondroitin Sulfate Proteoglycan 3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058581</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A BRAIN-specific hyalectin that may play a role in terminally differentiating NEURONS. It is found highly overexpressed in primary BRAIN TUMORS and in experimental models of GLIOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brevican</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chondroitin Sulfate Proteoglycan 7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brain-Enriched Hyaluronan-Binding Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058582</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endoscopy of the small intestines accomplished while advancing the endoscope into the intestines from the stomach by alternating the inflation of two balloons, one on an innertube of the endoscope and the other on an overtube.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Double-Balloon Enteroscopy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Push-and-Pull Enteroscopy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058585</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Recorded electrical responses from brain following stimulation of the EAR VESTIBULE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vestibular Evoked Myogenic Potentials</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recorded electrical responses from brain following stimulation of the EAR VESTIBULE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ocular Vestibular Evoked Myogenic Potentials</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recorded electrical responses from brain following stimulation of the EAR VESTIBULE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cervical Vestibular Evoked Myogenic Potentials</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recorded electrical responses from brain following stimulation of the EAR VESTIBULE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Evoked Neurogenic Vestibular Potentials</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vestibular Evoked Neurogenic Potentials</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058605</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A broad category of endogenous cellular factors that are used by VIRUSES for essential functions such as VIRUS REPLICATION. Many host-derived factors play normal cellular roles in non-infected cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Host-Derived Cellular Factors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058606</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Accessory Atrioventricular Bundle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accessory Atrioventricular Pathways</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kent Bundle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accessory Conducting Pathways</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bundle of Kent</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accessory Atrioventricular Pathway</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accessory Conducting Pathway</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Concealed Accessory Pathway</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fasciculoventricular Accessory Pathway</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fasciculoventricular Pathway</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nodoventricular Accessory Pathway</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nodoventricular Pathway</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>James Fibers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mahaim Fibers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Extra impulse-conducting tissue in the heart that creates abnormal impulse-conducting connections between HEART ATRIA and HEART VENTRICLES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Atriohisian Tract</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Atriohisian Fibers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Atrio-Hisian Bypass Tract</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058607</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that either share the structure of fibric acid in their molecular arrangement or are considered variants of the fibric acid structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fibric Acids</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Methyl-2-Phenoxypropanoic Acid Derivatives</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fibric Acid Derivatives</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>2-Phenoxy Isobutyric Acids</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>2-Phenoxy-2-Methylpropionic Acid Derivatives</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that either share the structure of fibric acid in their molecular arrangement or are considered variants of the fibric acid structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fibrates</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058608</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Small holes of nanometer dimensions in a membrane, that can be used as single molecule detectors. The pores can be biological or synthetic.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nanopores</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058609</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Method of measuring and mapping the scope of vision, from central to peripheral of each eye.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Visual Field Tests</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Visual Field Exam</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Method of measuring and mapping the scope of vision, from central to peripheral of each eye.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Campimetry</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Method of measuring and mapping the scope of vision, from central to peripheral of each eye.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tangent Screen Exam</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Method of measuring and mapping the scope of vision, from central to peripheral of each eye.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Perimetry</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Method of measuring and mapping the scope of vision, from central to peripheral of each eye.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Automated Perimetry Exam</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058610</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Aliphatic acids that contain four carbons in a branched-chain configuration.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Isobutyric Acids</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dimethylacetic Acids</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>2-Methylpropionic Acids</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Aliphatic acids that contain four carbons in a branched-chain configuration.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Isobutyrates</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058611</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A therapeutic approach in which horticultural artefacts are utilized in improving an individual's social, emotional, educational, psychological, and physical well-being.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Horticultural Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058612</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Diamond nanoparticles that exhibit unique biological, thermal, mechanical, and optoelectronic properties. They have important NANOMEDICINE applications including DRUG DELIVERY SYSTEMS; DIAGNOSTIC IMAGING; protein separation; and BIOSENSING TECHNIQUES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nanodiamonds</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058614</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The various physical methods which include wind, insects, animals, tension, and water, by which a plant scatters its seeds away from the parent plant.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Seed Dispersal</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058615</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A field of biological research combining engineering in the formulation, design, and building (synthesis) of novel biological structures, functions, and systems.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Synthetic Biology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058616</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Nutritional supplements combining PROBIOTICS (bacteria) and PREBIOTICS (sugars).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Synbiotics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058617</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Two or more distinct types of malignant lymphoid tumors occurring within a single organ or tissue at the same time. It may contain different types of non-Hodgkin lymphoma cells or both Hodgkin and non-Hodgkin lymphoma cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Composite Lymphoma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058618</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Collective name for a group of external MECHANORECEPTORS and chemoreceptors manifesting as sensory structures in ARTHROPODS. They include cuticular projections (setae, hairs, bristles), pores, and slits.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sensilla</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sensillum</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Collective name for a group of external MECHANORECEPTORS and chemoreceptors manifesting as sensory structures in ARTHROPODS. They include cuticular projections (setae, hairs, bristles), pores, and slits.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Setae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058619</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Periplasmic proteins that bind MALTOSE and maltodextrin. They take part in the maltose transport system of BACTERIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Maltose-Binding Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Maltose-Binding Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058620</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Nutritional physiology of adults aged 65 years of age and older.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Elder Nutritional Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Elder Nutritional Physiological Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aged Nutrition Physiology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Elderly Nutrition Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aged Nutritional Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Aged Nutrition Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Elder Nutrition Physiological Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Elder Nutritional Physiology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058621</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The fraction of a blood sample, following CENTRIFUGATION, that is distinguished as a thin light-colored layer between the RED BLOOD CELLS, underneath it, and the PLASMA, above it. It is composed mostly of WHITE BLOOD CELLS and PLATELETS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blood Buffy Coat</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Buffy Coat, Blood</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058625</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>End Stage Liver Disease</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Final stage of a liver disease when the liver failure is irreversible and LIVER TRANSPLANTATION is needed.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chronic Liver Failure</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Liver Failure, Chronic</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058626</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Ionized gases, consisting of free electrons and ionized atoms or molecules which collectively behave differently than gas, solid, or liquid. Plasma gases are used in biomedical fields in surface modification; biological decontamination; dentistry (e.g., PLASMA ARC DENTAL CURING LIGHTS); and in other treatments (e.g., ARGON PLASMA COAGULATION).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plasma Gases</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Ionized gases, consisting of free electrons and ionized atoms or molecules which collectively behave differently than gas, solid, or liquid. Plasma gases are used in biomedical fields in surface modification; biological decontamination; dentistry (e.g., PLASMA ARC DENTAL CURING LIGHTS); and in other treatments (e.g., ARGON PLASMA COAGULATION).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cold Plasma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Non-Thermal Atmospheric Pressure Plasma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Ionized gases, consisting of free electrons and ionized atoms or molecules which collectively behave differently than gas, solid, or liquid. Plasma gases are used in biomedical fields in surface modification; biological decontamination; dentistry (e.g., PLASMA ARC DENTAL CURING LIGHTS); and in other treatments (e.g., ARGON PLASMA COAGULATION).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thermal Plasma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058627</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A congenital abnormality in which the occipitofrontal circumference is greater than two standard deviations above the mean for a given age. It is associated with HYDROCEPHALUS; SUBDURAL EFFUSION; ARACHNOID CYSTS; or is part of a genetic condition (e.g., ALEXANDER DISEASE; SOTOS SYNDROME).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Macrocephaly</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058628</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Spindle-shaped cells with characteristic CONTRACTILE PROTEINS and structures that contribute to the WOUND HEALING process. They occur in GRANULATION TISSUE and also in pathological processes such as FIBROSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Myofibroblasts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058629</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cosmetic technique that uses PLASMA GASES in therapeutic treatment to help achieve skin REJUVENATION or REGENERATION and delay SKIN AGING.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plasma Skin Regeneration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plasma Skin Resurfacing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plasma Skin Rejuvenation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058630</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Repair of the damaged neuron function after SPINAL CORD INJURY or SPINAL CORD DISEASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spinal Cord Regeneration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal Cord Repair</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058631</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare autosomal recessive syndrome characterized by delayed closing of CRANIAL SUTURES, short stature, ACRO-OSTEOLYSIS of distal phalanges, dental and MAXILLOFACIAL ABNORMALITIES and an increase in bone density that results in frequent BONE FRACTURES. It is associated with BONE RESORPTION defect due to mutations in the lysosomal cysteine protease CATHEPSIN K.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pycnodysostosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pyknodysostosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058632</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Prostaglandin-like compounds produced by free radical-induced peroxidation of DOCOSAHEXAENOIC ACIDS, which are highly enriched in the brain. Formation is analogous to ISOPROSTANES formation from ARACHIDONIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neuroprostanes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058633</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that are used to reduce body temperature in fever.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antipyretics</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antipyretic Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antifebrile Agents</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs that are used to reduce body temperature in fever.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antipyretic Effect</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antipyretic Effects</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058634</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The large scale production of pharmaceutically important and commercially valuable RECOMBINANT PROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molecular Farming</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058635</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins that are covalently-linked to lipid molecules or hydrophobic molecules such as those that contain prenyl groups. The lipid moieties aid in the association of the proteins with CELL MEMBRANES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lipid-Linked Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lipid-Anchored Membrane Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Membrane Lipid-Linked Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lipid Anchored Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058636</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sterile fabric or fabric-like material used to isolate the surgical site from the rest of the body and other possible sources of contamination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Surgical Drapes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058637</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A raised flat surface on which a patient is placed during a PHYSICAL EXAMINATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Examination Tables</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058638</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A raised flat surface on which a patient is placed during surgical procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Operating Tables</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Operating Room Tables</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Operation Tables</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058639</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A constellation of responses that occur when an organism is exposed to excessive cold. In humans, a fall in skin temperature triggers gasping, hypertension, and hyperventilation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cold-Shock Response</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cold-Stress Reaction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cold-Stress Response</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058640</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-positive bacteria in the family Listeriaceae. It has 93% homology to LISTERIA and shares with it many phenotypic properties.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brochothrix</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058641</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of gram-positive bacteria in the order BACILLALES. Most are strict aerobic heterotrophs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Planococcaceae</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of gram-positive bacteria in the order BACILLALES. Most are strict aerobic heterotrophs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Caryophanon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058642</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of coccoid bacteria in the family PLANOCOCCACEAE. They are widely distributed in various habitats including sea water, freshwater ponds, cyanobacterial mats, and in marine animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Planococcus Bacteria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058643</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of insect in the mealybug family Pseudococcidae.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Planococcus Insect</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058644</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of endospore-forming bacteria in the family PLANOCOCCACEAE. The species are strict or facultative anerobes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sporosarcina</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058645</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Electrophoresis in which various denaturant gradients are used to induce nucleic acids to melt at various stages resulting in separation of molecules based on small sequence differences including SNPs. The denaturants used include heat, formamide, and urea.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Denaturing Gradient Gel Electrophoresis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Electrophoresis in which various denaturant gradients are used to induce nucleic acids to melt at various stages resulting in separation of molecules based on small sequence differences including SNPs. The denaturants used include heat, formamide, and urea.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Temperature Gradient Gel Electrophoresis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058646</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic alpha-1 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha-1 Receptor Agonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha1-Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha-1 Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058647</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic alpha-2 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha2-Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha-2 Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha-2 Receptor Agonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058665</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and activate ADRENERGIC BETA-1 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic beta-1 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-1 Receptor Agonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta1-Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-1 Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058666</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic beta-2 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta2-Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-2 Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-2 Receptor Agonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058667</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic beta-3 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-3 Receptor Agonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-3 Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058668</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic alpha-1 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha1-Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha-1 Adrenergic Blocking Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha1-Adrenoceptor Blocker</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha-1 Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha-1 Receptor Blockers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058669</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to and block the activation of ADRENERGIC ALPHA-2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic alpha-2 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha-2 Receptor Blockers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha-2 Adrenergic Blocking Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha-2 Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic alpha2-Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058670</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The possession of four chromosomes of any one type in an otherwise diploid cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tetrasomy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The possession of four chromosomes of any one type in an otherwise diploid cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Partial Tetrasomy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058671</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic beta-1 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta1-Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>beta-1 Adrenergic Blocking Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-1 Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-1 Receptor Blockers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058672</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to and block the activation of ADRENERGIC BETA-2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic beta-2 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta2-Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>beta-2 Adrenergic Blocking Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-2 Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-2 Receptor Blockers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058673</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to and block the activation of ADRENERGIC BETA-3 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic beta-3 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>beta-3 Adrenergic Blocking Agents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-3 Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adrenergic beta-3 Receptor Blockers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058674</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An aberration in which an extra chromosome or a chromosomal segment is made.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromosome Duplication</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Duplication, Chromosome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chromosomal Duplication</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Duplication, Chromosomal</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058675</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of GRAM-POSITIVE ENDOSPORE-FORMING RODS in the family Paenibacillaceae. Most strains have been isolated from the natural environment, particularly soils.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brevibacillus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058676</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family Pasteuriaceae. It is transmitted via soil or waterborne SPORES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pasteuria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058677</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family Bacillaceae. Most species have been isolated from HOT SPRINGS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anoxybacillus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058678</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA in the family BACILLACEAE. Species are widely distributed in a variety of hypersaline environments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Halobacillus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058679</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of GRAM-POSITIVE ENDOSPORE-FORMING RODS in the family BACILLACEAE. They have been isolated from salty environments, food, water, and clinical specimens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Virgibacillus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058685</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A single gene that influences several distinct and seemly unrelated phenotypic outcomes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genetic Pleiotropy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genetic Pleiotropism</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A single gene that influences several distinct and seemly unrelated phenotypic outcomes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pleiotropic Gene</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pleiotropic Genes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058686</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A complication of INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS whereby an occlusion or stenosis of the proximal SUBCLAVIAN ARTERY causes a reversal of the blood flow away from the CORONARY CIRCULATION, through the grafted INTERNAL MAMMARY ARTERY (internal thoracic artery), and back to the distal subclavian distribution.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coronary-Subclavian Steal Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058687</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Occurrence of heart arrest in an individual when there is no immediate access to medical personnel or equipment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Out-of-Hospital Cardiac Arrest</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Out-of-Hospital Heart Arrest</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058725</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The period shortly before, during, and immediately after giving birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peripartum Period</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peripartum</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The period shortly before, during, and immediately after giving birth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peripartum Women</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058726</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Tailored macromolecules harboring covalently-bound biologically active modules that target specific tissues and cells. The active modules or functional groups can include drugs, prodrugs, antibodies, and oligonucleotides, which can act synergistically and be multitargeting.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nanoconjugates</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058727</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Short RNA, about 200 base pairs in length or shorter, that does not code for protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RNA, Small Untranslated</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Non-Coding RNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Non-Messenger RNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Non-Protein-Coding RNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Untranslated RNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>sncRNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>sncRNAs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Short Noncoding RNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Small Noncoding RNA</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058728</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The prevention of growth and or spread of unwanted plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weed Control</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058729</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peripheral Arterial Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peripheral Arterial Diseases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peripheral Artery Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058731</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Activities involved in ensuring the safety of the blood for BLOOD TRANSFUSIONS including collecting information on BLOOD DONORS and recipients, collection, testing, and storage of the blood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Blood Safety</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Activities involved in ensuring the safety of the blood for BLOOD TRANSFUSIONS including collecting information on BLOOD DONORS and recipients, collection, testing, and storage of the blood.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hemovigilance</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058732</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Spontaneous aggregations of human embryonic stem cells that occur in vitro after culturing in a medium that lacks LEUKEMIC INHIBITORY FACTOR. The embryoid bodies can further differentiate into cells that represent different lineages.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Embryoid Bodies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058733</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Placement of one of the surgeon's gloved hands into the ABDOMINAL CAVITY to perform manual manipulations that facilitate the laparoscopic procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hand-Assisted Laparoscopy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Placement of one of the surgeon's gloved hands into the ABDOMINAL CAVITY to perform manual manipulations that facilitate the laparoscopic procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hand-Assisted Laparoscopic Surgical Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hand-Assisted Laparoscopic Surgery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058734</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rapid and extreme blood loss leading to HEMORRHAGIC SHOCK.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Exsanguination</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Exsanguinating Hemorrhage</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058735</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A course of action or principle adopted or proposed by a government, party, business, or individual that concerns human interactions with nature and natural resources.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Environmental Policy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Policies, Environmental</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Policy, Environmental</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Environmental Policies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058736</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The shifting in position or location of an INTRAUTERINE DEVICE from its original placement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intrauterine Device Migration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>IUD Migration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058737</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Replacement of the ANKLE JOINT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Arthroplasty, Replacement, Ankle</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ankle Replacement Arthroplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Total Ankle Replacement</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058738</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inflation of a balloon catheter within the uterine cavity to control UTERINE HEMORRHAGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uterine Balloon Tamponade</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058739</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Clusters of colonic crypts that appear different from the surrounding mucosa when visualized after staining. They are of interest as putative precursors to colorectal adenomas and potential biomarkers for colorectal carcinoma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aberrant Crypt Foci</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058745</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An overuse injury causing lateral knee pain that results from repetitive friction of the iliotibial band over the lateral femoral epicondyle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Iliotibial Band Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058746</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Round-shaped structure usually located in the upper fundus of the UTERUS in early pregnancy. It comprises EMBRYO; AMNIOTIC FLUID; and YOLK SAC. It is visible in PRENATAL ULTRASONOGRAPHY by the fifth week of pregnancy. Its size is often used to determine and monitor GESTATIONAL AGE; FETAL GROWTH; and PREGNANCY COMPLICATIONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gestational Sac</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gestation Sac</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058747</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rare disease characterized by COLOBOMA; CHOANAL ATRESIA; and abnormal SEMICIRCULAR CANALS. Mutations in CHD7 protein resulting in disturbed neural crest development are associated with CHARGE Syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CHARGE Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hall-Hittner Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CHARGE Association</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Rare disease characterized by COLOBOMA; CHOANAL ATRESIA; and abnormal SEMICIRCULAR CANALS. Mutations in CHD7 protein resulting in disturbed neural crest development are associated with CHARGE Syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Familial CHARGE Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058748</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process by which PAIN is recognized and interpreted by the brain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pain Perception</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058749</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Areas designated for use by the armed forces personnel.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Military Facilities</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas designated for use by the armed forces personnel.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Military Bases</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas designated for use by the armed forces personnel.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Military Forts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058750</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Phenotypic changes of EPITHELIAL CELLS to MESENCHYME type, which increase cell mobility critical in many developmental processes such as NEURAL TUBE development. NEOPLASM METASTASIS and DISEASE PROGRESSION may also induce this transition.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Epithelial-Mesenchymal Transition</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Epithelial-Mesenchymal Transformation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058751</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Domesticated farm animals raised for home use or profit but excluding POULTRY. Typically livestock includes CATTLE; SHEEP; HORSES; SWINE; GOATS; and others.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Livestock</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058752</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A mass of tissue that has been cut away from its surrounding areas to be used in TISSUE TRANSPLANTATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Free Tissue Flaps</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Free Tissue Transfer Flaps</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microsurgical Free Flaps</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Free Flaps</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058753</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of LARYNGOPLASTY carried out via the THYROID CARTILAGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laryngoplasty</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of LARYNGOPLASTY carried out via the THYROID CARTILAGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medialization Laryngoplasty</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of LARYNGOPLASTY carried out via the THYROID CARTILAGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thyroplasty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058765</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A biofeedback during which a continuous brain wave pattern is shared with the person in order to increase the percentage of a certain type of brain wave, such as ALPHA RHYTHM, which is associated with a state of relaxation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neurofeedback</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A biofeedback during which a continuous brain wave pattern is shared with the person in order to increase the percentage of a certain type of brain wave, such as ALPHA RHYTHM, which is associated with a state of relaxation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brainwave Biofeedback</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Alpha Feedback</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electromyography Feedback</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>EEG Feedback</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Electroencephalography Biofeedback</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Alpha Biofeedback</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brainwave Feedback</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058766</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Levoleucovorin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>6-S-leucovorin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>S-leucovorin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Leucovorin, (S)-Isomer</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>levo-leucovorin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>(6S)-leucovorin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>6S-leucovorin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leucovorin, Monosodium Salt, (S)-Isomer</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leucovorin, Monopotassium Salt, (S)-Isomer</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fusilev</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A folate analog consisting of the pharmacologically active isomer of LEUCOVORIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Leucovorin, Calcium (1:1) Salt, (S)-Isomer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058767</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Conformational transitions of the shape of a protein to various unfolded states.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Unfolding</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058785</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endogenous compounds and drugs that bind to and activate GABA-A RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>GABA-A Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA-A Receptor Agonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA-A Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058786</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endogenous compounds and drugs that bind to and activate GABA-B RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>GABA-B Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA-B Receptor Agonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA-B Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058787</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to but do not activate GABA-A RECEPTORS thereby blocking the actions of endogenous or exogenous GABA-A RECEPTOR AGONISTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>GABA-A Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA-A Receptor Antagonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA-A Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058788</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to but do not activate GABA-B RECEPTORS thereby blocking the actions of endogenous or exogenous GABA-B RECEPTOR AGONISTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>GABA-B Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA-B Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA-B Receptor Antagonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058805</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that suppress or block the plasma membrane transport of GAMMA-AMINOBUTYRIC ACID by GABA PLASMA MEMBRANE TRANSPORT PROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>GABA Uptake Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Uptake Inhibitors, Gamma-Aminobutyric Acid</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Uptake Inhibitors, GABA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GABA Reuptake Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gamma-Aminobutyric Acid Plasma Membrane Transport Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058825</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1 Agonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1 Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1B Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1B Agonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1D Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1D Agonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1A Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1A Agonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT1 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1B-D Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1B-D Agonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058826</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT2 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2 Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2 Agonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT2B Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2B Agonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT2C Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2C Agonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT2 RECEPTORS. Included under this heading are agonists for one or more of the specific 5-HT2 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT2A Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2A Agonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058827</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT3 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT3 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT3 Agonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT3 Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058828</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endogenous compounds and drugs that specifically stimulate SEROTONIN 5-HT4 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT4 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT4 Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT4 Agonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058829</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT1 RECEPTORS, thereby blocking the actions of SEROTONIN 5-HT1 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1 Antagonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1 Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT1 RECEPTORS, thereby blocking the actions of SEROTONIN 5-HT1 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1B Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1B Antagonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT1 RECEPTORS, thereby blocking the actions of SEROTONIN 5-HT1 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1D Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1D Antagonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT1 RECEPTORS, thereby blocking the actions of SEROTONIN 5-HT1 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1A Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1A Antagonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT1 RECEPTORS, thereby blocking the actions of SEROTONIN 5-HT1 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more of the specific 5-HT1 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT1B-D Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT1B-D Antagonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058830</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT2 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2 Antagonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT2C Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2C Antagonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT2A Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2A Antagonist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT2 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT2 RECEPTOR AGONISTS. Included under this heading are antagonists for one or more specific 5-HT2 receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT2B Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT2B Antagonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058831</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT3 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN 5-HT3 RECEPTOR AGONISTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT3 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT3 Antagonist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT3 Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058832</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to but do not activate SEROTONIN 5-HT4 RECEPTORS, thereby blocking the actions of SEROTONIN or SEROTONIN RECEPTOR AGONISTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonin 5-HT4 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT4 Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-HT4 Antagonist</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058833</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An endogenous family of proteins belonging to the serpin superfamily that neutralizes the action of thrombin. Six naturally occurring antithrombins have been identified and are designated by Roman numerals I to VI. Of these, Antithrombin I (see FIBRIN) and ANTITHROMBIN III appear to be of major importance.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antithrombin Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058834</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus that has been reclassified into BACILLALES incertae sedis because of its ambiguous taxonomy. Previously it was considered part of the Staphylococcaceae family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gemella</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058835</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-positive, facultatively anaerobic bacteria in the family AEROCOCCACEAE. There is only one species, Abiotrophia defectiva, in the genus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Abiotrophia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058836</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-positive, asporogenous, lactic acid bacteria, in the family LEUCONOSTOCACEAE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weissella</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058845</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram positive, acetogenic, thermophilic bacteria in the family Thermoanaerobacteraceae. Known habitats include HOT SPRINGS, horse manure, emu droppings, and sewage SLUDGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Moorella</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058846</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Antibodies obtained from a single clone of cells grown in mice or rats.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antibodies, Monoclonal, Murine-Derived</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Murine-Derived Monoclonal Antibodies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058847</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Multiprotein complexes that mediate the activation of CASPASE-1. Dysregulation of inflammasomes has also been linked to a number of autoinflammatory and autoimmune disorders.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inflammasomes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058848</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A widely distributed purinergic P2X receptor subtype that plays a role in pain sensation. P2X4 receptors found on MICROGLIA cells may also play a role in the mediation of allodynia-related NEUROPATHIC PAIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2X4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X4 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor P2X, Ligand-Gated Ion Channel, 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X4 Purinoceptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058849</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Conformational transitions of a protein from unfolded states to a more folded state.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Refolding</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058850</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Medical treatment for opioid dependence using a substitute opiate such as METHADONE or BUPRENORPHINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Opiate Substitution Treatment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Opioid Substitution Treatment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Opioid Substitution Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Opiate Replacement Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Opioid Replacement Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058851</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of lipid-linked proteins that contain a GLYCOSYLPHOSPHATIDYLINOSITOL LINKAGE which holds them to the CELL MEMBRANE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>GPI-Linked Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GPI-Linked Membrane Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glycosylphosphatidylinositol Linked Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058865</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Non-native species that threaten ecosystems, habitats, or other species and are likely to cause economic or environmental harm or harm to human health.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Introduced Species</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Non-native species that threaten ecosystems, habitats, or other species and are likely to cause economic or environmental harm or harm to human health.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Invasive Species</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058866</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Breaks in bones resulting from low bone mass and microarchitectural deterioration characteristic of OSTEOPOROSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Osteoporotic Fractures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058867</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that increase the enzymatic activity of LIPOPROTEIN LIPASE. Lipoprotein lipase activators have a potential role in the treatment of OBESITY by increasing LIPID METABOLISM. Note that substances that increase the synthesis of lipoprotein lipase are not included here.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lipoprotein Lipase Activators</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lipoprotein Lipase Activating Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058868</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Air that is reduced in volume by pressure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Compressed Air</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Air that is reduced in volume by pressure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pressurized Air</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058869</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Comprised of bimanual examination of the FEMALE GENITALIA performed as internal together with simultaneous external PALPITATION through the abdominal wall; speculum examination; CULPOSCOPY examination of cervix and vaginal wall epithelium; and VAGINAL SMEARS. (from Dictionary of Obstetrics and Gynecology)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gynecological Examination</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gynecological Exam</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Comprised of bimanual examination of the FEMALE GENITALIA performed as internal together with simultaneous external PALPITATION through the abdominal wall; speculum examination; CULPOSCOPY examination of cervix and vaginal wall epithelium; and VAGINAL SMEARS. (from Dictionary of Obstetrics and Gynecology)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pelvic Examination</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pelvic Exam</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Comprised of bimanual examination of the FEMALE GENITALIA performed as internal together with simultaneous external PALPITATION through the abdominal wall; speculum examination; CULPOSCOPY examination of cervix and vaginal wall epithelium; and VAGINAL SMEARS. (from Dictionary of Obstetrics and Gynecology)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vaginal Examinations</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vaginal Exam</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058870</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>ORGANIC AGRICULTURE products, especially fruits and vegetables.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Food, Organic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Organic Food</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>ORGANIC AGRICULTURE products, especially fruits and vegetables.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Produce</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058871</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Systems of agriculture which adhere to nationally regulated standards that restrict the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ANIMAL FEED.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Agriculture</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Systems of agriculture which adhere to nationally regulated standards that restrict the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ANIMAL FEED.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Farms</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Organic Farm</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Systems of agriculture which adhere to nationally regulated standards that restrict the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ANIMAL FEED.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Gardens</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Systems of agriculture which adhere to nationally regulated standards that restrict the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ANIMAL FEED.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Farming</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Systems of agriculture which adhere to nationally regulated standards that restrict the use of pesticides, non-organic fertilizers, genetic engineering, growth hormones, irradiation, antibiotics, and non-organic ANIMAL FEED.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Gardening</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058872</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sudden outbreaks of a disease in a country or region not previously recognized in that area, or a rapid increase in the number of new cases of a previous existing endemic disease. Epidemics can also refer to outbreaks of disease in animal or plant populations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Epidemics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058873</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pandemics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058874</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Reducing the SURFACE TENSION at a liquid/solid interface by the application of an electric current across the interface thereby enhancing the WETTABILITY of the surface.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrowetting</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Reducing the SURFACE TENSION at a liquid/solid interface by the application of an electric current across the interface thereby enhancing the WETTABILITY of the surface.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electrocapillary Effect</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058885</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Direct nucleotide sequencing of gene fragments from multiple housekeeping genes for the purpose of phylogenetic analysis, organism identification, and typing of species, strain, serovar, or other distinguishable phylogenetic level.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multilocus Sequence Typing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multilocus Sequence Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058886</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An NADPH-dependent P450 enzyme that plays an essential role in the sterol biosynthetic pathway by catalyzing the demethylation of 14-methyl sterols such as lanosterol. The enzyme acts via the repeated hydroxylation of the 14-methyl group, resulting in its stepwise conversion into an alcohol, an aldehyde and then a carboxylate, which is removed as formic acid. Sterol 14-demethylase is an unusual cytochrome P450 enzyme in that it is found in a broad variety of organisms including ANIMALS; PLANTS; FUNGI; and protozoa.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sterol 14-Demethylase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cytochrome P-450 CYP51</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eburicol 14 alpha-Demethylase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sterol 14-Demethylases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lanosterol 14 alpha-Demethylase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Obtusifoliol 14alpha-Demethylase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sterol 14-alpha-Demethylase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CYP51 Cytochrome P-450</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eburicol 14alpha-Demethylase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058887</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A malignant BRAINSTEM neoplasm of the PONS. They are more commonly found in children than adults.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pontine Glioma</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058888</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that specifically inhibit STEROL 14-DEMETHYLASE. A variety of azole-derived ANTIFUNGAL AGENTS act through this mechanism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>14-alpha Demethylase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CYP51 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lanosterol 14 alpha-Demethylase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>14alpha-Demethylase Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058889</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Using MOLECULAR BIOLOGY techniques, such as DNA SEQUENCE ANALYSIS; PULSED-FIELD GEL ELECTROPHORESIS; and DNA FINGERPRINTING, to identify, classify, and compare organisms and their subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molecular Typing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058890</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare, benign, inflammatory breast disease occurring in premenopausal women shortly after a recent pregnancy. The origin is unknown but it is commonly mistaken for malignancy and sometimes associated with BREAST FEEDING and the use of ORAL CONTRACEPTIVES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Granulomatous Mastitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058891</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>5-alpha Reductase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Testosterone 5-alpha-Reductase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>3-Oxo-5-alpha-Steroid 4-Dehydrogenase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Steroid 5-alpha-Reductase Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058892</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that inhibit ADENOSINE DEAMINASE activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine Deaminase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ADA Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058893</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A chosen region of DNA, about 650 basepair long, from a precise location in a well characterized, constitutively- expressed gene that is known to vary more between species than between individuals of a species. For example, a precise portion of the mitochondrial gene for CYCLOOXYGENASE 1 has been used as a standard DNA barcode for animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA Barcoding, Taxonomic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phylogenetic DNA Barcoding</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Taxonomic DNA Barcoding</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A chosen region of DNA, about 650 basepair long, from a precise location in a well characterized, constitutively- expressed gene that is known to vary more between species than between individuals of a species. For example, a precise portion of the mitochondrial gene for CYCLOOXYGENASE 1 has been used as a standard DNA barcode for animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA Barcode, Taxonomic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Taxonomic DNA Barcode</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Taxonomic DNA Barcodes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phylogenetic DNA Barcode</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058894</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A double-walled capsule found in jellyfish and other CNIDARIA whose functions include prey capture, defense, locomotion, and attachment. Nematocysts contain toxic CNIDARIAN VENOMS which are injected into the victim via a barbed tubule.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nematocyst</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058905</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that act on PURINERGIC RECEPTORS or influence the synthesis, storage, uptake, metabolism, or release of purinergic transmitters.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic Agents</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that act on PURINERGIC RECEPTORS or influence the synthesis, storage, uptake, metabolism, or release of purinergic transmitters.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic Effect</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Effects</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058906</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P1 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P1 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P1 Purinoceptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adenosine Receptor Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058907</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and stimulate ADENOSINE A1 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A1 Receptor Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058908</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that selectively bind to and activate ADENOSINE A2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A2 Receptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that selectively bind to and activate ADENOSINE A2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A2B Receptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that selectively bind to and activate ADENOSINE A2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A2A Receptor Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058909</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that selectively bind to and activate ADENOSINE A3 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A3 Receptor Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058910</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058911</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X2 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X2 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X7 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X7 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X4 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X4 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X5 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X5 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X6 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X6 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X1 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X1 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2X RECEPTORS. Included under this heading are agonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X3 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X3 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058912</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2Y RECEPTORS. Included under this heading are agonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2Y Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2Y RECEPTORS. Included under this heading are agonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2Y12 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y12 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2Y RECEPTORS. Included under this heading are agonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2Y2 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y2 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and stimulate PURINERGIC P2Y RECEPTORS. Included under this heading are agonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2Y1 Receptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y1 Purinoceptor Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058913</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and activate PURINERGIC RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinoceptor Agonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor Agonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058914</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drugs that bind to and block the activation of PURINERGIC RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinoceptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinergic Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058915</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P1 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P1 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P1 Purinoceptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adenosine Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058916</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A1 Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058917</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A2 Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A2B Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A2A Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058918</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that selectively bind to and block the activation of ADENOSINE A3 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine A3 Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058919</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2 RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058920</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X5 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X5 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X6 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X6 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X3 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X3 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X1 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X1 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X2 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X2 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X4 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X4 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2X RECEPTORS. Included under this heading are antagonists for specific P2X receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2X7 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2X7 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058921</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2Y Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2Y2 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y2 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2Y12 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y12 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adenosine Diphosphate Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ADP Receptor Blockers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ADP Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Compounds that bind to and block the stimulation of PURINERGIC P2Y RECEPTORS. Included under this heading are antagonists for specific P2Y receptor subtypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Purinergic P2Y1 Receptor Antagonists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y1 Purinoceptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058922</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inflammatory Breast Neoplasms</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inflammatory Breast Cancer (IBC)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inflammatory Breast Carcinoma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inflammatory Breast Cancer</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058923</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>SKELETAL MUSCLE pain and tenderness along the posteromedial TIBIA resulting from exercise such as running and other physical activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medial Tibial Stress Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medial Tibial Stress Syndrome (MTSS)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Shin Splints</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058924</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Heterocyclic compounds that contain 4H,5H,6H,7H-thieno[2,3-c]pyridine as part of their structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thienopyridines</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thienopyridine Derivatives</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058925</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of purinergic P2Y receptors that have a preference for ADP binding and are coupled to GTP-BINDING PROTEIN ALPHA SUBUNIT, GI. The P2Y12 purinergic receptors are found in PLATELETS where they play an important role regulating PLATELET ACTIVATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Purinergic P2Y12</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y(ADP) Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y(T) Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y12 Purinoceptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinoceptor P2T</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Purinoceptor P2Y12</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2T Purinoceptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>P2Y12 Purinoceptor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058926</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Occurence of a patient becoming conscious during a procedure performed under GENERAL ANESTHESIA and subsequently having recall of these events. (From Anesthesiology 2006, 104(4): 847-64.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intraoperative Awareness</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Awareness During Anesthesia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anesthesia Awareness</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058927</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Scaffolding proteins that play an important role in the localization and activation of 5-LIPOXYGENASE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>5-Lipoxygenase-Activating Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Arachidonate 5-Lipoxygenase Activating Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Arachidonate 5-Lipoxygenase Activating Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-Lipoxygenase-Activating Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>5-LO-Activating Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058928</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The metabolite/small molecule sensing domain of riboswitches.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Riboswitch</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Riboswitches</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The metabolite/small molecule sensing domain of riboswitches.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ribosensors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ribosensor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058945</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Dioxygenases that catalyze the peroxidation of methylene-interrupted UNSATURATED FATTY ACIDS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lipoxygenases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058946</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and inhibit the action of 5-LIPOXYGENASE-ACTIVATING PROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>5-Lipoxygenase-Activating Protein Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>FLAP Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058947</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Processes that translocate macromolecules across the cell envelope of gram negative bacteria, often directly into the host. These effectors modulate the defense response and thereby facilitate survival of the pathogen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bacterial Secretion Systems</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058948</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Non-invasive imaging of cells that have been labeled non-destructively, such as with nanoemulsions or reporter genes that can be detected by molecular imaging, to monitor their location, viability, cell lineage expansion, response to drugs, movement, or other behaviors in vivo.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell Tracking</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058949</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A glycosyl-phosphatidyl-inositol (GPI) - anchored membrane protein found on the thick ascending limb of the LOOP OF HENLE. The cleaved form of the protein is found abundantly in URINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uromodulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tamm-Horsfall Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tamm-Horsfall Glycoprotein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Uromucoid</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058950</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cellular antigens that are specific for MELANOMA cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Melanoma-Specific Antigens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melanoma Antigens</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058951</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A melanosome-associated protein that plays a role in the maturation of the MELANOSOME.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>gp100 Melanoma Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>gp100 Melanoma-Associated Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ME20 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melanocyte Lineage-Specific Antigen gp100</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melanocyte Protein Pmel 17</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Silver Locus Protein Homolog</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melanoma-Associated Antigen gp100</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melanoma-Associated ME20 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MLSA gp100</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pmel17 Melanoma Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>gp100 Melanocyte Differentiation Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melanoma Antigen Glycoprotein 100</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058952</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of ALPHAPAPILLOMAVIRUS associated with high risk for anogenital neoplasms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Human papillomavirus 31</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058953</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Self-renewing cells that generate the main phenotypes of the nervous system in both the embryo and adult. Neural stem cells are precursors to both NEURONS and NEUROGLIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neural Stem Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058954</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Star-shaped, myofibroblast-like cells located in the periacinar, perivascular, and periductal regions of the EXOCRINE PANCREAS. They play a key role in the pathobiology of FIBROSIS; PANCREATITIS; and PANCREATIC CANCER.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pancreatic Stellate Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058955</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A class of nonmetals such as arsenic that have some of the chemical properties of a metal.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metalloids</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intermediate Metals</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Semi-Metals</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058956</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Delivery of a drug or other substance into the body through the epithelium lining of MUCOUS MEMBRANE involved with absorption and secretion.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Administration, Mucosal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transmucosal Administration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mucosal Administration</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Delivery of a drug or other substance into the body through the epithelium lining of MUCOUS MEMBRANE involved with absorption and secretion.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transmucosal Routing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Delivery of a drug or other substance into the body through the epithelium lining of MUCOUS MEMBRANE involved with absorption and secretion.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transmucosal Administration Routes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058957</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species in the genus CORONAVIRUS causing upper and lower RESPIRATORY TRACT INFECTIONS. It shares the receptor used by the SARS VIRUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coronavirus NL63, Human</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HCoV-NL63</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Human Coronavirus NL63</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058958</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Organs which might be damaged during exposure to a toxin or to some form of therapy. It most frequently refers to healthy organs located in the radiation field during radiation therapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organs at Risk</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058965</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A melanosome-specific protein that plays a role in the expression, stability, trafficking, and processing of GP100 MELANOMA ANTIGEN, which is critical to the formation of Stage II MELANOSOMES. The protein is used as an antigen marker for MELANOMA cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>MART-1 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MART1 Antigens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MelanA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melanoma Antigen Recognized by T-Cells 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MART1 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melan-A</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058966</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of immunoglobulin-related cell adhesion molecules that are involved in NERVOUS SYSTEM patterning.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Contactins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058967</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A contactin subtype that is predominantly expressed in the CEREBELLUM; HIPPOCAMPUS; NEOCORTEX; and HYPOTHALAMUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Contactin 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neural Cell Surface Protein F3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glycoprotein gp135</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058968</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A granulomatous disease caused by the aquatic organism PYTHIUM insidiosum and occurring primarily in horses, cattle, dogs, cats, fishes, and rarely in humans. It is classified into three forms: ocular, cutaneous, and arterial.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pythiosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058969</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A contactin subtype that plays a role in axon outgrowth, axon fasciculation, and neuronal migration.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Contactin 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TAG-1 Axonal Glycoprotein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transient Axonal Glycoprotein 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Axonin-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TAX-1 Axonal Glycoprotein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058971</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgical division of a tendon for relief of a deformity that is caused by congenital or acquired shortening of a muscle (Stedman, 27th ed). Tenotomy is performed in order to lengthen a muscle that has developed improperly, or become shortened and is resistant to stretching.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tenotomy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Surgical division of a tendon for relief of a deformity that is caused by congenital or acquired shortening of a muscle (Stedman, 27th ed). Tenotomy is performed in order to lengthen a muscle that has developed improperly, or become shortened and is resistant to stretching.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tendon Release</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Surgical division of a tendon for relief of a deformity that is caused by congenital or acquired shortening of a muscle (Stedman, 27th ed). Tenotomy is performed in order to lengthen a muscle that has developed improperly, or become shortened and is resistant to stretching.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tendon Lengthening</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Surgical division of a tendon for relief of a deformity that is caused by congenital or acquired shortening of a muscle (Stedman, 27th ed). Tenotomy is performed in order to lengthen a muscle that has developed improperly, or become shortened and is resistant to stretching.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Heel-Cord Release</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058972</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins involved in the transport of FOLIC ACID and folate derivatives across the CELLULAR MEMBRANE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Folic Acid Transporters</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folic Acid Transport Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folate Transport Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folate Transporters</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058973</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cell surface receptors that bind to and transport FOLIC ACID, 5-methyltetrahydrofolate, and a variety of folic acid derivatives. The receptors are essential for normal NEURAL TUBE development and transport folic acid via receptor-mediated endocytosis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Folate Receptors, GPI-Anchored</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>GPI-Anchored Folate Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptors, Folate, GPI-Anchored</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058974</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A field of study concerned with the principles and processes governing the geographic distributions of genealogical lineages, especially those within and among closely related species. (Avise, J.C., Phylogeography: The History and Formation of Species. Harvard University Press, 2000)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phylogeography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phylogenetic Biogeography</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058975</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of GPI-anchored folate receptors that is expressed in tissues of epithelial origin. This protein is also identified as an ovarian-tumor-specific antigen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Folate Receptor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ovarian Tumor-Associated Antigen MOv18</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folate Receptor alpha</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058976</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of GPI-anchored folate receptors that is expressed in PLACENTA and hematopoietic cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Folate Receptor 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folate Receptor, Fetal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folic Acid Receptor beta</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Placental Folate-Binding Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folate Receptor beta</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folate Receptor, Placental</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058977</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The addition of descriptive information about the function or structure of an RNA or DNA SEQUENCE to its record in a database (NUCLEIC ACID DATABASES.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molecular Sequence Annotation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The addition of descriptive information about the function or structure of an RNA or DNA SEQUENCE to its record in a database (NUCLEIC ACID DATABASES.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Annotation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The addition of descriptive information about the function or structure of an RNA or DNA SEQUENCE to its record in a database (NUCLEIC ACID DATABASES.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gene Annotation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058978</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A ubiquitously expressed folic acid transporter that functions via an antiporter mechanism which is coupled to the transport of organic phosphates.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reduced Folate Carrier Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reduced Folate Carrier</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Solute Carrier Family 19, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folate Transporter 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058979</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A symporter protein that couples the transport of FOLIC ACID with HYDROGEN IONS. The transporter functions most effectively under acidic conditions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proton-Coupled Folate Transporter</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Solute Carrier Family 46, Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Folate Transporter, Proton-Coupled</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058980</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ability to recognize when information is needed and to locate, evaluate, and use the needed information effectively.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Information Literacy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058985</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of cells identified on FLOW CYTOMETRY profiles as distinct from the main group of cells by their ability to extrude the fluorescent dye Hoechst 33342, often a characteristic property of less differentiated progenitor and STEM CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Side-Population Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058986</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that specifically inhibit PHOSPHODIESTERASE 5.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phosphodiesterase 5 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PDE5 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PDE-5 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphodiesterase Type 5 Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058987</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that specifically inhibit PHOSPHODIESTERASE 3.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phosphodiesterase 3 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PDE3 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphodiesterase Type 3 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PDE-3 Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058988</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that specifically inhibit PHOSPHODIESTERASE 4.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phosphodiesterase 4 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphodiesterase Type 4 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PDE-4 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PDE4 Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058989</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The transformation of a liquid to a glassy solid i.e., without the formation of crystals during the cooling process.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vitrification</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058990</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Treatments with drugs which interact with or block synthesis of specific cellular components characteristic of the individual's disease in order to stop or interrupt the specific biochemical dysfunction involved in progression of the disease.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Molecular Targeted Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Targeted Molecular Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058991</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An Act prohibiting a health plan from establishing lifetime limits or annual limits on the dollar value of benefits for any participant or beneficiary after January 1, 2014. It permits a restricted annual limit for plan years beginning prior to January 1, 2014. It provides that a health plan shall not be prevented from placing annual or lifetime per-beneficiary limits on covered benefits. The Act sets up a new competitive health insurance market giving tens of millions of Americans the same choices of insurance that members of Congress will have. It aims to bring greater accountability to health care and to control cost of health insurance premiums.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Patient Protection and Affordable Care Act</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Public Law 111-148</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PL111-148</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Health Care Reform Act</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PL 111-148</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058992</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Involvement in community activities or programs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Social Participation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058993</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pharmacologic agents in the form of a mist or spray delivered into the body through the mouth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oral Sprays</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058994</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Excision of one or both of the FALLOPIAN TUBES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Salpingectomy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tubectomy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058995</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A device that delivers medication to the lungs in the form of a dry powder.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dry Powder Inhalers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058996</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The attainment or process of attaining a new level of performance or quality.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Quality Improvement</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058998</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Observation and aquisition of physical data from a distance by viewing and making measurements from a distance or receiving transmitted data from observations made at distant location.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Remote Sensing Technology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D058999</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Activities performed to obtain licit or illicit substances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drug-Seeking Behavior</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059000</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A climate pattern characterized by unusually cool Pacific Ocean water temperatures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>El Nino-Southern Oscillation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A climate pattern characterized by unusually cool Pacific Ocean water temperatures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>El Nino</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A climate pattern characterized by unusually cool Pacific Ocean water temperatures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>La Nina</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059001</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Organisms that live in the sea.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aquatic Organisms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Organisms that live in the sea.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Marine Organisms</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059002</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that bind to and inhibit the activation of ANDROGEN RECEPTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Androgen Receptor Antagonists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059003</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that inhibit the activity of DNA TOPOISOMERASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Topoisomerase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Topoisomerase Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059004</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that inhibit the activity of DNA TOPOISOMERASE I.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Topoisomerase I Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Topoisomerase 1 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Topoisomerase I Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Type 1 Topoisomerase Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059005</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Compounds that inhibit the activity of DNA TOPOISOMERASE II.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Topoisomerase II Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Type 2 Topoisomerase Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Topoisomerase 2 Inhibitors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Topoisomerase II Inhibitors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059006</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Structures within the CELL NUCLEUS of insect cells containing DNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromosomes, Insect</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059007</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An extra large chromosome consisting of many identical copies of a chromosome lying next to each other in parallel.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polytene Chromosome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Polytene Chromosomes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059008</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Recording serial images of a process at regular intervals spaced out over a longer period of time than the time in which the recordings will be played back.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Time-Lapse Imaging</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Time-Lapsed Imaging</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059009</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The area of those states which seceded in 1861 from the union of the United States of America. They include South Carolina, Mississippi, Florida, Alabama, Georgia, Louisiana, Texas, Virginia, Arkansas, North Carolina, and Tennessee.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Confederate States of America</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059010</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Assaying the products of or monitoring various biochemical processes and reactions in an individual cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Single-Cell Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059012</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Study subjects in COHORT STUDIES whose outcomes are unknown e.g., because they could not or did not wish to attend follow-up visits.(from Dictionary of Epidemiology, 5th ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lost to Follow-Up</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059013</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of different species of microorganisms that act together as a community.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microbial Consortia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microbial Consortium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059014</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques of nucleotide sequence analysis that increase the scale of operations enabling an increase in the depth of coverage (number of copies) to which each polynucleotide is sequenced.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>High-Throughput Nucleotide Sequencing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques of nucleotide sequence analysis that increase the scale of operations enabling an increase in the depth of coverage (number of copies) to which each polynucleotide is sequenced.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Massively-Parallel Sequencing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques of nucleotide sequence analysis that increase the scale of operations enabling an increase in the depth of coverage (number of copies) to which each polynucleotide is sequenced.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>High-Throughput RNA Sequencing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques of nucleotide sequence analysis that increase the scale of operations enabling an increase in the depth of coverage (number of copies) to which each polynucleotide is sequenced.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Deep Sequencing</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques of nucleotide sequence analysis that increase the scale of operations enabling an increase in the depth of coverage (number of copies) to which each polynucleotide is sequenced.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>High-Throughput DNA Sequencing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059015</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques using energy such as radio frequency, infrared light, laser light, visible light, or acoustic energy to transfer information without the use of wires, over both short and long distances.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wireless Technology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059016</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tumor Microenvironment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059017</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques or methods of patient care used by nurses as primary careproviders.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Primary Care Nursing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059018</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The presence of DNA from a source foreign to the sample being analysed.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA Contamination</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059019</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Process of substituting a symbol or code for a term such as a diagnosis or procedure.  (from Slee's Health Care Terms, 3d ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clinical Coding</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medical Coding</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Process of substituting a symbol or code for a term such as a diagnosis or procedure.  (from Slee's Health Care Terms, 3d ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coding</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059020</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A risk factor for suicide attempts and completions, it is the most common of all suicidal behavior, but only a minority of ideators engage in overt self-harm.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Suicidal Ideation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059021</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Assessments aimed at determining agreement in diagnostic test results among laboratories. Identical survey samples are distributed to participating laboratories, with results stratified according to testing methodologies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laboratory Proficiency Testing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059022</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Activities involved in ensuring the safety of FOOD including avoidance of bacterial and other contamination.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Food Safety</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059026</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Process by individual in valuation of specific traits, qualities, or abilities related to the individual.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diagnostic Self Evaluation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Process by individual in valuation of specific traits, qualities, or abilities related to the individual.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Self-Appraisal</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Process by individual in valuation of specific traits, qualities, or abilities related to the individual.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Self-Evaluation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059027</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The extraction and recovery of usable or valuable material from scrap or other discarded materials. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recycling</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059028</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Terminal facilities used for aircraft takeoff and landing and including facilities for handling passengers. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Airports</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Airport</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059029</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Discarded electronic devices containing valuable and sometimes hazardous materials such as LEAD, NICKEL, CADMIUM, and MERCURY. (from http://www.epa.gov/osw/conserve/materials/ecycling/faq.htm#impact accessed 4/25/2010)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electronic Waste</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059030</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A cabinet department in the Executive Branch of the United States Government whose mission is to provide the military forces needed to deter war and to protect the security of our country.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>United States Department of Defense</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>United States Dept. of Defense</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Department of Defense (U.S.)</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059031</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ability to foresee what is likely to happen on the basis of past experience. It is largely a frontal lobe function.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anticipation, Psychological</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059032</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The course of learning of an individual or a group. It is a measure of performance plotted over time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Learning Curve</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059033</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Health insurance plans that are intended to be for profit.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>For-Profit Insurance Plans</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059034</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Health insurance plans that are not intended to generate profit.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Not-For-Profit Insurance Plans</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059035</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The time periods immediately before, during and following a surgical operation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Perioperative Period</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059036</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Still images produced from radiation-sensitive materials (sensitive to light, electron beams, or nuclear radiation), generally by means of the chemical action of light on a sensitive film, paper, glass, or metal. Photographs may be positive or negative, opaque or transparent.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photographs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059037</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Trained lay women who provide emotional support during obstetric labor and the postpartum period for mothers and their partners.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Doulas</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Trained lay women who provide emotional support during obstetric labor and the postpartum period for mothers and their partners.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Labor Coachs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059038</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An inland sea between Europe and Asia. It is connected with the Aegean Sea by the Bosporus, the Sea of Marmara, and the Dardanelles.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Black Sea</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059039</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The minimum acceptable patient care, based on statutes, court decisions, policies, or professional guidelines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Standard of Care</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Standards of Care</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059040</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Used with articles which include video files or clips, or for articles which are entirely video.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Video-Audio Media</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Audiovisual Media</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Audio-Visual Media</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059041</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The condition characterized by uneven or irregular shape of the head often in parallelogram shape with a flat spot on the back or one side of the head. It can either result from the premature CRANIAL SUTURE closure (CRANIOSYNOSTOSIS) or from external forces (NONSYNOSTOTIC PLAGIOCEPHALY).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plagiocephaly</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059045</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Regions along polytene chromosomes that are uncondensed and active in DNA REPLICATION or RNA transcription (GENETIC TRANSCRIPTION).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chromosomal Puffs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chromosomal Puff</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chromosome Puffs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chromosome Puff</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Regions along polytene chromosomes that are uncondensed and active in DNA REPLICATION or RNA transcription (GENETIC TRANSCRIPTION).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Balbiani Rings</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Balbiani Ring</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059065</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The formal process of obtaining a complete and accurate list of each patient's current home medications including name, dosage, frequency, and route of administration, and comparing admission, transfer, and/or discharge medication orders to that list. The reconciliation is done to avoid medication errors.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medication Reconciliation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059066</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Value of all final goods and services produced in a country in one year.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gross Domestic Product</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Value of all final goods and services produced in a country in one year.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gross National Product</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059085</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pharmacologic agents delivered into the nostrils in the form of a mist or spray.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nasal Sprays</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nasal Mist</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nasal Aerosol</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059125</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Common name for an extinct species of the Homo genus. Fossils have been found in Europe and Asia. Genetic evidence suggests that limited interbreeding with modern HUMANS (Homo sapiens) took place.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neanderthals</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Homo sapiens neanderthalensis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neandertals</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Homo neanderthalensis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059126</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-negative opportunistic foodborne pathogens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cronobacter</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059127</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Family of gram-negative bacteria that occur in leaf nodules and the rhizosphere of higher plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phyllobacteriaceae</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059128</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-negative, rod-shaped bacteria in the family PHYLLOBACTERIACEAE. They are able to invade root-hairs of a wide range of plants, inciting the production of PLANT ROOT NODULES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mesorhizobium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059145</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The replacement of intervertebral discs in the spinal column with aritificial devices. The procedure is done in the lumbar or cervical spine to relieve severe pain resulting from INTERVERTEBRAL DISC DEGENERATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Total Disc Replacement</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Arthroplasty, Replacement, Disk</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Total Disk Replacement</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Artificial Disk Replacement</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Total Disc Arthroplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Total Disk Arthroplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Arthroplasty, Replacement, Disc</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Artificial Disc Replacement</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059146</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgery to remove one or more NEOPLASM METASTASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metastasectomy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059147</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The practice of making choices about SEXUAL PARTNERS based on their HIV status.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HIV Serosorting</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059165</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Biphasic dose responses of cells or organisms (including microorganisms) to an exogenous or intrinsic factor, in which the factor induces stimulatory or beneficial effects at low doses and inhibitory or adverse effects at high doses.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hormesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Biphasic dose responses of cells or organisms (including microorganisms) to an exogenous or intrinsic factor, in which the factor induces stimulatory or beneficial effects at low doses and inhibitory or adverse effects at high doses.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hormetic Dose-Response</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059166</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The branch of anatomy that concerns the structure and function of bones.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Osteology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059167</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Neurons that fire when an animal acts or observes the same action of another thus coding the motor response. They were originally discovered in the premotor and parietal cortex of the monkey and studies have shown that neurons that have a similar mechanism are present in humans. Mirror neurons are theorized to be related to social cognition.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mirror Neurons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059168</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A measurement of the thickness of the carotid artery walls. It is measured by B-mode ULTRASONOGRAPHY and is used as a surrogate marker for ATHEROSCLEROSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carotid Intima-Media Thickness</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059186</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Combined chemotherapy and radiotherapy given to augment some other form of treatment such as surgery. It is commonly used in the therapy of cancer.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemoradiotherapy, Adjuvant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adjuvant Radiochemotherapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Radiochemotherapy, Adjuvant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adjuvant Chemoradiotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059205</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Forms of energy that are constantly and rapidly renewed by natural processes such as solar, ocean wave, and wind energy. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Renewable Energy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Forms of energy that are constantly and rapidly renewed by natural processes such as solar, ocean wave, and wind energy. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sustainable Energy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059206</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A combustible, gaseous mixture of low-molecular weight PARAFFIN hydrocarbons, generated below the surface of the earth. It contains mostly METHANE and ETHANE with small amounts of PROPANE; BUTANES; and higher hydrocarbons, and sometimes NITROGEN; CARBON DIOXIDE; HYDROGEN SULFIDE; and HELIUM. (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gas, Natural</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059207</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Thermal energy contained in the earth. It can be used directly to supply heat or converted to mechanical or electrical energy.  (from McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Geothermal Energy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059208</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Measure of the number of the PARASITES present in a host organism.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Parasite Load</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Parasitic Load</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059225</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sensing of noxious mechanical, thermal or chemical stimuli by NOCICEPTORS. It is the sensory component of visceral and tissue pain (NOCICEPTIVE PAIN).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nociception</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nociperception</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059226</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Dull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nociceptive Pain</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Dull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tissue Pain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Somatic Pain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059227</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Physiological integration of multiple SYNAPTIC POTENTIAL signals to reach the threshold and initiate postsynaptic ACTION POTENTIALS. In spatial summation stimulations from additional synaptic junctions are recruited to generate s response. In temporal summation succeeding stimuli signals are summed up to reach the threshold. The postsynaptic potentials can be either excitatory or inhibitory (EPSP or IPSP).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Postsynaptic Potential Summation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Post-Synaptic Potential Summation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neurophysiology Summation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Physiological integration of multiple SYNAPTIC POTENTIAL signals to reach the threshold and initiate postsynaptic ACTION POTENTIALS. In spatial summation stimulations from additional synaptic junctions are recruited to generate s response. In temporal summation succeeding stimuli signals are summed up to reach the threshold. The postsynaptic potentials can be either excitatory or inhibitory (EPSP or IPSP).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Temporal Summation, Neurophysiology</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Physiological integration of multiple SYNAPTIC POTENTIAL signals to reach the threshold and initiate postsynaptic ACTION POTENTIALS. In spatial summation stimulations from additional synaptic junctions are recruited to generate s response. In temporal summation succeeding stimuli signals are summed up to reach the threshold. The postsynaptic potentials can be either excitatory or inhibitory (EPSP or IPSP).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spatial Summation, Neurophysiology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059228</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Left RENAL VEIN compression between the AORTA, ABDOMINAL and the SUPERIOR MESENTERIC ARTERY. Variable symptoms include HYPERTENSION, RENOVASCULAR; HEMATURIA; and VARICOSE VEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Renal Nutcracker Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Renal Vein Entrapment Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Left RENAL VEIN compression between the AORTA, ABDOMINAL and the SUPERIOR MESENTERIC ARTERY. Variable symptoms include HYPERTENSION, RENOVASCULAR; HEMATURIA; and VARICOSE VEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Renal Nutcracker Phenomenon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059229</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Sagittal sectioning and repositioning of the ramus of the MANDIBLE to correct a mandibular retrusion (Malocclusion, Angle Class III) and PROGNATHISM. The oblique sectioning line consists of multiple cuts horizontal and vertical to the mandibular ramus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Osteotomy, Sagittal Split Ramus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sagittal Split Ramus Osteotomy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sagittal Split Ramal Osteotomy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059230</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Trigeminocardiac reflex variant seen during TOOTH EXTRACTION procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reflex, Trigeminocardiac</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reflex, Trigemino-Cardiac</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Trigeminocardiac reflex variant seen during TOOTH EXTRACTION procedures.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reflex, Dento-Cardiac</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reflex, Dentocardiac</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059232</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Professionals, technicians, and assistants staffing LABORATORIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laboratory Personnel</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Professionals, technicians, and assistants staffing LABORATORIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laboratory Scientists</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Professionals, technicians, and assistants staffing LABORATORIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laboratory Technicians</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Professionals, technicians, and assistants staffing LABORATORIES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laboratory Assistants</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059245</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Abnormal increase in RESPIRATORY RATE in the newborn. It is self-limiting and attributed to the delayed fetal lung fluid clearance often in CAESAREAN SECTION delivery.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transient Tachypnea of the Newborn</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transient Tachypnea of Newborn</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059246</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Increased RESPIRATORY RATE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tachypnea</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059247</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A method of providing future reproductive opportunities before a medical treatment with known risk of loss of fertility. Typically reproductive organs or tissues (e.g., sperm, egg, embryos and ovarian or testicular tissues) are cryopreserved for future use before the medical treatment (e.g., chemotherapy, radiation) begins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fertility Preservation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059248</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Treatment that combines chemotherapy with radiotherapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemoradiotherapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Radiochemotherapy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Treatment that combines chemotherapy with radiotherapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Concurrent Chemoradiotherapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Synchronous Chemoradiotherapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Concurrent Radiochemotherapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Concomitant Chemoradiotherapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Concomitant Radiochemotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059249</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Fungus infection of the external ear, usually by ASPERGILLUS species</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Otomycosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059250</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Administration of low doses of a drug or a drug combination over prolonged periods of time usually at a regular interval.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Administration, Metronomic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metronomic Drug Therapy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metronomic Drug Administration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059265</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pain originating from internal organs (VISCERA) associated with autonomic phenomena (PALLOR; SWEATING; NAUSEA; and VOMITING). It often becomes a REFERRED PAIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Visceral Pain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059266</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bisphosphonate-Associated Osteonecrosis of the Jaw</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bisphosphonate-Induced Osteonecrosis of the Jaw</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bisphosphonate-Induced Osteonecrosis of the Jaws</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bisphosphonate-Related Osteonecrosis of the Jaw</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteonecrosis of the Jaws, Bisphosphonate-Associated</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteonecrosis of the Jaw, Bisphosphonate-Related</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteonecrosis of the Jaws, Bisphosphonate-Induced</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteonecrosis of the Jaws, Bisphosphonate-Related</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteonecrosis of the Jaw, Bisphosphonate-Associated</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bisphosphonate-Associated Osteonecrosis of the Jaws</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Osteonecrosis of the Jaw, Bisphosphonate-Induced</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Necrotic jaws or other maxillofacial skeleton necrosis associated with bisphosphonate use (see BISPHOSPHONATES). Injury, dental procedures, and trauma can trigger the necrotic process.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bisphosphonate-Associated Osteonecrosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bisphosphonate Osteonecrosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059267</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Heart enlargement and other remodeling in cardiac morphology and electrical circutry found in individuals who participate in intense repeated exercises.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardiomegaly, Exercise-Induced</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Athlete's Heart Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Heart enlargement and other remodeling in cardiac morphology and electrical circutry found in individuals who participate in intense repeated exercises.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Heart Enlargement, Physiological</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059268</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inflammation of the vagina due to thinning of the vaginal wall and decreased lubrication associated with reduced estrogen levels at MENOPAUSE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Atrophic Vaginitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059269</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Interposition of a portion of the colon (e.g., SIGMOID COLON) between the liver and teh diaphragm. It is associated with abdominal pain, vomiting, constipation, anorexia and volvulus. Chilaiditi anomoly refers to asymptomatic interposition.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chilaiditi Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chilaiditi's Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Interposition of a portion of the colon (e.g., SIGMOID COLON) between the liver and teh diaphragm. It is associated with abdominal pain, vomiting, constipation, anorexia and volvulus. Chilaiditi anomoly refers to asymptomatic interposition.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chilaiditi Anomaly</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chilaiditi's Anomaly</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059270</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inflammation of PETROUS BONE secondary to chronic OTITIS MEDIA. Its symptoms include fever, occipital headache, ear and retroorbital pain, and facial paralysis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Petrositis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Inflammation of PETROUS BONE secondary to chronic OTITIS MEDIA. Its symptoms include fever, occipital headache, ear and retroorbital pain, and facial paralysis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gradenigo Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gradenigo-Lannois Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Petrous Apicitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gradenigo's Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059285</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The condition of carrying TWINS simultaneously.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pregnancy, Twin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059286</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The condition of carrying TRIPLETS simultaneously.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pregnancy, Triplet</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059287</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The condition of carrying QUADRUPLETS simultaneously.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pregnancy, Quadruplet</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059288</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The condition of carrying QUINTUPLETS simultaneously.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pregnancy, Quintuplet</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059289</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Loss of vascular ELASTICITY due to factors such as AGING; and ARTERIOSCLEROSIS. Increased arterial stiffness is one of the RISK FACTORS for many CARDIOVASCULAR DISEASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vascular Stiffness</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Loss of vascular ELASTICITY due to factors such as AGING; and ARTERIOSCLEROSIS. Increased arterial stiffness is one of the RISK FACTORS for many CARDIOVASCULAR DISEASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Arterial Stiffness</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Loss of vascular ELASTICITY due to factors such as AGING; and ARTERIOSCLEROSIS. Increased arterial stiffness is one of the RISK FACTORS for many CARDIOVASCULAR DISEASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aortic Stiffness</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059290</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Neurons whose primary neurotransmitter is DOPAMINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dopaminergic Neurons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059305</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Consumption of excessive DIETARY FATS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diet, High-Fat</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Diet, High Fat</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059325</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pathological elevation of intra-abdominal pressure (&gt;12 mm Hg). It may develop as a result of SEPSIS; PANCREATITIS; capillary leaks, burns, or surgery. When the pressure is higher than 20 mm Hg, often with end-organ dysfunction, it is referred to as abdominal compartment syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intra-Abdominal Hypertension</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intraabdominal Hypertension</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Pathological elevation of intra-abdominal pressure (&gt;12 mm Hg). It may develop as a result of SEPSIS; PANCREATITIS; capillary leaks, burns, or surgery. When the pressure is higher than 20 mm Hg, often with end-organ dysfunction, it is referred to as abdominal compartment syndrome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Abdominal Compartment Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059326</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Neurons whose primary neurotransmitter is SEROTONIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Serotonergic Neurons</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Serotoninergic Neurons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059327</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital anomaly of abnormally short fingers or toes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brachydactyly</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brachydactylism</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Brachydactylia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059328</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A physiological process by which the perception of pain at a local area of the body is inhibited by a second painful stimulus administered at a distal body site</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Diffuse Noxious Inhibitory Control</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059329</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Neurons whose primary neurotransmitter is ACETYLCHOLINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cholinergic Neurons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059330</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Neurons whose primary neurotransmitter is GAMMA-AMINOBUTYRIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>GABAergic Neurons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059331</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Neurons whose primary neurotransmitter is NOREPINEPHRINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Adrenergic Neurons</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Neurons whose primary neurotransmitter is NOREPINEPHRINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Noradrenergic Neurons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059333</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An increased response to stimulation that is mediated by amplification of signaling in the CENTRAL NERVOUS SYSTEM (CNS).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Central Nervous System Sensitization</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Central Sensitization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059345</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cerebral Small Vessel Diseases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cerebral Small Vessel Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cerebral Microangiopathies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059346</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Objects that produce a magnetic field.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Magnets</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Objects that produce a magnetic field.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ferromagnets</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ferromagnet</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Objects that produce a magnetic field.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electromagnets</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Objects that produce a magnetic field.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ferrimagnets</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ferrimagnet</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059347</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Condition where a primary dysfunction of either heart or kidney results in failure of the other organ (e.g., HEART FAILURE with worsening RENAL INSUFFICIENCY).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cardio-Renal Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Renocardiac Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cardiorenal Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Reno-Cardiac Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059348</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Injuries to the PERIPHERAL NERVES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peripheral Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peripheral Nerve Injury</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059349</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods or procedures used to obtain samples of URINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Urine Specimen Collection</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Urine Collection</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059350</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of chronic pain that tends to be non-localized and wide-reaching.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chronic Pain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pain, Chronic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A form of chronic pain that tends to be non-localized and wide-reaching.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Widespread Chronic Pain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059351</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques, procedures, and therapies carried out on diseased organs in such a way to avoid complete removal of the organ and preserve the remaining organ function.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organ Sparing Treatments</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059352</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Discomfort stemming from muscles, ligaments, tendons, and bones.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Musculoskeletal Pain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059365</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An mRNA metabolic process that distinguishes a normal STOP CODON from a premature stop codon (NONSENSE CODON) and facilitates rapid degradation of aberrant mRNAs containing premature stop codons.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nonsense Mediated mRNA Decay</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nonsense-Mediated mRNA Decay</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059366</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Asthma attacks caused, triggered, or exacerbated by OCCUPATIONAL EXPOSURE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Asthma, Occupational</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059367</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A reaction that severs one of the sugar-phosphate linkages of the phosphodiester backbone of RNA. It is catalyzed enzymatically, chemically, or by radiation. Cleavage may be exonucleolytic, or endonucleolytic.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RNA Cleavage</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059368</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The different gene transcripts generated from a single gene by RNA EDITING or ALTERNATIVE SPLICING of RNA PRECURSORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RNA Isoforms</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The different gene transcripts generated from a single gene by RNA EDITING or ALTERNATIVE SPLICING of RNA PRECURSORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Messenger RNA Isoforms</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>mRNA Isoforms</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059369</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infection of the FRONTAL BONE often as a complication of FRONTAL SINUSITIS or trauma to the frontal bone and skull. It is characterized by subperiosteal abscess with OSTEOMYELITIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pott Puffy Tumor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pott's Puffy Tumor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059370</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The processes of RNA tertiary structure formation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RNA Folding</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The processes of RNA tertiary structure formation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RNA Refolding</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The processes of RNA tertiary structure formation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RNA Unfolding</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059371</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The most common form of DNA found in nature. It is a right-handed helix with 10 base pairs per turn, a pitch of 0.338 nm per base pair and a helical diameter of 1.9 nm.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA, B-Form</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B-DNA</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059372</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Commonly observed BASE SEQUENCE or nucleotide structural components which can be represented by a CONSENSUS SEQUENCE or a SEQUENCE LOGO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nucleotide Motifs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nucleotide Motif</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Commonly observed BASE SEQUENCE or nucleotide structural components which can be represented by a CONSENSUS SEQUENCE or a SEQUENCE LOGO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>RNA Motifs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>RNA Motif</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Commonly observed BASE SEQUENCE or nucleotide structural components which can be represented by a CONSENSUS SEQUENCE or a SEQUENCE LOGO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA Motifs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DNA Motif</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059373</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pain in the breast generally classified as cyclical (associated with menstrual periods), or noncyclical, i.e. originating from the breast or nearby muscles or joints, ranging from minor discomfort to severely incapacitating.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mastodynia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mastalgia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammalgia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Breast Pain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059385</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Exercises in which muscles are repeatedly and rapidly stretched, followed by shortening, concentric MUSCLE CONTRACTION (e.g. jumping and rebounding). They are designed to exert maximal force in minimal time by increasing STRETCH REFLEX.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plyometric Exercise</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plyometric Drill</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Plyometric Training</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Exercises in which muscles are repeatedly and rapidly stretched, followed by shortening, concentric MUSCLE CONTRACTION (e.g. jumping and rebounding). They are designed to exert maximal force in minimal time by increasing STRETCH REFLEX.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stretch-Shortening Exercise</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stretch-Shortening Drill</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stretch-Shortening Cycle Exercise</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059386</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of techniques that produce a functional MUTATION or an effect on GENE EXPRESSION of a specific gene of interest in order to identify the role or activity of the gene product of that gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reverse Genetics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059387</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Method of treating pain associated with the sphenopalatine ganglion located in the PTERYGOPALATINE FOSSA, posterior to the middle nasal turbinate. The transnasal approach involves application of suitable local anesthetic to the mucous membrane overlying the ganglion.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sphenopalatine Ganglion Block</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pterygopalatine Ganglion Block</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059388</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Discomfort associated with the bones that make up the pelvic girdle. It occurs frequently during pregnancy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pelvic Girdle Pain</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Discomfort associated with the bones that make up the pelvic girdle. It occurs frequently during pregnancy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Symphysis Pubis Dysfunction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059390</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Acute pain that comes on rapidly despite the use of pain medication.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Breakthrough Pain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pain, Breakthrough</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059392</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Release of oil into the environment usually due to human activity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Petroleum Pollution</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oil Spills</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oil Pollution</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059405</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A measure of relative protection provided by SUNSCREENING AGENTS against burns due to ultraviolet (UV) radiation from a light source.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sun Protection Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059407</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A yellowish thickened lesion on the conjunctiva near the CORNEA representing a benign degenerative change in the CONJUNCTIVA caused by the leakage and deposition of certain blood proteins through the permeable capillaries near the LIMBUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pinguecula</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059408</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A form of therapy that employs a coordinated and interdisciplinary approach for easing the suffering and improving the quality of life of those experiencing pain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pain Management</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059409</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Brain infarction that affects small subcortical vessels due to occlusion of a penetrating artery deep in the brain. It may lead to lacunar stroke.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stroke, Lacunar</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lacunar Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Brain infarction that affects small subcortical vessels due to occlusion of a penetrating artery deep in the brain. It may lead to lacunar stroke.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infarction, Lacunar</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Infarct, Lacunar</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059411</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Symptoms of disorders of the lower urinary tract including frequency, NOCTURIA; urgency, incomplete voiding, and URINARY INCONTINENCE. They are often associated with OVERACTIVE BLADDER; URINARY INCOMPETENCE; and INTERSTITIAL CYSTITIS. Lower urinary tract symptoms in males were traditionally called PROSTATISM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lower Urinary Tract Symptoms</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059413</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infection within the PERITONEAL CAVITY. A frequent cause is an ANASTOMOTIC LEAK following surgery.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intraabdominal Infections</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intra-Abdominal Infections</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059425</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The assay of INTERFERON-GAMMA released from lymphocytes after their exposure to a specific test antigen, to check for IMMUNOLOGIC MEMORY resulting from a previous exposure to the antigen. The amount of interferon-gamma released is usually assayed by an ENZYME-LINKED IMMUNOSORBENT ASSAY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Interferon-gamma Release Tests</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Interferon-gamma Release Assays</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059445</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anhedonia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Inability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Social Anhedonia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Inability to experience pleasure due to impairment or dysfunction of normal psychological and neurobiological mechanisms. It is a symptom of many PSYCHOTIC DISORDERS (e.g., DEPRESSIVE DISORDER, MAJOR; and SCHIZOPHRENIA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physical Anhedonia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059446</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital deformity in which the internal organs of the THORAX and the ABDOMEN are abnormally arranged across the mediolateral body axis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Heterotaxy Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Congenital deformity in which the internal organs of the THORAX and the ABDOMEN are abnormally arranged across the mediolateral body axis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Visceral Heterotaxy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Situs Ambiguus Viscerum</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Situs Ambiguus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Congenital deformity in which the internal organs of the THORAX and the ABDOMEN are abnormally arranged across the mediolateral body axis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polysplenia Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Situs Ambiguus with Polysplenia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Left Atrial Isomerism with Polysplenia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Congenital deformity in which the internal organs of the THORAX and the ABDOMEN are abnormally arranged across the mediolateral body axis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Right Atrial Isomerism</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Congenital deformity in which the internal organs of the THORAX and the ABDOMEN are abnormally arranged across the mediolateral body axis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Asplenia Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Situs Ambiguus with Asplenia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Right Atrial Isomerism with Asplenia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Asplenia with Cardiovascular Anomalies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ivemark Syndrome</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Congenital deformity in which the internal organs of the THORAX and the ABDOMEN are abnormally arranged across the mediolateral body axis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Left Atrial Isomerism</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059447</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The halting of progression of a cell through the CELL CYCLE when events in the CELL DIVISION process are not completed accurately or damage to cell components in the process are detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell Cycle Checkpoints</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The halting of progression of a cell through the CELL CYCLE when events in the CELL DIVISION process are not completed accurately or damage to cell components in the process are detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell Cycle Control</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The halting of progression of a cell through the CELL CYCLE when events in the CELL DIVISION process are not completed accurately or damage to cell components in the process are detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell Cycle Transition Points</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cell Cycle-Transition Points</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The halting of progression of a cell through the CELL CYCLE when events in the CELL DIVISION process are not completed accurately or damage to cell components in the process are detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell Cycle Arrest</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059451</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>BIOLOGIC PRODUCTS that are imitations but not exact replicas of innovator products.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biosimilar Pharmaceuticals</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059466</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Phenomenon where BLOOD PRESSURE readings are elevated only when taken in clinical settings.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>White Coat Hypertension</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Isolated Clinic Hypertension</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>White Coat Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059467</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The pattern of GENE EXPRESSION, at the level of genetic transcription, in a specific organism or under specific circumstances in specific cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transcriptome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Transcriptomes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059468</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Phenomenon where increased BLOOD PRESSURE readings taken in non-clinical settings (e.g., HOME BLOOD PRESSURE MONITORING) do not replicate in clinical settings.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Masked Hypertension</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059470</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large superfamily of cell surface membrane proteins characterized by their four transmembrane domains. They play a role in a variety of processes such as cellular adhesion and motility. They may be involved in the organization of cell surface MEMBRANE MICRODOMAINS that regulate the activation of LEUKOCYTES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tetraspanins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059471</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods used to induce premature oocytes, that are maintained in tissue culture, to progress through developmental stages including to a stage that is competent to undergo FERTILIZATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>In Vitro Oocyte Maturation Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oocyte In Vitro Maturation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>In Vitro Oocyte Maturation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>In Vitro Maturation of Oocytes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059472</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>That part of the genome that corresponds to the complete complement of EXONS of an organism or cell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Exome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Exomes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059485</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgical fixation of the stomach to the abdominal wall.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gastropexy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Gastropexis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059505</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Maintenance of TELOMERE length. During DNA REPLICATION, chromosome ends loose some of their telomere sequence (TELOMERE SHORTENING.) Various cellular mechanism are involved in repairing, extending, and recapping the telomere ends.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Telomere Homeostasis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Maintenance of TELOMERE length. During DNA REPLICATION, chromosome ends loose some of their telomere sequence (TELOMERE SHORTENING.) Various cellular mechanism are involved in repairing, extending, and recapping the telomere ends.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Telomere Length Maintenance</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Maintenance of TELOMERE length. During DNA REPLICATION, chromosome ends loose some of their telomere sequence (TELOMERE SHORTENING.) Various cellular mechanism are involved in repairing, extending, and recapping the telomere ends.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Telomere Lengthening</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059506</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The loss of some TELOMERE sequence during DNA REPLICATION of the first several base pairs of a linear DNA molecule; or from DNA DAMAGE. Cells have various mechanisms to restore length (TELOMERE HOMEOSTASIS.) Telomere shortening is involved in the progression of CELL AGING.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Telomere Shortening</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059525</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inflammation of the EPIGLOTTIS and supraglottic structures including the PHARYNX; UVULA; base of tongue; and aryepiglottic folds. It is usually caused by HAEMOPHILUS INFLUENZAE in children but often by different organisms in adults.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Supraglottitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059526</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgical enlargement of the intervertebral foramina to relieve NERVE ROOT COMPRESSION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Foraminotomy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059545</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Paraneoplastic Syndromes, Ocular</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Paraneoplastic Diseases, Ocular</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Melanoma-Associated Retinopathy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bilateral Diffuse Uveal Melanocytic Proliferation, Paraneoplastic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Paraneoplastic Melanocytic Proliferation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cancer-Associated Retinopathy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059546</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Guided BONE TRANSPLANTATION of the MAXILLARY SINUS surface with a BONE SUBSTITUTE grafting. It increases the bone volume at the site of the DENTAL IMPLANT and helps stabilize it.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sinus Floor Augmentation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Maxillary Sinus Floor Augmentation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sinus Augmentation Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059547</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Mechanosensing organelles of hair cells which respond to fluid motion or fluid pressure changes. They have various functions in many different animals, but are primarily used in hearing.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Stereocilia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stereovilli</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stereocilium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059549</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rebuilding of the ANTERIOR CRUCIATE LIGAMENT to restore functional stability of the knee. AUTOGRAFTING or ALLOGRAFTING of tissues is often used.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anterior Cruciate Ligament Reconstruction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059550</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Experiments designed to determine the potential toxic effects of mid-term (a few months) exposure to a chemical or chemicals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Toxicity Tests, Subchronic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Subchronic Toxicity Tests</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059551</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Experiments designed to determine the potential toxic effects of a short-term (a few weeks) exposure to a chemical or chemicals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Toxicity Tests, Subacute</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Subacute Toxicity Tests</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059552</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Geological formations consisting of underground enclosures with access from the surface.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Caves</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Caverns</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059565</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cell cycle controls at a phase between G2 PHASE and MITOSIS when chromosome condensation is reversible.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G2 Phase Cell Cycle Checkpoints</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>G2 Phase Checkpoints</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>G2 Cell Cycle Checkpoints</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell cycle controls at a phase between G2 PHASE and MITOSIS when chromosome condensation is reversible.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G2-M Cell Cycle Checkpoint</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell cycle controls at a phase between G2 PHASE and MITOSIS when chromosome condensation is reversible.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G2 Cell Cycle Control</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell cycle controls at a phase between G2 PHASE and MITOSIS when chromosome condensation is reversible.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G2 Restriction Point</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell cycle controls at a phase between G2 PHASE and MITOSIS when chromosome condensation is reversible.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antephase Checkpoint</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell cycle controls at a phase between G2 PHASE and MITOSIS when chromosome condensation is reversible.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G2 Cell Cycle Arrest</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059566</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will effect CHROMOSOME SEGREGATION is detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>M Phase Cell Cycle Checkpoints</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>M Phase Cell Cycle Checkpoint</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>M Phase Checkpoint</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will effect CHROMOSOME SEGREGATION is detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>M Phase Cell Cycle Arrest</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will effect CHROMOSOME SEGREGATION is detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spindle Assembly Checkpoint Network</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will effect CHROMOSOME SEGREGATION is detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mitotic Checkpoints</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will effect CHROMOSOME SEGREGATION is detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mitotic Spindle Checkpoints</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The cellular signaling system that halts the progression of cells through MITOSIS or MEIOSIS if a defect that will effect CHROMOSOME SEGREGATION is detected.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spindle Assembly Checkpoint</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059585</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Regulatory signalling systems that control the progression of the CELL CYCLE from G1 PHASE to S PHASE if the cells are not ready to undergo DNA REPLICATION. DNA DAMAGE, or the deficiencies in specific cellular components or nutrients may cause the cells to halt before progressing to S phase.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G1 Phase Cell Cycle Checkpoints</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>G1 Cell Cycle Checkpoints</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>G1 Phase Checkpoints</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Regulatory signalling systems that control the progression of the CELL CYCLE from G1 PHASE to S PHASE if the cells are not ready to undergo DNA REPLICATION. DNA DAMAGE, or the deficiencies in specific cellular components or nutrients may cause the cells to halt before progressing to S phase.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G1 Phase Restriction Point</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>G1 Restriction Point</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Regulatory signalling systems that control the progression of the CELL CYCLE from G1 PHASE to S PHASE if the cells are not ready to undergo DNA REPLICATION. DNA DAMAGE, or the deficiencies in specific cellular components or nutrients may cause the cells to halt before progressing to S phase.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>START Cell Cycle Checkpoint</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Regulatory signalling systems that control the progression of the CELL CYCLE from G1 PHASE to S PHASE if the cells are not ready to undergo DNA REPLICATION. DNA DAMAGE, or the deficiencies in specific cellular components or nutrients may cause the cells to halt before progressing to S phase.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G1 Cell Cycle Arrest</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Regulatory signalling systems that control the progression of the CELL CYCLE from G1 PHASE to S PHASE if the cells are not ready to undergo DNA REPLICATION. DNA DAMAGE, or the deficiencies in specific cellular components or nutrients may cause the cells to halt before progressing to S phase.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>G1-S Phase Cell Cycle Checkpoint</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059586</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of ascomycetous mitosporic fungi in the family Orbiliaceae. It is used for the biological control of nematodes in livestock.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Duddingtonia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059587</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Protein-mineral complexes that comprise substrates needed for the normal calcium-carbonate-phosphate homeostasis. Nanobacteria was the prior name for the particles which were originally thought to be microorganisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Calcifying Nanoparticles</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nanobacteria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059605</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Use of a DENTAL ABUTMENT which has a smaller diameter than the DENTAL IMPLANT at the junction. It improves the distribution of forces and helps reduce bone loss after the implant placement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dental Implant-Abutment Design</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Implant-Abutment Designs</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Use of a DENTAL ABUTMENT which has a smaller diameter than the DENTAL IMPLANT at the junction. It improves the distribution of forces and helps reduce bone loss after the implant placement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dental Implant-Abutment Interface</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dental Implant-Abutment Connection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Use of a DENTAL ABUTMENT which has a smaller diameter than the DENTAL IMPLANT at the junction. It improves the distribution of forces and helps reduce bone loss after the implant placement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Morse Taper Dental Implant-Abutment Interface</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Morse Taper Dental Implant-Abutment Connection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Use of a DENTAL ABUTMENT which has a smaller diameter than the DENTAL IMPLANT at the junction. It improves the distribution of forces and helps reduce bone loss after the implant placement.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dental Implant Platform Switching</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Platform Switching, Dental Implant</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059606</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Excessive thirst manifested by excessive fluid intake. It is characteristic of many diseases such as DIABETES MELLITUS; DIABETES INSIPIDUS; and NEPHROGENIC DIABETES INSIPIDUS. The condition may be psychogenic in origin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polydipsia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059607</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A clinical disorder characterized by excessive fluid intake (polydipsia); HYPONATREMIA; and POLYURIA in SCHIZOPHRENIA and other psychiatric disorders. Impaired water metabolism in psychogenic polydipsia can result in WATER INTOXICATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polydipsia, Psychogenic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Polydipsia, Primary</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059608</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Congenital anomalous dilitation of the laryngeal saccule that may extend internally into the airway or externally through the thyrohyoid membrane.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laryngocele</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059609</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cytoplasmic hyaline inclusions in HEPATOCYTES. They are associated with ALCOHOLIC STEATOHEPATITIS and non-alcoholic STEATOHEPATITIS, but are also present in benign and malignant hepatocellular neoplasms, and metabolic, toxic, and chronic cholestatic LIVER DISEASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mallory Bodies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059611</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of free-living soil amoeba in the family Balamuthiidae, causing AMEBIASIS and a deadly form of ENCEPHALITIS in humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Balamuthia mandrillaris</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059625</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The removal of a soluble component from a liquid mixture by contact with a second liquid, immiscible with the carrier liquid, in which the component is preferentially soluble. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Liquid-Liquid Extraction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Liquid Phase Extraction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059627</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Miniaturized methods of liquid-liquid extraction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Liquid Phase Microextraction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Micro Liquid Phase Extraction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Micro Liquid-Liquid Extraction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Liquid-Liquid Microextraction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059628</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques for the combination of overlapping SINGLE-PHOTON EMISSION COMPUTERIZED TOMOGRAPHY and X-RAY COMPUTED TOMOGRAPHY images.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Positron-Emission Tomography and Computed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>X-Ray Computed Tomography and Positron-Emission Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PET and CT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hybrid Pet and CT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Computed Tomography and Positron-Emission Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Integrated PET CT</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques for the combination of overlapping SINGLE-PHOTON EMISSION COMPUTERIZED TOMOGRAPHY and X-RAY COMPUTED TOMOGRAPHY images.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Single-Photon Emission Computerized Tomography and Computed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hybrid SPECT and CT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SPECT and CT</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Computed Tomography and Single-Photon Emission Computerized Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CT and SPECT</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059629</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The comparison of the quantity of meaningful data to the irrelevant or incorrect data.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Signal-To-Noise Ratio</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059630</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Mesenchymal stromal cells found in WHARTON JELLY, in the perivascular, intervascular, and subamnion regions of the UMBILICAL CORD. They are fibroblastic in appearance, rich in hyaluronic acid, and have been induced to form bone, cartilage, and adipose cells in vitro.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mesenchymal Stromal Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Mesenchymal stromal cells found in WHARTON JELLY, in the perivascular, intervascular, and subamnion regions of the UMBILICAL CORD. They are fibroblastic in appearance, rich in hyaluronic acid, and have been induced to form bone, cartilage, and adipose cells in vitro.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wharton Jelly Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wharton's Jelly Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059631</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Jelly-like connective tissue of the UMBILICAL CORD that contains MESENCHYMAL STROMAL CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wharton Jelly</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wharton's Jelly</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059645</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The number of mutations that occur in a specific sequence, GENE, or GENOME over a specified period of time such as years, CELL DIVISIONS, or generations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mutation Rate</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mutation Frequency</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059646</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The amount of DNA (or RNA) in one copy of a genome.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genome Size</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059647</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The combined effects of genotypes and environmental factors together on phenotypic characteristics.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gene-Environment Interaction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Environment-Gene Interaction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059648</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Intercellular signaling peptides that were originally characterized by their ability to suppress NEOPLASM METASTASIS. Kisspeptins have since been found to play an important role in the neuroendocrine regulation of REPRODUCTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kisspeptins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metastins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Intercellular signaling peptides that were originally characterized by their ability to suppress NEOPLASM METASTASIS. Kisspeptins have since been found to play an important role in the neuroendocrine regulation of REPRODUCTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kisspeptin-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Metastasis Suppressor KiSS-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>KiSS-1 Metastasis Suppressor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059665</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of affinity chromatography where ANTIBODIES are used in the affinity capture reaction on the solid support, in the mobile phase, or both.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immunochromatography</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A type of affinity chromatography where ANTIBODIES are used in the affinity capture reaction on the solid support, in the mobile phase, or both.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Immunochromatographic Assay</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059666</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A lysosomal-associated membrane glycoprotein that is expressed at high levels in mature DENDRITIC CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lysosomal-Associated Membrane Protein 3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>LAMP-3 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DC-LAMP Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD208</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD208 Antigens</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059685</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgical procedures undertaken to repair abnormal openings through which tissue or parts of organs can protrude or are already protruding.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Herniorrhaphy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hernia Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hernioplasty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059705</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Minute cells produced during development of an OOCYTE as it undergoes MEIOSIS. A polar body contains one of the nuclei derived from the first or second meiotic CELL DIVISION. Polar bodies have practically no CYTOPLASM. They are eventually discarded by the oocyte. (from King &amp; Stansfield, A Dictionary of Genetics, 4th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polar Bodies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Polar Body</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Polar Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059706</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-negative, rod-shaped bacteria in the family VIBRIONACEAE. They are found in the marine environment often associated with animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aliivibrio</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059707</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infections with bacteria of the genus ALIIVIBRIO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aliivibrio Infections</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059708</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-60 kHz, to cut through or remove tissue. The tissue fragmentation by ultrasonic surgical instruments is caused by mechanical effects not heat as with HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ultrasonic Surgical Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ultrasonic Surgery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059725</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Delivery of ventilator support based on the patient's changing respiratory mechanics which vary at each breathing cycle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Interactive Ventilatory Support</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Delivery of ventilator support based on the patient's changing respiratory mechanics which vary at each breathing cycle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neurally Adjusted Ventilatory Assist</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Delivery of ventilator support based on the patient's changing respiratory mechanics which vary at each breathing cycle.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proportional Assist Ventilation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059745</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-30 kHz, to cut through mineralized tissue.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Piezosurgery</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Piezo-Electric Surgery</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The use of HIGH-ENERGY SHOCK WAVES, in the frequency range of 20-30 kHz, to cut through mineralized tissue.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Piezo-Electric Bone Surgery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059746</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An emergency treatment commonly used to clear food and other foreign objects causing AIRWAY OBSTRUCTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Heimlich Maneuver</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Abdominal Thrusts</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059747</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgical operations on the nose and nasal cavity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nasal Surgical Procedures</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Rhinosurgery</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nasal Surgery</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Surgical operations on the nose and nasal cavity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intranasal Surgery</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059748</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cleavage of proteins into smaller peptides or amino acids either by PROTEASES or non-enzymatically (e.g., Hydrolysis). It does not include Protein Processing, Post-Translational.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proteolysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protein Degradation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cleavage of proteins into smaller peptides or amino acids either by PROTEASES or non-enzymatically (e.g., Hydrolysis). It does not include Protein Processing, Post-Translational.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Digestion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059765</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An exchange of DNA between matching or similar sequences.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Homologous Recombination</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059766</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The repair of DOUBLE-STRAND DNA BREAKS by rejoining the broken ends of DNA to each other directly.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA End-Joining Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>End-Joining DNA Repair</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The repair of DOUBLE-STRAND DNA BREAKS by rejoining the broken ends of DNA to each other directly.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microhomology-Mediated End Joining Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MMEJ DNA Repair</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The repair of DOUBLE-STRAND DNA BREAKS by rejoining the broken ends of DNA to each other directly.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Non-Homologous DNA End-Joining</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nonhomologous DNA End-Joining</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NHEJ DNA Repair</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059767</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Repair of DNA DAMAGE by exchange of DNA between matching sequences, usually between the allelic DNA (ALLELES) of sister chromatids.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recombinational DNA Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Homologous Recombination Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recombinational Repair of DNA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Homologous Recombinational Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recombination Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Homologous Recombination DNA Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Homologous Recombination Repair of DNA</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Repair of DNA DAMAGE by exchange of DNA between matching sequences, usually between the allelic DNA (ALLELES) of sister chromatids.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Homologous Recombination Double-Stranded Break DNA Repair</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Homology-Directed dsDNA Break Repair</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059785</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The full set of CHROMOSOMES presented as a systematized array of METAPHASE chromosomes from a photomicrograph of a single CELL NUCLEUS arranged in pairs in descending order of size and according to the position of the CENTROMERE. (From Stedman, 25th ed)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Karyotype</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059786</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A variation from the normal set of chromosomes characteristic of a species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Abnormal Karyotype</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Karyotype, Abnormal</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059787</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Intensely discomforting, distressful, or agonizing sensation associated with trauma or disease, with well-defined location, character, and timing.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acute Pain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059788</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques for using whole blood samples collected on filter paper for a variety of clinical laboratory tests.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dried Blood Spot Testing</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dried Blood Spot Method</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dried Blood Spot Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059805</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Transmembrane proteins that form the alpha subunits of the HLA-DR antigens. They are also referred to as the HLA-DR heavy chains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DR alpha-Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DR alpha</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DR alpha-Chain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MHC Class II Antigen DRA</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA Class II Histocompatibility Antigen, DR alpha Chain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DR Heavy Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059806</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Transmembrane proteins that form the beta subunits of the HLA-DR antigens. They are also referred to as the HLA-DR light chains.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DR beta-Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DR Light Chain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DR beta-Chain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA Class II Histocompatibility Antigen, DR beta Chain</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DR beta</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059807</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cell regulatory signaling system that controls progression through S PHASE and stabilizes the replication forks during conditions that could affect the fidelity of DNA REPLICATION, such as DNA DAMAGE or depletion of nucleotide pools.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>S Phase Cell Cycle Checkpoints</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>S Phase Checkpoint</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>S Phase Cell Cycle Checkpoint</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cell regulatory signaling system that controls progression through S PHASE and stabilizes the replication forks during conditions that could affect the fidelity of DNA REPLICATION, such as DNA DAMAGE or depletion of nucleotide pools.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Intra-S Checkpoints</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Intra-S Checkpoint</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059808</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large class of organic compounds having more than one PHENOL group.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polyphenols</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A large class of organic compounds having more than one PHENOL group.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Provinols</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059810</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>HLA-DR antigen subtypes that have been classified according to their affinity to specific ANTIBODIES. The DNA sequence analyses of HLA-DR ALPHA-CHAINS and HLA-DR BETA-CHAINS has for the most part revealed the specific alleles that are responsible for each serological subtype.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DR Serological Subtypes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059811</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of HLA-DRB beta chains that includes over one hundred allele variants. The HLA-DRB1 subtype is associated with several of the HLA-DR SEROLOGICAL SUBTYPES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DRB1 Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRB1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRB1 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA DRB1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059825</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Persons trained in PHYSICAL THERAPY (SPECIALTY) to make use of PHYSICAL THERAPY MODALITIES to prevent, correct, and alleviate movement dysfunction of anatomic or physiologic origin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Physical Therapists</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Physiotherapists</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059826</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of HLA-DRB beta chains that includes over 50 allelic variants.  The HLA-DRB3 beta-chain subtype is associated with HLA-DR52 serological subtype.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DRB3 Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRB3</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRB3 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA DRB3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059827</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Beneficial microorganisms (bacteria or fungi) encapsulated in carrier material and applied to the environment for remediation and enhancement of agricultural productivity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Agricultural Inoculants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Microbial Inoculants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bacterial Inoculants</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fungal Inoculants</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059828</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Basic functional unit of plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059845</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of HLA-DRB beta chains that is associated with the HLA-DR53 serological subtype.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DRB4 Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRB4 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA DRB4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRB4</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059846</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pain-alleviating drugs characterized by rapid action time.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Analgesics, Short-Acting</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059847</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of HLA-DRB beta chains that is associated with the HLA-DR51 serological subtype.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DRB5 Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRB5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-DRB5 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA DRB5</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059848</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Transmembrane proteins that form the alpha subunits of the HLA-DQ antigens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DQ alpha-Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA Class II Histocompatibility Antigen, DQ alpha Chains</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059865</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Various physiological or molecular disturbances that impair ENDOPLASMIC RETICULUM function. It triggers many responses, including UNFOLDED PROTEIN RESPONSE, which may lead to APOPTOSIS; and AUTOPHAGY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endoplasmic Reticulum Stress</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Stress, Endoplasmic Reticulum</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059866</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Transmembrane proteins that form the beta subunits of the HLA-DQ antigens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DQ beta-Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA Class II Histocompatibility Antigen, DQ beta Chains</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059867</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Transmembrane proteins that form the alpha subunits of the HLA-DP antigens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DP alpha-Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA Class II Histocompatibility Antigen, DP alpha Chains</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059868</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Transmembrane proteins that form the beta subunits of the HLA-DP antigens.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-DP beta-Chains</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA Class II Histocompatibility Antigen, DP beta Chains</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059869</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods for performing three-dimensional measurement and motion analysis using stereoscopic radiographs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radiostereometric Analysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Roentgen Stereophotogrammetry</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Radiostereometry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059870</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*11 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-A11 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-A11</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA A11</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*11 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, A-11 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059871</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*24 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-A24 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-A24</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA A24</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*24 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, A-24 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059885</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Rapidly growing vascular lesion along the midline axis of the neck, upper trunk, and extremities that is characterized by CONSUMPTION COAGULOPATHY; THROMBOCYTOPENIA; and HEMOLYTIC ANEMIA. It is often associated with infantile Kaposiform HEMANGIOENDOTHELIOMA and other vascular tumors such as tufted ANGIOMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kasabach-Merritt Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kasabach-Merritt Phenomenon</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thrombocytopenia-Hemangioma Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hemangioma Thrombocytopenia Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059905</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Formation of a non-infectious THROMBUS, referred to as vegetation, on previously undamaged ENDOCARDIUM. It usually occurs as a complication of connective-tissue diseases and cancers because of the associated hypercoagulable state (see THROMBOPHILIA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endocarditis, Non-Infective</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Marantic Endocarditis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Non-Infective Endocarditis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Formation of a non-infectious THROMBUS, referred to as vegetation, on previously undamaged ENDOCARDIUM. It usually occurs as a complication of connective-tissue diseases and cancers because of the associated hypercoagulable state (see THROMBOPHILIA).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Non-Bacterial Thrombotic Endocarditis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endocarditis, Non-Bacterial Thrombotic</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059906</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Non-invasive methods of visualizing the CENTRAL NERVOUS SYSTEM, especially the brain, by various imaging modalities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neuroimaging</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Non-invasive methods of visualizing the CENTRAL NERVOUS SYSTEM, especially the brain, by various imaging modalities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brain Imaging</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059907</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods for visualing REGIONAL BLOOD FLOW, metabolic, electrical, or other physiological activities in the CENTRAL NERVOUS SYSTEM using various imaging modalities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Functional Neuroimaging</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods for visualing REGIONAL BLOOD FLOW, metabolic, electrical, or other physiological activities in the CENTRAL NERVOUS SYSTEM using various imaging modalities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Functional Brain Imaging</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059908</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*13 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B13 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B13</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B13</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*13 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-13 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059909</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*14 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B14 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B14</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B14</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B14 Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*14 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-14 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059910</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*15 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B15 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B15 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B15</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B15</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*15 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-15 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059911</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*18 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B18 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B18</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B18</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*18 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-18 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059912</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*37 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B37 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B37</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B37</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*37 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-37 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059925</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Reference points located by visual inspection, palpation, or computer assistance, that are useful in localizing structures on or within the human body.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anatomic Landmarks</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059945</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*38 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B38 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B38 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B38</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B38</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*38 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-38 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059946</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*39 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B39 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B39</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B39</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*39 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-39 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059947</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*40 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B40 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B40</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*40 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-40 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059948</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*44 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B44 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B44 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B44</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B44</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*44 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-44 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059949</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*51 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B51 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B51</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*51 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-51 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059950</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*52 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-B52 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-B52</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA B52 Antigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*52 allele family.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA Class I Histocompatibility Antigen, B-52 alpha Chain</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059951</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-G Antigens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA G</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-G2 Isoform</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G2</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-G7 Isoform</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G7 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G7</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-G4 Isoform</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G4</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-G5 Isoform</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G5</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-G6 Isoform</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G6</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-G1 Isoform</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G1</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Class I human histocompatibility (HLA) surface antigens encoded by alleles on locus B of the HLA complex. The HLA-G antigens are considered non-classical class I antigens due to their distinct tissue distribution which differs from HLA-A; HLA-B; and HLA-C antigens. Note that several isoforms of HLA-G antigens result from alternative splicing of messenger RNAs produced from the HLA-G*01 allele.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HLA-G3 Isoform</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HLA-G3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059952</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Injury, weakening, or PROLAPSE of the pelvic muscles, surrounding connective tissues or ligaments (PELVIC FLOOR).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pelvic Floor Disorders</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pelvic Floor Diseases</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059965</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A species of POLYOMAVIRUS suspected to be the cause of most cases of MERKEL CELL CARCINOMA, a rare but highly lethal form of skin cancer.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Merkel cell polyomavirus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D059985</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Macroporous hydrogels that are produced at subzero temperatures. Cryogels have pores that are produced by growing ice crystals and have been developed with a tissue-like elasticity that is suitable for cell immunization experiments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cryogels</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cryogel</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060005</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods used to determine individuals' specific ALLELES or SNPS (single nucleotide polymorphisms).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genotyping Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genotype Assignment Methodology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genotype Calling Methods</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genotype Determination Methods</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060026</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An endosymbiont that is either a bacterium or fungus living part of its life in a plant. Endophytes can benefit host plants by preventing pathogenic organisms from colonizing them.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endophytes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060045</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>GENES with ALLELES that affect the PHENOTYPE associated with a nonallelic gene.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genes, Modifier</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Modifier Gene</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Modifier Genes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060046</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Treatment designed to help prevent a relapse of a disease following the successful primary treatments (INDUCTION THERAPY and CONSOLIDATION THERAPY) with a long-term low-dose drug therapy.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Maintenance Chemotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060047</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Mechanisms that prevent different populations from exchanging genes (GENE FLOW), resulting in or maintaining GENETIC SPECIATION. It can either prevent mating to take place or ensure that any offspring produced is either inviable or sterile, thereby preventing further REPRODUCTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reproductive Isolation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Mechanisms that prevent different populations from exchanging genes (GENE FLOW), resulting in or maintaining GENETIC SPECIATION. It can either prevent mating to take place or ensure that any offspring produced is either inviable or sterile, thereby preventing further REPRODUCTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hybridization Barriers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060048</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A developmental deformity in which the metaphysis of the FEMUR moves proximally and anteriorly away from FEMUR HEAD (epiphysis) at the upper GROWTH PLATE. It is most common in male adolescents and is associated with a greater risk of early OSTEOARTHRITIS of the hip.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Slipped Capital Femoral Epiphyses</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Adolescent Coxa Vara</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Slipped Capital Femoral Epiphysis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A developmental deformity in which the metaphysis of the FEMUR moves proximally and anteriorly away from FEMUR HEAD (epiphysis) at the upper GROWTH PLATE. It is most common in male adolescents and is associated with a greater risk of early OSTEOARTHRITIS of the hip.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bilateral Slipped Capital Femoral Epiphyses</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bilateral Slipped Capital Femoral Epiphysis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A developmental deformity in which the metaphysis of the FEMUR moves proximally and anteriorly away from FEMUR HEAD (epiphysis) at the upper GROWTH PLATE. It is most common in male adolescents and is associated with a greater risk of early OSTEOARTHRITIS of the hip.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Unilateral Slipped Capital Femoral Epiphyses</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Unilateral Slipped Capital Femoral Epiphysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060049</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Type of cell division of stem cells resulting in one daughter cell identical to the original stem cell and another non-stem daughter cell. This type of cell differentiation is achieved by asymmetrical segregation of cell fate determinants (see CELL POLARITY) and orientation of the MITOTIC SPINDLE in the context of intrinsic and extrinsic cues (STEM CELL NICHE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Asymmetric Cell Division</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Type of cell division of stem cells resulting in one daughter cell identical to the original stem cell and another non-stem daughter cell. This type of cell differentiation is achieved by asymmetrical segregation of cell fate determinants (see CELL POLARITY) and orientation of the MITOTIC SPINDLE in the context of intrinsic and extrinsic cues (STEM CELL NICHE).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Asymmetric Stem Cell Division</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Asymmetric Stem Cell Differentiation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060050</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Persistent and reproducible chest discomfort usually precipitated by a physical exertion that dissipates upon cessation of such an activity. The symptoms are manifestations of MYOCARDIAL ISCHEMIA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Angina, Stable</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chronic Stable Angina</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Angina Pectoris, Stable</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060051</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Injuries sustained from incidents in the course of work-related activities.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Occupational Injuries</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060052</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A skin crease on each side of the face that runs from the outer corners of the nose to the corner of the mouth. It is a common site of PLASTIC SURGERY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nasolabial Fold</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060053</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The body location or part from which tissue is taken for TRANSPLANTATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transplant Donor Site</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060054</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram negative, aerobic, rod-shaped bacteria found in soil, plants, and marine mud.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Agrobacterium</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060066</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Graphs representing sets of measurable, non-covalent physical contacts with specific PROTEINS in living organisms or in cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Protein Interaction Maps</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protein Interaction Networks</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Protein-Protein Interaction Map</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060085</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Simultaneous infection of a host organism by two or more pathogens. In virology, coinfection commonly refers to simultaneous infection of a single cell by two or more different viruses.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coinfection</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Secondary Infections</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Polymicrobial Infection</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Co-infection</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mixed Infection</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060086</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hot springs on the ocean floor. They are commonly found near volcanically active places such as mid-oceanic ridges.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hydrothermal Vents</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Deep Sea Vents</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hot springs on the ocean floor. They are commonly found near volcanically active places such as mid-oceanic ridges.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Black Smoker Vents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060105</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Shells of marine animals most often composed of CALCIUM CARBONATE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Animal Shells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Shells of marine animals most often composed of CALCIUM CARBONATE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Seashells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060106</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inland bodies of still or slowly moving FRESH WATER or salt water, larger than a pond, and supplied by RIVERS and streams.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lakes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Inland bodies of still or slowly moving FRESH WATER or salt water, larger than a pond, and supplied by RIVERS and streams.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Soda Lakes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060125</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of fresh water fish with 18 families and over 1600 species. The order includes CHARACINS, hatchetfish, piranhas, and TETRAS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Characiformes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An order of fresh water fish with 18 families and over 1600 species. The order includes CHARACINS, hatchetfish, piranhas, and TETRAS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Piranhas</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060126</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of fresh water fish in the order CHARACIFORMES, which includes the Tetras.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Characidae</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Characins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Characids</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of fresh water fish in the order CHARACIFORMES, which includes the Tetras.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tetras</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tetragonopterus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060127</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A method of continuously holding a partially wrapped baby to the chest, involving skin-to-skin contact. Originally it was a method of caring for LOW-BIRTH-WEIGHT INFANT in developing countries and is now more widespread in developed nations. Aside from encouraging breast feeding, the extra sleep that the infant gets assists in regulating body temperature, helps the baby conserve energy, and redirects calorie expenditures toward growth and weight gain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kangaroo-Mother Care Method</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kangaroo-Mother Care</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Kangaroo Mother Care</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060145</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A TELECOMMUNICATIONS protocol used to send text messages between CELL PHONE users.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Text Messaging</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Texting</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A TELECOMMUNICATIONS protocol used to send text messages between CELL PHONE users.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Short Message Service</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A TELECOMMUNICATIONS protocol used to send text messages between CELL PHONE users.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Text Messages</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060146</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Geographic variety, population, or race, within a species, that is genetically adapted to a particular habitat. An ecotype typically exhibits phenotypic differences but is capable of interbreeding with other ecotypes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ecotype</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060148</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The map of human HAPLOTYPES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HapMap Project</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The map of human HAPLOTYPES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>HapMap</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Human Haplotype Map</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060149</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Ubiquitously-expressed tetraspanin proteins that are found in late ENDOSOMES and LYSOSOMES and have been implicated in intracellular transport of proteins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antigens, CD63</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Granulophysin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>LIMP-CD63</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Platelet Glycoprotein 40 kDa</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pltgp40</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tetraspanin 30</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD63 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Melanoma Antigen ME491</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060151</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>B-cells that have a role in regulating the immune response including the production of CYTOKINES. This function is in addition to their traditional role in making antibodies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>B-Lymphocytes, Regulatory</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Breg Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Regulatory B-Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B-Cells, Regulatory</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060152</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process by which the V (variable), D (diversity), and J (joining) segments of IMMUNOGLOBULIN GENES or T-CELL RECEPTOR GENES are assembled during the development of LYMPHOID CELLS using NONHOMOLOGOUS DNA END-JOINING.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>V(D)J Recombination</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>VDJ Recombination</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060165</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specialized membrane glycoproteins that are found on UROTHELIUM cells. They associate into a hexagonal array of 16-nm cell surface particles which form the asymmetric unit membrane of urothelial plaques.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uroplakins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Uroplakin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060166</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hollow cylindrical objects with an internal diameter that is small enough to fill by and hold liquids inside by CAPILLARY ACTION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Capillary Tubing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060167</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A tetraspanin domain-containing uroplakin subtype. It heterodimerizes with UROPLAKIN II to form a component of the asymmetric unit membrane found in urothelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uroplakin Ia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Uroplakin 1a</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060168</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>HEMATOPOIETIC PROGENITOR CELLS that have migrated to the THYMUS where they differentiate into T-LYMPHOCYTES. Thymocytes are classified into maturational stages based on the expression of CELL SURFACE ANTIGENS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thymocytes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060169</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A tetraspanin domain-containing uroplakin subtype. It heterodimerizes with UROPLAKIN III to form a component of the asymmetric unit membrane found in urothelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uroplakin Ib</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Uroplakin 1b</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060170</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A uroplakin subtype that heterodimerizes with UROPLAKIN IA to form a component of the asymmetric unit membrane found in urothelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uroplakin II</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Uroplakin 2</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060171</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A uroplakin subtype that heterodimerizes with UROPLAKIN IB to form a component of the asymmetric unit membrane found in urothelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uroplakin III</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A uroplakin subtype that heterodimerizes with UROPLAKIN IB to form a component of the asymmetric unit membrane found in urothelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uroplakin IIIb</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A uroplakin subtype that heterodimerizes with UROPLAKIN IB to form a component of the asymmetric unit membrane found in urothelial cells.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uroplakin IIIa</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060172</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Synthetic analogs of NUCLEIC ACIDS composed of morpholine ring derivatives (MORPHOLINES) linked by phosphorodimidates. One standard DNA nucleic acid base (ADENINE; GUANINE; CYTOSINE; OR THYMINE) is bound to each morpholine ring.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Morpholinos</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Morpholino Oligonucleotides</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phosphorodiamidate Morpholino Oligomers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PMO Oligomers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>MORF Oligomers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Morpholino Oligos</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060185</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Tetraspanin proteins found associated with LAMININ-binding INTEGRINS. The CD151 antigens may play a role in the regulation of CELL MOTILITY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antigens, CD151</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD151 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigen CD151</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tetraspanin 24</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060186</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The administration of medication by insertion of a tiny needle or catheter into the spinal sac or epidural cavity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Infusions, Spinal</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060205</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods used to temporarily or permanently block the flow of BODY FLUIDS through various ducts and tubules throughout the body, including BLOOD VESSELS and LYMPHATIC VESSELS such as by THERAPEUTIC EMBOLIZATION or LIGATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Therapeutic Occlusion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060225</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Tetraspanin proteins that are involved in a variety of cellular functions including BASEMENT MEMBRANE assembly, and in the formation of a molecular complexes on the surface of LYMPHOCYTES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antigens, CD81</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tetraspanin 28</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD81 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>TAPA-1 Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060226</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A primitive form of vertebrate kidney that is found in adults of some primitive FISHES and in the embryos of more advanced fishes. In some species of fishes it contains phagocytic cells and is also a major site of HEMATOPOIESIS, analogous to the mammalian BONE MARROW.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Head Kidney</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anterior Kidney</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060227</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hollow sacs of cells in LARVA that form adult structures in insects during BIOLOGICAL METAMORPHOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Imaginal Discs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Imaginal Disks</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060245</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subtype of tetraspanin proteins that play a role in cell adhesion, cell motility, and tumor metastasis. CD9 antigens take part in the process of platelet activation and aggregation, the formation of paranodal junctions in neuronal tissue, and the fusion of sperm with egg.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antigens, CD9</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD9 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tetraspanin-29</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Leukemia-Associated Cell Surface Antigen p24</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Motility-Related Protein-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>p24-CD9 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>27 kDa Diphtheria Toxin Receptor-Associated Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>DRAP27 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060265</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Tetraspanin proteins found at high levels in cells of the lymphoid-myeloid lineage. CD53 antigens may be involved regulating the differentiation of T-LYMPHOCYTES and the activation of B-LYMPHOCYTES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antigens, CD53</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tetraspanin-25</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD53 Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060285</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cell surface receptors for AUTOCRINE MOTILITY FACTOR, which is the secreted form of GLUCOSE-6-PHOSPHATE ISOMERASE. The receptor has an unusual composition in that it shares some structural similarities with G-PROTEIN-COUPLED RECEPTORS and functions as an ubiquitin protein ligase when internalized.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Autocrine Motility Factor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Autocrine Motility Factor Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tumor Autocrine Motility Factor Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AMF Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptor, Tumor Autocrine Motility Factor</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060305</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Transfer from pediatric to adult care.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transition to Adult Care</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pediatric Transition To Adult Care</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060306</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The measurement of various aspects of MAGNETIC FIELDS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Magnetometry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060326</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chemistry Techniques, Synthetic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Synthetic Chemistry Techniques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inorganic Synthesis Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Methods of Inorganic Synthesis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inorganic Synthesis Methods</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peptide Synthesis, Synthetic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Synthetic Peptide Synthesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Synthesis Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Organic Synthesis Methods</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Methods of Organic Synthesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peptide Synthesis Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peptide Synthesis Methods</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Methods of Peptide Synthesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inorganic Synthesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Organic Synthesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060327</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Solid-Phase Synthesis Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Solid-Phase Synthesis Methods</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Solid-Phase Synthesis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Synthesis, Solid-Phase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Solid-Phase Peptide Synthesis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peptide Synthesis, Solid-Phase</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Solid-Phase Peptide Synthesis Techniques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Solid-Phase Nucleotide Synthesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Techniques used to synthesize chemicals using molecular substrates that are bound to a solid surface. Typically a series of reactions are conducted on the bound substrate that results in either the covalent attachment of specific moieties or the modification of existing function groups. These techniques offer an advantage to those involving solution reactions in that the substrate compound does not have to be isolated and purified between the reaction steps.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Solid-Phase Nucleotide Synthesis Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060328</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Characteristics, properties, and effects of magnetic substances and magnetic fields.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Magnetic Phenomena</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Magnetic Phenomenon</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060329</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The teaching or training of those individuals with visual disability.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Education of Visually Disabled</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Education of Blind</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Education of Persons With Impaired Vision</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060345</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The teaching or training of those individuals with hearing disability or impairment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Education of Hearing Disabled</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060347</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Membrane transport proteins that actively co-transport ASCORBIC ACID and sodium ions across the CELL MEMBRANE. Dietary absorption of VITAMIN C is highly dependent upon this class of transporters and a subset of SODIUM GLUCOSE TRANSPORTERS which transport the oxidized form of vitamin C, DEHYDROASCORBIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sodium-Coupled Vitamin C Transporters</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sodium-Dependent Vitamin C Transporter</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Membrane transport proteins that actively co-transport ASCORBIC ACID and sodium ions across the CELL MEMBRANE. Dietary absorption of VITAMIN C is highly dependent upon this class of transporters and a subset of SODIUM GLUCOSE TRANSPORTERS which transport the oxidized form of vitamin C, DEHYDROASCORBIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sodium-Dependent Vitamin C Transporter 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Solute Carrier Family 23 (Nucleobase Transporters), Member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SVCT 1, Ascorbic Acid Transporter</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SLC23A1 Transporter</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Membrane transport proteins that actively co-transport ASCORBIC ACID and sodium ions across the CELL MEMBRANE. Dietary absorption of VITAMIN C is highly dependent upon this class of transporters and a subset of SODIUM GLUCOSE TRANSPORTERS which transport the oxidized form of vitamin C, DEHYDROASCORBIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sodium-Dependent Vitamin C Transporter 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Solute Carrier Family 23 (Nucleobase Transporters), Member 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SVCT 2, Ascorbic Acid Transporter</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>SLC23A2 Transporter</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060348</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A filarial parasite primarily affecting dogs and cats, but causing an emerging zoonosis in humans involving subcutaneous lesions. It is transmitted by MOSQUITOES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dirofilaria repens</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060365</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins encoded by the CHLOROPLAST GENOME or proteins encoded by the nuclear genome that are imported to and resident in the CHOROPLASTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chloroplast Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Proteins encoded by the CHLOROPLAST GENOME or proteins encoded by the nuclear genome that are imported to and resident in the CHOROPLASTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plastid Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Proteins encoded by the CHLOROPLAST GENOME or proteins encoded by the nuclear genome that are imported to and resident in the CHOROPLASTS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chloroplast Genome-Encoded Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chloroplast Encoded Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060366</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of nonhelical (ENTOMOPLASMATACEAE) and helical (SPIROPLASMATACEAE) gram-negative bacteria in the class MOLLICUTES, that are regularly associated with arthropod or plant hosts.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Entomoplasmatales</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060367</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A mitosporic ONYGENALES fungal genus. The species Lacazia loboi is the etiological agent of LOBOMYCOSIS in humans, dolphins, and other wild animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lacazia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A mitosporic ONYGENALES fungal genus. The species Lacazia loboi is the etiological agent of LOBOMYCOSIS in humans, dolphins, and other wild animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lacazia loboi</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060368</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A chronic, fungal, subcutaneous infection endemic in rural regions in South America and Central America. The causal organism is Lacazia labol.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lobomycosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lacaziosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Keloidal Blastomycosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Jorge Lobo Disease</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Jorge Lobo's Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060386</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>People who engage in occupational sexual behavior in exchange for economic rewards or other extrinsic considerations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sex Workers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostitutes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Sex Worker</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060387</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Peroxidases that utilize ASCORBIC ACID as an electron donor to reduce HYDROGEN PEROXIDE to WATER. The reaction results in the production of monodehydroascorbic acid and DEHYDROASCORBIC ACID.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ascorbate Peroxidases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ascorbate Peroxidase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>L-Ascorbic Acid Peroxidase</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060388</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Learning algorithms which are a set of related supervised computer learning methods that analyze data and recognize patterns, and used for classification and regression analysis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Support Vector Machines</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060389</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The aggregate business enterprise of building.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Construction Industry</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Building Trades</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Construction Trades</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Building Industry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060405</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Molecule produced in plant leaves that acts like a hormone by inducing flowering in the shoot apical meristem of buds and growing tips.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Florigen</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Molecule produced in plant leaves that acts like a hormone by inducing flowering in the shoot apical meristem of buds and growing tips.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Flowering Hormone</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060406</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Plant steroids ubiquitously distributed throughout the plant kingdom. They play essential roles in modulating growth and differentiation of cells at nanomolar to micromolar concentrations.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Brassinosteroids</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060425</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>CNS infections caused by neurotropic dematiaceous fungi that contain melanin in their cell walls. The infections often result in BRAIN ABSCESS; ENCEPHALITIS; and MENINGITIS in patients who are often immunocompetent. The common causative fungi include members Cladophialophora bantiana, Exophiala dermatitidis, Rhinocladiella mackenziei, and Ochroconis gallopavum. R. mackenziei infection is seen almost exclusively in patients from the MIDDLE EAST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cerebral Phaeohyphomycosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Central Nervous System Phaeohyphomycosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phaeohyphomycosis, Central Nervous System</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>CNS infections caused by neurotropic dematiaceous fungi that contain melanin in their cell walls. The infections often result in BRAIN ABSCESS; ENCEPHALITIS; and MENINGITIS in patients who are often immunocompetent. The common causative fungi include members Cladophialophora bantiana, Exophiala dermatitidis, Rhinocladiella mackenziei, and Ochroconis gallopavum. R. mackenziei infection is seen almost exclusively in patients from the MIDDLE EAST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Primary Central Nervous System Phaeohyphomycosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phaeohyphomycosis, Central Nervous System, Primary</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Central Nervous System Phaeohyphomycosis, Primary</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060426</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anti-N-Methyl-D-Aspartate Receptor Encephalitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anti-NMDA Receptor Encephalitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Anti-NMDAR Encephalitis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Non-paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Non-paraneoplastic Anti-NMDAR Encephalitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Non-paraneoplastic Anti-NMDA Receptor Encephalitis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Paraneoplastic Anti-NMDAR Encephalitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Paraneoplastic Anti-NMDA Receptor Encephalitis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060431</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins found within the THYLAKOID MEMBRANES of photosynthetic organisms such as PLANTS and PHYTOPLANKTON. Many of the proteins in this class are involved in the process of PHOTOSYNTHESIS and the generation of ADENOSINE TRIPHOSPHATE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thylakoid Membrane Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060432</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Field of social science that is concerned with differences between human groups as related to health status and beliefs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Anthropology, Medical</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Medical Anthropology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060433</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Application of pharmaceutically active agents on the tissues of the eye ball.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Administration, Ophthalmic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Administration, Ocular</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ocular Administration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060434</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The act of feeding on plants by animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Herbivory</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Herbivore</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The act of feeding on plants by animals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Animal Grazing</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060435</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The consumption of animal flesh.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Carnivory</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060436</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A mechanism for avoiding inbreeding specifically involving the gametes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Self-Incompatibility in Flowering Plants</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A mechanism for avoiding inbreeding specifically involving the gametes.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gametophytic Self-Incompatibilty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060437</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The shifting and or tilting of implanted artificial lens resulting in impaired vision.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Artificial Lens Implant Migration</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Artificial Lens Implant Dislocation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Artificial Intra-ocular Implant Dislocation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060446</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by the dematiaceous (darkly pigmented) MITOSPORIC FUNGI of ALTERNARIA, Bipolaris, CLADOSPORIUM, Curvularia, and EXOPHIALA. These fungi have pigmented HYPHAE due to MELANIN in the cell wall. The initial subcutaneous cyst from the infection can become systemic and spread rapidly to renal, pulmonary and cerebral systems (see CEREBRAL PHAEOHYPHOMYCOSIS) in an IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phaeohyphomycosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by the dematiaceous (darkly pigmented) MITOSPORIC FUNGI of ALTERNARIA, Bipolaris, CLADOSPORIUM, Curvularia, and EXOPHIALA. These fungi have pigmented HYPHAE due to MELANIN in the cell wall. The initial subcutaneous cyst from the infection can become systemic and spread rapidly to renal, pulmonary and cerebral systems (see CEREBRAL PHAEOHYPHOMYCOSIS) in an IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Subcutaneous Phaeohyphomycosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by the dematiaceous (darkly pigmented) MITOSPORIC FUNGI of ALTERNARIA, Bipolaris, CLADOSPORIUM, Curvularia, and EXOPHIALA. These fungi have pigmented HYPHAE due to MELANIN in the cell wall. The initial subcutaneous cyst from the infection can become systemic and spread rapidly to renal, pulmonary and cerebral systems (see CEREBRAL PHAEOHYPHOMYCOSIS) in an IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cutaneous Phaeohyphomycosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060447</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Temporary shelter provided in response to a major disaster or emergency.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Emergency Shelter</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Evacuation Shelter</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060449</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A complex signaling pathway whose name is derived from the DROSOPHILA Wg gene, which when mutated results in the wingless phenotype, and the vertebrate INT gene, which is located near integration sites of MOUSE MAMMARY TUMOR VIRUS. The signaling pathway is initiated by the binding of WNT PROTEINS to cells surface WNT RECEPTORS which interact with the AXIN SIGNALING COMPLEX and an array of second messengers that influence the actions of BETA CATENIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wnt Signaling Pathway</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt Pathway</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A complex signaling pathway whose name is derived from the DROSOPHILA Wg gene, which when mutated results in the wingless phenotype, and the vertebrate INT gene, which is located near integration sites of MOUSE MAMMARY TUMOR VIRUS. The signaling pathway is initiated by the binding of WNT PROTEINS to cells surface WNT RECEPTORS which interact with the AXIN SIGNALING COMPLEX and an array of second messengers that influence the actions of BETA CATENIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wnt beta-Catenin Signaling Pathway</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt Pathway, Canonical</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060465</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specific complex of WNT SIGNALING PATHWAY proteins that mediates the phosphorylation-dependent destruction of cytosolic BETA-CATENIN. The complex is disrupted by cell surface binding of WNT PROTEINS, which allows beta-catenin levels to rise to the point where they migrate to the CELL NUCLEUS and activate transcription.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Axin Signaling Complex</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Axin Signaling Complex Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>beta-Catenin Destruction Complex</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060466</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A scaffolding protein that is a critical component of the axin signaling complex which binds to ADENOMATOUS POLYPOSIS COLI PROTEIN; GLYCOGEN SYNTHASE KINASE 3; and CASEIN KINASE I.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Axin Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Axin Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060467</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The capacity of an organism to defend itself against pathological processes or the agents of those processes. This most often involves innate immunity whereby the organism responds to pathogens in a generic way. The term disease resistance is used most frequently when referring to plants.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Disease Resistance</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Resistance, Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060485</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-negative, aerobic, rod-shaped bacteria in the family Sphingobacteriaceae. They exhibit gliding motility.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pedobacter</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060486</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Childhood-onset of recurrent headaches with an oculomotor cranial nerve palsy. Typically, ABDUCENS NERVE; OCULOMOTOR NERVE; and TROCHLEAR NERVE are involved with DIPLOPIA and BLEPHAROPTOSIS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ophthalmoplegic Migraine</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ophthalmoplegic Migraine Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060487</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Opportunistic fungal infection by a member of ALTERNARIA genus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Alternariosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Opportunistic fungal infection by a member of ALTERNARIA genus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dermal Alternariosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Opportunistic fungal infection by a member of ALTERNARIA genus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Subcutaneous Alternariosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Opportunistic fungal infection by a member of ALTERNARIA genus.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cutaneous Alternariosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060488</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An LDL-receptor related protein that combines with cell surface FRIZZLED RECEPTORS to form WNT PROTEIN-binding receptors. The protein plays an important role in the WNT SIGNALING PATHWAY during EMBRYONIC DEVELOPMENT and in regulation of vascular cell proliferation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Low Density Lipoprotein Receptor-Related Protein-6</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Low Density Lipoprotein Receptor-Related Protein 6</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lipoprotein Receptor-Related Protein 6</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060489</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Holding a PROSTHESIS in place.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prosthesis Retention</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Holding a PROSTHESIS in place.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prosthesis Fixation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060490</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cell-surface receptors that specifically bind to WNT PROTEINS and activate the WNT SIGNALING PATHWAY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Receptors, Wnt</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060492</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>LDL-receptor related protein that combines with FRIZZLED RECEPTORS at the cell surface to form receptors that bind WNT PROTEINS. The protein plays an important role in the WNT SIGNALING PATHWAY in OSTEOBLASTS and during EMBRYONIC DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Low Density Lipoprotein Receptor-Related Protein-5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lipoprotein Receptor-Related Protein 5</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Low Density Lipoprotein Receptor-Related Protein 5</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060493</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-negative, rod-shaped bacteria in the family FLAVOBACTERIACEAE. Tenacibaculum adheres to surfaces of marine organisms and is pathogenic to fish.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tenacibaculum</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060494</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A genus of gram-negative, rod-shaped bacteria in the family FLAVOBACTERIACEAE that causes exudative SEPTICEMIA in ducks, pigeons, and other domestic and wild birds.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Riemerella</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060508</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A Wnt protein subtype that plays a role in cell-cell signaling during EMBRYONIC DEVELOPMENT and the morphogenesis of the developing NEURAL TUBE. Defects in Wnt3 protein are associated with autosomal recessive tetra-AMELIA in humans.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wnt3 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt-3 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt3 Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060509</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A Wnt protein subtype that plays a role in cell-cell signaling during EMBRYONIC DEVELOPMENT and the morphogenesis of the developing NEURAL TUBE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wnt3A Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt-3A Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt-3 Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060525</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A nerve which originates in the sacral spinal cord (S2 to S4) and innervates the PERINEUM, the external GENITALIA, the external ANAL SPHINCTER and the external urethral sphincter. It has three major branches: the perineal nerve, inferior anal nerves, and the dorsal nerve of penis or clitoris.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pudendal Nerve</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A nerve which originates in the sacral spinal cord (S2 to S4) and innervates the PERINEUM, the external GENITALIA, the external ANAL SPHINCTER and the external urethral sphincter. It has three major branches: the perineal nerve, inferior anal nerves, and the dorsal nerve of penis or clitoris.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Perineal Nerve</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A nerve which originates in the sacral spinal cord (S2 to S4) and innervates the PERINEUM, the external GENITALIA, the external ANAL SPHINCTER and the external urethral sphincter. It has three major branches: the perineal nerve, inferior anal nerves, and the dorsal nerve of penis or clitoris.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inferior Hemorrhoidal Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inferior Anal Nerve</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A nerve which originates in the sacral spinal cord (S2 to S4) and innervates the PERINEUM, the external GENITALIA, the external ANAL SPHINCTER and the external urethral sphincter. It has three major branches: the perineal nerve, inferior anal nerves, and the dorsal nerve of penis or clitoris.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dorsal Clitoris Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dorsal Nerve of Clitoris</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A nerve which originates in the sacral spinal cord (S2 to S4) and innervates the PERINEUM, the external GENITALIA, the external ANAL SPHINCTER and the external urethral sphincter. It has three major branches: the perineal nerve, inferior anal nerves, and the dorsal nerve of penis or clitoris.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dorsal Penile Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Dorsal Nerve of Penis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060526</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Areas of attractive or repulsive force surrounding MAGNETS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Magnetic Fields</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Magnetic Field</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060527</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Fibroblasts which occur in the CORNEAL STROMA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Corneal Keratocytes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060528</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A Wnt protein that is involved in regulating multiple developmental processes such as the formation of the KIDNEY; ADRENAL GLANDS; MAMMARY GLANDS; the PITUITARY GLAND; and the female reproductive system. Defects in WNT4 are a cause of ROKITANSKY KUSTER HAUSER SYNDROME.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Wnt4 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt-4 Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Wnt-4 Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060545</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pain associated with a damaged PUDENDAL NERVE. Clinical features may include positional pain with sitting in the perineal and genital areas, sexual dysfunction and FECAL INCONTINENCE and URINARY INCONTINENCE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pudendal Neuralgia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pudendal Neuropathy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neuralgia, Pudendal</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Pain associated with a damaged PUDENDAL NERVE. Clinical features may include positional pain with sitting in the perineal and genital areas, sexual dysfunction and FECAL INCONTINENCE and URINARY INCONTINENCE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pudendal Nerve Entrapment Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pudendal Nerve Entrapment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pudendal Canal Entrapment Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060565</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subfamily of argonaute proteins is related to the Drosphila PIWI protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Argonaute Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subfamily of argonaute proteins is related to the Drosphila PIWI protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ago Subfamily of Argonaute Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A subfamily of argonaute proteins is related to the Drosphila PIWI protein.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>PIWI Subfamily of Argonaute Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060585</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>OPPORTUNISTIC INFECTIONS with the soil fungus FUSARIUM. Typically the infection is limited to the nail plate (ONYCHOMYCOSIS). The infection can however become systemic especially in an IMMUNOCOMPROMISED HOST (e.g., NEUTROPENIA) and results in cutaneous and subcutaneous lesions, fever, KERATITIS, and pulmonary infections.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fusariosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fusarium Infection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS with the soil fungus FUSARIUM. Typically the infection is limited to the nail plate (ONYCHOMYCOSIS). The infection can however become systemic especially in an IMMUNOCOMPROMISED HOST (e.g., NEUTROPENIA) and results in cutaneous and subcutaneous lesions, fever, KERATITIS, and pulmonary infections.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Disseminated Fusariosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Invasive Fusariosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS with the soil fungus FUSARIUM. Typically the infection is limited to the nail plate (ONYCHOMYCOSIS). The infection can however become systemic especially in an IMMUNOCOMPROMISED HOST (e.g., NEUTROPENIA) and results in cutaneous and subcutaneous lesions, fever, KERATITIS, and pulmonary infections.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pulmonary Fusariosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Invasive Pulmonary Fusariosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060586</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Fungal infections caused by TRICHOSPORON that may become systemic especially in an IMMUNOCOMPROMISED HOST. Clinical manifestations range from superficial cutaneous infections to systemic lesions in multiple organs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trichosporonosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Fungal infections caused by TRICHOSPORON that may become systemic especially in an IMMUNOCOMPROMISED HOST. Clinical manifestations range from superficial cutaneous infections to systemic lesions in multiple organs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Summer-Type Hypersensitivity Pneumonitis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Japanese Summer-Type Hypersensitivity Pneumonitis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Fungal infections caused by TRICHOSPORON that may become systemic especially in an IMMUNOCOMPROMISED HOST. Clinical manifestations range from superficial cutaneous infections to systemic lesions in multiple organs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Disseminated Trichosporonosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Invasive Trichosporonosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060587</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Liquid water present beneath the surface of the earth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Groundwater</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ground-Water</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Underground Water</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ground Water</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Liquid water present beneath the surface of the earth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Water Table</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Liquid water present beneath the surface of the earth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Underground Streams</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Liquid water present beneath the surface of the earth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Aquifiers</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Liquid water present beneath the surface of the earth.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Underground Lakes</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Subterranean Lakes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060588</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large class of structurally-related proteins that contain one or more LIM zinc finger domains. Many of the proteins in this class are involved in intracellular signaling processes and mediate their effects via LIM domain protein-protein interactions. The name LIM is derived from the first three proteins in which the motif was found: LIN-11, Isl1 and Mec-3.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>LIM Domain Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060589</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A zinc-binding phosphoprotein that concentrates at focal adhesions and along the actin cytoskeleton. Zyxin has an N-terminal proline-rich domain and three LIM domains in its C-terminal half.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Zyxin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Zyxin Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060605</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by a heterogeneous group of MITOSPORIC FUNGI with clear (hyalo-) HYPHAE in the host. Common causative agents include ACREMONIUM; ASPERGILLUS; CHRYSOSPORIUM; FUSARIUM; PAECILOMYCES; PENICILLIUM; PSEUDALLESCHERIA; SCEDOSPORIUM; and SCOPULARIOPSIS. Normally a dermatomycoses, it can become invasive in the IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hyalohyphomycosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by a heterogeneous group of MITOSPORIC FUNGI with clear (hyalo-) HYPHAE in the host. Common causative agents include ACREMONIUM; ASPERGILLUS; CHRYSOSPORIUM; FUSARIUM; PAECILOMYCES; PENICILLIUM; PSEUDALLESCHERIA; SCEDOSPORIUM; and SCOPULARIOPSIS. Normally a dermatomycoses, it can become invasive in the IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Subcutaneous Hyalohyphomycosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by a heterogeneous group of MITOSPORIC FUNGI with clear (hyalo-) HYPHAE in the host. Common causative agents include ACREMONIUM; ASPERGILLUS; CHRYSOSPORIUM; FUSARIUM; PAECILOMYCES; PENICILLIUM; PSEUDALLESCHERIA; SCEDOSPORIUM; and SCOPULARIOPSIS. Normally a dermatomycoses, it can become invasive in the IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pulmonary Hyalohyphomycosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by a heterogeneous group of MITOSPORIC FUNGI with clear (hyalo-) HYPHAE in the host. Common causative agents include ACREMONIUM; ASPERGILLUS; CHRYSOSPORIUM; FUSARIUM; PAECILOMYCES; PENICILLIUM; PSEUDALLESCHERIA; SCEDOSPORIUM; and SCOPULARIOPSIS. Normally a dermatomycoses, it can become invasive in the IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Splenic Hyalohyphomycosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by a heterogeneous group of MITOSPORIC FUNGI with clear (hyalo-) HYPHAE in the host. Common causative agents include ACREMONIUM; ASPERGILLUS; CHRYSOSPORIUM; FUSARIUM; PAECILOMYCES; PENICILLIUM; PSEUDALLESCHERIA; SCEDOSPORIUM; and SCOPULARIOPSIS. Normally a dermatomycoses, it can become invasive in the IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cutaneous Hyalohyphomycosis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>OPPORTUNISTIC INFECTIONS caused by a heterogeneous group of MITOSPORIC FUNGI with clear (hyalo-) HYPHAE in the host. Common causative agents include ACREMONIUM; ASPERGILLUS; CHRYSOSPORIUM; FUSARIUM; PAECILOMYCES; PENICILLIUM; PSEUDALLESCHERIA; SCEDOSPORIUM; and SCOPULARIOPSIS. Normally a dermatomycoses, it can become invasive in the IMMUNOCOMPROMISED HOST.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Disseminated Hyalohyphomycosis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Invasive Hyalohyphomycosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060645</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A mitosporic fungal genus commonly found in soil. It includes both saprophytes and animal pathogens. Scopulariopsis brevicaulis and related species may convert ARSENIC to volatile and toxic arsine. ONYCHOMYCOSIS and rarely BRAIN ABSCESS; MYCETOMA, and disseminated infections mainly in the IMMUNOCOMPROMISED HOSTS are associated with Scopulariopsis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Scopulariopsis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A mitosporic fungal genus commonly found in soil. It includes both saprophytes and animal pathogens. Scopulariopsis brevicaulis and related species may convert ARSENIC to volatile and toxic arsine. ONYCHOMYCOSIS and rarely BRAIN ABSCESS; MYCETOMA, and disseminated infections mainly in the IMMUNOCOMPROMISED HOSTS are associated with Scopulariopsis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Scopulariopsis brevicaulis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060666</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Removal of an endotracheal tube from the patient.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Airway Extubation</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Removal of an endotracheal tube from the patient.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tracheal Extubation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Extubation, Intratracheal</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endotracheal Extubation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060685</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A view of the world and the individual's environment as comprehensible, manageable, and meaningful, claiming that the way people view their life has a positive influence on their health.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sense of Coherence</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060705</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Impairment in mathematical abilities secondary to a damage to a specific region of the brain often caused by a stroke, tumor, or trauma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Dyscalculia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acalculia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Impairment in mathematical abilities secondary to a damage to a specific region of the brain often caused by a stroke, tumor, or trauma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Developmental Dyscalculia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Primary Dyscalculia</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Impairment in mathematical abilities secondary to a damage to a specific region of the brain often caused by a stroke, tumor, or trauma.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acquired Dyscalculia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Secondary Acalculia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060725</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A retroverted UTERUS entrapped in the pelvis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uterine Retroversion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tipped Uterus</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retroverted Uterus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A retroverted UTERUS entrapped in the pelvis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Retroverted Gravid Uterus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A retroverted UTERUS entrapped in the pelvis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Uterine Retroflexion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Retroflexed Uterus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A retroverted UTERUS entrapped in the pelvis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Incarcerated Retroverted Uterus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060726</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The central part of the body to which the neck and limbs are attached.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Torso</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060728</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The status of one's reproductive system and its function.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reproductive Health</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060729</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Fraction of coal ash collected at the top section of chimneys.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coal Ash</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Fraction of coal ash collected at the top section of chimneys.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Soft Coal Fly Ash</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Fraction of coal ash collected at the top section of chimneys.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oil Fly Ash</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ROFA Pollutant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Fraction of coal ash collected at the top section of chimneys.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bottom Ash</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Fraction of coal ash collected at the top section of chimneys.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fly Ash</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060730</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A specialized barrier in the kidney, consisting of the fenestrated CAPILLARY ENDOTHELIUM; GLOMERULAR BASEMENT MEMBRANE; and glomerular epithelium (PODOCYTES). The barrier prevents the filtration of PLASMA PROTEINS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glomerular Filtration Barrier</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060731</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Personnel trained to provide the initial services, care, and support in EMERGENCIES or DISASTERS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Emergency Responders</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Emergency First Responders</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060733</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Waves of oscillating electric and MAGNETIC FIELDS which move at right angles to each other and outward from the source.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electromagnetic Radiation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Radiation, Electromagnetic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Waves of oscillating electric and MAGNETIC FIELDS which move at right angles to each other and outward from the source.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electromagnetic Energy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Waves of oscillating electric and MAGNETIC FIELDS which move at right angles to each other and outward from the source.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Electromagnetic Waves</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060734</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A biomineral consisting of layers of crystalized ARAGONITE, separated by interlamellar layers of organic matrix containing beta-CHITIN, and surrounded by an intercrystalline organic membrane of silk fibroin. Nacre is the iridescent substance better known as mother-of-pearl that is secreted by MOLLUSCS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nacre</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mother of Pearl</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060735</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The detection of long and short term side effects of conventional and traditional medicines through research, data mining, monitoring, and evaluation of healthcare information obtained from healthcare providers and patients.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pharmacovigilance</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060737</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Infections of the genital tract in females or males. They can be caused by endogenous, iatrogenic, or sexually transmitted organisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Reproductive Tract Infections</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Genital Tract Infections</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060739</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Phonons generated by the effect of light on some crystals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Phonons</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phonon</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Phonons generated by the effect of light on some crystals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Optical Phonons</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Phonons generated by the effect of light on some crystals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acoustic Phonons</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060740</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Termination of all transmission of infection by global extermination of the infectious agent through surveillance and containment (From Porta, A Dictionary of Epidemiology, 5th ed).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Disease Eradication</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Termination of all transmission of infection by global extermination of the infectious agent through surveillance and containment (From Porta, A Dictionary of Epidemiology, 5th ed).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Disease Elimination</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060745</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques used to expose dental surface below the gingival margin in order to obtain better dental impression during periodental and peri-implant applications. The retraction of the gingival tissue can be achieved surgically (e.g., laser gingivectomy and rotary curettage) or chemically with a retraction cord.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gingival Retraction Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060746</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A degradation process whereby incorrectly folded proteins are selectively transported out of the ENDOPLASMIC RETICULUM and into the CYTOSOL. The misfolded proteins are subsequently ubiquitinated and degraded by the PROTEASOME.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Endoplasmic Reticulum-Associated Degradation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ERAD Pathway</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060747</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specialized proteins that are preferentially expressed during FETAL DEVELOPMENT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fetal Globulins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060748</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of calcium-binding alpha-globulins that are synthesized in the LIVER and play an essential role in maintaining the solubility of CALCIUM in the BLOOD. In addition the fetuins contain aminoterminal cystatin domains and are classified as type 3 cystatins.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fetuins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fetuin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060749</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A fetuin subtype that is synthesized by HEPATOCYTES and secreted into the circulation. It plays a major role in preventing CALCIUM precipitation in the BLOOD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>alpha-2-HS-Glycoprotein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha(2) HS Glycoprotein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha-2HS Glycoprotein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha2HS Glycoprotein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fetuin-A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>AHSG Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>alpha2 Heremans-Schmid Glycoprotein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060750</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Malalignment of a bone in which its head and neck is rotated excessively forward or inward.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Anteversion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Antetorsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060751</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Attachment of a bone in which its head and neck is rotated excessively backward.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bone Retroversion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Bone Retrotorsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060752</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A fetuin subtype that is closely-related to ALPHA-2-HS-GLYCOPROTEIN. Although fetuin-B binds calcium, it is a minor component of SERUM and therefore it may not play a primary role in preventing serum calcium phosphate precipitation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fetuin-B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fetuin-Like Protein IRL685</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060753</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rating of a body of water based on measurable physical, chemical, and biological characteristics.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Water Quality</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060754</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A non-steroidal ESTROGEN generated when soybean products are metabolized by certain bacteria in the intestines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Equol</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A non-steroidal ESTROGEN generated when soybean products are metabolized by certain bacteria in the intestines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>6'-Hydroxy-Equol</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A non-steroidal ESTROGEN generated when soybean products are metabolized by certain bacteria in the intestines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>4'-O-Methyl Equol</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>4'-methoxy-7-isoflavanol</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A non-steroidal ESTROGEN generated when soybean products are metabolized by certain bacteria in the intestines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>(+-)-Isomer of Equol</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A non-steroidal ESTROGEN generated when soybean products are metabolized by certain bacteria in the intestines.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>3'-Hydroxy-Equol</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060755</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The fundamental tenet of modern medicine that certain diseases are caused by microorganisms. It was confirmed by the work of Pasteur, Lister, and Koch.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Germ Theory of Disease</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060756</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Individuals connecting by family, work or other interests. It also includes connectivity facilitated by computer-based communications.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Social Networking</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060765</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A structurally-related family of small, multimeric proteins that are secreted in the mucosa of mammalian epithelial tissues. A variety of proteins are classed under this heading including some secretoglobin subtypes that appear unique to a particular mammalian species, and others whose functions differ between species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Secretoglobins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060766</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Water that is intended to be ingested.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Drinking Water</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Water that is intended to be ingested.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Potable Water</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Water that is intended to be ingested.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bottled Water</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060785</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A secretoglobin that is produced by the MAMMARY GLAND of HUMANS and may be involved in the binding of ANDROGENS and other STEROIDS. The expression of this protein in normal breast epithelium and in human breast cancer has made it an important histological marker.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mammaglobin A</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Secretoglobin Family 2A Member 2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammaglobin 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammaglobin-A</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060786</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Realm in central Europe consisting of a confederation of German and Italian territories under the suzerainty of an emperor and existing from the 9th or 10th century to 1806.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Holy Roman Empire</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060787</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>System of grading PROSTATE CANCER based on the degree of abnormality of the glandular archtecture of the tumor.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neoplasm Grading</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tumor Grading</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>System of grading PROSTATE CANCER based on the degree of abnormality of the glandular archtecture of the tumor.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gleason Score</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>System of grading PROSTATE CANCER based on the degree of abnormality of the glandular archtecture of the tumor.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gleason Grading</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060788</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A MAMMAGLOBIN A-related secretoglobin that is expressed in several HUMAN tissues including the UTERUS; BREAST; SALIVARY GLAND; and LACRIMAL GLAND.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mammaglobin B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Secretoglobin family 2A member 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammaglobin-2</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mammaglobin-B</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lacryglobin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lipophilin-C</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060789</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A secreted prostate-specific protein which can bind non-polar steroids, cholesterol and a group of small, proline-rich peptides. The protein is specifically found in RATS and comprises three distinct secretoglobin-related subunits referred to as prostatic steroid-binding protein C1, C2 and C3.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Prostatein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prostatic Steroid-Binding Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060805</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Anxiety related to the execution of a task.  (Campbell's Psychiatric Dictionary, 9th ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Performance Anxiety</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060807</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques for determining the proximity of molecules based on ENERGY TRANSFER between bioluminescent chromophores and acceptor fluorophores that have overlapping emission and absorption spectra.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bioluminescence Resonance Energy Transfer Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060825</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A prodromal phase of cognitive decline that may precede the emergence of ALZHEIMER DISEASE and other dementias. It may include impairment of cognition, such as impairments in language, visuospatial awareness, ATTENTION and MEMORY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mild Cognitive Impairment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060826</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Injection of BONE CEMENTS into bone to treat bone lesions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cementoplasty</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Injection of BONE CEMENTS into bone to treat bone lesions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Percutaneous Cementoplasty</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Percutaneous Osteoplasty</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060828</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Initial drug treatment designed to bring about REMISSION INDUCTION. It is typically a short-term and high-dose drug treatment that is followed by CONSOLIDATION CHEMOTHERAPY and then MAINTENANCE CHEMOTHERAPY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Induction Chemotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060829</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Proteins synthesized by organisms belonging to the phylum ARTHROPODA. Included in this heading are proteins from the subdivisions ARACHNIDA; CRUSTACEA; and HORSESHOE CRABS. Note that a separate heading for INSECT PROTEINS is listed under this heading.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Arthropod Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Proteins synthesized by organisms belonging to the phylum ARTHROPODA. Included in this heading are proteins from the subdivisions ARACHNIDA; CRUSTACEA; and HORSESHOE CRABS. Note that a separate heading for INSECT PROTEINS is listed under this heading.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Crustacean Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Proteins synthesized by organisms belonging to the phylum ARTHROPODA. Included in this heading are proteins from the subdivisions ARACHNIDA; CRUSTACEA; and HORSESHOE CRABS. Note that a separate heading for INSECT PROTEINS is listed under this heading.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Spider Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Proteins synthesized by organisms belonging to the phylum ARTHROPODA. Included in this heading are proteins from the subdivisions ARACHNIDA; CRUSTACEA; and HORSESHOE CRABS. Note that a separate heading for INSECT PROTEINS is listed under this heading.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tick Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Proteins synthesized by organisms belonging to the phylum ARTHROPODA. Included in this heading are proteins from the subdivisions ARACHNIDA; CRUSTACEA; and HORSESHOE CRABS. Note that a separate heading for INSECT PROTEINS is listed under this heading.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Arachnid Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Proteins synthesized by organisms belonging to the phylum ARTHROPODA. Included in this heading are proteins from the subdivisions ARACHNIDA; CRUSTACEA; and HORSESHOE CRABS. Note that a separate heading for INSECT PROTEINS is listed under this heading.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Horseshoe Crab Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060830</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Drug treatment designed to further diminish the disease toward complete remission following INDUCTION CHEMOTHERAPY. It helps to consolidate the gains during induction chemotherapy and may be followed by MAINTENANCE CHEMOTHERAPY.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Consolidation Chemotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060831</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemotherapy-induced dermal side effects that are associated with the use of various CYTOSTATIC AGENTS. Symptoms range from mild ERYTHEMA and/or PARESTHESIA to severe ulcerative dermatitis with debilitating pain involving typically palmoplantar and intertriginous areas. These cutaneous manifestations are sometimes accompanied by nail anomalies.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hand-Foot Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chemotherapy-Induced Palmoplantar Erythrodysesthesia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chemotherapy-Induced Acral Erythema</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060832</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A rare form of apomixis in which only pollen (i.e. male gamete) is required to produce viable seeds.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Apomixis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A rare form of apomixis in which only pollen (i.e. male gamete) is required to produce viable seeds.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Male Apomixis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060833</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Local surroundings with which cells interact by processing various chemical and physical signals, and by contributing their own effects to this environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cellular Microenvironment</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Local surroundings with which cells interact by processing various chemical and physical signals, and by contributing their own effects to this environment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell Microenvironment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060845</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Persistent difficulty discarding or parting with possessions, regardless of the value of these possessions. Epidemiological studies suggest that hoarding occurs in 2-5% of the population and can lead to substantial distress and disability, as well as serious public health consequences.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Obsessive Hoarding</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Persistent difficulty discarding or parting with possessions, regardless of the value of these possessions. Epidemiological studies suggest that hoarding occurs in 2-5% of the population and can lead to substantial distress and disability, as well as serious public health consequences.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hoarding</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060846</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods and techniques used to modify or select cells and develop conditions for growing cells for biosynthetic production of molecules (METABOLIC ENGINEERING), for generation of tissue structures and organs in vitro (TISSUE ENGINEERING), or for other BIOENGINEERING research objectives.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Cell Engineering</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cellular Engineering</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060847</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods and techniques used to genetically modify cells' biosynthetic product output and develop conditions for growing the cells as BIOREACTORS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Metabolic Engineering</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060848</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A class of polyamine and peptide toxins which are isolated from the venom of spiders such as Agelenopsis aperta.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Agatoxins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A class of polyamine and peptide toxins which are isolated from the venom of spiders such as Agelenopsis aperta.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>mu-Agatoxins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A class of polyamine and peptide toxins which are isolated from the venom of spiders such as Agelenopsis aperta.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>omega-Agatoxins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A class of polyamine and peptide toxins which are isolated from the venom of spiders such as Agelenopsis aperta.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>alpha-Agatoxins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060850</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A subclass of LIM domain proteins that include an additional centrally-located homeodomain region that binds AT-rich sites on DNA. Many LIM-homeodomain proteins play a role as transcriptional regulators that direct cell fate.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>LIM-Homeodomain Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060851</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A body of water located at the southeastern corner of North America. It is bordered by the states to the north of Florida, Alabama, Mississippi, Louisiana, Texas; by five Mexican states to the west: Tamaulipas, Veracruz, Tabasco, Campeche, Yucatan; and by Cuba to the southeast.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gulf of Mexico</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060865</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A type of procedural memory manifested as a change in the ability to identify an item as a result of a previous encounter with the item or stimuli.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Repetition Priming</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060866</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Organizations of health care providers that agree to be accountable for the quality, cost, and overall care of Medicare beneficiaries who are enrolled in the traditional fee-for-service program who are assigned to it. Assigned means those beneficiaries for whom the professionals in the organization provide the bulk of primary care services. (www.cms.gov/OfficeofLegislation/Downloads/Accountable CareOrganization.pdf accessed 03/16/2011)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Accountable Care Organizations</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accountable Care Organization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060867</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A method of soothing PREMATURE INFANTS during POSTNATAL CARE. It involves holding the infant's arms and legs in flexed positions close to the midline of the TORSO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Facilitated Tucking</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060885</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods for using more than one primer set in a polymerase chain reaction to amplify more than one segment of the target DNA sequence in a single reaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multiplex Polymerase Chain Reaction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multiplex PCR</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods for using more than one primer set in a polymerase chain reaction to amplify more than one segment of the target DNA sequence in a single reaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Triplex Polymerase Chain Reaction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Triplex PCR</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060887</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of cell-surface proteins found on ANTIGEN-PRESENTING CELLS. B7 antigens are ligands for specific cell surface receptor subtypes found on T-CELLS. They play an immunomodulatory role by stimulating or inhibiting the T-CELL activation process.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>B7 Antigens</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B-7 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7 Molecules</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7 Costimulatory Molecules</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigen, B7</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7 Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060888</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Real-Time Polymerase Chain Reaction</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Real-Time PCR</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Quantitative Real-Time Polymerase Chain Reaction</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods used for detecting the amplified DNA products from the polymerase chain reaction as they accumulate instead of at the end of the reaction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Kinetic Polymerase Chain Reaction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060889</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A costimulatory receptor that is specific for INDUCIBLE T-CELL CO-STIMULATOR LIGAND. The receptor is associated with a diverse array of immunologically-related effects including the increased synthesis of INTERLEUKIN 10 in REGULATORY T-LYMPHOCYTES and the induction of PERIPHERAL TOLERANCE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inducible T-Cell Co-Stimulator Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD278</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD278 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inducible Co-Stimulator (ICOS)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inducible Costimulator (ICOS)</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inducible T-Cell Co-Stimulator</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Activation-Inducible Lymphocyte Immunomediatory Molecule</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ICOS Inducible T-Cell Co-Stimulator</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060890</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An inhibitory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 PROTEIN. CD274 antigen provides negative signals that control and inhibit T-cell responses and is found at higher than normal levels on tumor cells, suggesting its potential role in TUMOR IMMUNE EVASION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antigens, CD274</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-H1 Immune Costimulatory Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Programmed Cell Death 1 Ligand 1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD274 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PD-L1 Costimulatory Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Programmed Cell Death 1 Ligand 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-H1 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7H1 Immune Costimulatory Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060891</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Multi-step systematic review process used for improving safety by investigation of incidents to find what happened, why it happened, and to determine what can be done to prevent it from happening again.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Root Cause Analysis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060905</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hip deformity in which the femoral neck leans forward resulting in a decrease in the angle between femoral neck and its shaft. It may be congenital often syndromic, acquired, or developmental.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coxa Vara</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Coxa Varus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hip deformity in which the femoral neck leans forward resulting in a decrease in the angle between femoral neck and its shaft. It may be congenital often syndromic, acquired, or developmental.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Developmental Coxa Vara</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Infantile Coxa Vara</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Developmental Coxa Varus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hip deformity in which the femoral neck leans forward resulting in a decrease in the angle between femoral neck and its shaft. It may be congenital often syndromic, acquired, or developmental.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acquired Coxa Vara</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acquired Coxa Varus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hip deformity in which the femoral neck leans forward resulting in a decrease in the angle between femoral neck and its shaft. It may be congenital often syndromic, acquired, or developmental.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Congenital Coxa Vara</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Coxa Vara, Congenital</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Congenital Coxa Varus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060906</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Hip deformity in which the angle between the femoral neck and its shaft is increased. It may be congenital, acquired, or developmental.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Coxa Valga</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Coxa Valgus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hip deformity in which the angle between the femoral neck and its shaft is increased. It may be congenital, acquired, or developmental.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Developmental Coxa Valga</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Developmental Coxa Valgus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hip deformity in which the angle between the femoral neck and its shaft is increased. It may be congenital, acquired, or developmental.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acquired Coxa Valga</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acquired Coxa Valgus</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Hip deformity in which the angle between the femoral neck and its shaft is increased. It may be congenital, acquired, or developmental.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Congenital Coxa Valga</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Congenital Coxa Valgus</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060907</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A B7 antigen subtype that inhibits the costimulation of T-cell activation, proliferation, cytokine production and development of cytotoxicity. The over expression of this protein in a variety of tumor cell types suggests its role in TUMOR IMMUNE EVASION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>V-Set Domain-Containing T-Cell Activation Inhibitor 1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Immune Costimulatory Protein B7-H4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>T-Cell Costimulatory Molecule B7x</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7H4 Immune Costimulatory Protein</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060908</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An inhibitory T CELL receptor that is closely related to CD28 ANTIGEN. It has specificity for CD80 ANTIGEN and CD86 ANTIGEN and acts as a negative regulator of peripheral T cell function. CTLA-4 antigen is believed to play role in inducing PERIPHERAL TOLERANCE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>CTLA-4 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cytotoxic T-Lymphocyte-Associated Antigen 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cytotoxic T-Lymphocyte Antigen 4</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD152</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD152 Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060909</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The combined discipline of psychology and economics that investigates what happens in markets in which some of the agents display human limitations and complications.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Economics, Behavioral</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Behavioral Economics</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060910</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The primordial kidney that develops from the INTERMEDIATE MESODERM in the embryos of vertebrates, and is succeeded by the MESONEPHROS. In higher vertebrates and humans, the pronephros is a vestigial and transient structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pronephros</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pronephroi</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060926</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Payment for a service or for a commodity such as a body part.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Remuneration</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060945</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A B7 antigen that binds specifically to INDUCIBLE T-CELL CO-STIMULATOR PROTEIN on T-CELLS. It provides a costimulatory signal for T-cell proliferation and cytokine secretion.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inducible T-Cell Co-Stimulator Ligand</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-H2 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-H2 Ligand</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-Like Protein Gl50</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-Related Protein-1</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7H2 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD275 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD275</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-Related Protein 1</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060946</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pharmacy services accessed via electronic means.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pharmaceutical Services, Online</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pharmacy Services, Online</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pharmacies, Online</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Online Pharmaceutical Services</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Online Pharmacies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060965</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The process of accumulation of genetic and epigenetic changes over time in individual cells and the effect of the changes on CELL PROLIFERATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clonal Evolution</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The process of accumulation of genetic and epigenetic changes over time in individual cells and the effect of the changes on CELL PROLIFERATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Somatic Evolution</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060966</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>LYMPHOCYTE ACTIVATION by a specific ANTIGEN thus triggering clonal expansion of LYMPHOCYTES already capable of mounting an immune response to the antigen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clonal Selection, Antigen-Mediated</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigen-Mediated Clonal Selection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>LYMPHOCYTE ACTIVATION by a specific ANTIGEN thus triggering clonal expansion of LYMPHOCYTES already capable of mounting an immune response to the antigen.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Clonal Selection Theory</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060985</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Water that emerges to the surface of the earth from underground.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Natural Springs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D060986</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Constructions built to access underground water which will rise to the surface under hydrostatic pressure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Water Wells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Constructions built to access underground water which will rise to the surface under hydrostatic pressure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Artesian Wells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061005</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Inland bodies of standing FRESHWATER usually smaller than LAKES. They can be man-made or natural but there is no universal agreement as to their exact size. Some consider a pond to be a small body of water that is shallow enough for sunlight to reach the bottom.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ponds</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061006</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Recesses in the shore in a large body of water and usually the actual connection between a bay and the ocean.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Bays</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Recesses in the shore in a large body of water and usually the actual connection between a bay and the ocean.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inlets</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061025</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A family of receptors that modulate the activation of T-LYMPHOCYTES by the T-CELL ANTIGEN RECEPTOR. The receptors are responsive to one or more B7 ANTIGENS found on ANTIGEN-PRESENTING CELLS and, depending upon the specific ligand-receptor combination, modulate a variety of T-cell functions such as the rate of clonal expansion, CELL SURVIVAL and cytokine production. Although commonly referred to as costimulatory receptors, some of the receptors have inhibitory effects such as inducing PERIPHERAL TOLERANCE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Costimulatory and Inhibitory T-Cell Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Costimulatory and Inhibitory T-Lymphocyte Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptors, Costimulatory and Inhibitory, T-Lymphocyte</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of receptors that modulate the activation of T-LYMPHOCYTES by the T-CELL ANTIGEN RECEPTOR. The receptors are responsive to one or more B7 ANTIGENS found on ANTIGEN-PRESENTING CELLS and, depending upon the specific ligand-receptor combination, modulate a variety of T-cell functions such as the rate of clonal expansion, CELL SURVIVAL and cytokine production. Although commonly referred to as costimulatory receptors, some of the receptors have inhibitory effects such as inducing PERIPHERAL TOLERANCE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Costimulatory T-Cell Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptors, Costimulatory, T-Lymphocyte</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Costimulatory T-Lymphocyte Receptors</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A family of receptors that modulate the activation of T-LYMPHOCYTES by the T-CELL ANTIGEN RECEPTOR. The receptors are responsive to one or more B7 ANTIGENS found on ANTIGEN-PRESENTING CELLS and, depending upon the specific ligand-receptor combination, modulate a variety of T-cell functions such as the rate of clonal expansion, CELL SURVIVAL and cytokine production. Although commonly referred to as costimulatory receptors, some of the receptors have inhibitory effects such as inducing PERIPHERAL TOLERANCE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Inhibitory T-Cell Receptors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Receptors, Inhibitory, T-Cell</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Inhibitory T-Lymphocyte Receptors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061026</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An inhibitory T-lymphocyte receptor that has specificity for CD274 ANTIGEN and PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN. Signaling by the receptor limits T cell proliferation and INTERFERON GAMMA synthesis. The receptor also may play an essential role in the regulatory pathway that induces PERIPHERAL TOLERANCE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Programmed Cell Death 1 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Programmed Cell Death 1 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PD-1 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PD1 Receptor</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD279</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD279 Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061027</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A costimulatory B7 antigen that has specificity for the T-CELL receptor PROGRAMMED CELL DEATH 1 RECEPTOR. It is closely-related to CD274 antigen; however, its expression is restricted to DENDRITIC CELLS and activated MACROPHAGES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Programmed Cell Death 1 Ligand 2 Protein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PD-L2 Ligand</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-DC Ligand</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>CD273 Antigen</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antigens, CD273</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B7-DC Antigen</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061028</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Specific locations in the body which when stimulated will give rise to sensations or symptoms elsewhere in the body.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trigger Points</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Trigger Point</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Specific locations in the body which when stimulated will give rise to sensations or symptoms elsewhere in the body.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trigger Area</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061046</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Organisms used strategically for their positive or adverse effect on the physiology and/or reproductive health of other species.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biological Control Agents</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061065</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A monomeric unit of polyketides containing adjacent methylene and carbonyl functional groups.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Polyketides</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A monomeric unit of polyketides containing adjacent methylene and carbonyl functional groups.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ketides</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061066</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Study of plant diseases of fungal origin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Pathology</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Phytopathology</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Study of plant diseases of fungal origin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Virology</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Study of plant diseases of fungal origin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant bacteriology</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Study of plant diseases of fungal origin.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Plant Mycology</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061067</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Antibodies, Monoclonal, Humanized</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Antibodies, Humanized</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061085</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Birth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Agenesis of Corpus Callosum</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Corpus Callosum Hypogenesis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Corpus Callosum Dysgenesis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Absence of Corpus Callosum</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Corpus Callosum Agenesis</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Birth defect that results in a partial or complete absence of the CORPUS CALLOSUM. It may be isolated or a part of a syndrome (e.g., AICARDI'S SYNDROME; ACROCALLOSAL SYNDROME; ANDERMANN SYNDROME; and HOLOPROSENCEPHALY). Clinical manifestations include neuromotor skill impairment and INTELLECTUAL DISABILITY of variable severity.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Corpus Callosum Malformation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061086</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A NADP transhydrogenase subtype found in certain types of BACTERIA. This transhydrogenase uses a mechanism that transfers hydrogen to the B side of the NAD(+) or NADP(+) ring structure.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NADP Transhydrogenase, B-Specific</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pyridine Nucleotide Transhydrogenase, B-Specific</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061087</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A NADP transhydrogenase subtype found in certain types of BACTERIA and mammalian MITOCHONDRIA. This transhydrogenase uses a mechanism that can transfer hydrogen to either side, A or B, of the NAD(+) or NADP(+) ring structure. In heart mitochondria, the enzyme is A-specific with respect to NAD(+) and B-specific with respect to NADP(+).</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NADP Transhydrogenase, AB-Specific</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pyridine nucleotide transhydrogenase, AB-Specific</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061088</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Investigative and diagnostic methods and procedures based on the photoacoustic effect, which is the generation of SOUND WAVES from the absorption of ELECTROMAGNETIC RADIATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Photoacoustic Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Photoacoustic Technologies</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optoacoustic Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Optoacoustic Technologies</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061089</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The use of pre-treament imaging modalities to position the patient, delineate the target, and align the beam of radiation to achieve optimal accuracy and reduce radiation damage to surrounding non-target tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radiotherapy, Image-Guided</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The use of pre-treament imaging modalities to position the patient, delineate the target, and align the beam of radiation to achieve optimal accuracy and reduce radiation damage to surrounding non-target tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radiotherapy Target Organ Alignment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Target Organ Alignment, Radiotherapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061105</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A THIOREDOXIN-dependent hydroperoxidase that is localized in the mitochondrial matrix. The enzyme plays a crucial role in protecting mitochondrial components from elevated levels of HYDROGEN PEROXIDE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peroxiredoxin III</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thioredoxin-Dependent Peroxide Reductase, Mitochondrial</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>PRDX3 Peroxidase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mitochondrial Thioredoxin-Dependent Antioxidant Protein SP-22</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Peroxiredoxin 3</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061106</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Mistakes committed in the preparations for radiotherapy, including errors in positioning of patients, alignment radiation beams, or calculation of radiation doses.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Radiotherapy Setup Errors</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061107</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A nucleoside diphosphate kinase subtype that is localized to the intermembrane space of MITOCHONDRIA.  It is believed to play a role in the synthesis of triphosphonucleotides using ATP formed through OXIDATIVE PHOSPHORYLATION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nucleoside Diphosphate Kinase D</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NM23-M4 Nucleoside Diphosphate Kinase</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nucleoside Diphosphate Kinase, Mitochondrial</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061108</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>INTERNET applications such as blogs and virtual worlds used for social communication.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Social Media</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Social Medium</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>INTERNET applications such as blogs and virtual worlds used for social communication.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Web 2.0</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061125</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Those nucleic acid sequences that function as units of heredity which are located within the CHLOROPLAST DNA.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Genes, Chloroplast</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chloroplast Genes</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061145</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Surgery performed to relieve pressure from MICROVESSELS that are located around nerves and are causing NERVE COMPRESSION SYNDROMES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microvascular Decompression Surgery</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Surgery performed to relieve pressure from MICROVESSELS that are located around nerves and are causing NERVE COMPRESSION SYNDROMES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Microvascular Decompression</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061146</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A large family of proteins that have been traditionally classified as the light-harvesting proteins of the photosynthetic reaction complex. Chlorophyll binding proteins are also found in non-photosynthetic settings where they may play a photoprotective role in response to light stress.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chlorophyll Binding Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chlorophyll Protein Complexes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A large family of proteins that have been traditionally classified as the light-harvesting proteins of the photosynthetic reaction complex. Chlorophyll binding proteins are also found in non-photosynthetic settings where they may play a photoprotective role in response to light stress.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fucoxanthin Chlorophyll a-c Binding Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fucoxanthin Chlorophyll Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fucoxanthin Chlorophyll Binding Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A large family of proteins that have been traditionally classified as the light-harvesting proteins of the photosynthetic reaction complex. Chlorophyll binding proteins are also found in non-photosynthetic settings where they may play a photoprotective role in response to light stress.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chlorophyll a-c Binding Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chlorophyll ac-Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A large family of proteins that have been traditionally classified as the light-harvesting proteins of the photosynthetic reaction complex. Chlorophyll binding proteins are also found in non-photosynthetic settings where they may play a photoprotective role in response to light stress.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chlorophyll a Binding Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chlorophyll a-Proteins</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>A large family of proteins that have been traditionally classified as the light-harvesting proteins of the photosynthetic reaction complex. Chlorophyll binding proteins are also found in non-photosynthetic settings where they may play a photoprotective role in response to light stress.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chlorophyll a-b Binding Proteins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chlorophyll ab-Proteins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061147</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The treatment of immune system diseases by deliberate infestation with helminths. This therapy is partly based on the HYGIENE HYPOTHESIS which states that the absence of parasites increases immune dysregulation because of the lack of stimulation of REGULATORY T-CELLS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Therapy with Helminths</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Helminthic Therapy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061148</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The theory that infectious agents, symbiotic microorganisms, and parasites are normal stimulants for the maturation of the immune system toward a balanced immune response. The theory predicts that lack of such stimulation leads to allergies and AUTOIMMUNE DISEASES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hygiene Hypothesis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061149</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An order of very small, fringed-wing INSECTS including many agricultural pests.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Thysanoptera</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Thrips</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061165</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A depression in the lateral angle of the scapula that articulates with the head of the HUMERUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glenoid Cavity</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glenoid Fossa of the Scapula</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061166</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The mechanism, in peripheral lymphoid organs (LYMPH NODES; SPLEEN; TONSILS; and mucosal-associated lymphoid tissue), that prevents mature lymphocytes from reacting to SELF-ANTIGENS. This is accomplished through a variety of means including CLONAL ANERGY and CLONAL DELETION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Peripheral Tolerance</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061167</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The mechanism, in central lymphoid organs (THYMUS; BONE MARROW), that prevents immature lymphocytes from reacting to SELF-ANTIGENS. This is accomplished by CLONAL ANERGY and CLONAL DELETION.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Central Tolerance</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061185</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Procedures to cause the disintegration of THROMBI by physical interventions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mechanical Thrombolysis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mechanical Clot Disruption</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061186</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The act of evacuating BREAST MILK by hand or with a pump.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Breast Milk Expression</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Breastmilk Expression</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The act of evacuating BREAST MILK by hand or with a pump.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Breast Milk Collection</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Breastmilk Collection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The act of evacuating BREAST MILK by hand or with a pump.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Breast Pumping</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061205</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vascular Calcification</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vascular Calcinosis</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061206</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Newly arising secondary tumors so small they are difficult to detect by physical examination or routine imaging techniques.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Neoplasm Micrometastasis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Micrometastasis</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Neoplasm Micrometastases</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Micrometastases, Neoplasm</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Micrometastasis, Neoplasm</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061207</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemical agents that increase the permeability of CELL MEMBRANES to CALCIUM ions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Calcium Ionophores</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061208</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The application, via IMPLANTED ELECTRODES, of short bursts of electrical energy in the radiofrequency range, interspersed with pauses in delivery of the current long enough to dissipate the generated heat and avoid heat-induced tissue necrosis.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pulsed Radiofrequency Treatment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Pulsed Radio Frequency Treatment</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061209</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemical agents that increase the permeability of CELL MEMBRANES to PROTONS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Proton Ionophores</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061210</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemical agents that increase the permeability of CELL MEMBRANES to SODIUM ions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sodium Ionophores</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061212</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Dissociable form of episodic memory involving the ability to execute a future intention. (Campbell's Psychiatric Dictionary, 9th ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Memory, Episodic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Episodic Memory</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Autobiographical Memory</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Dissociable form of episodic memory involving the ability to execute a future intention. (Campbell's Psychiatric Dictionary, 9th ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Memory, Prospective</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Prospective Memory</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061213</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Deaths that occur before LIFE EXPECTANCY is reached within a given population.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Mortality, Premature</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Premature Death</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Premature Mortality</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Death, Premature</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061214</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Efforts to reduce risk, to address and reduce incidents and accidents that may negatively impact healthcare consumers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Patient Safety</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061215</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Beverages consumed as stimulants and tonics. They usually contain a combination of CAFFEINE with other substances such as herbal supplements; VITAMINS; AMINO ACIDS; and sugar or sugar derivatives.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Energy Drinks</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061216</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Chemical agents that increase the permeability of CELL MEMBRANES to POTASSIUM ions.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Potassium Ionophores</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061217</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Services providing counseling and activities that help overweight individuals to attain a more healthy body weight.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Weight Reduction Programs</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Weight Loss Programs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061218</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Depressive Disorder, Treatment-Resistant</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Therapy-Resistant Depression</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Treatment Resistant Depression</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Refractory Depression</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061219</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Olfactory Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve I Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>First Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>First Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic First-Nerve Palsy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>First-Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve I</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, First Cranial Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Olfactory Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Olfactory Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Olfactory Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>First-Nerve Palsy, Traumatic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Olfactory Nerve Contusion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Olfactory Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Olfactory Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061220</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the OCULOMOTOR NERVE. This may result in various eye movement dysfunction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oculomotor Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oculomotor Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oculomotor Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve III Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic Third-Nerve Palsy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Third Cranial Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Third Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Third Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Third-Nerve Palsy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Third-Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Oculomotor Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve III</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the OCULOMOTOR NERVE. This may result in various eye movement dysfunction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oculomotor Nerve Contusion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the OCULOMOTOR NERVE. This may result in various eye movement dysfunction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oculomotor Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the OCULOMOTOR NERVE. This may result in various eye movement dysfunction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oculomotor Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061221</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing.  It is sometimes associated with various dental treatments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trigeminal Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fifth Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fifth Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fifth-Nerve Palsy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fifth-Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Fifth Cranial Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic Fifth-Nerve Palsy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Trigeminal Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Trigeminal Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Trigeminal Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve V Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve V</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing.  It is sometimes associated with various dental treatments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trigeminal Nerve Contusion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing.  It is sometimes associated with various dental treatments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trigeminal Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the TRIGEMINAL NERVE. It may result in extreme pain, abnormal sensation in the areas the nerve innervates on face, jaw, gums and tongue and can cause difficulties with speech and chewing.  It is sometimes associated with various dental treatments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trigeminal Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061222</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the LINGUAL NERVE. It may be a complication following dental treatments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lingual Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lingual Nerve Injury</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the LINGUAL NERVE. It may be a complication following dental treatments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lingual Neuropathy, Traumatic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the LINGUAL NERVE. It may be a complication following dental treatments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lingual Nerve Contusion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the LINGUAL NERVE. It may be a complication following dental treatments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lingual Nerve Transection</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061223</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the VAGUS NERVE. Because the vagus nerve innervates multiple organs, injuries in the nerve fibers may result in any gastrointestinal organ dysfunction downstream of the injury site.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vagus Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve X</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Tenth Cranial Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tenth Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tenth Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tenth-Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic Tenth-Nerve Palsy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vagus Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vagus Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve X Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Tenth-Nerve Palsy, Traumatic</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the VAGUS NERVE. Because the vagus nerve innervates multiple organs, injuries in the nerve fibers may result in any gastrointestinal organ dysfunction downstream of the injury site.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vagus Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the VAGUS NERVE. Because the vagus nerve innervates multiple organs, injuries in the nerve fibers may result in any gastrointestinal organ dysfunction downstream of the injury site.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vagus Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the VAGUS NERVE. Because the vagus nerve innervates multiple organs, injuries in the nerve fibers may result in any gastrointestinal organ dysfunction downstream of the injury site.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vagus Nerve Contusion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061224</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the LARYNGEAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laryngeal Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Laryngeal Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Laryngeal Nerve Trauma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the LARYNGEAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laryngeal Nerve Contusion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the LARYNGEAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laryngeal Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the LARYNGEAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laryngeal Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061226</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the RECURRENT LARYNGEAL NERVE that may result in vocal cord dysfunction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recurrent Laryngeal Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recurrent Laryngeal Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recurrent Laryngeal Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Recurrent Laryngeal Nerve Injury</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the RECURRENT LARYNGEAL NERVE that may result in vocal cord dysfunction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recurrent Laryngeal Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the RECURRENT LARYNGEAL NERVE that may result in vocal cord dysfunction.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Recurrent Laryngeal Nerve Contusion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061227</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the ACCESSORY NERVE. Damage to the nerve may produce weakness in head rotation and shoulder elevation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Accessory Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accessory Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve XI Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eleventh Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eleventh Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eleventh-Nerve Palsy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve XI</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Eleventh Cranial Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal Accessory Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal Accessory Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal Accessory Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic Eleventh-Nerve Palsy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Accessory Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eleventh-Nerve Trauma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the ACCESSORY NERVE. Damage to the nerve may produce weakness in head rotation and shoulder elevation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Accessory Nerve Transection</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal Accessory Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the ACCESSORY NERVE. Damage to the nerve may produce weakness in head rotation and shoulder elevation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Accessory Nerve Avulsion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal Accessory Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the ACCESSORY NERVE. Damage to the nerve may produce weakness in head rotation and shoulder elevation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Accessory Nerve Contusion</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Spinal Accessory Nerve Contusion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061228</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the HYPOGLOSSAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hypoglossal Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hypoglossal Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Hypoglossal Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve XII</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Twelfth Cranial Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Twelfth Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Twelfth Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Twelfth-Nerve Palsy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Twelfth-Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve XII Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic Twelfth-Nerve Palsy</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the HYPOGLOSSAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hypoglossal Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the HYPOGLOSSAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hypoglossal Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the HYPOGLOSSAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hypoglossal Nerve Contusion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061245</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Culture of an isolated organism free from any other associating or comtaminating organisms.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Axenic Culture</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Axenic Cultures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061247</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the TROCHLEAR NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trochlear Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fourth Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fourth Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fourth-Nerve Palsy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Trochlear Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve IV</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Fourth Cranial Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic Fourth-Nerve Palsy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Trochlear Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve IV Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fourth-Nerve Trauma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the TROCHLEAR NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trochlear Nerve Contusion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the TROCHLEAR NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trochlear Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the TROCHLEAR NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Trochlear Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061249</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Methods for cultivation of cells, usually on a large-scale, in a closed system for the purpose of producing cells or cellular products to harvest. The culture is fed with nutrients throughout the process instead of all at once in the beginning.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Batch Cell Culture Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Batch Culture</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Batch Culture Techniques</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Methods for cultivation of cells, usually on a large-scale, in a closed system for the purpose of producing cells or cellular products to harvest. The culture is fed with nutrients throughout the process instead of all at once in the beginning.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fed-Batch Culture Techniques</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fed-Batch Culture</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fed Batch Culture Techniques</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061250</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A group of iron-binding proteins that tightly bind two ferrate ions along with two carbonate ions. They are found in the bodily fluids of vertebrates where they act as transport and storage molecules for iron.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Transferrins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061251</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The initial culturing of cells derived directly from fresh TISSUES.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Primary Cell Culture</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061252</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cells used in COCULTURE TECHNIQUES which support the growth of the other cells in the culture. Feeder cells provide auxillary substances including attachment substrates, nutrients, or other factors that are needed for growth in culture.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Feeder Cells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cells used in COCULTURE TECHNIQUES which support the growth of the other cells in the culture. Feeder cells provide auxillary substances including attachment substrates, nutrients, or other factors that are needed for growth in culture.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Feeder Layer Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Feeder Layer Cell</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Cells used in COCULTURE TECHNIQUES which support the growth of the other cells in the culture. Feeder cells provide auxillary substances including attachment substrates, nutrients, or other factors that are needed for growth in culture.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Feeder Cell Layers</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Feeder Layer</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Feeder Cell</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Feeder Layers</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061265</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An insulin preparation that is designed to provide immediate and long term glycemic control in a single dosage. Biphasic insulin typically contains a mixture of REGULAR INSULIN or SHORT-ACTING INSULIN combined with a LONG-ACTING INSULIN.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Biphasic Insulins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Mixed Insulins</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Biphasic Insulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin Mixtures</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061266</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Insulin derivatives and preparations that are designed to induce a rapid HYPOGLYCEMIC EFFECT.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin, Short-Acting</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin, Rapid-Acting</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061267</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin Aspart</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin B28asp</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin-Aspart</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>B28-Asp-Insulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin, Aspartic Acid(B28)-</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>NovoLog</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>NovoRapid</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Novo Nordisk Brand of Insulin Aspart</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061268</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin Lispro</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>28(B)-Lysine-29(B)-Prolineinsulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>LYSPRO</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin, Lysyl(28B)-Prolyl(28B)-</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lispro</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>28(B)-Lys-29(B)-Pro-Insulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin, Lys(28B)-Pro(29B)-</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Humalog</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eli Lilly brand of Insulin Lispro</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061269</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The ability of bacterial cells to take up exogenous DNA and be genetically transformed by it.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>DNA Transformation Competence</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Competence, DNA Transformation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061270</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An opening or hole in the NASAL SEPTUM that is caused by TRAUMA, injury, drug use, or pathological process.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nasal Septal Perforation</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nasal Septum Perforation</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061271</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A physiologically diverse phylum of acidophilic, gram-negative bacteria found in a wide variety of habitats, but particularly abundant in soils and sediments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acidobacteria</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061285</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the VESTIBULOCOCHLEAR NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vestibulocochlear Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eighth Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eighth Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eighth-Nerve Palsy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vestibulocochlear Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve VIII</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Eighth Cranial Nerve</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic Eighth-Nerve Palsy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Vestibulocochlear Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve VIII Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Eighth-Nerve Trauma</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the VESTIBULOCOCHLEAR NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vestibulocochlear Nerve Contusion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the VESTIBULOCOCHLEAR NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vestibulocochlear Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the VESTIBULOCOCHLEAR NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Vestibulocochlear Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061286</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Measurement of the OSMOLARITY of solutions or BODY FLUIDS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Osmometry</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061287</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Traumatic injuries to the GLOSSOPHARYNGEAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glossopharyngeal Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glossopharyngeal Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Glossopharyngeal Neuropathy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Cranial Nerve IX</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Traumatic Ninth-Nerve Palsy</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ninth Cranial Nerve Injuries</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ninth Cranial Nerve Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ninth-Nerve Palsy, Traumatic</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ninth-Nerve Trauma</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Cranial Nerve IX Injury</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Injury, Ninth Cranial Nerve</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the GLOSSOPHARYNGEAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glossopharyngeal Nerve Contusion</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the GLOSSOPHARYNGEAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glossopharyngeal Nerve Transection</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Traumatic injuries to the GLOSSOPHARYNGEAL NERVE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Glossopharyngeal Nerve Avulsion</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061305</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Radionuclide imaging of the LYMPHATIC SYSTEM.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lymphoscintigraphy</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061306</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of gram-negative bacteria closely related to the BACTEROIDETES. Species have been found in the gastrointestinal tracts of animals, especially termites, though indications are that species are more broadly distributed in other environments.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Fibrobacteres</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061307</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Endothelial cells that line venous vessels of the UMBILICAL CORD.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Human Umbilical Vein Endothelial Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Endothelial Cells, Human Umbilical Vein</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HUVEC Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061325</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Autosomal dominant HEREDITARY CANCER SYNDROME in which a mutation most often in either BRCA1 or BRCA2 is associated with a significantly increased risk for breast and ovarian cancers.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Hereditary Breast and Ovarian Cancer Syndrome</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>HBOC Syndrome</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061326</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A dental health survey developed to evaluate a patient's orthodontic treatment need and priority for orthodontic care. The index is based on an assessment of degree of MALOCCLUSION and the potential aesthetic and dental health benefit of the treatment under consideration.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Index of Orthodontic Treatment Need</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Index for Need of Orthodontic Treatment</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Index of Orthodontic Treatment Needs</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061327</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of gram-negative bacteria containing seven class-level groups from a wide variety of environments. Most members are chemoheterotrophs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Verrucomicrobia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061328</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A phylum of gram-negative bacteria whose members are found in a variety of water habitats as well as animal tissues.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Planctomycetales</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061329</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oil and Gas Fields</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gas Reservoirs</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gas Wells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oil and Gas Reservoirs</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oil Fields</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oil Reservoirs</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oil Wells</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Gas Fields</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Areas of the earth where hydrocarbon deposits of PETROLEUM and/or NATURAL GAS are located.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Oil and Gas Wells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061330</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Types of spiral computed tomography technology in which multiple slices of data are acquired simultaneously improving the resolution over single slice acquisition technology.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Multidetector Computed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multisection Computed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multislice Computed Tomography</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Multidetector-Row Computed Tomography</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061345</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Action taken to reduce susceptibility or exposure to health problems and to detect and treat disease in early stages.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Early Medical Intervention</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061346</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Techniques using a laser to cut away and harvest a specific cell or cluster of cells from a tissue section while viewing it under the microscope.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Laser Capture Microdissection</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061347</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Excusing or pardoning for an offense or release of anger or resentment.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Forgiveness</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061348</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Individuals who are present as a third party during medical encounters such as physical examination by a healthcare professional of an individual of the opposite sex.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Medical Chaperones</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Patient Chaperones</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061349</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Providers of tissues for transplant to non-related individuals.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Unrelated Donors</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Donors, Unrelated</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061350</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>In evolutionary theory, overlapping geographic distribution of diverging species. In sympatric GENETIC SPECIATION, genetic diversion occurs without geographic separation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sympatry</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>In evolutionary theory, overlapping geographic distribution of diverging species. In sympatric GENETIC SPECIATION, genetic diversion occurs without geographic separation.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Sympatric Species</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061351</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Instruments used to observe distant objects.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Telescopes</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Instruments used to observe distant objects.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Binoculars</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061352</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Treatment of food with physical methods such as heat, high pressure, radiation, or electric current to destroy organisms that cause disease or food spoilage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Pasteurization</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Treatment of food with physical methods such as heat, high pressure, radiation, or electric current to destroy organisms that cause disease or food spoilage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Ultrapasteurization</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061353</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Keeping food for later consumption.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Food Storage</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061354</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Cells lining the saclike dilatations known as acini of various glands or the lungs.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Acinar Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acinus Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acinous Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acini Cells</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Acinic Cells</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061365</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An ethnic group with shared religious beliefs. Originating in Switzerland in the late 1600s, and first migrating to the mid-Atlantic, they now live throughout Eastern and Mid-Western United States and elsewhere. Communities are usually close-knit and marriage is within the community.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Amish</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061366</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>The difference in rates of bad outcomes between experimental and control participants in a trial.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Numbers Needed To Treat</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>The difference in rates of bad outcomes between experimental and control participants in a trial.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Absolute Risk Reduction</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061385</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Peptide hormones that cause an increase in the absorption of GLUCOSE by cells within organs such as LIVER, MUSCLE and ADIPOSE TISSUE. During normal metabolism insulins are produced by the PANCREATIC BETA CELLS in response to increased GLUCOSE. Natural and chemically-modified forms of insulin are also used in the treatment of GLUCOSE METABOLISM DISORDERS such as DIABETES MELLITUS.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulins</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061386</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Regular insulin preparations that contain the HUMAN insulin peptide sequence.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin, Regular, Human</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Regular insulin preparations that contain the HUMAN insulin peptide sequence.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Humulin S</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Lilly Brand of Recombinant Human Insulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Humulin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061387</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Pneumonia caused by infections with the genus CHLAMYDiA; and CHLAMYDOPHILA, usually with CHLAMYDOPHILA PNEUMONIAE.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Chlamydial Pneumonia</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Chlamydophila Pneumonia</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061388</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Professional or volunteer members of a fire department who are trained to suppress fire and respond to related emergency.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Firefighters</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fire and Rescue Personnel</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Fire Fighters</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061389</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>Regular insulin preparations that contain the SUS SCROFA insulin peptide sequence.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin, Regular, Pork</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Insulin, Regular, Porcine</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Porcine Insulin</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>Regular insulin preparations that contain the SUS SCROFA insulin peptide sequence.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Velosulin</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nordisk Brand of Porcine Insulin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061405</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin, Lente</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin, Lente, Monocomponent</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin, Monotard</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An insulin, zinc chloride preparation in the form of a suspension of crystals and amorphous material in a ratio of approximately 7:3. Typically, lente insulin has a duration of activity that lasts between 13-20 hours after dosage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin Novo Monotard</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061406</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>A preparation of insulin and zinc chloride in the form of a crystalline suspension. Typically the duration of ultralente insulin activity lasts between 18-30 hours after dosage.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Insulin, Ultralente</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Ultralente Insulin</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061466</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>An antiretroviral drug of the protease inhibitor class used as a fixed-dose combination with RITONAVIR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Lopinavir</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An antiretroviral drug of the protease inhibitor class used as a fixed-dose combination with RITONAVIR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>ABT 378</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>ABT-378</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>An antiretroviral drug of the protease inhibitor class used as a fixed-dose combination with RITONAVIR.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>A-157378.0</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
<DescriptorRecord>
<DescriptorUI>D061485</DescriptorUI>
<LocationList>
</LocationList>
<ConceptList>
<Concept PreferredConceptYN="Y">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Tobacco Use Cessation Products</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nicorette</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nicotine Chewing Gum</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nicotine Inhalant</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Smoking Cessation Products</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nicotine Nasal Spray</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nicotine Patch</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nicotine Transdermal Patch</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nicotine Polacrilex</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nicotine Replacement Products</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Commit</String>
</Term>
</TermList>
</Concept>
<Concept PreferredConceptYN="N">
<ScopeNote>DOSAGE FORMS of NICOTINE designed to deliver nicotine to the body as alternatives to using TOBACCO.</ScopeNote>
<TermList>
<Term ConceptPreferredTermYN="Y">
<String>Nicotine Lozenge</String>
</Term>
<Term ConceptPreferredTermYN="N">
<String>Nicotine Lozenges</String>
</Term>
</TermList>
</Concept>
</ConceptList>
</DescriptorRecord>
</DescriptorRecordSet>